group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00022,1.702755814893283,FUN_000219-T1,Peve_00019412,Pocillopora_meandrina_HIv1___RNAseq.g28928.t1,three_way,64.90866666666666,,,,,,,,,,,,,,,,,
OG_00033,1.113910877755184,FUN_000239-T1,Peve_00033353,Pocillopora_meandrina_HIv1___RNAseq.g28955.t1,three_way,97.61933333333332,FUN_000239-T1,Q2KHT7,,,,,89.3,84.0,1.7e-38,159.5,sp|Q2KHT7|RS27_BOVIN Small ribosomal subunit protein eS27 OS=Bos taurus OX=9913 GN=RPS27 PE=1 SV=3,,,,,,
OG_00047,2.019838483376554,FUN_000283-T1,Peve_00033555,Pocillopora_meandrina_HIv1___RNAseq.g29073.t1,three_way,79.09333333333333,FUN_000283-T1,Q9I8C7,,,,,46.3,322.0,4.6e-86,320.1,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_00069,1.0414267281024714,FUN_000391-T1,Peve_00033595,Pocillopora_meandrina_HIv1___RNAseq.g2525.t1,three_way,47.93233333333333,,,,,,,,,,,,,,,,,
OG_00076,1.0509537101728024,FUN_000401-T1,Peve_00033535,Pocillopora_meandrina_HIv1___RNAseq.13430_t,three_way,67.23816666666667,FUN_000401-T1,Q8TDX6,,,,,40.5,375.0,2.6e-77,291.2,sp|Q8TDX6|CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=CSGALNACT1 PE=1 SV=2,,,,,,
OG_00085,1.1928359646790636,FUN_000433-T1,Peve_00011195,Pocillopora_meandrina_HIv1___RNAseq.g2325.t1,three_way,73.84433333333334,FUN_000433-T1,P26714,,,,,33.7,291.0,2.3e-51,204.9,sp|P26714|GBRB_LYMST Gamma-aminobutyric acid receptor subunit beta OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_00095,1.08739965101574,FUN_000470-T1,Peve_00005610,Pocillopora_meandrina_HIv1___RNAseq.g2424.t1,three_way,78.67266666666667,,,,,,,,,,,,,,,,,
OG_00114,1.0416685724310135,FUN_000531-T1,Peve_00008085,Pocillopora_meandrina_HIv1___RNAseq.g27136.t1,three_way,60.4415,FUN_000531-T1,P22671,,,,,27.0,293.0,3.3e-28,127.5,sp|P22671|OPSD_LETCA Rhodopsin OS=Lethenteron camtschaticum OX=980415 GN=RHO PE=2 SV=1,,,,,,
OG_00115,1.1521602758470593,FUN_000533-T1,Peve_00039811,Pocillopora_meandrina_HIv1___RNAseq.g2384.t1,three_way,81.9405,FUN_000533-T1,P20693,,,,,34.0,147.0,3.6e-17,94.0,sp|P20693|FCER2_MOUSE Low affinity immunoglobulin epsilon Fc receptor OS=Mus musculus OX=10090 GN=Fcer2 PE=1 SV=1,,,,,,
OG_00144,1.4575484643070944,FUN_000586-T1,Peve_00025314,Pocillopora_meandrina_HIv1___TS.g6498.t2,three_way,63.92666666666666,FUN_000586-T1,O00339,MATN2_HUMAN,,Matrilin-2,Homo sapiens (Human),30.2,192.0,2.3e-14,82.4,sp|O00339|MATN2_HUMAN Matrilin-2 OS=Homo sapiens OX=9606 GN=MATN2 PE=1 SV=4,GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_00163,2.1495137666785165,FUN_000637-T1,Peve_00012867,Pocillopora_meandrina_HIv1___RNAseq.g16016.t1,three_way,83.68833333333333,FUN_000637-T1,O97125,,,,,74.2,613.0,9.1e-265,914.1,sp|O97125|HSP68_DROME Heat shock protein 68 OS=Drosophila melanogaster OX=7227 GN=Hsp68 PE=1 SV=1,,,,,,
OG_00179,1.1203548248212378,FUN_000872-T1,Peve_00002057,Pocillopora_meandrina_HIv1___RNAseq.g1815.t1,three_way,56.59033333333333,FUN_000872-T1,Q08288,LYAR_MOUSE,,Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264),Mus musculus (Mouse),40.4,406.0,2.3e-39,164.5,sp|Q08288|LYAR_MOUSE Cell growth-regulating nucleolar protein OS=Mus musculus OX=10090 GN=Lyar PE=1 SV=2,GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008270; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0048821; GO:0050766; GO:0140297; GO:0140416,erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750],DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0048856; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity
OG_00180,1.7019749137787326,FUN_000873-T1,Peve_00002058,Pocillopora_meandrina_HIv1___RNAseq.g1816.t2,three_way,74.32466666666667,FUN_000873-T1,Q8R087,B4GT7_MOUSE,,"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)",Mus musculus (Mouse),61.2,242.0,6.8e-86,318.9,"sp|Q8R087|B4GT7_MOUSE Beta-1,4-galactosyltransferase 7 OS=Mus musculus OX=10090 GN=B4galt7 PE=2 SV=1",GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016020; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435,carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435],Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020],"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]",GO:0003824; GO:0005794; GO:0005975; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00186,1.3568344533573706,FUN_000885-T1,Peve_00029323,Pocillopora_meandrina_HIv1___RNAseq.g29436.t1,three_way,58.51866666666667,,,,,,,,,,,,,,,,,
OG_00188,1.1080844643187282,FUN_000892-T1,Peve_00026758,Pocillopora_meandrina_HIv1___RNAseq.g29444.t1,three_way,81.38833333333334,,,,,,,,,,,,,,,,,
OG_00225,1.995523081680587,FUN_000960-T1,Peve_00021379,Pocillopora_meandrina_HIv1___RNAseq.13437_t,three_way,86.795,FUN_000960-T1,P28271,ACOHC_MOUSE,,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),Mus musculus (Mouse),71.1,869.0,0.0,1303.1,sp|P28271|ACOHC_MOUSE Cytoplasmic aconitate hydratase OS=Mus musculus OX=10090 GN=Aco1 PE=1 SV=3,GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0050892; GO:0051538; GO:0051539,citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]",GO:0003723; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006091; GO:0016829; GO:0022600; GO:0043226; GO:0055086,RNA binding; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; cytosol; generation of precursor metabolites and energy; lyase activity; digestive system process; organelle; nucleobase-containing small molecule metabolic process
OG_00236,1.3644796373410566,FUN_000990-T1,Peve_00022152,Pocillopora_meandrina_HIv1___RNAseq.g29207.t1,three_way,69.63933333333333,,,,,,,,,,,,,,,,,
OG_00259,2.412418122126015,FUN_001028-T1,Peve_00041059,Pocillopora_meandrina_HIv1___RNAseq.g29614.t1,three_way,51.323,,,,,,,,,,,,,,,,,
OG_00274,1.7383381934455675,FUN_001054-T1,Peve_00023871,Pocillopora_meandrina_HIv1___RNAseq.g29645.t1,three_way,68.80666666666667,,,,,,,,,,,,,,,,,
OG_00298,1.4164399415565383,FUN_001089-T1,Peve_00003177,Pocillopora_meandrina_HIv1___RNAseq.g29382.t1,three_way,67.06783333333333,,,,,,,,,,,,,,,,,
OG_00390,1.037504962598509,FUN_001246-T1,Peve_00037027,Pocillopora_meandrina_HIv1___RNAseq.g2298.t1,three_way,69.81466666666667,FUN_001246-T1,Q7LL04,,,,,34.3,297.0,3.9e-30,133.7,sp|Q7LL04|YQK1_SCHPO UPF0676 protein C1494.01 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC1494.01 PE=3 SV=2,,,,,,
OG_00396,1.907147720328111,FUN_001258-T1,Peve_00008780,Pocillopora_meandrina_HIv1___RNAseq.g2178.t1,three_way,48.20666666666666,FUN_001258-T1,F7J220,,,,,29.4,595.0,1.9e-54,216.1,sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1,,,,,,
OG_00408,1.297514970401683,FUN_001298-T1,Peve_00037001,Pocillopora_meandrina_HIv1___RNAseq.g2230.t1,three_way,69.0665,,,,,,,,,,,,,,,,,
OG_00409,1.307719615027489,FUN_001299-T1,Peve_00036999,Pocillopora_meandrina_HIv1___RNAseq.g2232.t1,three_way,50.557,,,,,,,,,,,,,,,,,
OG_00414,1.3305678513192931,FUN_001316-T1,Peve_00036964,Pocillopora_meandrina_HIv1___RNAseq.g2261.t1,three_way,53.97383333333333,FUN_001316-T1,Q8IVL1,,,,,36.1,388.0,7.2e-66,255.0,sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3,,,,,,
OG_00444,1.0634938840208956,FUN_001363-T1,Peve_00005010,Pocillopora_meandrina_HIv1___RNAseq.g2149.t1,three_way,43.592,,,,,,,,,,,,,,,,,
OG_00450,1.1485061976016158,FUN_001370-T2,Peve_00025098,Pocillopora_meandrina_HIv1___RNAseq.g2140.t1,three_way,55.64983333333333,FUN_001370-T2,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),39.1,422.0,6.900000000000001e-67,257.3,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_00453,4.28848213881526,FUN_001377-T1,Peve_00021886,Pocillopora_meandrina_HIv1___RNAseq.g2136.t1,three_way,56.78516666666667,,,,,,,,,,,,,,,,,
OG_00458,1.676023649846552,FUN_001389-T1,Peve_00019355,Pocillopora_meandrina_HIv1___RNAseq.g2126.t1,three_way,44.8,,,,,,,,,,,,,,,,,
OG_00460,1.8222388077580232,FUN_001392-T1,Peve_00019358,Pocillopora_meandrina_HIv1___RNAseq.g2123.t1,three_way,90.084,,,,,,,,,,,,,,,,,
OG_00461,1.210225699077514,FUN_001393-T1,Peve_00019359,Pocillopora_meandrina_HIv1___RNAseq.g2122.t1,three_way,60.874500000000005,,,,,,,,,,,,,,,,,
OG_00467,1.462276653998405,FUN_001403-T1,Peve_00008765,Pocillopora_meandrina_HIv1___RNAseq.g2111.t1,three_way,78.99133333333334,FUN_001403-T1,Q8AYK6,,,,,49.5,509.0,2.5e-117,424.1,sp|Q8AYK6|WEE1A_XENLA Wee1-like protein kinase 1-A OS=Xenopus laevis OX=8355 GN=wee1-a PE=2 SV=1,,,,,,
OG_00483,1.030695628482229,FUN_001447-T1,Peve_00019961,Pocillopora_meandrina_HIv1___RNAseq.g1952.t1,three_way,57.163,FUN_001447-T1,Q61824,,,,,37.3,714.0,8.5e-130,466.5,sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2,,,,,,
OG_00487,1.5708943997506724,FUN_001453-T1,Peve_00018442,Pocillopora_meandrina_HIv1___RNAseq.g1954.t1,three_way,80.51,FUN_001453-T1,Q9UBR2,CATZ_HUMAN,,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),Homo sapiens (Human),61.6,297.0,1.4000000000000005e-111,404.1,sp|Q9UBR2|CATZ_HUMAN Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1,GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0005938; GO:0006508; GO:0008234; GO:0009986; GO:0010757; GO:0016807; GO:0030134; GO:0030426; GO:0031410; GO:0033116; GO:0035580; GO:0043231; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:1904813,angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580],carboxypeptidase activity [GO:0004180]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_00499,4.139131578993609,FUN_001472-T1,Peve_00026259,Pocillopora_meandrina_HIv1___RNAseq.g1911.t1,three_way,72.17666666666666,FUN_001472-T1,Q8VHT6,AS3MT_RAT,,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),Rattus norvegicus (Rat),46.2,366.0,6.1e-86,319.3,sp|Q8VHT6|AS3MT_RAT Arsenite methyltransferase OS=Rattus norvegicus OX=10116 GN=As3mt PE=1 SV=1,GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685,arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404],cytosol [GO:0005829],arsenite methyltransferase activity [GO:0030791]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_00509,1.3173382131209457,FUN_001493-T1,Peve_00002848,Pocillopora_meandrina_HIv1___RNAseq.g1906.t1,three_way,65.069,FUN_001493-T1,Q9NQA5,TRPV5_HUMAN,,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),Homo sapiens (Human),28.2,170.0,3.5e-07,58.9,sp|Q9NQA5|TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens OX=9606 GN=TRPV5 PE=1 SV=3,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809],apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003014; GO:0005215; GO:0005886; GO:0055085; GO:0065003,renal system process; transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_00526,1.2988725941349448,FUN_001530-T1,Peve_00000625,Pocillopora_meandrina_HIv1___RNAseq.g2045.t2,three_way,82.98033333333333,FUN_001530-T1,Q2KIH7,PH4H_BOVIN,,Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase),Bos taurus (Bovine),64.8,423.0,7.6e-165,581.6,sp|Q2KIH7|PH4H_BOVIN Phenylalanine-4-hydroxylase OS=Bos taurus OX=9913 GN=PAH PE=2 SV=1,GO:0004505; GO:0005506; GO:0006559; GO:0006571,L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571],,iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505],GO:0003824; GO:0006520; GO:0016491,catalytic activity; amino acid metabolic process; oxidoreductase activity
OG_00529,1.445072904586851,FUN_001534-T1,Peve_00014191,Pocillopora_meandrina_HIv1___RNAseq.12922_t,three_way,52.932500000000005,FUN_001534-T1,O13024,,,,,52.7,110.0,1.1e-20,104.0,sp|O13024|INCEA_XENLA Inner centromere protein A OS=Xenopus laevis OX=8355 GN=incenp-a PE=1 SV=1,,,,,,
OG_00531,4.705063801529029,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_00547,1.2384730831464017,FUN_001583-T1,Peve_00005423,Pocillopora_meandrina_HIv1___RNAseq.g2035.t1,three_way,72.56533333333333,,,,,,,,,,,,,,,,,
OG_00551,1.2260209554425128,FUN_001592-T1,Peve_00023231,Pocillopora_meandrina_HIv1___RNAseq.g1991.t1,three_way,51.281666666666666,FUN_001592-T1,O35144,TERF2_MOUSE,,Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein),Mus musculus (Mouse),20.8,457.0,4.8e-06,54.3,sp|O35144|TERF2_MOUSE Telomeric repeat-binding factor 2 OS=Mus musculus OX=10090 GN=Terf2 PE=1 SV=3,GO:0000723; GO:0000781; GO:0000782; GO:0001673; GO:0001701; GO:0003691; GO:0003720; GO:0005654; GO:0016233; GO:0016604; GO:0019899; GO:0030424; GO:0031627; GO:0031848; GO:0032206; GO:0032208; GO:0032211; GO:0042162; GO:0042803; GO:0044877; GO:0061820; GO:0070187; GO:0070198; GO:0098505; GO:0099088; GO:1904354; GO:1904430; GO:1905839; GO:2000773,"axonal transport of messenger ribonucleoprotein complex [GO:0099088]; in utero embryonic development [GO:0001701]; negative regulation of cellular senescence [GO:2000773]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomere cap complex [GO:0000782]",double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomerase activity [GO:0003720]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0007018; GO:0016740; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule-based movement; transferase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_00553,1.649234192484537,FUN_001596-T1,Peve_00004147,Pocillopora_meandrina_HIv1___RNAseq.g1984.t1,three_way,49.91966666666666,,,,,,,,,,,,,,,,,
OG_00584,1.1493913422726894,FUN_001657-T1,Peve_00038362,Pocillopora_meandrina_HIv1___RNAseq.g29404.t1,three_way,76.9125,FUN_001657-T1,Q5ZK05,,,,,53.3,276.0,1e-67,258.5,sp|Q5ZK05|TOLIP_CHICK Toll-interacting protein OS=Gallus gallus OX=9031 GN=TOLLIP PE=2 SV=1,,,,,,
OG_00593,1.2535202047655165,FUN_001728-T1,Peve_00007897,Pocillopora_meandrina_HIv1___RNAseq.g2699.t1,three_way,58.2605,,,,,,,,,,,,,,,,,
OG_00603,1.447609874525409,FUN_001764-T1,Peve_00031949,Pocillopora_meandrina_HIv1___RNAseq.g2672.t1,three_way,81.31933333333333,FUN_001764-T1,P49582,,,,,39.7,174.0,3.9e-35,149.8,sp|P49582|ACHA7_MOUSE Neuronal acetylcholine receptor subunit alpha-7 OS=Mus musculus OX=10090 GN=Chrna7 PE=1 SV=1,,,,,,
OG_00605,1.307770405232987,FUN_001766-T1,Peve_00023732,Pocillopora_meandrina_HIv1___RNAseq.g2675.t1,three_way,76.47133333333333,,,,,,,,,,,,,,,,,
OG_00640,1.0947952829790757,FUN_001879-T1,Peve_00030499,Pocillopora_meandrina_HIv1___RNAseq.g2593.t1,three_way,62.20333333333333,FUN_001879-T1,Q6NTR1,,,,,38.1,691.0,1.8e-112,408.3,sp|Q6NTR1|EFNMT_XENLA eEF1A lysine and N-terminal methyltransferase OS=Xenopus laevis OX=8355 GN=mettl13 PE=2 SV=1,,,,,,
OG_00643,4.662314660487231,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_00654,1.6133641833761538,FUN_001940-T1,Peve_00024481,Pocillopora_meandrina_HIv1___RNAseq.20168_t,three_way,77.20733333333334,FUN_001940-T1,Q87PP5,,,,,35.6,547.0,4.6e-98,360.5,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_00660,2.342908587518459,FUN_001952-T1,Peve_00024485,Pocillopora_meandrina_HIv1___RNAseq.g29226.t1,three_way,75.02666666666667,FUN_001952-T1,D3UW23,AMPE_BITRH,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A),Bitis rhinoceros (West African gaboon viper) (Vipera rhinoceros),41.8,928.0,1.4e-203,711.4,sp|D3UW23|AMPE_BITRH Glutamyl aminopeptidase OS=Bitis rhinoceros OX=715877 PE=1 SV=1,GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0042277; GO:0043171; GO:0070006,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_00669,1.7887608162208477,FUN_002034-T1,Peve_00001971,Pocillopora_meandrina_HIv1___RNAseq.g10113.t1,three_way,36.083666666666666,,,,,,,,,,,,,,,,,
OG_00678,1.0816222590028928,FUN_002093-T1,Peve_00004291,Pocillopora_meandrina_HIv1___RNAseq.g1731.t2,three_way,44.53733333333333,,,,,,,,,,,,,,,,,
OG_00717,1.2471803390221958,FUN_002649-T1,Peve_00040095,Pocillopora_meandrina_HIv1___RNAseq.g25705.t1,three_way,67.51933333333334,,,,,,,,,,,,,,,,,
OG_00732,1.2001298022529987,FUN_002698-T1,Peve_00034497,Pocillopora_meandrina_HIv1___RNAseq.g20728.t1,three_way,72.25633333333333,FUN_002698-T1,Q6IRB2,HES1A_XENLA,,Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1),Xenopus laevis (African clawed frog),39.2,245.0,2.4e-26,120.6,sp|Q6IRB2|HES1A_XENLA Transcription factor HES-1-A OS=Xenopus laevis OX=8355 GN=hes1-a PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0043425; GO:0043565; GO:0045665; GO:0045892; GO:0046982; GO:0048635; GO:0050767,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],bHLH transcription factor binding [GO:0043425]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_00746,1.0197570749125917,FUN_002736-T1,Peve_00041437,Pocillopora_meandrina_HIv1___RNAseq.g14951.t1,three_way,65.202,FUN_002736-T1,Q9BXT6,M10L1_HUMAN,,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),Homo sapiens (Human),39.3,1153.0,1.3999999999999999e-221,771.5,sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196,germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; cytosol; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00756,1.0987021084382262,FUN_002871-T1,Peve_00013073,Pocillopora_meandrina_HIv1___TS.g15581.t1,three_way,81.83266666666667,FUN_002871-T1,Q21086,GNL3_CAEEL,,Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1),Caenorhabditis elegans,46.8,457.0,2.7e-109,397.5,sp|Q21086|GNL3_CAEEL Guanine nucleotide-binding protein-like 3 homolog OS=Caenorhabditis elegans OX=6239 GN=nst-1 PE=3 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127,germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_00759,1.1049451673673654,FUN_003165-T1,Peve_00013725,Pocillopora_meandrina_HIv1___RNAseq.g6224.t1,three_way,89.89566666666667,FUN_003165-T1,Q5U4C9,DYRK2_MOUSE,,Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1),Mus musculus (Mouse),67.4,556.0,1.1e-208,727.6,sp|Q5U4C9|DYRK2_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Mus musculus OX=10090 GN=Dyrk2 PE=2 SV=1,GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007224; GO:0030145; GO:0042771; GO:0045725; GO:0070885; GO:0106310; GO:1990904,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; smoothened signaling pathway [GO:0007224],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00770,1.4334366057110874,FUN_003718-T1,Peve_00001366,Pocillopora_meandrina_HIv1___RNAseq.g26671.t1,three_way,75.134,FUN_003718-T1,P37193,,,,,70.1,134.0,2.9999999999999995e-54,213.0,"sp|P37193|ADXH1_DROME Adrenodoxin-like protein 1, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Fdx1 PE=2 SV=3",,,,,,
OG_00800,1.7898172602644964,FUN_003996-T1,Peve_00038453,Pocillopora_meandrina_HIv1___RNAseq.g17200.t1,three_way,59.2325,FUN_003996-T1,P24524,GLRA3_RAT,,Glycine receptor subunit alpha-3,Rattus norvegicus (Rat),27.8,399.0,5.9e-36,153.3,sp|P24524|GLRA3_RAT Glycine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Glra3 PE=1 SV=1,GO:0004888; GO:0005886; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0042734; GO:0043204; GO:0046872; GO:0051260; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099171; GO:0099634; GO:1902476,cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734],extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0005886; GO:0055085; GO:0060089; GO:0065003,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity; protein-containing complex assembly
OG_00805,1.4887923778171082,FUN_004003-T1,Peve_00034340,Pocillopora_meandrina_HIv1___RNAseq.g11702.t1,three_way,76.87066666666666,FUN_004003-T1,O35819,,,,,73.6,106.0,5.5e-11,70.1,sp|O35819|KLF6_RAT Krueppel-like factor 6 OS=Rattus norvegicus OX=10116 GN=Klf6 PE=2 SV=2,,,,,,
OG_00822,1.4353524367221595,FUN_004041-T1,Peve_00003961,Pocillopora_meandrina_HIv1___TS.g18508.t1,three_way,50.96333333333333,FUN_004041-T1,Q9UMZ3,PTPRQ_HUMAN,,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q),Homo sapiens (Human),22.8,219.0,1.7e-06,55.8,sp|Q9UMZ3|PTPRQ_HUMAN Phosphatidylinositol phosphatase PTPRQ OS=Homo sapiens OX=9606 GN=PTPRQ PE=1 SV=2,GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0034485; GO:0043235; GO:0043813; GO:0045598; GO:0050910; GO:0052629; GO:0120044,detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of fat cell differentiation [GO:0045598],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044],"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein tyrosine phosphatase activity [GO:0004725]",GO:0003824; GO:0016787; GO:0050877; GO:0140096,"catalytic activity; hydrolase activity; nervous system process; catalytic activity, acting on a protein"
OG_00829,1.130435685518114,FUN_004060-T1,Peve_00028225,Pocillopora_meandrina_HIv1___RNAseq.g17246.t2,three_way,51.38283333333333,FUN_004060-T1,O97827,,,,,33.2,554.0,1.4000000000000001e-74,282.3,sp|O97827|AGRL3_BOVIN Adhesion G protein-coupled receptor L3 OS=Bos taurus OX=9913 GN=ADGRL3 PE=2 SV=1,,,,,,
OG_00833,1.3216092670546746,FUN_004078-T1,Peve_00006662,Pocillopora_meandrina_HIv1___RNAseq.g17237.t1,three_way,69.94466666666666,FUN_004078-T1,B1AS42,NB5R5_MOUSE,,NADH-cytochrome b5 reductase-like (EC 1.6.2.2),Mus musculus (Mouse),39.5,311.0,9.999999999999999e-64,245.4,sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1,GO:0004128; GO:0005654; GO:0005789,,endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]",GO:0003824; GO:0005654; GO:0016491,catalytic activity; nucleoplasm; oxidoreductase activity
OG_00853,1.1409531833072848,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_00866,1.2589260856202518,FUN_004140-T2,Peve_00009429,Pocillopora_meandrina_HIv1___RNAseq.g11564.t1,three_way,92.6315,FUN_004140-T2,Q07343,PDE4B_HUMAN,,"3',5'-cyclic-AMP phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) (cAMP-specific phosphodiesterase 4B)",Homo sapiens (Human),56.3,551.0,1.1000000000000001e-168,595.1,"sp|Q07343|PDE4B_HUMAN 3',5'-cyclic-AMP phosphodiesterase 4B OS=Homo sapiens OX=9606 GN=PDE4B PE=1 SV=1",GO:0000930; GO:0001780; GO:0004115; GO:0005246; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0008021; GO:0014069; GO:0019933; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0047555; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071466; GO:0071872; GO:0071878; GO:0086004; GO:1901898; GO:1902514,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; leukocyte migration [GO:0050900]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of type II interferon production [GO:0032729]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell contraction [GO:0086004]; T cell receptor signaling pathway [GO:0050852],centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]",GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0055086; GO:0098772; GO:1901135,immune system process; catalytic activity; microtubule organizing center; cytosol; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; nucleobase-containing small molecule metabolic process; molecular function regulator activity; carbohydrate derivative metabolic process
OG_00869,1.490344195602178,FUN_004156-T1,Peve_00031561,Pocillopora_meandrina_HIv1___RNAseq.g16776.t1,three_way,93.97166666666666,FUN_004156-T1,Q5F359,,,,,67.0,188.0,1.2e-68,260.8,sp|Q5F359|TPPC5_CHICK Trafficking protein particle complex subunit 5 OS=Gallus gallus OX=9031 GN=TRAPPC5 PE=2 SV=1,,,,,,
OG_00912,1.2317439184470595,FUN_004246-T1,Peve_00019439,Pocillopora_meandrina_HIv1___RNAseq.g11530.t1,three_way,76.00466666666667,FUN_004246-T1,Q2T9T9,,,,,28.8,393.0,4.6e-38,160.6,sp|Q2T9T9|FBXW9_BOVIN F-box/WD repeat-containing protein 9 OS=Bos taurus OX=9913 GN=FBXW9 PE=2 SV=1,,,,,,
OG_00915,1.078790807545123,FUN_004252-T1,Peve_00001934,Pocillopora_meandrina_HIv1___RNAseq.g11419.t1,three_way,88.62766666666667,FUN_004252-T1,Q96MC6,,,,,67.7,439.0,6.8e-170,598.6,sp|Q96MC6|MF14A_HUMAN Hippocampus abundant transcript 1 protein OS=Homo sapiens OX=9606 GN=MFSD14A PE=1 SV=2,,,,,,
OG_00916,2.112083592356832,FUN_004253-T1,Peve_00001928,Pocillopora_meandrina_HIv1___RNAseq.g11418.t1,three_way,75.71549999999999,FUN_004253-T1,Q9MA55,,,,,30.2,364.0,6e-33,143.7,sp|Q9MA55|ACBP4_ARATH Acyl-CoA-binding domain-containing protein 4 OS=Arabidopsis thaliana OX=3702 GN=ACBP4 PE=1 SV=1,,,,,,
OG_00923,1.1424763594093583,FUN_004265-T1,Peve_00021038,Pocillopora_meandrina_HIv1___RNAseq.g11654.t1,three_way,45.958666666666666,,,,,,,,,,,,,,,,,
OG_00939,1.212733286457378,FUN_004290-T1,Peve_00008387,Pocillopora_meandrina_HIv1___RNAseq.g11768.t1,three_way,59.25366666666667,FUN_004290-T1,P41180,CASR_HUMAN,,Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1),Homo sapiens (Human),28.5,868.0,9.7e-87,323.2,sp|P41180|CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens OX=9606 GN=CASR PE=1 SV=3,GO:0001503; GO:0002931; GO:0004435; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0007635; GO:0008284; GO:0009653; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],"amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]",GO:0003013; GO:0003824; GO:0005886; GO:0016787; GO:0048856; GO:0055085; GO:0060089,circulatory system process; catalytic activity; plasma membrane; hydrolase activity; anatomical structure development; transmembrane transport; molecular transducer activity
OG_00943,1.158230721201959,FUN_004295-T1,Peve_00015845,Pocillopora_meandrina_HIv1___TS.g7893.t1,three_way,62.836666666666666,FUN_004295-T1,O96952,,,,,47.5,101.0,6.5e-21,101.7,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00948,1.317101294997908,FUN_004307-T1,Peve_00033930,Pocillopora_meandrina_HIv1___RNAseq.g11779.t1,three_way,63.568666666666665,FUN_004307-T1,O96952,,,,,51.0,102.0,1.3e-23,111.3,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00957,3.1569201258870647,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_00962,1.0463975971350234,FUN_004331-T1,Peve_00016476,Pocillopora_meandrina_HIv1___TS.g18404.t1,three_way,55.634,FUN_004331-T1,Q9V9S7,,,,,33.4,347.0,5.9e-43,177.9,sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2,,,,,,
OG_00969,1.1199869885195868,FUN_004342-T1,Peve_00016486,Pocillopora_meandrina_HIv1___RNAseq.g12543.t1,three_way,62.193333333333335,FUN_004342-T1,Q9Y5Q9,,,,,36.5,824.0,3.8999999999999996e-142,507.3,sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1,,,,,,
OG_00994,1.0543518844527184,FUN_004402-T1,Peve_00009341,Pocillopora_meandrina_HIv1___TS.g8719.t1,three_way,63.466166666666666,FUN_004402-T1,F4JG10,,,,,38.8,366.0,3.3e-66,254.2,"sp|F4JG10|XYN3_ARATH Endo-1,4-beta-xylanase 3 OS=Arabidopsis thaliana OX=3702 GN=XYN3 PE=2 SV=1",,,,,,
OG_01011,1.0163039488711507,FUN_004438-T1,Peve_00033213,Pocillopora_meandrina_HIv1___RNAseq.g11482.t1,three_way,40.127,,,,,,,,,,,,,,,,,
OG_01013,1.8593095266866897,FUN_004441-T1,Peve_00033211,Pocillopora_meandrina_HIv1___RNAseq.g11480.t1,three_way,74.31,FUN_004441-T1,Q0P5N6,ARL16_HUMAN,,ADP-ribosylation factor-like protein 16,Homo sapiens (Human),43.7,174.0,6.4000000000000005e-28,125.6,sp|Q0P5N6|ARL16_HUMAN ADP-ribosylation factor-like protein 16 OS=Homo sapiens OX=9606 GN=ARL16 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005737,,cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016787,catalytic activity; GTPase activity; hydrolase activity
OG_01019,1.1283467633824251,FUN_004448-T1,Peve_00024324,Pocillopora_meandrina_HIv1___RNAseq.g11247.t1,three_way,61.9365,FUN_004448-T1,Q3UVK0,ERMP1_MOUSE,,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),Mus musculus (Mouse),39.5,837.0,2.0000000000000003e-164,581.3,sp|Q3UVK0|ERMP1_MOUSE Endoplasmic reticulum metallopeptidase 1 OS=Mus musculus OX=10090 GN=Ermp1 PE=1 SV=2,GO:0005789; GO:0006508; GO:0008235; GO:0030968; GO:0034599; GO:0046872,cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508],endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_01031,1.02138796942591,FUN_004466-T1,Peve_00007163,Pocillopora_meandrina_HIv1___RNAseq.g4955.t1,three_way,66.68966666666667,,,,,,,,,,,,,,,,,
OG_01040,1.8670354932594977,FUN_004477-T1,Peve_00033228,Pocillopora_meandrina_HIv1___RNAseq.g4945.t1,three_way,66.27733333333333,FUN_004477-T1,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),27.2,949.0,1.1e-65,253.4,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_01060,1.2876661669772205,FUN_004515-T1,Peve_00044063,Pocillopora_meandrina_HIv1___RNAseq.g11318.t1,three_way,65.01150000000001,FUN_004515-T1,Q9Z1P7,,,,,39.5,253.0,1.3e-45,186.8,sp|Q9Z1P7|KANK3_MOUSE KN motif and ankyrin repeat domain-containing protein 3 OS=Mus musculus OX=10090 GN=Kank3 PE=1 SV=1,,,,,,
OG_01068,2.328086393087547,FUN_004549-T1,Peve_00042944,Pocillopora_meandrina_HIv1___RNAseq.15379_t,three_way,64.58533333333334,FUN_004549-T1,P9WIT2,,,,,20.5,493.0,1.5e-10,69.3,"sp|P9WIT2|GULDH_MYCTO L-gulono-1,4-lactone dehydrogenase OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT1821 PE=3 SV=1",,,,,,
OG_01081,1.007083853095604,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),27.6,757.0,3.2999999999999997e-41,172.6,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01081,1.007083853095604,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),34.8,224.0,3.6e-27,125.9,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01098,1.0628919450942045,FUN_004598-T1,Peve_00012407,Pocillopora_meandrina_HIv1___RNAseq.g6588.t1,three_way,65.93233333333333,,,,,,,,,,,,,,,,,
OG_01116,1.1988527658437775,FUN_004660-T1,Peve_00035113,Pocillopora_meandrina_HIv1___TS.g20469.t1,three_way,89.59433333333334,,,,,,,,,,,,,,,,,
OG_01124,1.4496117533359758,FUN_004693-T1,Peve_00003276,Pocillopora_meandrina_HIv1___RNAseq.g8747.t1,three_way,73.396,,,,,,,,,,,,,,,,,
OG_01127,1.4026560588941934,FUN_004696-T1,Peve_00044673,Pocillopora_meandrina_HIv1___RNAseq.g8775.t1,three_way,45.049,,,,,,,,,,,,,,,,,
OG_01128,1.009200335936599,FUN_004698-T1,Peve_00044677,Pocillopora_meandrina_HIv1___RNAseq.g8778.t1,three_way,56.21066666666667,,,,,,,,,,,,,,,,,
OG_01144,1.0013638472577344,FUN_004736-T1,Peve_00026106,Pocillopora_meandrina_HIv1___RNAseq.g8831.t1,three_way,87.41533333333334,FUN_004736-T1,Q9VWH4,,,,,72.9,332.0,5.9e-139,495.4,"sp|Q9VWH4|IDH3A_DROME Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Idh3a PE=2 SV=1",,,,,,
OG_01155,1.8476685337964085,FUN_004766-T1,Peve_00019319,Pocillopora_meandrina_HIv1___RNAseq.g6698.t2,three_way,68.8935,FUN_004766-T1,Q5R4N8,,,,,40.4,779.0,6.3e-146,519.6,sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1,,,,,,
OG_01164,1.32029483919861,FUN_004784-T1,Peve_00037754,Pocillopora_meandrina_HIv1___RNAseq.g8519.t1,three_way,81.05533333333334,,,,,,,,,,,,,,,,,
OG_01172,1.60676964746428,FUN_004797-T1,Peve_00010271,Pocillopora_meandrina_HIv1___RNAseq.g8564.t1,three_way,55.6755,FUN_004797-T1,Q9DBN1,STR6L_MOUSE,,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),Mus musculus (Mouse),28.0,633.0,1.8e-62,242.3,sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1,GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939,establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],plasma membrane [GO:0005886],retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_01173,1.2172728673660471,FUN_004799-T1,Peve_00027138,Pocillopora_meandrina_HIv1___TS.g20303.t1b,three_way,56.354,FUN_004799-T1,Q9UKP4,ATS7_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-),Homo sapiens (Human),29.2,343.0,6.6e-28,127.9,sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2,GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773,cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0140096; GO:1901135,"catalytic activity; extracellular region; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01178,1.67353421875759,FUN_004817-T1,Peve_00023828,Pocillopora_meandrina_HIv1___RNAseq.g8576.t1,three_way,76.47766666666666,FUN_004817-T1,Q9VIP7,,,,,51.0,257.0,1.2999999999999998e-69,264.6,sp|Q9VIP7|ACASE_DROME Alkaline ceramidase OS=Drosophila melanogaster OX=7227 GN=bwa PE=2 SV=2,,,,,,
OG_01181,1.812445588249148,FUN_004831-T2,Peve_00013711,Pocillopora_meandrina_HIv1___RNAseq.g8583.t1,three_way,66.76283333333333,,,,,,,,,,,,,,,,,
OG_01188,1.5796630855533444,FUN_004841-T1,Peve_00019429,Pocillopora_meandrina_HIv1___RNAseq.g8617.t1,three_way,76.224,FUN_004841-T1,P32297,ACHA3_HUMAN,,Neuronal acetylcholine receptor subunit alpha-3,Homo sapiens (Human),35.1,490.0,2.6e-86,320.9,sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4,GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0043231; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098878; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005730; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; nucleolus; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; signaling; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_01200,1.0848404386911594,FUN_004864-T1,Peve_00043710,Pocillopora_meandrina_HIv1___RNAseq.g8629.t1,three_way,43.367666666666665,,,,,,,,,,,,,,,,,
OG_01207,1.102440425111365,FUN_004880-T1,Peve_00043729,Pocillopora_meandrina_HIv1___RNAseq.g8656.t1,three_way,70.81866666666667,FUN_004880-T1,Q6DFB8,,,,,33.7,1627.0,1.2000000000000001e-223,778.9,sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1,,,,,,
OG_01216,1.0791109487572352,FUN_004897-T1,Peve_00015867,Pocillopora_meandrina_HIv1___RNAseq.g8671.t1,three_way,80.57000000000001,FUN_004897-T1,Q9Y3U8,,,,,63.4,93.0,7.6e-25,114.4,sp|Q9Y3U8|RL36_HUMAN Large ribosomal subunit protein eL36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,,,,,,
OG_01221,1.1344192470412946,FUN_004903-T1,Peve_00028646,Pocillopora_meandrina_HIv1___RNAseq.g8331.t1,three_way,93.306,FUN_004903-T1,A5PK63,,,,,79.9,134.0,9.9e-55,214.2,sp|A5PK63|RS17_BOVIN Small ribosomal subunit protein eS17 OS=Bos taurus OX=9913 GN=RPS17 PE=2 SV=1,,,,,,
OG_01231,1.7007889924675554,FUN_004916-T1,Peve_00044501,Pocillopora_meandrina_HIv1___RNAseq.g8349.t1,three_way,65.203,FUN_004916-T1,Q9BXW7,,,,,43.7,389.0,6.600000000000001e-78,292.7,sp|Q9BXW7|HDHD5_HUMAN Haloacid dehalogenase-like hydrolase domain-containing 5 OS=Homo sapiens OX=9606 GN=HDHD5 PE=1 SV=1,,,,,,
OG_01269,1.2047526799035548,FUN_005037-T1,Peve_00016741,Pocillopora_meandrina_HIv1___RNAseq.g8314.t1,three_way,56.831,FUN_005037-T1,Q6GLK2,THEM4_XENLA,,Acyl-coenzyme A thioesterase THEM4 (Acyl-CoA thioesterase THEM4) (EC 3.1.2.2) (Thioesterase superfamily member 4),Xenopus laevis (African clawed frog),35.5,200.0,5.9e-25,116.3,sp|Q6GLK2|THEM4_XENLA Acyl-coenzyme A thioesterase THEM4 OS=Xenopus laevis OX=8355 GN=them4 PE=2 SV=2,GO:0005743; GO:0005758; GO:0006631; GO:0006915; GO:0016787; GO:0032587,apoptotic process [GO:0006915]; fatty acid metabolic process [GO:0006631],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; ruffle membrane [GO:0032587],hydrolase activity [GO:0016787],GO:0003824; GO:0006629; GO:0012501; GO:0016787,catalytic activity; lipid metabolic process; programmed cell death; hydrolase activity
OG_01270,1.2598692660298116,FUN_005038-T1,Peve_00016739,Pocillopora_meandrina_HIv1___RNAseq.15354_t,three_way,78.13883333333332,FUN_005038-T1,Q568D2,,,,,42.8,304.0,1.8e-61,237.7,sp|Q568D2|CF161_DANRE Cilia- and flagella-associated protein 161 OS=Danio rerio OX=7955 GN=cfap161 PE=2 SV=1,,,,,,
OG_01279,1.7745337617274204,FUN_005059-T2,Peve_00030172,Pocillopora_meandrina_HIv1___TS.g20044.t1,three_way,73.71433333333334,FUN_005059-T2,Q16348,,,,,37.5,704.0,2.9e-116,421.0,sp|Q16348|S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens OX=9606 GN=SLC15A2 PE=1 SV=2,,,,,,
OG_01295,1.1236042152726442,FUN_005120-T1,Peve_00026681,Pocillopora_meandrina_HIv1___TS.g20003.t1,three_way,92.25233333333334,FUN_005120-T1,P37380,,,,,81.6,185.0,9.3e-77,287.7,sp|P37380|RL17_PODCA Large ribosomal subunit protein uL22 OS=Podocoryna carnea OX=6096 GN=RPL17 PE=2 SV=1,,,,,,
OG_01314,1.083870049988614,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_01316,1.0016619813969745,FUN_005181-T1,Peve_00039094,Pocillopora_meandrina_HIv1___RNAseq.g8093.t1,three_way,72.30133333333333,FUN_005181-T1,O81916,,,,,31.0,261.0,3.9000000000000004e-27,123.6,sp|O81916|YC22_ARATH Uncharacterized calcium-binding protein At1g02270 OS=Arabidopsis thaliana OX=3702 GN=At1g02270 PE=2 SV=2,,,,,,
OG_01323,1.1608739021140977,FUN_005193-T1,Peve_00017151,Pocillopora_meandrina_HIv1___RNAseq.g8103.t1,three_way,58.305,FUN_005193-T1,P55249,LX12E_MOUSE,,"Polyunsaturated fatty acid (12S)/(13S)-lipoxygenase, epidermal-type (EC 1.13.11.-) (Arachidonate (12S)-lipoxygenase, epidermal-type) (12-LOX-e) (e(12S)-LOX) (EC 1.13.11.31) (Linoleate (13S)-lipoxygenase)",Mus musculus (Mouse),26.7,484.0,9.5e-28,126.7,"sp|P55249|LX12E_MOUSE Polyunsaturated fatty acid (12S)/(13S)-lipoxygenase, epidermal-type OS=Mus musculus OX=10090 GN=Alox12e PE=1 SV=1",GO:0004052; GO:0005506; GO:0005737; GO:0016165; GO:0019369; GO:0019372; GO:0034440,arachidonate metabolic process [GO:0019369]; lipid oxidation [GO:0034440]; lipoxygenase pathway [GO:0019372],cytoplasm [GO:0005737],arachidonate 12(S)-lipoxygenase activity [GO:0004052]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_01324,4.961010520269613,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
OG_01326,2.0221758740554394,FUN_005202-T1,Peve_00031640,Pocillopora_meandrina_HIv1___TS.g19875.t2,three_way,66.72316666666667,FUN_005202-T1,Q21974,UNC8_CAEEL,,Degenerin unc-8 (Putative ligand-gated sodium channel unc-8) (Uncoordinated protein 8),Caenorhabditis elegans,31.3,393.0,2.7999999999999998e-39,164.9,sp|Q21974|UNC8_CAEEL Degenerin unc-8 OS=Caenorhabditis elegans OX=6239 GN=unc-8 PE=2 SV=1,GO:0005261; GO:0005886; GO:0006812; GO:0015280; GO:0016322; GO:0035725; GO:0040011; GO:0043025,locomotion [GO:0040011]; monoatomic cation transport [GO:0006812]; neuron remodeling [GO:0016322]; sodium ion transmembrane transport [GO:0035725],neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01333,1.5535716524922745,FUN_005230-T1,Peve_00042881,Pocillopora_meandrina_HIv1___RNAseq.g8115.t1,three_way,67.631,FUN_005230-T1,Q8C9M2,,,,,67.3,49.0,1.1e-13,79.7,sp|Q8C9M2|CCD15_MOUSE Coiled-coil domain-containing protein 15 OS=Mus musculus OX=10090 GN=Ccdc15 PE=2 SV=2,,,,,,
OG_01353,1.7678315479427449,FUN_005265-T1,Peve_00003353,Pocillopora_meandrina_HIv1___RNAseq.g8152.t1,three_way,57.54216666666667,FUN_005265-T1,Q8BH97,RCN3_MOUSE,,Reticulocalbin-3,Mus musculus (Mouse),34.2,149.0,1.2e-11,72.0,sp|Q8BH97|RCN3_MOUSE Reticulocalbin-3 OS=Mus musculus OX=10090 GN=Rcn3 PE=1 SV=1,GO:0005509; GO:0005783; GO:0005788; GO:0009306; GO:0010952; GO:0015031; GO:0032964; GO:0036503; GO:0043129; GO:0051896; GO:0055091; GO:0060428,collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; surfactant homeostasis [GO:0043129],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509],GO:0005783; GO:0030163; GO:0043226; GO:0048856,endoplasmic reticulum; protein catabolic process; organelle; anatomical structure development
OG_01354,1.34242963275066,FUN_005267-T1,Peve_00003352,Pocillopora_meandrina_HIv1___RNAseq.g8154.t1,three_way,58.39033333333333,FUN_005267-T1,B5X4E0,,,,,38.4,289.0,2.6000000000000003e-44,180.6,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_01364,1.310909051692286,FUN_005307-T1,Peve_00003314,Pocillopora_meandrina_HIv1___RNAseq.g8172.t1,three_way,66.42383333333333,FUN_005307-T1,A7YSY2,AFG2B_BOVIN,,ATPase family gene 2 protein homolog B (EC 3.6.4.10) (AFG2 AAA ATPase homolog B) (Ribosome biogenesis protein SPATA5L1) (Spermatogenesis-associated protein 5-like protein 1),Bos taurus (Bovine),41.4,789.0,4.1000000000000005e-161,570.1,sp|A7YSY2|AFG2B_BOVIN ATPase family gene 2 protein homolog B OS=Bos taurus OX=9913 GN=AFG2B PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0016887; GO:0030970; GO:0031593; GO:0034098; GO:0042273; GO:0042802; GO:0043161; GO:0051228; GO:0097352; GO:1990275,"autophagosome maturation [GO:0097352]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ribosomal large subunit biogenesis [GO:0042273]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0007010; GO:0016787; GO:0030163; GO:0043226,catalytic activity; nucleus; cytosol; intracellular protein transport; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle
OG_01372,1.0625672601200675,FUN_005322-T1,Peve_00003306,Pocillopora_meandrina_HIv1___RNAseq.g8184.t1,three_way,57.38966666666666,FUN_005322-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),52.9,136.0,2.7999999999999998e-39,164.9,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01372,1.0625672601200675,FUN_005322-T1,Peve_00003306,Pocillopora_meandrina_HIv1___RNAseq.g8184.t1,three_way,57.38966666666666,FUN_005322-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),38.1,63.0,8.4e-07,57.0,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01399,1.2860026544329086,FUN_005387-T1,Peve_00044223,Pocillopora_meandrina_HIv1___RNAseq.g6614.t1,three_way,86.572,FUN_005387-T1,Q32LQ4,,,,,68.3,262.0,1.9e-105,384.0,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_01403,1.430522489048315,FUN_005467-T1,Peve_00002034,Pocillopora_meandrina_HIv1___TS.g362.t1,three_way,65.028,FUN_005467-T1,Q25197,,,,,37.8,1370.0,2.5e-238,827.4,sp|Q25197|HTK7_HYDVU Putative insulin-like peptide receptor OS=Hydra vulgaris OX=6087 GN=HTK7 PE=2 SV=1,,,,,,
OG_01418,1.1007408198885225,FUN_005725-T1,Peve_00039545,Pocillopora_meandrina_HIv1___RNAseq.g19424.t1,three_way,40.257666666666665,,,,,,,,,,,,,,,,,
OG_01484,1.2523995609672092,FUN_006118-T1,Peve_00011316,Pocillopora_meandrina_HIv1___RNAseq.g20403.t1,three_way,34.93533333333333,,,,,,,,,,,,,,,,,
OG_01487,1.1519424828955918,FUN_006163-T1,Peve_00023605,Pocillopora_meandrina_HIv1___RNAseq.g20424.t1,three_way,83.34083333333334,FUN_006163-T1,Q8NI27,,,,,59.9,1202.0,0.0,1382.1,sp|Q8NI27|THOC2_HUMAN THO complex subunit 2 OS=Homo sapiens OX=9606 GN=THOC2 PE=1 SV=2,,,,,,
OG_01492,1.318656763329995,FUN_006168-T1,Peve_00021029,Pocillopora_meandrina_HIv1___RNAseq.g20428.t1,three_way,70.18666666666667,FUN_006168-T1,Q07G10,,,,,42.8,661.0,8.4e-152,538.9,sp|Q07G10|ALKB8_XENTR tRNA (carboxymethyluridine(34)-5-O)-methyltransferase alkbh8 OS=Xenopus tropicalis OX=8364 GN=alkbh8 PE=2 SV=2,,,,,,
OG_01494,1.5977539831649452,FUN_006172-T1,Peve_00028675,Pocillopora_meandrina_HIv1___RNAseq.g20432.t1,three_way,61.756,FUN_006172-T1,Q9QXG2,,,,,42.3,684.0,1.2000000000000002e-124,448.7,sp|Q9QXG2|RAE1_MOUSE Rab proteins geranylgeranyltransferase component A 1 OS=Mus musculus OX=10090 GN=Chm PE=1 SV=1,,,,,,
OG_01501,1.0154310965836524,FUN_006227-T1,Peve_00002943,Pocillopora_meandrina_HIv1___TS.g29772.t1,three_way,66.25183333333334,FUN_006227-T1,P49793,,,,,37.4,1753.0,1.3e-226,788.9,sp|P49793|NUP98_RAT Nuclear pore complex protein Nup98-Nup96 OS=Rattus norvegicus OX=10116 GN=Nup98 PE=1 SV=2,,,,,,
OG_01504,1.1492418843068049,FUN_006236-T1,Peve_00011453,Pocillopora_meandrina_HIv1___RNAseq.g20448.t1,three_way,65.54733333333333,,,,,,,,,,,,,,,,,
OG_01521,1.2809165926702968,FUN_006275-T1,Peve_00019725,Pocillopora_meandrina_HIv1___RNAseq.g20370.t1,three_way,75.4355,FUN_006275-T1,Q8R3S6,,,,,43.7,924.0,1.3e-200,701.4,sp|Q8R3S6|EXOC1_MOUSE Exocyst complex component 1 OS=Mus musculus OX=10090 GN=Exoc1 PE=1 SV=4,,,,,,
OG_01556,1.3526553224158675,FUN_006436-T1,Peve_00024930,Pocillopora_meandrina_HIv1___RNAseq.g20293.t1,three_way,69.03933333333335,FUN_006436-T1,Q8BW70,,,,,34.7,1038.0,8.4e-156,552.7,sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2,,,,,,
OG_01564,1.982182394852992,FUN_006446-T2,Peve_00038423,Pocillopora_meandrina_HIv1___RNAseq.g20305.t1,three_way,34.80533333333334,,,,,,,,,,,,,,,,,
OG_01580,1.0107451462204782,FUN_006614-T1,Peve_00040860,Pocillopora_meandrina_HIv1___RNAseq.g20509.t1,three_way,66.381,FUN_006614-T1,Q5SSI6,,,,,41.4,493.0,2.2e-97,357.8,sp|Q5SSI6|UTP18_MOUSE U3 small nucleolar RNA-associated protein 18 homolog OS=Mus musculus OX=10090 GN=Utp18 PE=1 SV=1,,,,,,
OG_01605,1.1149986360307589,FUN_006649-T1,Peve_00029032,Pocillopora_meandrina_HIv1___RNAseq.g19952.t1,three_way,81.72066666666667,FUN_006649-T1,Q9W7L4,,,,,61.3,333.0,1.2e-117,424.5,sp|Q9W7L4|LDHB_SCEUN L-lactate dehydrogenase B chain OS=Sceloporus undulatus OX=8520 GN=LDHB PE=2 SV=3,,,,,,
OG_01606,1.3030747010048178,FUN_006650-T1,Peve_00029034,Pocillopora_meandrina_HIv1___RNAseq.g19953.t1,three_way,78.253,FUN_006650-T1,Q9UI36,DACH1_HUMAN,,Dachshund homolog 1 (Dach1),Homo sapiens (Human),27.6,479.0,9.2e-19,96.7,sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_01617,1.319240610292738,FUN_006726-T1,Peve_00039553,Pocillopora_meandrina_HIv1___RNAseq.g20012.t1,three_way,75.165,FUN_006726-T1,O75976,,,,,54.5,404.0,2.8999999999999996e-127,457.2,sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2,,,,,,
OG_01628,1.2169394075743754,FUN_006742-T1,Peve_00039577,Pocillopora_meandrina_HIv1___RNAseq.g20528.t1,three_way,72.99733333333333,FUN_006742-T1,A6QLE6,ANO4_BOVIN,,Anoctamin-4 (Transmembrane protein 16D),Bos taurus (Bovine),30.5,846.0,4e-91,337.8,sp|A6QLE6|ANO4_BOVIN Anoctamin-4 OS=Bos taurus OX=9913 GN=ANO4 PE=2 SV=1,GO:0005229; GO:0005886; GO:0006869; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869],plasma membrane [GO:0005886],intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01639,1.580488528092694,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,35.5,262.0,1.3000000000000001e-30,136.3,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_01639,1.580488528092694,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,54.2,72.0,2.9e-14,82.0,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_01647,1.0094799188533627,FUN_006799-T1,Peve_00019091,Pocillopora_meandrina_HIv1___RNAseq.g20493.t1,three_way,63.5435,FUN_006799-T1,O08623,SQSTM_RAT,,Sequestosome-1 (Protein kinase C-zeta-interacting protein) (PKC-zeta-interacting protein) (Ubiquitin-binding protein p62),Rattus norvegicus (Rat),22.9,462.0,1.0999999999999998e-24,115.9,sp|O08623|SQSTM_RAT Sequestosome-1 OS=Rattus norvegicus OX=10116 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0005080; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0033554; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0045202; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140313; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; cellular response to stress [GO:0033554]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; inclusion body [GO:0016234]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; synapse [GO:0045202],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; molecular sequestering activity [GO:0140313]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; molecular sequestering activity
OG_01659,1.5432268291753473,FUN_006830-T1,Peve_00023775,Pocillopora_meandrina_HIv1___RNAseq.g20471.t1,three_way,73.49133333333333,FUN_006830-T1,Q9U637,,,,,37.9,198.0,7.3e-17,89.0,sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1,,,,,,
OG_01667,1.1868510083796855,FUN_006852-T1,Peve_00042993,Pocillopora_meandrina_HIv1___RNAseq.g20241.t1,three_way,74.726,,,,,,,,,,,,,,,,,
OG_01674,1.5927738186414893,FUN_006869-T2,Peve_00039239,Pocillopora_meandrina_HIv1___RNAseq.g19796.t1,three_way,64.51466666666667,FUN_006869-T2,P00530,,,,,25.6,437.0,2e-18,96.7,sp|P00530|FPS_FUJSV Tyrosine-protein kinase transforming protein Fps OS=Fujinami sarcoma virus OX=11885 GN=V-FPS PE=3 SV=1,,,,,,
OG_01704,2.082758606267485,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_01709,1.2468530631320571,FUN_006982-T1,Peve_00045260,Pocillopora_meandrina_HIv1___TS.g29608.t2b,three_way,78.57366666666667,FUN_006982-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),44.9,187.0,1.9e-40,167.5,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01722,1.8937941128662368,FUN_007010-T2,Peve_00021640,Pocillopora_meandrina_HIv1___RNAseq.g20536.t1,three_way,59.11533333333334,FUN_007010-T2,Q7TS74,CKP2L_MOUSE,,Cytoskeleton-associated protein 2-like (Radial fiber and mitotic spindle protein) (Radmis),Mus musculus (Mouse),26.1,326.0,2e-10,68.9,sp|Q7TS74|CKP2L_MOUSE Cytoskeleton-associated protein 2-like OS=Mus musculus OX=10090 GN=Ckap2l PE=1 SV=1,GO:0000922; GO:0005813; GO:0005829; GO:0005929; GO:0072686,,centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922],,GO:0005815; GO:0005829; GO:0005929; GO:0043226,microtubule organizing center; cytosol; cilium; organelle
OG_01746,1.3256177116394672,FUN_007072-T2,Peve_00019898,Pocillopora_meandrina_HIv1___RNAseq.g20086.t1,three_way,53.24433333333334,FUN_007072-T2,B1AT66,MOT7_MOUSE,,Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6),Mus musculus (Mouse),24.3,202.0,2.2e-15,85.1,sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1,GO:0005368; GO:0016323,,basolateral plasma membrane [GO:0016323],taurine transmembrane transporter activity [GO:0005368],GO:0005215,transporter activity
OG_01759,1.6211905550728778,FUN_007111-T1,Peve_00017835,Pocillopora_meandrina_HIv1___RNAseq.g19017.t1,three_way,39.03566666666666,,,,,,,,,,,,,,,,,
OG_01784,1.6022844012036728,FUN_007160-T1,Peve_00028234,Pocillopora_meandrina_HIv1___RNAseq.g19727.t1,three_way,78.381,FUN_007160-T1,Q9JMD3,STA10_MOUSE,,START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10),Mus musculus (Mouse),43.5,237.0,4.3e-54,213.0,sp|Q9JMD3|STA10_MOUSE START domain-containing protein 10 OS=Mus musculus OX=10090 GN=Stard10 PE=1 SV=1,GO:0005829; GO:0005902; GO:0006869; GO:0008289; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581,bile acid secretion [GO:0032782]; lipid transport [GO:0006869]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226,cytosol; cilium; lipid binding; organelle
OG_01792,1.3540318040022687,FUN_007172-T1,Peve_00019754,Pocillopora_meandrina_HIv1___RNAseq.g19765.t1b,three_way,69.35266666666666,FUN_007172-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),43.9,1072.0,5.8e-264,912.1,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_01798,1.1761214623904752,FUN_007183-T1,Peve_00017407,Pocillopora_meandrina_HIv1___RNAseq.g19787.t1,three_way,70.00833333333333,FUN_007183-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),45.2,1072.0,3.400000000000001e-277,956.1,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_01822,1.3610396428981708,FUN_007695-T1,Peve_00026597,Pocillopora_meandrina_HIv1___RNAseq.g18003.t1,three_way,72.62466666666667,,,,,,,,,,,,,,,,,
OG_01829,2.339556979967265,FUN_007725-T1,Peve_00023369,Pocillopora_meandrina_HIv1___RNAseq.g15954.t1,three_way,47.985,,,,,,,,,,,,,,,,,
OG_01832,1.0529179326724876,FUN_007748-T1,Peve_00033175,Pocillopora_meandrina_HIv1___RNAseq.g5860.t1,three_way,75.091,FUN_007748-T1,Q5ZKL5,,,,,33.3,672.0,1.5e-98,362.1,sp|Q5ZKL5|PPCEL_CHICK Prolyl endopeptidase-like OS=Gallus gallus OX=9031 GN=PREPL PE=2 SV=1,,,,,,
OG_01921,1.1826168046184982,FUN_007951-T1,Peve_00039191,Pocillopora_meandrina_HIv1___RNAseq.g30068.t1,three_way,75.82233333333333,,,,,,,,,,,,,,,,,
OG_01924,1.5718511746889734,FUN_007960-T1,Peve_00039187,Pocillopora_meandrina_HIv1___RNAseq.g30071.t1,three_way,67.50933333333333,,,,,,,,,,,,,,,,,
OG_01957,2.0183909356105576,FUN_008025-T1,Peve_00011341,Pocillopora_meandrina_HIv1___RNAseq.g30350.t1,three_way,62.04266666666667,,,,,,,,,,,,,,,,,
OG_02009,1.4050977315390043,FUN_008125-T1,Peve_00037858,Pocillopora_meandrina_HIv1___TS.g22275.t2,three_way,83.81533333333334,FUN_008125-T1,I0IUP3,,,,,59.4,783.0,9.4e-262,904.4,sp|I0IUP3|MCM8_CHICK DNA helicase MCM8 OS=Gallus gallus OX=9031 GN=MCM8 PE=1 SV=1,,,,,,
OG_02025,1.1818637449008669,FUN_008215-T1,Peve_00005269,Pocillopora_meandrina_HIv1___RNAseq.g30184.t1,three_way,71.14333333333333,FUN_008215-T1,Q8VCX6,,,,,42.6,394.0,6.2e-84,312.8,sp|Q8VCX6|KPTN_MOUSE KICSTOR complex protein kaptin OS=Mus musculus OX=10090 GN=Kptn PE=2 SV=1,,,,,,
OG_02030,1.0332055817441046,FUN_008231-T1,Peve_00039954,Pocillopora_meandrina_HIv1___TS.g22494.t1,three_way,70.35033333333334,,,,,,,,,,,,,,,,,
OG_02033,1.221509658639362,FUN_008234-T1,Peve_00039959,Pocillopora_meandrina_HIv1___TS.g20911.t1b,three_way,72.315,,,,,,,,,,,,,,,,,
OG_02065,1.000753982130845,FUN_008279-T1,Peve_00001967,Pocillopora_meandrina_HIv1___RNAseq.g17987.t1,three_way,61.07833333333333,FUN_008279-T1,Q8TDX7,NEK7_HUMAN,,Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),Homo sapiens (Human),27.6,250.0,2e-22,108.2,sp|Q8TDX7|NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1,GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032206; GO:0035865; GO:0046872; GO:0051225; GO:0106310; GO:0140677; GO:1900227,cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02070,1.7520286902143936,FUN_008285-T1,Peve_00015340,Pocillopora_meandrina_HIv1___RNAseq.g17924.t1,three_way,57.32183333333333,FUN_008285-T1,Q9Z2I4,,,,,29.1,268.0,6.6e-24,114.0,sp|Q9Z2I4|ROBO3_MOUSE Roundabout homolog 3 OS=Mus musculus OX=10090 GN=Robo3 PE=1 SV=3,,,,,,
OG_02076,1.1462622799445483,FUN_008293-T1,Peve_00012969,Pocillopora_meandrina_HIv1___RNAseq.g18016.t1,three_way,83.616,FUN_008293-T1,Q88S50,,,,,29.2,113.0,2.7e-09,63.2,sp|Q88S50|RHAM_LACPL L-rhamnose mutarotase OS=Lactiplantibacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1) OX=220668 GN=rhaM PE=3 SV=1,,,,,,
OG_02118,1.1043817125409887,FUN_008403-T1,Peve_00001052,Pocillopora_meandrina_HIv1___RNAseq.g18035.t1,three_way,75.79083333333332,FUN_008403-T1,Q9U518,,,,,39.1,594.0,1.1e-117,425.6,sp|Q9U518|ASPG_DIRIM L-asparaginase OS=Dirofilaria immitis OX=6287 PE=1 SV=1,,,,,,
OG_02119,1.219116107175118,FUN_008404-T1,Peve_00031485,Pocillopora_meandrina_HIv1___RNAseq.g18034.t1,three_way,63.198,,,,,,,,,,,,,,,,,
OG_02128,1.2622429293283233,FUN_008428-T1,Peve_00009801,Pocillopora_meandrina_HIv1___RNAseq.g18051.t1,three_way,69.97866666666667,FUN_008428-T1,Q9NQT4,EXOS5_HUMAN,,Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B),Homo sapiens (Human),41.1,202.0,7.2e-36,151.8,sp|Q9NQT4|EXOS5_HUMAN Exosome complex component RRP46 OS=Homo sapiens OX=9606 GN=EXOSC5 PE=1 SV=1,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000791; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0006402; GO:0016075; GO:0034475; GO:0045006; GO:0051607; GO:0071028; GO:0071051; GO:0101019,defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_02137,1.2039356368839431,FUN_008443-T1,Peve_00024979,Pocillopora_meandrina_HIv1___TS.g21051.t1,three_way,76.96133333333333,FUN_008443-T1,P82458,TRI18_RAT,,E3 ubiquitin-protein ligase Midline-1 (EC 2.3.2.27) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18),Rattus norvegicus (Rat),28.6,704.0,1.1e-67,260.4,sp|P82458|TRI18_RAT E3 ubiquitin-protein ligase Midline-1 OS=Rattus norvegicus OX=10116 GN=Mid1 PE=2 SV=1,GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005881; GO:0007026; GO:0008017; GO:0008270; GO:0015630; GO:0016740; GO:0019899; GO:0031625; GO:0032874; GO:0034451; GO:0035372; GO:0042802; GO:0042803; GO:0051219; GO:0070507,negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]; regulation of microtubule cytoskeleton organization [GO:0070507],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle
OG_02152,1.5593420255706696,FUN_008479-T1,Peve_00028798,Pocillopora_meandrina_HIv1___RNAseq.g30398.t1,three_way,78.626,FUN_008479-T1,Q21279,,,,,37.7,459.0,7.099999999999999e-90,332.8,sp|Q21279|TTL15_CAEEL Probable tubulin polyglutamylase ttll-15 OS=Caenorhabditis elegans OX=6239 GN=ttll-15 PE=2 SV=3,,,,,,
OG_02154,1.2542074777321963,FUN_008484-T2,Peve_00028794,Pocillopora_meandrina_HIv1___RNAseq.g30394.t1,three_way,58.80383333333334,FUN_008484-T2,Q8BK35,NOP53_MOUSE,,Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (PreS1-binding protein),Mus musculus (Mouse),34.6,448.0,5.4e-35,150.2,sp|Q8BK35|NOP53_MOUSE Ribosome biogenesis protein NOP53 OS=Mus musculus OX=10090 GN=Nop53 PE=1 SV=1,GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0007095; GO:0008097; GO:0031333; GO:0032435; GO:0032436; GO:0033553; GO:0039535; GO:0042802; GO:0042981; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173,cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; ribosomal large subunit assembly [GO:0000027],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553],5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006355; GO:0043226; GO:0065003,RNA binding; nucleoplasm; nucleolus; cytosol; DNA repair; regulation of DNA-templated transcription; organelle; protein-containing complex assembly
OG_02163,2.0742202439249477,FUN_008499-T1,Peve_00010577,Pocillopora_meandrina_HIv1___RNAseq.g5887.t1,three_way,57.13483333333333,FUN_008499-T1,Q06194,FA8_MOUSE,,Coagulation factor VIII (Procoagulant component),Mus musculus (Mouse),39.2,153.0,3.6e-26,122.9,sp|Q06194|FA8_MOUSE Coagulation factor VIII OS=Mus musculus OX=10090 GN=F8 PE=2 SV=2,GO:0005507; GO:0005576; GO:0006953; GO:0007596; GO:0016491,acute-phase response [GO:0006953]; blood coagulation [GO:0007596],extracellular region [GO:0005576],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005576; GO:0006954; GO:0016491,catalytic activity; extracellular region; inflammatory response; oxidoreductase activity
OG_02164,1.2679895815687832,FUN_008512-T1,Peve_00000372,Pocillopora_meandrina_HIv1___RNAseq.g425.t1,three_way,73.32933333333334,FUN_008512-T1,P51955,NEK2_HUMAN,,Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1),Homo sapiens (Human),69.3,270.0,6e-113,409.1,sp|P51955|NEK2_HUMAN Serine/threonine-protein kinase Nek2 OS=Homo sapiens OX=9606 GN=NEK2 PE=1 SV=1,GO:0000278; GO:0000776; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0006468; GO:0007059; GO:0007088; GO:0019903; GO:0030496; GO:0032206; GO:0032991; GO:0036064; GO:0045171; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051988; GO:0090307; GO:0106310; GO:1903126,blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; positive regulation of telomere maintenance [GO:0032206]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000228; GO:0000278; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"nuclear chromosome; mitotic cell cycle; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02186,2.1141839780631715,FUN_008540-T1,Peve_00014611,Pocillopora_meandrina_HIv1___RNAseq.g14661.t1,three_way,66.877,FUN_008540-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),40.3,295.0,2.3e-52,210.3,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_02187,1.958906165451067,FUN_008541-T1,Peve_00026391,Pocillopora_meandrina_HIv1___RNAseq.g6362.t1,three_way,76.138,,,,,,,,,,,,,,,,,
OG_02197,1.554856741511662,FUN_008561-T1,Peve_00044734,Pocillopora_meandrina_HIv1___RNAseq.g70.t1,three_way,79.849,FUN_008561-T1,Q07646,,,,,48.7,318.0,3.7e-84,313.2,sp|Q07646|MEST_MOUSE Mesoderm-specific transcript protein OS=Mus musculus OX=10090 GN=Mest PE=2 SV=1,,,,,,
OG_02210,1.0128833684623186,FUN_008586-T1,Peve_00028409,Pocillopora_meandrina_HIv1___RNAseq.g12772.t1,three_way,68.07300000000001,FUN_008586-T1,Q8K0U4,,,,,37.4,623.0,1.5e-107,391.7,sp|Q8K0U4|HS12A_MOUSE Heat shock 70 kDa protein 12A OS=Mus musculus OX=10090 GN=Hspa12a PE=1 SV=1,,,,,,
OG_02255,1.168757225392291,FUN_008701-T1,Peve_00034980,Pocillopora_meandrina_HIv1___RNAseq.g25726.t1,three_way,81.37066666666666,FUN_008701-T1,Q925U4,,,,,59.6,530.0,3.8e-185,649.4,sp|Q925U4|EDEM1_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 1 OS=Mus musculus OX=10090 GN=Edem1 PE=1 SV=1,,,,,,
OG_02257,2.462837497472662,FUN_008703-T1,Peve_00034982,Pocillopora_meandrina_HIv1___RNAseq.g25724.t1,three_way,65.04466666666667,FUN_008703-T1,Q4R684,,,,,36.8,288.0,1.1e-45,185.3,sp|Q4R684|AMZ2_MACFA Archaemetzincin-2 OS=Macaca fascicularis OX=9541 GN=AMZ2 PE=2 SV=2,,,,,,
OG_02284,1.1166303673267464,FUN_008781-T1,Peve_00042606,Pocillopora_meandrina_HIv1___RNAseq.g12693.t1,three_way,80.42633333333333,,,,,,,,,,,,,,,,,
OG_02312,1.3663006547963286,FUN_008903-T1,Peve_00013993,Pocillopora_meandrina_HIv1___RNAseq.g4000.t1,three_way,73.99,FUN_008903-T1,Q9VU77,JMJD7_DROME,,Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 (EC 1.14.11.63) (EC 3.4.-.-) (Jumonji domain containing protein 7),Drosophila melanogaster (Fruit fly),29.7,296.0,2.5e-29,131.3,sp|Q9VU77|JMJD7_DROME Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 OS=Drosophila melanogaster OX=7227 GN=JMJD7 PE=1 SV=1,GO:0004175; GO:0005634; GO:0005737; GO:0008198; GO:0016706; GO:0042802; GO:0048512; GO:0106155,circadian behavior [GO:0048512],cytoplasm [GO:0005737]; nucleus [GO:0005634],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; endopeptidase activity [GO:0004175]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; peptidyl-lysine 3-dioxygenase activity [GO:0106155],GO:0003824; GO:0005634; GO:0016491; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02320,1.5998331036542477,FUN_008912-T1,Peve_00033001,Pocillopora_meandrina_HIv1___RNAseq.g3977.t1,three_way,63.34133333333334,,,,,,,,,,,,,,,,,
OG_02321,1.2128333119166723,FUN_008913-T1,Peve_00033015,Pocillopora_meandrina_HIv1___RNAseq.g3978.t1,three_way,86.956,FUN_008913-T1,Q56K14,RLA1_BOVIN,,Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1),Bos taurus (Bovine),67.7,65.0,1.8e-17,90.1,sp|Q56K14|RLA1_BOVIN Large ribosomal subunit protein P1 OS=Bos taurus OX=9913 GN=RPLP1 PE=3 SV=1,GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0030295; GO:0043021,cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414],cytosolic large ribosomal subunit [GO:0022625],protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0098772,cytoplasmic translation; structural molecule activity; molecular function regulator activity
OG_02326,1.975761052006917,FUN_008918-T2,Peve_00033006,Pocillopora_meandrina_HIv1___TS.g30030.t1,three_way,71.68133333333333,FUN_008918-T2,Q78KK3,,,,,40.6,389.0,7.000000000000002e-75,282.7,sp|Q78KK3|S67A1_MOUSE Solute carrier family 22 member 18 OS=Mus musculus OX=10090 GN=Slc67a1 PE=1 SV=2,,,,,,
OG_02340,1.3863269611862183,FUN_008938-T1,Peve_00007199,Pocillopora_meandrina_HIv1___RNAseq.g4080.t1,three_way,43.816833333333335,FUN_008938-T1,Q5F4A1,,,,,43.0,300.0,1.6000000000000001e-71,272.3,sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1,,,,,,
OG_02343,2.3204568952400355,FUN_008944-T1,Peve_00011189,Pocillopora_meandrina_HIv1___RNAseq.g4060.t1,three_way,64.23383333333334,FUN_008944-T1,Q6P0U3,,,,,31.3,211.0,1.6000000000000002e-23,112.1,sp|Q6P0U3|RSLBB_DANRE Ras-like protein family member 11B OS=Danio rerio OX=7955 GN=rasl11b PE=2 SV=1,,,,,,
OG_02350,1.2969684571925766,FUN_008951-T1,Peve_00008912,Pocillopora_meandrina_HIv1___RNAseq.29356_t,three_way,82.56166666666667,FUN_008951-T1,Q6IRP4,,,,,49.8,301.0,2.3e-82,307.4,sp|Q6IRP4|ABHDD_XENLA Protein ABHD13 OS=Xenopus laevis OX=8355 GN=abhd13 PE=2 SV=1,,,,,,
OG_02358,1.0249148986759389,FUN_008961-T1,Peve_00006948,Pocillopora_meandrina_HIv1___RNAseq.g4042.t1,three_way,60.446,,,,,,,,,,,,,,,,,
OG_02364,1.3317917433620077,FUN_008969-T1,Peve_00007346,Pocillopora_meandrina_HIv1___RNAseq.g14271.t1,three_way,68.706,FUN_008969-T1,Q9NWM8,FKB14_HUMAN,,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase),Homo sapiens (Human),43.3,194.0,6.7e-38,159.5,sp|Q9NWM8|FKB14_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP14 OS=Homo sapiens OX=9606 GN=FKBP14 PE=1 SV=1,GO:0003755; GO:0005509; GO:0005788,,endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0016853; GO:0140096,"catalytic activity; isomerase activity; catalytic activity, acting on a protein"
OG_02366,1.4303166580672104,FUN_008973-T1,Peve_00044338,Pocillopora_meandrina_HIv1___RNAseq.g3943.t1,three_way,66.187,FUN_008973-T1,P70057,,,,,37.0,573.0,1.5999999999999999e-83,312.4,sp|P70057|KCNQ1_XENLA Potassium voltage-gated channel subfamily KQT member 1 OS=Xenopus laevis OX=8355 GN=kcnq1 PE=1 SV=2,,,,,,
OG_02396,2.1298312992980786,FUN_009026-T1,Peve_00017792,Pocillopora_meandrina_HIv1___RNAseq.g14344.t1,three_way,55.13933333333333,FUN_009026-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),33.5,346.0,4.5e-42,173.7,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_02401,1.0343309116060575,FUN_009042-T1,Peve_00033723,Pocillopora_meandrina_HIv1___RNAseq.g14377.t1,three_way,63.53966666666667,FUN_009042-T1,O95551,TYDP2_HUMAN,,Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (hTDP2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (ETS1-associated protein 2) (ETS1-associated protein II) (EAPII) (TRAF and TNF receptor-associated protein) (Tyrosyl-RNA phosphodiesterase) (VPg unlinkase),Homo sapiens (Human),39.8,334.0,1.1999999999999999e-61,238.4,sp|O95551|TYDP2_HUMAN Tyrosyl-DNA phosphodiesterase 2 OS=Homo sapiens OX=9606 GN=TDP2 PE=1 SV=1,GO:0000287; GO:0003697; GO:0003714; GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0007166; GO:0016235; GO:0016604; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260,cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666],aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0016787; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140098; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; hydrolase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; transcription regulator activity"
OG_02408,2.903067409346439,FUN_009228-T2,Peve_00014803,Pocillopora_meandrina_HIv1___RNAseq.g6343.t1,three_way,63.64683333333333,FUN_009228-T2,Q24JV9,,,,,50.0,106.0,4.5000000000000003e-23,113.6,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02414,1.294823133075583,FUN_009283-T1,Peve_00000866,Pocillopora_meandrina_HIv1___RNAseq.g15507.t1,three_way,65.01933333333334,,,,,,,,,,,,,,,,,
OG_02421,1.4757048984467458,FUN_009312-T2,Peve_00021837,Pocillopora_meandrina_HIv1___RNAseq.g14441.t1,three_way,44.22516666666667,,,,,,,,,,,,,,,,,
OG_02431,2.1418270933718366,FUN_009401-T1,Peve_00004579,Pocillopora_meandrina_HIv1___RNAseq.g4531.t1,three_way,45.29166666666666,,,,,,,,,,,,,,,,,
OG_02442,1.312626624016591,FUN_009488-T1,Peve_00016361,Pocillopora_meandrina_HIv1___RNAseq.g28392.t1,three_way,82.25866666666667,FUN_009488-T1,Q95J75,,,,,55.1,207.0,2.0000000000000002e-60,233.8,sp|Q95J75|S2532_MACFA Solute carrier family 25 member 32 OS=Macaca fascicularis OX=9541 GN=SLC25A32 PE=2 SV=1,,,,,,
OG_02455,1.0689934269222616,FUN_009533-T1,Peve_00009554,Pocillopora_meandrina_HIv1___RNAseq.g24492.t1,three_way,81.537,FUN_009533-T1,Q27958,DPOLB_BOVIN,,DNA polymerase beta (EC 2.7.7.7) (5'-deoxyribose-phosphate lyase) (5'-dRP lyase) (EC 4.2.99.-) (AP lyase) (EC 4.2.99.18),Bos taurus (Bovine),65.8,336.0,2.1999999999999998e-121,436.8,sp|Q27958|DPOLB_BOVIN DNA polymerase beta OS=Bos taurus OX=9913 GN=POLB PE=2 SV=3,GO:0003677; GO:0003887; GO:0005634; GO:0005737; GO:0006261; GO:0006284; GO:0006303; GO:0006974; GO:0016829; GO:0046872; GO:0051575; GO:0140078,base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303],cytoplasm [GO:0005737]; nucleus [GO:0005634],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_02463,1.0403686943164991,FUN_009654-T1,Peve_00003555,Pocillopora_meandrina_HIv1___RNAseq.g24583.t1,three_way,69.71183333333333,FUN_009654-T1,A6H8T7,CBPC2_DANRE,,Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) (Testis-expressed protein 25),Danio rerio (Zebrafish) (Brachydanio rerio),48.3,484.0,1.8e-128,462.2,sp|A6H8T7|CBPC2_DANRE Cytosolic carboxypeptidase 2 OS=Danio rerio OX=7955 GN=zte25 PE=2 SV=1,GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064,protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02486,2.4494472110073278,FUN_009818-T1,Peve_00042916,Pocillopora_meandrina_HIv1___RNAseq.g24548.t1,three_way,67.266,FUN_009818-T1,Q8MIR4,,,,,38.3,574.0,3.8e-94,347.1,sp|Q8MIR4|COASY_PIG Bifunctional coenzyme A synthase OS=Sus scrofa OX=9823 GN=COASY PE=1 SV=1,,,,,,
OG_02491,1.4723346997362132,FUN_009825-T1,Peve_00042910,Pocillopora_meandrina_HIv1___RNAseq.g24543.t1,three_way,67.082,FUN_009825-T1,Q8NC69,KCTD6_HUMAN,,BTB/POZ domain-containing protein KCTD6 (KCASH3 protein) (Potassium channel tetramerization domain-containing protein 6),Homo sapiens (Human),62.2,98.0,8.7e-27,122.1,sp|Q8NC69|KCTD6_HUMAN BTB/POZ domain-containing protein KCTD6 OS=Homo sapiens OX=9606 GN=KCTD6 PE=1 SV=2,GO:0005829; GO:0006511; GO:0016567; GO:0030506; GO:0031430; GO:0042802; GO:0045879; GO:0051260; GO:0097602,negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; M band [GO:0031430],ankyrin binding [GO:0030506]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802],GO:0005829; GO:0008092; GO:0065003,cytosol; cytoskeletal protein binding; protein-containing complex assembly
OG_02492,1.5731084590348772,FUN_009826-T1,Peve_00042909,Pocillopora_meandrina_HIv1___TS.g12488.t1,three_way,47.22083333333333,FUN_009826-T1,Q91WI7,,,,,34.6,257.0,1.2000000000000001e-30,136.0,sp|Q91WI7|ITFG2_MOUSE KICSTOR complex protein ITFG2 OS=Mus musculus OX=10090 GN=Itfg2 PE=2 SV=1,,,,,,
OG_02508,1.317948642791916,FUN_010020-T1,Peve_00036457,Pocillopora_meandrina_HIv1___RNAseq.g24255.t1,three_way,74.96866666666666,FUN_010020-T1,Q7ZWN6,Z703A_XENLA,,Zinc finger protein 703-A,Xenopus laevis (African clawed frog),29.2,517.0,1.9e-22,108.6,sp|Q7ZWN6|Z703A_XENLA Zinc finger protein 703-A OS=Xenopus laevis OX=8355 GN=znf703-a PE=2 SV=2,GO:0005634; GO:0005737; GO:0008270; GO:0016363; GO:0017015; GO:0030335; GO:0034111; GO:0034333; GO:0045892; GO:0051726; GO:0060828,adherens junction assembly [GO:0034333]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0006355; GO:0034330; GO:0043226,nucleus; regulation of DNA-templated transcription; cell junction organization; organelle
OG_02517,1.0390309507881557,FUN_010576-T1,Peve_00032735,Pocillopora_meandrina_HIv1___RNAseq.g21522.t1,three_way,61.242666666666665,,,,,,,,,,,,,,,,,
OG_02531,1.091443885885489,FUN_010606-T1,Peve_00032719,Pocillopora_meandrina_HIv1___RNAseq.g21491.t1,three_way,76.36316666666666,FUN_010606-T1,Q5SSZ7,ZNRF3_MOUSE,,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),Mus musculus (Mouse),50.3,302.0,2.7e-80,300.8,sp|Q5SSZ7|ZNRF3_MOUSE E3 ubiquitin-protein ligase ZNRF3 OS=Mus musculus OX=10090 GN=Znrf3 PE=1 SV=1,GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0060173; GO:0060828; GO:0072089; GO:0090090; GO:2000051; GO:2000095,"limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]",plasma membrane [GO:0005886],frizzled binding [GO:0005109]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02532,2.830443675937639,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_02537,3.063562802382659,FUN_010620-T1,Peve_00031460,Pocillopora_meandrina_HIv1___TS.g26115.t1,three_way,50.77283333333333,FUN_010620-T1,O14514,AGRB1_HUMAN,,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],Homo sapiens (Human),29.6,659.0,1.9999999999999999e-63,246.9,sp|O14514|AGRB1_HUMAN Adhesion G protein-coupled receptor B1 OS=Homo sapiens OX=9606 GN=ADGRB1 PE=1 SV=2,GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016020; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]",cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786],GO:0002376; GO:0005615; GO:0005886; GO:0007155; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0060089; GO:0061024; GO:0098542,immune system process; extracellular space; plasma membrane; cell adhesion; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; molecular transducer activity; membrane organization; defense response to other organism
OG_02550,1.673592396816865,FUN_010638-T1,Peve_00009636,Pocillopora_meandrina_HIv1___RNAseq.g21309.t1,three_way,85.60366666666667,FUN_010638-T1,P79733,RIR2_DANRE,,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),Danio rerio (Zebrafish) (Brachydanio rerio),79.4,335.0,5.3e-151,535.4,sp|P79733|RIR2_DANRE Ribonucleoside-diphosphate reductase subunit M2 OS=Danio rerio OX=7955 GN=rrm2 PE=1 SV=1,GO:0004748; GO:0005829; GO:0009263; GO:0046872,deoxyribonucleotide biosynthetic process [GO:0009263],cytosol [GO:0005829],"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",GO:0003824; GO:0005829; GO:0016491; GO:0055086; GO:1901135,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02560,1.010949593998168,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_02587,2.6344323095114435,FUN_010707-T1,Peve_00005096,Pocillopora_meandrina_HIv1___RNAseq.g8834.t1,three_way,53.306333333333335,FUN_010707-T1,A0A2B4RP11,,,,,26.2,378.0,3.4e-14,81.6,sp|A0A2B4RP11|CGLR1_STYPI Cyclic GMP-AMP synthase-like receptor 1 OS=Stylophora pistillata OX=50429 GN=cGLR1 PE=1 SV=1,,,,,,
OG_02602,1.144169756411963,FUN_010728-T1,Peve_00038973,Pocillopora_meandrina_HIv1___RNAseq.g20945.t1,three_way,73.28566666666667,FUN_010728-T1,Q503V9,,,,,57.0,186.0,2.6e-54,213.4,sp|Q503V9|ENDUB_DANRE Uridylate-specific endoribonuclease B OS=Danio rerio OX=7955 GN=endoub PE=2 SV=1,,,,,,
OG_02609,1.4677046589571878,FUN_010740-T1,Peve_00038406,Pocillopora_meandrina_HIv1___TS.g25693.t1,three_way,77.805,FUN_010740-T1,P21291,CSRP1_HUMAN,,Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141),Homo sapiens (Human),48.3,176.0,9.1e-43,174.9,sp|P21291|CSRP1_HUMAN Cysteine and glycine-rich protein 1 OS=Homo sapiens OX=9606 GN=CSRP1 PE=1 SV=3,GO:0003723; GO:0005634; GO:0005737; GO:0005925; GO:0008270; GO:0008307; GO:0030018; GO:0042805; GO:0045214; GO:0060537; GO:0070062; GO:0070527,muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018],actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270],GO:0003723; GO:0005198; GO:0005634; GO:0007010; GO:0007155; GO:0008092; GO:0043226; GO:0048856,RNA binding; structural molecule activity; nucleus; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle; anatomical structure development
OG_02621,1.3533765003159732,FUN_010767-T1,Peve_00004501,Pocillopora_meandrina_HIv1___RNAseq.g21289.t1,three_way,81.65766666666667,FUN_010767-T1,A5HUI5,AMPE_GLOBR,,Aminopeptidase A (AP-A) (APA) (EC 3.4.11.7) (Glutamyl aminopeptidase) (EAP),Gloydius brevicauda (Korean slamosa snake) (Agkistrodon halys brevicaudus),37.6,896.0,1.4999999999999999e-173,611.7,sp|A5HUI5|AMPE_GLOBR Aminopeptidase A OS=Gloydius brevicauda OX=3148161 PE=1 SV=2,GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0042277; GO:0043171; GO:0070006,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_02643,1.2535055254743264,FUN_010811-T1,Peve_00006518,Pocillopora_meandrina_HIv1___RNAseq.g20907.t1,three_way,57.91116666666667,FUN_010811-T1,Q0P4V4,,,,,29.0,715.0,7.6e-73,276.9,sp|Q0P4V4|KTU_XENTR Protein kintoun OS=Xenopus tropicalis OX=8364 GN=dnaaf2 PE=2 SV=1,,,,,,
OG_02648,1.0795262882571592,FUN_010830-T1,Peve_00017535,Pocillopora_meandrina_HIv1___RNAseq.g20913.t1,three_way,81.01133333333334,FUN_010830-T1,Q9NXB0,MKS1_HUMAN,,Tectonic-like complex member MKS1 (Meckel syndrome type 1 protein),Homo sapiens (Human),42.4,557.0,5.1e-126,453.0,sp|Q9NXB0|MKS1_HUMAN Tectonic-like complex member MKS1 OS=Homo sapiens OX=9606 GN=MKS1 PE=1 SV=2,GO:0001843; GO:0003271; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0008589; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1905515; GO:1990403; GO:2000095,"branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway [GO:0008589]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]",centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0043226; GO:0044782; GO:0048856,nucleoplasm; nucleolus; microtubule organizing center; cytosol; organelle; cilium organization; anatomical structure development
OG_02673,1.0640121906452429,FUN_010898-T1,Peve_00044945,Pocillopora_meandrina_HIv1___RNAseq.g20990.t1,three_way,73.07133333333333,FUN_010898-T1,Q9GZU0,,,,,57.6,229.0,3.4e-76,286.2,sp|Q9GZU0|CF062_HUMAN Uncharacterized protein C6orf62 OS=Homo sapiens OX=9606 GN=C6orf62 PE=1 SV=1,,,,,,
OG_02689,1.041761268046281,FUN_010949-T1,Peve_00040395,Pocillopora_meandrina_HIv1___RNAseq.g21802.t1,three_way,77.62,FUN_010949-T1,Q7ZU90,CHD1L_DANRE,,Chromodomain-helicase-DNA-binding protein 1-like (EC 3.6.4.-),Danio rerio (Zebrafish) (Brachydanio rerio),52.9,877.0,3.7999999999999996e-235,816.2,sp|Q7ZU90|CHD1L_DANRE Chromodomain-helicase-DNA-binding protein 1-like OS=Danio rerio OX=7955 GN=chd1l PE=2 SV=1,GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0006281; GO:0006338; GO:0006974; GO:0007420; GO:0016887; GO:0031491; GO:0035861; GO:0140566; GO:0140658; GO:0160004,brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281],nucleus [GO:0005634]; site of double-strand break [GO:0035861],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; histone reader activity [GO:0140566]; nucleosome binding [GO:0031491]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004],GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140657,"catalytic activity; nucleus; DNA repair; chromatin organization; hydrolase activity; isomerase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02693,1.05344438716106,FUN_010956-T1,Peve_00015009,Pocillopora_meandrina_HIv1___RNAseq.g21824.t1,three_way,40.20633333333333,,,,,,,,,,,,,,,,,
OG_02698,1.8340795137656896,FUN_010966-T1,Peve_00007917,Pocillopora_meandrina_HIv1___RNAseq.g21968.t1,three_way,49.817166666666665,,,,,,,,,,,,,,,,,
OG_02717,1.0012042941448338,FUN_011000-T1,Peve_00013408,Pocillopora_meandrina_HIv1___RNAseq.g22022.t1,three_way,93.14033333333332,FUN_011000-T1,A7S8T5,,,,,85.2,304.0,7.2e-122,438.3,sp|A7S8T5|CCD42_NEMVE Coiled-coil domain-containing protein 42 homolog OS=Nematostella vectensis OX=45351 GN=v1g187067 PE=3 SV=1,,,,,,
OG_02726,1.1386989945745,FUN_011068-T3,Peve_00009495,Pocillopora_meandrina_HIv1___RNAseq.g22350.t1,three_way,48.02816666666667,,,,,,,,,,,,,,,,,
OG_02728,1.7046163946303932,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_02734,1.2382417621709247,FUN_011264-T1,Peve_00030536,Pocillopora_meandrina_HIv1___RNAseq.g22310.t1,three_way,79.29683333333332,FUN_011264-T1,P02401,,,,,70.6,68.0,7.3e-19,94.7,sp|P02401|RLA2_RAT Large ribosomal subunit protein P2 OS=Rattus norvegicus OX=10116 GN=Rplp2 PE=1 SV=2,,,,,,
OG_02740,1.2254259392706075,FUN_011283-T1,Peve_00037294,Pocillopora_meandrina_HIv1___RNAseq.g22317.t1,three_way,93.90933333333334,FUN_011283-T1,Q8VHI7,,,,,53.9,453.0,2.5e-124,447.2,sp|Q8VHI7|DRC2_MOUSE Dynein regulatory complex subunit 2 OS=Mus musculus OX=10090 GN=Ccdc65 PE=1 SV=1,,,,,,
OG_02741,1.582928852131079,FUN_011284-T1,Peve_00033625,Pocillopora_meandrina_HIv1___RNAseq.g22145.t2,three_way,53.47266666666667,FUN_011284-T1,Q5M775,CYTSB_HUMAN,,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),Homo sapiens (Human),46.2,106.0,1.9e-21,106.3,sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0048856; GO:0050877,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; organelle; anatomical structure development; nervous system process
OG_02759,1.373670026442181,FUN_011696-T1,Peve_00010715,Pocillopora_meandrina_HIv1___RNAseq.g23904.t1,three_way,73.33366666666667,FUN_011696-T1,A8XJZ8,,,,,45.2,93.0,1.1e-14,83.2,sp|A8XJZ8|LST2_CAEBR Lateral signaling target protein 2 OS=Caenorhabditis briggsae OX=6238 GN=lst-2 PE=3 SV=1,,,,,,
OG_02777,1.167502054394193,FUN_011725-T1,Peve_00039709,Pocillopora_meandrina_HIv1___RNAseq.g23849.t1,three_way,80.71566666666666,FUN_011725-T1,Q4R918,KIF25_MACFA,,Kinesin-like protein KIF25,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),41.1,604.0,4.1000000000000004e-111,403.7,sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647,establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; protein-containing complex assembly; ATP-dependent activity
OG_02809,1.4508934708989998,FUN_011782-T1,Peve_00041236,Pocillopora_meandrina_HIv1___RNAseq.g23305.t1,three_way,58.14066666666667,FUN_011782-T1,Q8R149,,,,,48.5,204.0,3.2e-45,184.5,sp|Q8R149|BUD13_MOUSE BUD13 homolog OS=Mus musculus OX=10090 GN=Bud13 PE=1 SV=1,,,,,,
OG_02845,1.10603706861486,FUN_011871-T1,Peve_00018844,Pocillopora_meandrina_HIv1___RNAseq.g23396.t1,three_way,78.22483333333334,FUN_011871-T1,Q9UA35,,,,,47.3,545.0,2e-125,451.1,sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1,,,,,,
OG_02858,1.0312981654369435,FUN_011900-T1,Peve_00010115,Pocillopora_meandrina_HIv1___RNAseq.g23788.t1,three_way,86.81633333333333,FUN_011900-T1,Q9GRC0,,,,,48.8,256.0,1.1e-61,238.4,sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1,,,,,,
OG_02903,1.1299416317989617,FUN_011973-T1,Peve_00001000,Pocillopora_meandrina_HIv1___RNAseq.g23724.t1,three_way,61.82216666666667,FUN_011973-T1,Q54G43,SHKE_DICDI,,Dual specificity protein kinase shkE (EC 2.7.11.1) (SH2 domain-containing protein 5) (SH2 domain-containing protein E),Dictyostelium discoideum (Social amoeba),31.5,251.0,1.8e-23,113.2,sp|Q54G43|SHKE_DICDI Dual specificity protein kinase shkE OS=Dictyostelium discoideum OX=44689 GN=shkE PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_02907,1.3010121294649486,FUN_011984-T1,Peve_00000523,Pocillopora_meandrina_HIv1___TS.g16589.t1,three_way,64.19166666666666,FUN_011984-T1,Q8JHI3,AR13B_DANRE,,ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein scorpion),Danio rerio (Zebrafish) (Brachydanio rerio),53.8,208.0,2.4999999999999997e-62,241.1,sp|Q8JHI3|AR13B_DANRE ADP-ribosylation factor-like protein 13B OS=Danio rerio OX=7955 GN=arl13b PE=1 SV=1,GO:0003924; GO:0005525; GO:0005929; GO:0007224; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0035845; GO:0060170; GO:0060271; GO:0097500; GO:0097730; GO:1905515,cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224],ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005929; GO:0016787; GO:0043226; GO:0044782; GO:0048870,catalytic activity; GTPase activity; cilium; hydrolase activity; organelle; cilium organization; cell motility
OG_02942,2.568526500835178,FUN_012054-T3,Peve_00004085,Pocillopora_meandrina_HIv1___RNAseq.g23646.t1,three_way,73.15266666666666,FUN_012054-T3,Q7Z020,,,,,22.2,504.0,9.3e-26,120.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02948,2.82854081458016,FUN_012066-T1,Peve_00004089,Pocillopora_meandrina_HIv1___RNAseq.g23637.t1,three_way,63.71233333333333,FUN_012066-T1,Q7Z020,,,,,25.4,562.0,7.2e-37,157.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02949,1.6761792902436707,FUN_012067-T1,Peve_00004104,Pocillopora_meandrina_HIv1___RNAseq.g23636.t1,three_way,67.023,FUN_012067-T1,Q7Z020,,,,,28.6,553.0,9.3e-45,184.1,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02953,2.066640592024524,FUN_012073-T1,Peve_00025862,Pocillopora_meandrina_HIv1___TS.g16505.t2,three_way,61.68833333333333,FUN_012073-T1,Q3U3W5,ANM9_MOUSE,,Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10) (EC 2.1.1.320),Mus musculus (Mouse),33.8,864.0,6.1e-123,443.4,sp|Q3U3W5|ANM9_MOUSE Protein arginine N-methyltransferase 9 OS=Mus musculus OX=10090 GN=Prmt9 PE=2 SV=2,GO:0005737; GO:0006397; GO:0016274; GO:0032259; GO:0035243,methylation [GO:0032259]; mRNA processing [GO:0006397],cytoplasm [GO:0005737],protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243],GO:0003824; GO:0016071; GO:0016740; GO:0140096,"catalytic activity; mRNA metabolic process; transferase activity; catalytic activity, acting on a protein"
OG_02967,1.2727887466814785,FUN_012126-T1,Peve_00035474,Pocillopora_meandrina_HIv1___RNAseq.g23920.t1,three_way,60.626333333333335,FUN_012126-T1,B3EWY9,,,,,38.6,166.0,3.9999999999999994e-28,128.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02968,1.6370760762075738,FUN_012130-T1,Peve_00035469,Pocillopora_meandrina_HIv1___RNAseq.g23786.t1,three_way,43.8205,FUN_012130-T1,Q5R7K9,,,,,32.1,156.0,7.5e-10,66.6,sp|Q5R7K9|EDIL3_PONAB EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Pongo abelii OX=9601 GN=EDIL3 PE=2 SV=1,,,,,,
OG_02974,1.0106749549677734,FUN_012139-T1,Peve_00001103,Pocillopora_meandrina_HIv1___RNAseq.g23864.t3,three_way,77.9845,FUN_012139-T1,Q8N7X0,ADGB_HUMAN,,Androglobin,Homo sapiens (Human),29.8,1939.0,1.4e-185,652.5,sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3,GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227,proteolysis [GO:0006508]; spermatid development [GO:0007286],sperm annulus [GO:0097227]; sperm midpiece [GO:0097225],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825],GO:0003824; GO:0016787; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; hydrolase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_02997,1.8048268192712336,FUN_012176-T1,Peve_00040994,Pocillopora_meandrina_HIv1___RNAseq.g23858.t1,three_way,63.23466666666666,FUN_012176-T1,Q709C8,VP13C_HUMAN,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Homo sapiens (Human),24.7,4222.0,0.0,1083.2,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090,Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0007005; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; mitochondrion organization; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03032,1.0055359613702224,FUN_012266-T1,Peve_00036382,Pocillopora_meandrina_HIv1___RNAseq.g23541.t2,three_way,83.19966666666666,FUN_012266-T1,Q921C3,BRWD1_MOUSE,,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),Mus musculus (Mouse),45.5,1509.0,1.3e-305,1051.2,sp|Q921C3|BRWD1_MOUSE Bromodomain and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Brwd1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005930; GO:0006357; GO:0007010; GO:0008360; GO:0031514,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006355; GO:0007010; GO:0043226,nucleus; nucleoplasm; nucleolus; cytosol; cilium; regulation of DNA-templated transcription; cytoskeleton organization; organelle
OG_03040,1.0333578071780811,FUN_012279-T1,Peve_00014710,Pocillopora_meandrina_HIv1___RNAseq.g23569.t1,three_way,80.28833333333333,FUN_012279-T1,Q8BHB4,,,,,63.4,938.0,2.5e-138,494.6,sp|Q8BHB4|WDR3_MOUSE WD repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Wdr3 PE=1 SV=1,,,,,,
OG_03057,1.04008946695653,FUN_012315-T1,Peve_00038609,Pocillopora_meandrina_HIv1___RNAseq.g23742.t1,three_way,75.115,FUN_012315-T1,Q63159,COQ3_RAT,,"Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (3-demethylubiquinone 3-O-methyltransferase) (EC 2.1.1.-) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114)",Rattus norvegicus (Rat),47.0,247.0,2.6000000000000003e-60,233.8,"sp|Q63159|COQ3_RAT Ubiquinone biosynthesis O-methyltransferase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Coq3 PE=2 SV=2",GO:0005739; GO:0005743; GO:0005759; GO:0006071; GO:0006744; GO:0008171; GO:0010420; GO:0031314; GO:0032259; GO:0061542; GO:0110142; GO:0120537,glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142],3-demethylubiquinol 3-O-methyltransferase activity [GO:0061542]; 3-demethylubiquinone 3-O-methyltransferase activity [GO:0120537]; O-methyltransferase activity [GO:0008171]; polyprenyldihydroxybenzoate methyltransferase activity [GO:0010420],GO:0003824; GO:0005739; GO:0005975; GO:0016740; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; transferase activity; organelle
OG_03060,1.3810187783037509,FUN_012324-T1,Peve_00022884,Pocillopora_meandrina_HIv1___RNAseq.g23750.t1,three_way,74.87566666666666,,,,,,,,,,,,,,,,,
OG_03070,2.5402856206028024,FUN_012340-T1,Peve_00042542,Pocillopora_meandrina_HIv1___RNAseq.g23343.t1,three_way,61.76633333333333,FUN_012340-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),30.7,205.0,2.5e-17,91.7,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_03072,1.2016366218987686,FUN_012343-T1,Peve_00012045,Pocillopora_meandrina_HIv1___TS.g16934.t2,three_way,67.75016666666667,FUN_012343-T1,E1C7T6,,,,,29.5,237.0,9e-14,79.7,sp|E1C7T6|TYW5_CHICK tRNA wybutosine-synthesizing protein 5 OS=Gallus gallus OX=9031 GN=TYW5 PE=3 SV=1,,,,,,
OG_03079,1.3789017022177177,FUN_012351-T1,Peve_00042524,Pocillopora_meandrina_HIv1___RNAseq.g23280.t1,three_way,33.19883333333333,,,,,,,,,,,,,,,,,
OG_03084,1.7588150842947534,FUN_012357-T1,Peve_00042558,Pocillopora_meandrina_HIv1___TS.g16156.t2,three_way,49.562333333333335,,,,,,,,,,,,,,,,,
OG_03085,1.2552700237832422,FUN_012358-T1,Peve_00042557,Pocillopora_meandrina_HIv1___RNAseq.g23273.t1,three_way,74.58133333333333,FUN_012358-T1,Q24133,DNAJ1_DROME,,DnaJ protein homolog 1 (DROJ1),Drosophila melanogaster (Fruit fly),53.0,332.0,1.4e-84,314.7,sp|Q24133|DNAJ1_DROME DnaJ protein homolog 1 OS=Drosophila melanogaster OX=7227 GN=DnaJ-1 PE=1 SV=3,GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408],cytosol [GO:0005829],DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005829; GO:0006457,cytosol; protein folding
OG_03087,1.288271857663141,FUN_012360-T1,Peve_00042555,Pocillopora_meandrina_HIv1___RNAseq.g23271.t1,three_way,62.67783333333333,,,,,,,,,,,,,,,,,
OG_03096,1.02865643812654,FUN_012381-T1,Peve_00015999,Pocillopora_meandrina_HIv1___RNAseq.g23344.t1,three_way,59.2625,FUN_012381-T1,Q924V1,NOX4_RAT,,NADPH oxidase 4 (EC 1.6.3.1) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase),Rattus norvegicus (Rat),42.4,556.0,9.999999999999999e-123,442.2,sp|Q924V1|NOX4_RAT NADPH oxidase 4 OS=Rattus norvegicus OX=10116 GN=Nox4 PE=1 SV=2,GO:0000902; GO:0001666; GO:0001725; GO:0003015; GO:0005634; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005925; GO:0006801; GO:0006952; GO:0008285; GO:0010467; GO:0010729; GO:0014911; GO:0016174; GO:0016175; GO:0016324; GO:0016529; GO:0020037; GO:0042554; GO:0043020; GO:0043065; GO:0045453; GO:0048471; GO:0050664; GO:0050667; GO:0051496; GO:0051897; GO:0055007; GO:0070374; GO:0071288; GO:0071320; GO:0071333; GO:0071347; GO:0071480; GO:0071560; GO:0071944; GO:0072341; GO:0072593; GO:0097038; GO:0106292; GO:0106294; GO:1990782; GO:2000379; GO:2000573,bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell morphogenesis [GO:0000902]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to interleukin-1 [GO:0071347]; cellular response to mercury ion [GO:0071288]; cellular response to transforming growth factor beta stimulus [GO:0071560]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; response to hypoxia [GO:0001666]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; stress fiber [GO:0001725],"heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH oxidase H202-forming activity [GO:0106294]; oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO:0050664]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activity [GO:0106292]",GO:0003013; GO:0003824; GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0006520; GO:0006790; GO:0016491; GO:0030154; GO:0043226,circulatory system process; catalytic activity; nucleus; mitochondrion; endoplasmic reticulum; plasma membrane; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; cell differentiation; organelle
OG_03100,1.0660384647729446,FUN_012387-T1,Peve_00042538,Pocillopora_meandrina_HIv1___TS.g16230.t1,three_way,60.22266666666667,FUN_012387-T1,O04854,,,,,39.0,236.0,9.599999999999999e-43,175.3,sp|O04854|CAMT_EUCGU Caffeoyl-CoA O-methyltransferase OS=Eucalyptus gunnii OX=3933 PE=2 SV=1,,,,,,
OG_03103,1.33502100592408,FUN_012390-T1,Peve_00022229,Pocillopora_meandrina_HIv1___RNAseq.g23656.t1,three_way,66.252,,,,,,,,,,,,,,,,,
OG_03104,1.101289003519127,FUN_012391-T1,Peve_00022230,Pocillopora_meandrina_HIv1___RNAseq.g23657.t1,three_way,59.73266666666667,FUN_012391-T1,Q6DRM0,GET1_DANRE,,Guided entry of tail-anchored proteins factor 1 (Tail-anchored protein insertion receptor WRB) (Tryptophan-rich basic protein),Danio rerio (Zebrafish) (Brachydanio rerio),31.2,157.0,2.2e-16,87.4,sp|Q6DRM0|GET1_DANRE Guided entry of tail-anchored proteins factor 1 OS=Danio rerio OX=7955 GN=get1 PE=2 SV=1,GO:0001964; GO:0005783; GO:0005789; GO:0007507; GO:0007605; GO:0010996; GO:0043495; GO:0043529; GO:0060041; GO:0071816,heart development [GO:0007507]; response to auditory stimulus [GO:0010996]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529],protein-membrane adaptor activity [GO:0043495],GO:0005783; GO:0043226; GO:0048856; GO:0050877; GO:0060090,endoplasmic reticulum; organelle; anatomical structure development; nervous system process; molecular adaptor activity
OG_03106,1.7412790450502575,FUN_012402-T1,Peve_00023469,Pocillopora_meandrina_HIv1___RNAseq.g23670.t1,three_way,45.885,FUN_012402-T1,Q6UXI7,VITRN_HUMAN,,Vitrin,Homo sapiens (Human),28.8,184.0,5.1e-15,84.7,sp|Q6UXI7|VITRN_HUMAN Vitrin OS=Homo sapiens OX=9606 GN=VIT PE=1 SV=1,GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198,extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510],extracellular region [GO:0005576]; interstitial matrix [GO:0005614],glycosaminoglycan binding [GO:0005539],GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03108,2.202781727701178,FUN_012405-T1,Peve_00002856,Pocillopora_meandrina_HIv1___RNAseq.g9951.t1,three_way,66.98066666666666,,,,,,,,,,,,,,,,,
OG_03111,1.3192838902185666,FUN_012414-T1,Peve_00037988,Pocillopora_meandrina_HIv1___RNAseq.g23679.t1,three_way,75.20233333333333,FUN_012414-T1,Q04892,,,,,39.6,164.0,6.9e-21,102.4,sp|Q04892|SOX14_MOUSE Transcription factor SOX-14 OS=Mus musculus OX=10090 GN=Sox14 PE=2 SV=2,,,,,,
OG_03113,1.6020098469447015,FUN_012418-T1,Peve_00026919,Pocillopora_meandrina_HIv1___RNAseq.g23687.t1,three_way,85.58083333333333,FUN_012418-T1,Q4V7D3,MACOI_RAT,,Macoilin (Macoilin-1) (Transmembrane protein 57),Rattus norvegicus (Rat),39.0,715.0,7.6e-111,402.9,sp|Q4V7D3|MACOI_RAT Macoilin OS=Rattus norvegicus OX=10116 GN=Maco1 PE=1 SV=1,GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0043005; GO:0044306; GO:0045202,brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041],axon [GO:0030424]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202],microtubule binding [GO:0008017],GO:0005634; GO:0008092; GO:0043226; GO:0048856,nucleus; cytoskeletal protein binding; organelle; anatomical structure development
OG_03116,2.359052021752269,FUN_012430-T1,Peve_00026925,Pocillopora_meandrina_HIv1___RNAseq.g23681.t1,three_way,55.942,FUN_012430-T1,Q7TXL8,,,,,25.4,2226.0,7.9e-140,501.5,sp|Q7TXL8|PPSC_MYCBO Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=ppsC PE=1 SV=1,,,,,,
OG_03147,1.8454262395795504,FUN_012533-T1,Peve_00034230,Pocillopora_meandrina_HIv1___RNAseq.g23954.t1,three_way,57.28066666666667,,,,,,,,,,,,,,,,,
OG_03157,1.2466592758167776,FUN_012548-T1,Peve_00030413,Pocillopora_meandrina_HIv1___RNAseq.g23609.t1,three_way,63.32366666666667,FUN_012548-T1,Q8NBP5,,,,,33.7,409.0,6.600000000000001e-57,223.0,sp|Q8NBP5|MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens OX=9606 GN=MFSD9 PE=1 SV=2,,,,,,
OG_03163,1.4417609044080493,FUN_012561-T1,Peve_00016373,Pocillopora_meandrina_HIv1___RNAseq.g23582.t1,three_way,69.20983333333334,FUN_012561-T1,Q92834,RPGR_HUMAN,,X-linked retinitis pigmentosa GTPase regulator,Homo sapiens (Human),44.0,448.0,1.1e-68,263.1,sp|Q92834|RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens OX=9606 GN=RPGR PE=1 SV=2,GO:0001750; GO:0003723; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0006511; GO:0006886; GO:0007601; GO:0010508; GO:0016567; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0060271; GO:0061630; GO:0097499,cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; positive regulation of autophagy [GO:0010508]; protein localization to non-motile cilium [GO:0097499]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630],GO:0003723; GO:0003824; GO:0005794; GO:0005815; GO:0005929; GO:0006886; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0098772; GO:0140096,"RNA binding; catalytic activity; Golgi apparatus; microtubule organizing center; cilium; intracellular protein transport; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03187,1.103212717331146,FUN_012657-T1,Peve_00022119,Pocillopora_meandrina_HIv1___RNAseq.g22895.t1,three_way,70.13616666666667,FUN_012657-T1,Q9UK58,,,,,56.1,173.0,6.700000000000001e-48,193.0,sp|Q9UK58|CCNL1_HUMAN Cyclin-L1 OS=Homo sapiens OX=9606 GN=CCNL1 PE=1 SV=1,,,,,,
OG_03196,1.0500496740131742,FUN_012675-T1,Peve_00025241,Pocillopora_meandrina_HIv1___RNAseq.g22881.t1,three_way,86.62966666666667,FUN_012675-T1,Q9UNL2,,,,,60.6,180.0,9.9e-55,214.5,sp|Q9UNL2|SSRG_HUMAN Translocon-associated protein subunit gamma OS=Homo sapiens OX=9606 GN=SSR3 PE=1 SV=1,,,,,,
OG_03204,1.0951435770729636,FUN_012693-T1,Peve_00016824,Pocillopora_meandrina_HIv1___TS.g15743.t1,three_way,82.26066666666667,FUN_012693-T1,Q7L8C5,SYT13_HUMAN,,Synaptotagmin-13 (Synaptotagmin XIII) (SytXIII),Homo sapiens (Human),29.4,194.0,6.1e-11,70.5,sp|Q7L8C5|SYT13_HUMAN Synaptotagmin-13 OS=Homo sapiens OX=9606 GN=SYT13 PE=1 SV=1,GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0030133; GO:0030424; GO:0030672; GO:0031045; GO:0043231; GO:0061891; GO:0070382; GO:0099502; GO:2000300,calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of synaptic vesicle exocytosis [GO:2000300]; vesicle-mediated transport [GO:0016192],axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; transport vesicle [GO:0030133],calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149],GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_03214,1.0737751110862015,FUN_012711-T1,Peve_00000958,Pocillopora_meandrina_HIv1___RNAseq.g12836.t1c,three_way,66.162,FUN_012711-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),32.7,284.0,9.999999999999999e-33,142.9,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_03226,1.3120335252650717,FUN_012768-T1,Peve_00011054,Pocillopora_meandrina_HIv1___RNAseq.g13663.t1,three_way,69.79666666666667,FUN_012768-T1,Q91Y77,,,,,32.0,456.0,3.9999999999999994e-68,260.4,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_03230,1.1257512382397872,FUN_012772-T1,Peve_00007600,Pocillopora_meandrina_HIv1___RNAseq.g13653.t1,three_way,86.02266666666667,FUN_012772-T1,Q9DFQ7,,,,,76.6,111.0,5.199999999999999e-43,175.6,sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2,,,,,,
OG_03246,1.2172948846680798,FUN_012889-T1,Peve_00033084,Pocillopora_meandrina_HIv1___RNAseq.g13862.t1,three_way,72.43866666666666,FUN_012889-T1,P53111,,,,,34.3,361.0,2.6e-35,151.0,sp|P53111|ARI1_YEAST NADPH-dependent aldehyde reductase ARI1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ARI1 PE=1 SV=1,,,,,,
OG_03252,1.2538665433528526,FUN_012983-T1,Peve_00028830,Pocillopora_meandrina_HIv1___RNAseq.g30380.t2,three_way,73.10633333333334,,,,,,,,,,,,,,,,,
OG_03268,1.9907552778153164,FUN_013137-T1,Peve_00042384,Pocillopora_meandrina_HIv1___RNAseq.g23023.t1,three_way,71.50933333333333,FUN_013137-T1,Q7M3E1,,,,,42.1,254.0,7.8e-44,179.5,sp|Q7M3E1|CTRC_BOVIN Chymotrypsin-C OS=Bos taurus OX=9913 GN=CTRC PE=1 SV=2,,,,,,
OG_03275,1.2411639247182626,FUN_013154-T1,Peve_00022448,Pocillopora_meandrina_HIv1___RNAseq.g12979.t1,three_way,50.74516666666667,FUN_013154-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),29.3,369.0,1.8000000000000002e-28,130.2,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_03288,1.3741171417210136,FUN_013329-T1,Peve_00022430,Pocillopora_meandrina_HIv1___RNAseq.g12994.t1,three_way,67.42033333333333,FUN_013329-T1,Q8IS64,,,,,36.0,688.0,9.5e-131,469.2,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_03289,1.1169084167235583,FUN_013330-T1,Peve_00022425,Pocillopora_meandrina_HIv1___RNAseq.g12990.t1a,three_way,66.249,FUN_013330-T1,P42893,,,,,37.2,686.0,2.6000000000000003e-133,477.6,sp|P42893|ECE1_RAT Endothelin-converting enzyme 1 OS=Rattus norvegicus OX=10116 GN=Ece1 PE=1 SV=2,,,,,,
OG_03327,1.2561535419593657,FUN_013418-T1,Peve_00028073,Pocillopora_meandrina_HIv1___RNAseq.g22949.t1,three_way,55.11866666666667,FUN_013418-T1,Q8X187,,,,,28.7,143.0,4e-10,67.4,sp|Q8X187|CALM_PAXIN Calmodulin OS=Paxillus involutus OX=71150 GN=calA PE=2 SV=3,,,,,,
OG_03371,1.0164716866984618,FUN_013617-T1,Peve_00035878,Pocillopora_meandrina_HIv1___RNAseq.g13536.t1,three_way,73.67233333333334,FUN_013617-T1,Q5T089,,,,,72.7,44.0,3.4e-13,78.2,sp|Q5T089|MORN1_HUMAN MORN repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=MORN1 PE=1 SV=2,,,,,,
OG_03394,1.3785889109677267,FUN_014166-T1,Peve_00026508,Pocillopora_meandrina_HIv1___RNAseq.g7362.t1,three_way,57.504,FUN_014166-T1,Q9H2K2,,,,,28.4,211.0,3.9e-08,62.0,sp|Q9H2K2|TNKS2_HUMAN Poly [ADP-ribose] polymerase tankyrase-2 OS=Homo sapiens OX=9606 GN=TNKS2 PE=1 SV=1,,,,,,
OG_03400,1.066533959911971,FUN_014439-T1,Peve_00000664,Pocillopora_meandrina_HIv1___TS.g12605.t1,three_way,76.63716666666666,FUN_014439-T1,O43913,,,,,52.0,431.0,1.4999999999999999e-120,434.5,sp|O43913|ORC5_HUMAN Origin recognition complex subunit 5 OS=Homo sapiens OX=9606 GN=ORC5 PE=1 SV=1,,,,,,
OG_03431,1.0074291926505234,FUN_014487-T1,Peve_00037295,Pocillopora_meandrina_HIv1___RNAseq.1965_t,three_way,57.88816666666667,FUN_014487-T1,Q9D4H7,,,,,33.6,619.0,5e-91,337.0,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_03441,1.1661989868996174,FUN_014501-T1,Peve_00013880,Pocillopora_meandrina_HIv1___RNAseq.g22638.t1,three_way,67.336,FUN_014501-T1,P06734,FCER2_HUMAN,,Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form],Homo sapiens (Human),32.5,126.0,1.1e-07,60.1,sp|P06734|FCER2_HUMAN Low affinity immunoglobulin epsilon Fc receptor OS=Homo sapiens OX=9606 GN=FCER2 PE=1 SV=1,GO:0002020; GO:0002450; GO:0002925; GO:0005178; GO:0005886; GO:0006955; GO:0009897; GO:0010628; GO:0019769; GO:0019863; GO:0030246; GO:0038096; GO:0038187; GO:0042116; GO:0042742; GO:0046872; GO:0070062; GO:0160006,B cell antigen processing and presentation [GO:0002450]; defense response to bacterium [GO:0042742]; Fc receptor-mediated immune complex endocytosis [GO:0160006]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; macrophage activation [GO:0042116]; positive regulation of gene expression [GO:0010628]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925],external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; low-affinity IgE receptor activity [GO:0019769]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; protease binding [GO:0002020],GO:0002376; GO:0005886; GO:0016192; GO:0043226; GO:0060089,immune system process; plasma membrane; vesicle-mediated transport; organelle; molecular transducer activity
OG_03445,1.7336909866142554,FUN_014509-T1,Peve_00031996,Pocillopora_meandrina_HIv1___RNAseq.g22632.t1,three_way,69.32416666666667,FUN_014509-T1,Q5F3V0,SMYD4_CHICK,,Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4),Gallus gallus (Chicken),28.4,401.0,4.9999999999999996e-26,121.3,sp|Q5F3V0|SMYD4_CHICK Protein-lysine N-methyltransferase SMYD4 OS=Gallus gallus OX=9031 GN=SMYD4 PE=2 SV=1,GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0008270; GO:0032259; GO:0042826,heart development [GO:0007507]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],histone deacetylase binding [GO:0042826]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; transferase activity; organelle; anatomical structure development
OG_03464,1.021801929861667,FUN_014545-T1,Peve_00035995,Pocillopora_meandrina_HIv1___RNAseq.g22593.t1,three_way,72.14533333333333,FUN_014545-T1,Q5ZIT9,MFSD1_CHICK,,Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1),Gallus gallus (Chicken),31.1,212.0,1.8e-17,91.3,sp|Q5ZIT9|MFSD1_CHICK Lysosomal dipeptide transporter MFSD1 OS=Gallus gallus OX=9031 GN=MFSD1 PE=2 SV=1,GO:0005764; GO:0005765; GO:0042803; GO:0050821; GO:0061462; GO:0141204; GO:0160178,dipeptide transmembrane transport from lysosomal lumen to cytosol [GO:0141204]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821],lysosomal membrane [GO:0005765]; lysosome [GO:0005764],dipeptide uniporter activity [GO:0160178]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005764; GO:0005773; GO:0043226; GO:0055085,transporter activity; lysosome; vacuole; organelle; transmembrane transport
OG_03469,1.1164937330605065,FUN_014554-T1,Peve_00035992,Pocillopora_meandrina_HIv1___RNAseq.g22696.t1,three_way,75.109,FUN_014554-T1,P0DL28,FBXW8_RAT,,F-box/WD repeat-containing protein 8 (F-box and WD-40 domain-containing protein 8),Rattus norvegicus (Rat),42.7,178.0,5.8e-39,162.2,sp|P0DL28|FBXW8_RAT F-box/WD repeat-containing protein 8 OS=Rattus norvegicus OX=10116 GN=Fbxw8 PE=1 SV=1,GO:0005737; GO:0005794; GO:0005814; GO:0005829; GO:0006511; GO:0007030; GO:0008283; GO:0016567; GO:0019005; GO:0031467; GO:0032436; GO:0036064; GO:0043161; GO:0046627; GO:0048471; GO:0050775; GO:0060271; GO:0060712; GO:0060716; GO:1990393; GO:1990756,cell population proliferation [GO:0008283]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511],3M complex [GO:1990393]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005794; GO:0005815; GO:0005829; GO:0030163; GO:0043226; GO:0044782; GO:0048856; GO:0060090,Golgi apparatus; microtubule organizing center; cytosol; protein catabolic process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_03472,2.071199840695054,FUN_014560-T1,Peve_00009691,Pocillopora_meandrina_HIv1___RNAseq.g22702.t1,three_way,77.68633333333334,FUN_014560-T1,Q96NN9,,,,,45.9,510.0,5.4e-137,489.6,sp|Q96NN9|AIFM3_HUMAN Apoptosis-inducing factor 3 OS=Homo sapiens OX=9606 GN=AIFM3 PE=1 SV=1,,,,,,
OG_03493,1.076692630559278,FUN_014602-T1,Peve_00028207,Pocillopora_meandrina_HIv1___RNAseq.g22747.t1,three_way,77.274,FUN_014602-T1,Q9CXS4,CENPV_MOUSE,,Centromere protein V (CENP-V) (Proline-rich protein 6),Mus musculus (Mouse),58.8,131.0,2.4e-45,183.0,sp|Q9CXS4|CENPV_MOUSE Centromere protein V OS=Mus musculus OX=10090 GN=Cenpv PE=1 SV=2,GO:0000776; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0031965; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301,ameboidal-type cell migration [GO:0001667]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044],cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233],carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0006325; GO:0016829; GO:0043226; GO:0048870; GO:0065003,catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; chromatin organization; lyase activity; organelle; cell motility; protein-containing complex assembly
OG_03507,1.2032542481600002,FUN_014617-T2,Peve_00002398,Pocillopora_meandrina_HIv1___RNAseq.g22768.t1,three_way,61.22316666666666,FUN_014617-T2,Q96F81,DISP1_HUMAN,,Protein dispatched homolog 1,Homo sapiens (Human),35.4,1037.0,4.9e-151,537.0,sp|Q96F81|DISP1_HUMAN Protein dispatched homolog 1 OS=Homo sapiens OX=9606 GN=DISP1 PE=1 SV=3,GO:0007224; GO:0007225; GO:0007368; GO:0009880; GO:0009953; GO:0015833; GO:0016020; GO:0016323; GO:0050708; GO:0060539; GO:0070207; GO:0140104,determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708]; smoothened signaling pathway [GO:0007224],basolateral plasma membrane [GO:0016323]; membrane [GO:0016020],molecular carrier activity [GO:0140104],GO:0048856; GO:0051604; GO:0065003; GO:0140104,anatomical structure development; protein maturation; protein-containing complex assembly; molecular carrier activity
OG_03511,1.088196562959865,FUN_014622-T1,Peve_00002409,Pocillopora_meandrina_HIv1___RNAseq.g22779.t1,three_way,69.165,FUN_014622-T1,Q6GNG8,,,,,57.8,109.0,3e-27,123.2,sp|Q6GNG8|PKRI1_XENLA PRKR-interacting protein 1 homolog OS=Xenopus laevis OX=8355 GN=prkrip1 PE=2 SV=1,,,,,,
OG_03516,1.1270577595042113,FUN_014627-T1,Peve_00002415,Pocillopora_meandrina_HIv1___TS.g27554.t1,three_way,87.76583333333333,FUN_014627-T1,Q5ZML3,,,,,65.0,200.0,3.2e-57,223.4,sp|Q5ZML3|SRSF1_CHICK Serine/arginine-rich splicing factor 1 OS=Gallus gallus OX=9031 GN=SRSF1 PE=1 SV=3,,,,,,
OG_03526,1.0398803070072236,FUN_014641-T1,Peve_00002430,Pocillopora_meandrina_HIv1___RNAseq.g22798.t1,three_way,72.066,FUN_014641-T1,Q96CM3,,,,,36.0,250.0,5.5e-33,142.9,"sp|Q96CM3|RUSD4_HUMAN Pseudouridylate synthase RPUSD4, mitochondrial OS=Homo sapiens OX=9606 GN=RPUSD4 PE=1 SV=1",,,,,,
OG_03538,1.4788518360218457,FUN_014657-T1,Peve_00014510,Pocillopora_meandrina_HIv1___RNAseq.g22581.t2,three_way,74.71600000000001,FUN_014657-T1,Q9NUQ2,PLCE_HUMAN,,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon),Homo sapiens (Human),45.6,261.0,1.9e-63,244.2,sp|Q9NUQ2|PLCE_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens OX=9606 GN=AGPAT5 PE=1 SV=3,GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016024; GO:0016746; GO:0036149,acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746],GO:0003824; GO:0005635; GO:0005730; GO:0005739; GO:0005783; GO:0006629; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nuclear envelope; nucleolus; mitochondrion; endoplasmic reticulum; lipid metabolic process; transferase activity; cell differentiation; organelle
OG_03539,1.583182801981528,FUN_014659-T1,Peve_00014504,Pocillopora_meandrina_HIv1___TS.g27418.t1,three_way,76.663,FUN_014659-T1,Q8TB45,DPTOR_HUMAN,,DEP domain-containing mTOR-interacting protein (hDEPTOR) (DEP domain-containing protein 6),Homo sapiens (Human),51.2,84.0,3.5e-17,89.0,sp|Q8TB45|DPTOR_HUMAN DEP domain-containing mTOR-interacting protein OS=Homo sapiens OX=9606 GN=DEPTOR PE=1 SV=2,GO:0004860; GO:0005085; GO:0005096; GO:0005765; GO:0005886; GO:0006469; GO:0007186; GO:0010508; GO:0030291; GO:0032007; GO:0035556; GO:0045792; GO:0070300; GO:1903940; GO:1904262; GO:2001236,G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of autophagy [GO:0010508]; regulation of extrinsic apoptotic signaling pathway [GO:2001236],lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase inhibitor activity [GO:0030291],GO:0005886; GO:0008289; GO:0098772,plasma membrane; lipid binding; molecular function regulator activity
OG_03540,1.0028802756324926,FUN_014660-T1,Peve_00032454,Pocillopora_meandrina_HIv1___RNAseq.g22661.t1,three_way,97.681,FUN_014660-T1,Q2YDI3,,,,,92.9,113.0,1.6e-58,226.5,sp|Q2YDI3|YPEL2_BOVIN Protein yippee-like 2 OS=Bos taurus OX=9913 GN=YPEL2 PE=3 SV=1,,,,,,
OG_03551,1.3735630368451897,FUN_014683-T2,Peve_00033420,Pocillopora_meandrina_HIv1___RNAseq.g22591.t1,three_way,70.162,FUN_014683-T2,Q9Y3E5,PTH2_HUMAN,,"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)",Homo sapiens (Human),59.4,160.0,4.000000000000001e-45,182.6,"sp|Q9Y3E5|PTH2_HUMAN Peptidyl-tRNA hydrolase 2, mitochondrial OS=Homo sapiens OX=9606 GN=PTRH2 PE=1 SV=1",GO:0004045; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0010629; GO:0016020; GO:2000210; GO:2000811,apoptotic process [GO:0006915]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],peptidyl-tRNA hydrolase activity [GO:0004045],GO:0003824; GO:0005739; GO:0005829; GO:0012501; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; mitochondrion; cytosol; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03565,1.892789660885364,FUN_014714-T1,Peve_00023481,Pocillopora_meandrina_HIv1___RNAseq.g22526.t1,three_way,80.59266666666667,FUN_014714-T1,Q6GQN5,PPR42_DANRE,,Protein phosphatase 1 regulatory subunit 42 (Leucine-rich repeat-containing protein 67),Danio rerio (Zebrafish) (Brachydanio rerio),66.7,252.0,2.1e-35,151.4,sp|Q6GQN5|PPR42_DANRE Protein phosphatase 1 regulatory subunit 42 OS=Danio rerio OX=7955 GN=ppp1r42 PE=2 SV=1,GO:0002177; GO:0003779; GO:0005737; GO:0005813; GO:0005815; GO:0015630; GO:0015631; GO:0070840,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815],actin binding [GO:0003779]; dynein complex binding [GO:0070840]; tubulin binding [GO:0015631],GO:0005815; GO:0005856; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cytoskeletal protein binding; organelle
OG_03574,1.2336394096955203,FUN_014728-T1,Peve_00009505,Pocillopora_meandrina_HIv1___RNAseq.g22491.t1,three_way,50.2435,,,,,,,,,,,,,,,,,
OG_03579,1.4333853413195312,FUN_014734-T1,Peve_00010435,Pocillopora_meandrina_HIv1___RNAseq.1641_t,three_way,71.44800000000001,,,,,,,,,,,,,,,,,
OG_03583,1.55788032194564,FUN_014738-T1,Peve_00010439,Pocillopora_meandrina_HIv1___TS.g27242.t1,three_way,73.03666666666666,FUN_014738-T1,Q08AX9,,,,,40.9,648.0,2.6999999999999998e-121,437.6,sp|Q08AX9|SANBR_XENLA SANT and BTB domain regulator of class switch recombination OS=Xenopus laevis OX=8355 GN=sanbr PE=2 SV=1,,,,,,
OG_03587,1.3124798013982872,FUN_014743-T1,Peve_00007238,Pocillopora_meandrina_HIv1___RNAseq.g22471.t2,three_way,64.66933333333333,FUN_014743-T1,Q5YCC5,,,,,31.2,557.0,2.8e-64,248.1,sp|Q5YCC5|TMC7_CHICK Transmembrane channel-like protein 7 OS=Gallus gallus OX=9031 GN=Tmc7 PE=2 SV=1,,,,,,
OG_03591,1.169588548797855,FUN_014749-T1,Peve_00007240,Pocillopora_meandrina_HIv1___RNAseq.g22454.t1,three_way,56.16033333333333,FUN_014749-T1,Q795M8,,,,,40.2,97.0,6.1e-08,60.8,sp|Q795M8|YUGO_BACSU Putative potassium channel protein YugO OS=Bacillus subtilis (strain 168) OX=224308 GN=yugO PE=4 SV=2,,,,,,
OG_03627,2.0576333288098243,FUN_014818-T1,Peve_00038833,Pocillopora_meandrina_HIv1___RNAseq.g22396.t1,three_way,36.711666666666666,,,,,,,,,,,,,,,,,
OG_03638,1.9218531443194613,FUN_014858-T1,Peve_00024576,Pocillopora_meandrina_HIv1___RNAseq.g22374.t1,three_way,82.99766666666666,FUN_014858-T1,Q7ZXK9,,,,,61.6,352.0,1.4999999999999999e-96,354.8,sp|Q7ZXK9|NLE1_XENLA Notchless protein homolog 1 OS=Xenopus laevis OX=8355 GN=nle1 PE=2 SV=1,,,,,,
OG_03652,1.0279279390796623,FUN_014885-T1,Peve_00003527,Pocillopora_meandrina_HIv1___TS.g25809.t1,three_way,62.263,,,,,,,,,,,,,,,,,
OG_03659,1.2140883185580662,FUN_014896-T1,Peve_00003546,Pocillopora_meandrina_HIv1___RNAseq.g21104.t1,three_way,65.60683333333333,FUN_014896-T1,Q69ZX6,MOR2A_MOUSE,,ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1),Mus musculus (Mouse),41.3,920.0,5.7999999999999996e-151,536.6,sp|Q69ZX6|MOR2A_MOUSE ATPase MORC2A OS=Mus musculus OX=10090 GN=Morc2a PE=1 SV=2,GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042803; GO:0140719; GO:0141005,chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; transposable element silencing by heterochromatin formation [GO:0141005],cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0016787; GO:0042393; GO:0043226,catalytic activity; nucleus; cytosol; chromatin organization; hydrolase activity; histone binding; organelle
OG_03667,1.143687438276769,FUN_014907-T1,Peve_00003536,Pocillopora_meandrina_HIv1___RNAseq.g21072.t1,three_way,37.61533333333333,,,,,,,,,,,,,,,,,
OG_03673,1.0966790630199517,FUN_014924-T1,Peve_00006268,Pocillopora_meandrina_HIv1___RNAseq.g21081.t1,three_way,64.52166666666666,FUN_014924-T1,Q6PAJ1,BCR_MOUSE,,Breakpoint cluster region protein (EC 2.7.11.1),Mus musculus (Mouse),38.2,798.0,2e-142,508.8,sp|Q6PAJ1|BCR_MOUSE Breakpoint cluster region protein OS=Mus musculus OX=10090 GN=Bcr PE=1 SV=3,GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006909; GO:0007264; GO:0007420; GO:0014069; GO:0016477; GO:0030036; GO:0030216; GO:0030424; GO:0032496; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043312; GO:0043314; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051649; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0106310; GO:1905517; GO:1905522; GO:2000378,actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; establishment of localization in cell [GO:0051649]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; regulation of cell cycle [GO:0051726]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003013; GO:0003014; GO:0003824; GO:0005829; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0098772; GO:0140096,"immune system process; circulatory system process; renal system process; catalytic activity; cytosol; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03677,3.1012978290717,FUN_014931-T1,Peve_00037145,Pocillopora_meandrina_HIv1___RNAseq.g21089.t1,three_way,68.721,FUN_014931-T1,Q4FAT7,,,,,40.9,580.0,7.9e-123,442.6,sp|Q4FAT7|BGLR_PIG Beta-glucuronidase OS=Sus scrofa OX=9823 GN=GUSB PE=3 SV=1,,,,,,
OG_03680,1.364031106792265,FUN_014939-T1,Peve_00037138,Pocillopora_meandrina_HIv1___RNAseq.g21096.t2,three_way,83.04633333333334,FUN_014939-T1,Q2KJ16,PHKG2_BOVIN,,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-2)",Bos taurus (Bovine),53.3,360.0,1.2e-111,404.8,"sp|Q2KJ16|PHKG2_BOVIN Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Bos taurus OX=9913 GN=PHKG2 PE=2 SV=1",GO:0004689; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005964; GO:0005977; GO:0005980; GO:0007165; GO:0045819,glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0140096,"catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; catalytic activity, acting on a protein"
OG_03696,1.5664740773102828,FUN_014965-T1,Peve_00006259,Pocillopora_meandrina_HIv1___RNAseq.g21129.t1,three_way,85.602,FUN_014965-T1,Q8TBY9,,,,,45.2,938.0,2.5999999999999998e-244,846.7,sp|Q8TBY9|CF251_HUMAN Cilia- and flagella-associated protein 251 OS=Homo sapiens OX=9606 GN=CFAP251 PE=1 SV=2,,,,,,
OG_03698,1.5694095288625878,FUN_014969-T1,Peve_00006263,Pocillopora_meandrina_HIv1___RNAseq.g21132.t2,three_way,67.03883333333333,FUN_014969-T1,B2RXZ1,PNDC1_MOUSE,,Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1),Mus musculus (Mouse),35.4,463.0,4.3e-65,250.4,sp|B2RXZ1|PNDC1_MOUSE Poly(A)-specific ribonuclease PNLDC1 OS=Mus musculus OX=10090 GN=Pnldc1 PE=1 SV=1,GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005783; GO:0005789; GO:0007283; GO:0034587; GO:0046872,"blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005783; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; endoplasmic reticulum; mRNA metabolic process; hydrolase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_03700,1.1073945505391185,FUN_014972-T1,Peve_00006265,Pocillopora_meandrina_HIv1___RNAseq.g21134.t1,three_way,36.17366666666666,,,,,,,,,,,,,,,,,
OG_03710,1.1342644852688786,FUN_014984-T1,Peve_00039939,Pocillopora_meandrina_HIv1___RNAseq.g21146.t1,three_way,63.29966666666667,FUN_014984-T1,Q29RU9,SOX_BOVIN,,Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase),Bos taurus (Bovine),43.6,397.0,5.7e-87,322.8,sp|Q29RU9|SOX_BOVIN Peroxisomal sarcosine oxidase OS=Bos taurus OX=9913 GN=PIPOX PE=2 SV=2,GO:0005777; GO:0008115; GO:0033514; GO:0050031; GO:0050660,L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514],peroxisome [GO:0005777],flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115],GO:0003824; GO:0005777; GO:0006520; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; peroxisome; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03740,1.1304696345425302,FUN_015044-T1,Peve_00031330,Pocillopora_meandrina_HIv1___RNAseq.g21255.t1,three_way,47.4195,,,,,,,,,,,,,,,,,
OG_03763,1.2094090282058592,FUN_015086-T1,Peve_00025601,Pocillopora_meandrina_HIv1___RNAseq.g21189.t1,three_way,82.73233333333333,FUN_015086-T1,O18835,,,,,54.3,619.0,1.3e-195,684.5,sp|O18835|BGLR_CANLF Beta-glucuronidase OS=Canis lupus familiaris OX=9615 GN=GUSB PE=1 SV=1,,,,,,
OG_03779,1.0922824630200667,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_03785,1.4419453864557503,FUN_015145-T1,Peve_00001083,Pocillopora_meandrina_HIv1___RNAseq.g21746.t2,three_way,73.53316666666667,FUN_015145-T1,Q640I9,,,,,30.3,1123.0,1.7999999999999998e-141,505.0,sp|Q640I9|KDM2B_XENLA Lysine-specific demethylase 2B OS=Xenopus laevis OX=8355 GN=kdm2b PE=2 SV=1,,,,,,
OG_03787,1.3938688643250046,FUN_015147-T1,Peve_00020566,Pocillopora_meandrina_HIv1___RNAseq.g29743.t1,three_way,50.849,,,,,,,,,,,,,,,,,
OG_03791,2.171100220011949,FUN_015156-T2,Peve_00001867,Pocillopora_meandrina_HIv1___RNAseq.g21763.t1,three_way,63.6845,FUN_015156-T2,Q6NS15,MED15_XENLA,,Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (xARC105) (Mediator complex subunit 15),Xenopus laevis (African clawed frog),37.3,314.0,2.2e-45,185.3,sp|Q6NS15|MED15_XENLA Mediator of RNA polymerase II transcription subunit 15 OS=Xenopus laevis OX=8355 GN=med15 PE=1 SV=1,GO:0003712; GO:0005654; GO:0005737; GO:0006355; GO:0070847,regulation of DNA-templated transcription [GO:0006355],core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654],transcription coregulator activity [GO:0003712],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_03793,1.3196789400244828,FUN_015164-T1,Peve_00001860,Pocillopora_meandrina_HIv1___TS.g25730.t1,three_way,68.88416666666667,FUN_015164-T1,Q14667,,,,,30.3,2363.0,1.9999999999999998e-285,984.6,sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3,,,,,,
OG_03800,1.019804487023651,FUN_015183-T1,Peve_00023878,Pocillopora_meandrina_HIv1___RNAseq.g22309.t1,three_way,61.66833333333334,FUN_015183-T1,Q86US8,EST1A_HUMAN,,Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a),Homo sapiens (Human),34.5,918.0,1.2999999999999999e-129,466.1,sp|Q86US8|EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens OX=9606 GN=SMG6 PE=1 SV=2,GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006406; GO:0032204; GO:0032210; GO:0035303; GO:0036064; GO:0042162; GO:0043021; GO:0046872; GO:0070034; GO:0070182; GO:1904354,"mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]","chromosome, telomeric region [GO:0000781]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; telomerase holoenzyme complex [GO:0005697]",DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0006913; GO:0016071; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; nucleolus; microtubule organizing center; cytosol; plasma membrane; nucleocytoplasmic transport; mRNA metabolic process; organelle; catalytic activity, acting on RNA"
OG_03809,1.2943493415777187,FUN_015218-T1,Peve_00022749,Pocillopora_meandrina_HIv1___RNAseq.g22337.t1,three_way,67.37333333333333,FUN_015218-T1,Q9NXW9,ALKB4_HUMAN,,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (Alkylated DNA repair protein alkB homolog 4) (DNA N6-methyl adenine demethylase ALKBH4) (EC 1.14.11.51) (Lysine-specific demethylase ALKBH4) (EC 1.14.11.-),Homo sapiens (Human),49.6,232.0,7.100000000000001e-59,228.8,sp|Q9NXW9|ALKB4_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 OS=Homo sapiens OX=9606 GN=ALKBH4 PE=1 SV=1,GO:0003779; GO:0005730; GO:0005737; GO:0016706; GO:0030496; GO:0031032; GO:0032451; GO:0035516; GO:0036090; GO:0046872; GO:0070938; GO:0070988; GO:0140457; GO:0141131; GO:0141137,"actomyosin structure organization [GO:0031032]; cleavage furrow ingression [GO:0036090]; demethylation [GO:0070988]; positive regulation of gene expression, epigenetic [GO:0141137]",contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; actin binding [GO:0003779]; broad specificity oxidative DNA demethylase activity [GO:0035516]; demethylase activity [GO:0032451]; DNA N6-methyladenine demethylase activity [GO:0141131]; metal ion binding [GO:0046872]; protein demethylase activity [GO:0140457],GO:0003824; GO:0005730; GO:0006325; GO:0007010; GO:0008092; GO:0016491; GO:0043226; GO:0061024; GO:0140096; GO:0140097,"catalytic activity; nucleolus; chromatin organization; cytoskeleton organization; cytoskeletal protein binding; oxidoreductase activity; organelle; membrane organization; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_03820,1.0725215982645389,FUN_015231-T1,Peve_00016438,Pocillopora_meandrina_HIv1___RNAseq.g22178.t1,three_way,73.793,FUN_015231-T1,Q9CWQ2,,,,,39.3,135.0,2.2e-23,110.2,sp|Q9CWQ2|ZSWM7_MOUSE Zinc finger SWIM domain-containing protein 7 OS=Mus musculus OX=10090 GN=Zswim7 PE=2 SV=1,,,,,,
OG_03850,1.0500822974531925,FUN_015341-T1,Peve_00011271,Pocillopora_meandrina_HIv1___RNAseq.g21717.t1,three_way,80.268,FUN_015341-T1,A0A1S4F2V5,,,,,44.7,311.0,4.2e-66,254.2,sp|A0A1S4F2V5|CATL_AEDAE Cathepsin L-like peptidase OS=Aedes aegypti OX=7159 PE=1 SV=1,,,,,,
OG_03854,1.562607135298963,FUN_015346-T1,Peve_00017513,Pocillopora_meandrina_HIv1___RNAseq.g21715.t1,three_way,54.33833333333333,,,,,,,,,,,,,,,,,
OG_03857,1.3777751302462509,FUN_015350-T1,Peve_00017519,Pocillopora_meandrina_HIv1___RNAseq.g21710.t1,three_way,76.06583333333333,FUN_015350-T1,P13277,,,,,36.8,321.0,1.5999999999999998e-49,199.1,sp|P13277|CYSP1_HOMAM Digestive cysteine proteinase 1 OS=Homarus americanus OX=6706 GN=LCP1 PE=1 SV=2,,,,,,
OG_03859,1.3014673236160896,FUN_015357-T1,Peve_00000218,Pocillopora_meandrina_HIv1___RNAseq.g21699.t1,three_way,59.97833333333333,FUN_015357-T1,Q18297,TRPA1_CAEEL,,Transient receptor potential cation channel subfamily A member 1 homolog,Caenorhabditis elegans,26.7,737.0,7.4e-60,234.2,sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5,GO:0005216; GO:0005886; GO:0043025; GO:0097730,,neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],monoatomic ion channel activity [GO:0005216],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_03869,1.6061234732311656,FUN_015381-T1,Peve_00000227,Pocillopora_meandrina_HIv1___TS.g26436.t1,three_way,62.752,,,,,,,,,,,,,,,,,
OG_03880,1.9514490618450977,FUN_015414-T1,Peve_00000229,Pocillopora_meandrina_HIv1___TS.g26435.t1,three_way,64.94816666666667,FUN_015414-T1,Q9Z2W8,,,,,38.5,436.0,1.3e-81,305.4,sp|Q9Z2W8|GRIA4_MOUSE Glutamate receptor 4 OS=Mus musculus OX=10090 GN=Gria4 PE=1 SV=2,,,,,,
OG_03895,1.0321740683575995,FUN_015470-T1,Peve_00009523,Pocillopora_meandrina_HIv1___RNAseq.g20981.t1,three_way,61.727,FUN_015470-T1,Q12872,SFSWA_HUMAN,,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",Homo sapiens (Human),40.4,451.0,5e-19,97.8,"sp|Q12872|SFSWA_HUMAN Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3",GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]",nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03899,1.9805953270498675,FUN_015485-T1,Peve_00009508,Pocillopora_meandrina_HIv1___TS.g25731.t1,three_way,66.67466666666667,FUN_015485-T1,Q9EP89,LACTB_MOUSE,,"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)",Mus musculus (Mouse),44.9,432.0,2.1e-105,384.0,"sp|Q9EP89|LACTB_MOUSE Serine beta-lactamase-like protein LACTB, mitochondrial OS=Mus musculus OX=10090 GN=Lactb PE=1 SV=1",GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802,lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216],cytosol [GO:0005829]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; peptidase activity [GO:0008233],GO:0003824; GO:0005739; GO:0005829; GO:0006629; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; lipid metabolic process; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03903,1.3481213794606604,FUN_015977-T1,Peve_00032728,Pocillopora_meandrina_HIv1___RNAseq.g21409.t1,three_way,72.505,,,,,,,,,,,,,,,,,
OG_03909,1.1009785493151074,FUN_015985-T1,Peve_00024008,Pocillopora_meandrina_HIv1___RNAseq.g21401.t1,three_way,57.967666666666666,,,,,,,,,,,,,,,,,
OG_03916,1.0606044290184256,FUN_016002-T1,Peve_00004542,Pocillopora_meandrina_HIv1___RNAseq.g21371.t1,three_way,80.09833333333333,FUN_016002-T1,Q9D7A8,,,,,43.2,273.0,7.999999999999999e-53,208.8,sp|Q9D7A8|ARMC1_MOUSE Armadillo repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Armc1 PE=1 SV=1,,,,,,
OG_03926,1.4281618714973732,FUN_016038-T1,Peve_00011807,Pocillopora_meandrina_HIv1___RNAseq.g21648.t2,three_way,64.21833333333333,FUN_016038-T1,Q8TDN4,CABL1_HUMAN,,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),Homo sapiens (Human),43.4,295.0,2.7e-61,237.7,sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2,GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726,cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0043226; GO:0048856,nucleus; cytosol; organelle; anatomical structure development
OG_03929,1.0016400023853165,FUN_016044-T1,Peve_00011802,Pocillopora_meandrina_HIv1___RNAseq.g21643.t1,three_way,75.492,,,,,,,,,,,,,,,,,
OG_03932,3.3188043738657247,FUN_016048-T1,Peve_00011790,Pocillopora_meandrina_HIv1___RNAseq.g26043.t1,three_way,52.87083333333334,,,,,,,,,,,,,,,,,
OG_03933,4.217310550486415,FUN_016049-T1,Peve_00011814,Pocillopora_meandrina_HIv1___RNAseq.g21636.t1,three_way,52.112,,,,,,,,,,,,,,,,,
OG_03941,1.0372697978931216,FUN_016076-T1,Peve_00021921,Pocillopora_meandrina_HIv1___RNAseq.g21616.t1,three_way,70.497,FUN_016076-T1,Q9C9C6,,,,,49.4,180.0,1.2e-34,147.9,sp|Q9C9C6|RL62_ARATH Large ribosomal subunit protein eL6y OS=Arabidopsis thaliana OX=3702 GN=RPL6B PE=2 SV=1,,,,,,
OG_03950,1.2228864054979136,FUN_016089-T1,Peve_00013364,Pocillopora_meandrina_HIv1___RNAseq.g21562.t1,three_way,69.75566666666667,FUN_016089-T1,Q4V9Y5,,,,,40.3,201.0,9.1e-34,146.4,sp|Q4V9Y5|CRLD2_XENTR Cysteine-rich secretory protein LCCL domain-containing 2 OS=Xenopus tropicalis OX=8364 GN=crispld2 PE=2 SV=1,,,,,,
OG_03967,1.3685241649253097,FUN_016116-T1,Peve_00013351,Pocillopora_meandrina_HIv1___TS.g26292.t1a,three_way,59.283,FUN_016116-T1,Q01097,NMDE2_MOUSE,,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B)",Mus musculus (Mouse),22.8,689.0,2.1e-31,139.0,"sp|Q01097|NMDE2_MOUSE Glutamate receptor ionotropic, NMDA 2B OS=Mus musculus OX=10090 GN=Grin2b PE=1 SV=3",GO:0001662; GO:0001701; GO:0001964; GO:0001967; GO:0004972; GO:0005261; GO:0005262; GO:0005764; GO:0005770; GO:0005789; GO:0005856; GO:0005886; GO:0006812; GO:0006816; GO:0007268; GO:0007423; GO:0007611; GO:0007612; GO:0007613; GO:0008021; GO:0008270; GO:0009986; GO:0014069; GO:0016020; GO:0016595; GO:0017146; GO:0022849; GO:0030425; GO:0030658; GO:0035235; GO:0042596; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0048266; GO:0050966; GO:0051290; GO:0051968; GO:0060078; GO:0060079; GO:0060291; GO:0097060; GO:0097553; GO:0098655; GO:0098794; GO:0098839; GO:0098978; GO:0141161; GO:1902951; GO:1904062; GO:2000463,"behavioral fear response [GO:0001662]; behavioral response to pain [GO:0048266]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; excitatory postsynaptic potential [GO:0060079]; fear response [GO:0042596]; in utero embryonic development [GO:0001701]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; sensory organ development [GO:0007423]; startle response [GO:0001964]; suckling behavior [GO:0001967]",cell surface [GO:0009986]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; transport vesicle membrane [GO:0030658],calcium channel activity [GO:0005262]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005856; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0060089; GO:0065003,transporter activity; lysosome; endosome; vacuole; cytoskeleton; plasma membrane; signaling; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly
OG_03975,1.0553905981904013,FUN_016129-T1,Peve_00013443,Pocillopora_meandrina_HIv1___TS.g26226.t1,three_way,44.653,,,,,,,,,,,,,,,,,
OG_03985,1.983128420047844,FUN_016150-T1,Peve_00013422,Pocillopora_meandrina_HIv1___RNAseq.g22094.t1,three_way,87.48066666666666,,,,,,,,,,,,,,,,,
OG_03986,1.0550768305733658,FUN_016151-T3,Peve_00022570,Pocillopora_meandrina_HIv1___RNAseq.g21228.t1,three_way,51.66783333333333,FUN_016151-T3,Q5SW75,SSH2_MOUSE,,Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (mSSH-2L),Mus musculus (Mouse),48.9,509.0,4.7e-124,448.0,sp|Q5SW75|SSH2_MOUSE Protein phosphatase Slingshot homolog 2 OS=Mus musculus OX=10090 GN=Ssh2 PE=1 SV=2,GO:0001669; GO:0003779; GO:0004722; GO:0004725; GO:0005856; GO:0005925; GO:0007283; GO:0030154; GO:0030837,cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925],actin binding [GO:0003779]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005856; GO:0008092; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; cytoskeletal protein binding; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_04001,1.1320374003915947,FUN_016296-T1,Peve_00043168,Pocillopora_meandrina_HIv1___RNAseq.g503.t1,three_way,73.475,FUN_016296-T1,Q99758,ABCA3_HUMAN,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Homo sapiens (Human),35.3,1952.0,2.1e-296,1020.8,sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2,GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005615; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; extracellular space; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_04008,1.199302805229308,FUN_016308-T1,Peve_00032290,Pocillopora_meandrina_HIv1___RNAseq.g10037.t1,three_way,81.12333333333333,,,,,,,,,,,,,,,,,
OG_04016,1.1285990229043907,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),36.6,361.0,7e-47,191.0,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04016,1.1285990229043907,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),47.1,70.0,3e-13,79.3,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04020,1.0817188541414169,FUN_016325-T1,Peve_00032381,Pocillopora_meandrina_HIv1___RNAseq.g9684.t1,three_way,69.31866666666667,,,,,,,,,,,,,,,,,
OG_04022,1.5676225098963148,FUN_016327-T1,Peve_00032378,Pocillopora_meandrina_HIv1___RNAseq.g9682.t1,three_way,50.593,,,,,,,,,,,,,,,,,
OG_04039,1.5325595527201163,FUN_016347-T1,Peve_00004355,Pocillopora_meandrina_HIv1___RNAseq.g9679.t1,three_way,82.813,FUN_016347-T1,Q9JHX2,,,,,31.5,321.0,1.9e-18,95.1,sp|Q9JHX2|SP5_MOUSE Transcription factor Sp5 OS=Mus musculus OX=10090 GN=Sp5 PE=2 SV=1,,,,,,
OG_04044,1.0283503002639471,FUN_016353-T1,Peve_00004336,Pocillopora_meandrina_HIv1___RNAseq.g9674.t1,three_way,74.80966666666667,FUN_016353-T1,B5XBI1,,,,,63.4,123.0,2.7e-34,147.1,sp|B5XBI1|IF43A_SALSA Intraflagellar transport protein 43 homolog A OS=Salmo salar OX=8030 GN=ift43a PE=2 SV=1,,,,,,
OG_04045,2.392204977358284,FUN_016357-T1,Peve_00004337,Pocillopora_meandrina_HIv1___RNAseq.g9673.t1,three_way,68.83566666666667,FUN_016357-T1,Q8NBP0,,,,,36.6,470.0,3.1e-84,314.3,sp|Q8NBP0|TTC13_HUMAN Tetratricopeptide repeat protein 13 OS=Homo sapiens OX=9606 GN=TTC13 PE=1 SV=3,,,,,,
OG_04049,1.1523603677561725,FUN_016365-T1,Peve_00004342,Pocillopora_meandrina_HIv1___RNAseq.g9605.t1,three_way,60.6625,FUN_016365-T1,Q58D84,,,,,40.3,72.0,1.4e-09,67.0,sp|Q58D84|FSTL1_BOVIN Follistatin-related protein 1 OS=Bos taurus OX=9913 GN=FSTL1 PE=2 SV=1,,,,,,
OG_04072,1.2613022013580493,FUN_016393-T1,Peve_00006406,Pocillopora_meandrina_HIv1___RNAseq.g9756.t1,three_way,90.81433333333334,FUN_016393-T1,Q3T087,,,,,81.8,176.0,2.5e-82,306.2,sp|Q3T087|RL11_BOVIN Large ribosomal subunit protein uL5 OS=Bos taurus OX=9913 GN=RPL11 PE=2 SV=3,,,,,,
OG_04082,1.2100047643776533,FUN_016418-T1,Peve_00023003,Pocillopora_meandrina_HIv1___RNAseq.g9800.t1,three_way,48.49066666666666,,,,,,,,,,,,,,,,,
OG_04116,1.223605089490185,FUN_016492-T1,Peve_00042752,Pocillopora_meandrina_HIv1___RNAseq.g179.t1,three_way,63.57866666666666,FUN_016492-T1,Q8L706,,,,,24.4,312.0,1.1e-15,87.4,sp|Q8L706|SYT5_ARATH Synaptotagmin-5 OS=Arabidopsis thaliana OX=3702 GN=SYT5 PE=2 SV=1,,,,,,
OG_04122,2.347646664383149,FUN_016503-T1,Peve_00016813,Pocillopora_meandrina_HIv1___RNAseq.g9722.t1,three_way,69.429,FUN_016503-T1,Q32LQ4,,,,,58.3,336.0,3.3e-117,422.9,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_04163,1.7634021554238926,FUN_016642-T1,Peve_00042750,Pocillopora_meandrina_HIv1___RNAseq.g209.t1,three_way,69.53533333333333,FUN_016642-T1,Q5ZHV5,JMJD4_CHICK,,2-oxoglutarate and iron-dependent oxygenase JMJD4 (EC 1.14.11.-) (JmjC domain-containing protein 4) (Jumonji domain-containing protein 4) (Lysyl-hydroxylase JMJD4),Gallus gallus (Chicken),54.8,325.0,8.5e-110,398.7,sp|Q5ZHV5|JMJD4_CHICK 2-oxoglutarate and iron-dependent oxygenase JMJD4 OS=Gallus gallus OX=9031 GN=JMJD4 PE=2 SV=1,GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0043565; GO:0045905; GO:0046872; GO:0106156,positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126],cytoplasm [GO:0005737]; nucleus [GO:0005634],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; peptidyl-lysine 4-dioxygenase activity [GO:0106156]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0003824; GO:0005634; GO:0016491; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_04165,1.242993124696889,FUN_016646-T1,Peve_00042745,Pocillopora_meandrina_HIv1___RNAseq.g199.t1,three_way,51.387166666666666,FUN_016646-T1,P30173,,,,,42.1,378.0,2.2e-80,302.4,sp|P30173|ACT13_SOLTU Actin-101 OS=Solanum tuberosum OX=4113 GN=AC101 PE=3 SV=1,,,,,,
OG_04188,1.3868200798341963,FUN_016709-T1,Peve_00024195,Pocillopora_meandrina_HIv1___RNAseq.g276.t1,three_way,51.529833333333336,FUN_016709-T1,P79763,,,,,33.7,543.0,6e-73,277.3,sp|P79763|FSHR_CHICK Follicle-stimulating hormone receptor OS=Gallus gallus OX=9031 GN=FSHR PE=2 SV=1,,,,,,
OG_04200,1.135146514936914,FUN_016733-T1,Peve_00014686,Pocillopora_meandrina_HIv1___RNAseq.g235.t1,three_way,72.43933333333334,,,,,,,,,,,,,,,,,
OG_04213,2.436287377572259,FUN_016850-T1,Peve_00018595,Pocillopora_meandrina_HIv1___RNAseq.g15658.t1,three_way,64.21766666666667,,,,,,,,,,,,,,,,,
OG_04230,2.5564809688836863,FUN_017693-T1,Peve_00030752,Pocillopora_meandrina_HIv1___RNAseq.g23495.t1,three_way,47.43216666666667,,,,,,,,,,,,,,,,,
OG_04233,1.5619876428876494,FUN_017710-T1,Peve_00005948,Pocillopora_meandrina_HIv1___RNAseq.g25375.t1,three_way,60.20766666666667,FUN_017710-T1,P0DXC0,,,,,43.8,336.0,8.8e-67,256.5,sp|P0DXC0|CGLR3_STYPI Cyclic GMP-AMP synthase-like receptor 3 OS=Stylophora pistillata OX=50429 PE=1 SV=1,,,,,,
OG_04236,1.0475489030132,FUN_017757-T1,Peve_00033745,Pocillopora_meandrina_HIv1___RNAseq.g426.t1,three_way,66.6565,FUN_017757-T1,Q5SS90,,,,,34.7,245.0,5.6e-26,119.8,sp|Q5SS90|CG057_MOUSE Uncharacterized protein C7orf57 homolog OS=Mus musculus OX=10090 GN=Gm11992 PE=1 SV=1,,,,,,
OG_04245,1.1074601815921867,FUN_017767-T1,Peve_00014745,Pocillopora_meandrina_HIv1___RNAseq.g460.t1,three_way,69.89833333333333,,,,,,,,,,,,,,,,,
OG_04250,2.14941010899726,FUN_017780-T1,Peve_00029909,Pocillopora_meandrina_HIv1___RNAseq.g9514.t1,three_way,48.56066666666667,,,,,,,,,,,,,,,,,
OG_04252,1.2286528814946125,FUN_017782-T1,Peve_00029910,Pocillopora_meandrina_HIv1___TS.g23048.t1,three_way,68.84083333333334,FUN_017782-T1,P77952,,,,,33.3,129.0,1.6e-06,55.8,sp|P77952|GLSA_STRGR L-glutamine:scyllo-inosose aminotransferase OS=Streptomyces griseus OX=1911 GN=stsC PE=1 SV=1,,,,,,
OG_04256,1.4901119532139873,FUN_017787-T1,Peve_00040530,Pocillopora_meandrina_HIv1___RNAseq.g9522.t1,three_way,41.8165,FUN_017787-T1,Q5VT06,CE350_HUMAN,,Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa),Homo sapiens (Human),39.4,66.0,1.1e-06,56.2,sp|Q5VT06|CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens OX=9606 GN=CEP350 PE=1 SV=1,GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0008017; GO:0016020; GO:0034453; GO:0036064; GO:0043231; GO:0071539; GO:1905515,microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226; GO:0044782,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_04264,1.6368810128606943,FUN_017814-T1,Peve_00006860,Pocillopora_meandrina_HIv1___RNAseq.g9542.t1,three_way,84.417,FUN_017814-T1,Q91029,WNT1_CHICK,,Protein Wnt-1,Gallus gallus (Chicken),51.2,283.0,2.4e-87,323.6,sp|Q91029|WNT1_CHICK Protein Wnt-1 OS=Gallus gallus OX=9031 GN=WNT1 PE=1 SV=3,GO:0005102; GO:0005576; GO:0006915; GO:0009953; GO:0016055; GO:0030509; GO:0031334; GO:0048263,apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of protein-containing complex assembly [GO:0031334]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],signaling receptor binding [GO:0005102],GO:0005576; GO:0012501,extracellular region; programmed cell death
OG_04283,1.0895905372201795,FUN_017846-T1,Peve_00018628,Pocillopora_meandrina_HIv1___RNAseq.g9585.t1,three_way,60.34483333333333,,,,,,,,,,,,,,,,,
OG_04291,2.2548481141409185,FUN_017854-T1,Peve_00019169,Pocillopora_meandrina_HIv1___RNAseq.g20298.t1,three_way,61.41483333333333,FUN_017854-T1,P09875,UD2B1_RAT,,UDP-glucuronosyltransferase 2B1 (UDPGT 2B1) (UGT2B1) (EC 2.4.1.17) (UDPGTr-2),Rattus norvegicus (Rat),34.3,505.0,7.5e-76,286.2,sp|P09875|UD2B1_RAT UDP-glucuronosyltransferase 2B1 OS=Rattus norvegicus OX=10116 GN=Ugt2b1 PE=1 SV=1,GO:0005789; GO:0006805; GO:0008210; GO:0015020; GO:0032496; GO:0070980; GO:0071361; GO:0071378; GO:0071385; GO:0071394,biphenyl catabolic process [GO:0070980]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to testosterone stimulus [GO:0071394]; estrogen metabolic process [GO:0008210]; response to lipopolysaccharide [GO:0032496]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],glucuronosyltransferase activity [GO:0015020],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_04311,1.0155308175385362,FUN_017899-T1,Peve_00000241,Pocillopora_meandrina_HIv1___RNAseq.g341.t1,three_way,85.13083333333333,FUN_017899-T1,Q8ND07,,,,,40.7,477.0,4.6e-76,287.0,sp|Q8ND07|BBOF1_HUMAN Basal body-orientation factor 1 OS=Homo sapiens OX=9606 GN=BBOF1 PE=1 SV=3,,,,,,
OG_04317,1.808273625653946,FUN_017917-T1,Peve_00013070,Pocillopora_meandrina_HIv1___RNAseq.g329.t1,three_way,70.42633333333333,FUN_017917-T1,Q9DAJ5,,,,,51.1,92.0,3.9e-20,99.4,sp|Q9DAJ5|DLRB2_MOUSE Dynein light chain roadblock-type 2 OS=Mus musculus OX=10090 GN=Dynlrb2 PE=1 SV=1,,,,,,
OG_04341,1.232956323952402,FUN_017958-T1,Peve_00000385,Pocillopora_meandrina_HIv1___RNAseq.g25238.t1,three_way,52.00333333333333,FUN_017958-T1,Q6L9W6,B4GN3_HUMAN,,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",Homo sapiens (Human),38.5,327.0,5.7e-66,253.8,"sp|Q6L9W6|B4GN3_HUMAN Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=B4GALNT3 PE=1 SV=2",GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231,,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0005794; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; transferase activity; organelle
OG_04366,1.0390782643625367,FUN_018019-T1,Peve_00026634,Pocillopora_meandrina_HIv1___RNAseq.29613_t,three_way,80.27433333333333,FUN_018019-T1,Q9I3S3,,,,,66.9,314.0,3.5000000000000005e-125,449.5,sp|Q9I3S3|GBUA_PSEAE Guanidinobutyrase OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=gbuA PE=1 SV=1,,,,,,
OG_04371,1.1536582230572516,FUN_018030-T1,Peve_00017616,Pocillopora_meandrina_HIv1___RNAseq.g25339.t1,three_way,71.04333333333334,FUN_018030-T1,P59054,CSRN1_MOUSE,,Cysteine/serine-rich nuclear protein 1 (CSRNP-1) (Axin-1 up-regulated gene 1 protein) (TGF-beta-induced apoptosis protein 3) (TAIP-3),Mus musculus (Mouse),35.6,222.0,4.2e-30,132.9,sp|P59054|CSRN1_MOUSE Cysteine/serine-rich nuclear protein 1 OS=Mus musculus OX=10090 GN=Csrnp1 PE=2 SV=1,GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006915; GO:0009791; GO:0043565; GO:0045944; GO:0048008; GO:0048705; GO:0060021; GO:0060325,apoptotic process [GO:0006915]; face morphogenesis [GO:0060325]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; transcription regulator activity
OG_04373,1.160563367425507,FUN_018033-T1,Peve_00020008,Pocillopora_meandrina_HIv1___TS.g25636.t1,three_way,60.77283333333334,,,,,,,,,,,,,,,,,
OG_04390,1.4944645395764278,FUN_018389-T1,Peve_00032312,Pocillopora_meandrina_HIv1___RNAseq.g10090.t1,three_way,51.62566666666667,,,,,,,,,,,,,,,,,
OG_04418,1.1812857766855875,FUN_018526-T1,Peve_00039209,Pocillopora_meandrina_HIv1___TS.g23531.t1,three_way,63.84433333333334,,,,,,,,,,,,,,,,,
OG_04427,1.993162196075944,FUN_018550-T1,Peve_00032304,Pocillopora_meandrina_HIv1___RNAseq.g10049.t1,three_way,68.13333333333334,FUN_018550-T1,Q5BLD8,,,,,33.1,166.0,2.1e-17,90.9,sp|Q5BLD8|MT21A_DANRE Protein N-lysine methyltransferase METTL21A OS=Danio rerio OX=7955 GN=mettl21a PE=2 SV=1,,,,,,
OG_04434,1.002097573380668,FUN_018790-T1,Peve_00013151,Pocillopora_meandrina_HIv1___RNAseq.g14712.t1,three_way,68.35233333333333,,,,,,,,,,,,,,,,,
OG_04435,1.0610906742019592,FUN_018802-T1,Peve_00013887,Pocillopora_meandrina_HIv1___RNAseq.g9880.t1,three_way,68.601,,,,,,,,,,,,,,,,,
OG_04447,2.090603907468505,FUN_018948-T1,Peve_00035804,Pocillopora_meandrina_HIv1___RNAseq.g366.t1,three_way,49.209500000000006,FUN_018948-T1,P51954,NEK1_MOUSE,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1),Mus musculus (Mouse),41.7,266.0,6.8e-57,223.8,sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2,GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007283; GO:0010212; GO:0030030; GO:0035264; GO:0046872; GO:0051301; GO:0071889; GO:0106310; GO:2000001,cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04449,1.514578876958877,FUN_019015-T1,Peve_00035805,Pocillopora_meandrina_HIv1___RNAseq.g384.t1,three_way,68.97266666666667,FUN_019015-T1,Q03336,RGN_RAT,,Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30),Rattus norvegicus (Rat),49.3,134.0,6.5e-34,145.6,sp|Q03336|RGN_RAT Regucalcin OS=Rattus norvegicus OX=10116 GN=Rgn PE=1 SV=3,GO:0001822; GO:0001889; GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0007283; GO:0008270; GO:0010558; GO:0010867; GO:0010907; GO:0019853; GO:0030234; GO:0032781; GO:0043066; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0097421; GO:1901318; GO:1902679; GO:1903011; GO:1903052; GO:1903625; GO:2000279,intracellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of macromolecule biosynthetic process [GO:0010558]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005975; GO:0006766; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; carbohydrate metabolic process; vitamin metabolic process; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_04470,1.1118614970270724,FUN_020838-T1,Peve_00041429,Pocillopora_meandrina_HIv1___RNAseq.g20756.t1,three_way,72.166,FUN_020838-T1,E9Q634,MYO1E_MOUSE,,Unconventional myosin-Ie (Unconventional myosin 1E),Mus musculus (Mouse),41.5,697.0,1.0999999999999999e-148,529.3,sp|E9Q634|MYO1E_MOUSE Unconventional myosin-Ie OS=Mus musculus OX=10090 GN=Myo1e PE=1 SV=1,GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005903; GO:0005912; GO:0006897; GO:0016459; GO:0016887; GO:0030097; GO:0032836; GO:0035091; GO:0035166; GO:0045334; GO:0048008; GO:0051015; GO:0072015,endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091],GO:0003014; GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856,renal system process; cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_04478,1.4467748304157246,FUN_021108-T1,Peve_00008861,Pocillopora_meandrina_HIv1___RNAseq.g4371.t1,three_way,84.41233333333334,FUN_021108-T1,Q15119,PDK2_HUMAN,,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",Homo sapiens (Human),50.9,385.0,7.8e-108,392.1,"sp|Q15119|PDK2_HUMAN [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2",GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0045254; GO:0050848; GO:0072332,cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; mitochondrion; cytosol; carbohydrate metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04487,1.4679044050084502,FUN_021608-T1,Peve_00002684,Pocillopora_meandrina_HIv1___RNAseq.g2921.t1,three_way,51.73733333333333,FUN_021608-T1,A0JPF9,ISPD_DANRE,,D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein),Danio rerio (Zebrafish) (Brachydanio rerio),46.1,323.0,1e-73,278.9,sp|A0JPF9|ISPD_DANRE D-ribitol-5-phosphate cytidylyltransferase OS=Danio rerio OX=7955 GN=crppa PE=2 SV=2,GO:0005829; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0048854; GO:0055001; GO:0060049; GO:0070567,brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle cell development [GO:0055001]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049],cytosol [GO:0005829],cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006629; GO:0009101; GO:0016740; GO:0048856; GO:1901135,catalytic activity; cytosol; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_04489,1.888846042086701,FUN_021612-T1,Peve_00021567,Pocillopora_meandrina_HIv1___RNAseq.g4223.t1,three_way,65.06666666666666,FUN_021612-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),35.3,439.0,6.1e-64,246.5,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04524,2.1790753802484737,FUN_022059-T1,Peve_00014932,Pocillopora_meandrina_HIv1___RNAseq.g4610.t1,three_way,48.778,FUN_022059-T1,Q9NVV4,PAPD1_HUMAN,,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",Homo sapiens (Human),35.3,292.0,4.3e-40,167.9,"sp|Q9NVV4|PAPD1_HUMAN Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1",GO:0000287; GO:0000965; GO:0002134; GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0006397; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817,histone mRNA catabolic process [GO:0071044]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123],intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140053,RNA binding; catalytic activity; nucleoplasm; mitochondrion; mRNA metabolic process; transferase activity; organelle; mitochondrial gene expression
OG_04538,2.641082661089314,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_04566,2.311603563149883,FUN_022209-T1,Peve_00008601,Pocillopora_meandrina_HIv1___RNAseq.g4801.t1,three_way,46.54666666666667,FUN_022209-T1,Q7KM13,,,,,52.7,91.0,2.1e-14,81.3,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_04574,1.9086367003482303,FUN_022224-T1,Peve_00008148,Pocillopora_meandrina_HIv1___RNAseq.g4744.t1,three_way,83.988,,,,,,,,,,,,,,,,,
OG_04575,1.1908340942580775,FUN_022225-T1,Peve_00008146,Pocillopora_meandrina_HIv1___RNAseq.g4746.t1b,three_way,48.185,FUN_022225-T1,P35448,,,,,39.9,158.0,7.7e-07,57.8,sp|P35448|TSP1_XENLA Thrombospondin-1 OS=Xenopus laevis OX=8355 GN=thbs1 PE=2 SV=1,,,,,,
OG_04585,1.2060972396784653,FUN_022251-T1,Peve_00021288,Pocillopora_meandrina_HIv1___RNAseq.g4724.t1,three_way,52.4535,FUN_022251-T1,P35969,,,,,30.3,511.0,3.1999999999999996e-49,198.7,sp|P35969|VGFR1_MOUSE Vascular endothelial growth factor receptor 1 OS=Mus musculus OX=10090 GN=Flt1 PE=1 SV=1,,,,,,
OG_04587,1.192066834238725,FUN_022259-T1,Peve_00043995,Pocillopora_meandrina_HIv1___RNAseq.g4721.t1,three_way,56.8915,,,,,,,,,,,,,,,,,
OG_04592,1.1968045423081506,FUN_022267-T1,Peve_00043987,Pocillopora_meandrina_HIv1___RNAseq.g4714.t2,three_way,76.18966666666667,FUN_022267-T1,Q63357,MYO1D_RAT,,Unconventional myosin-Id (Myosin heavy chain myr 4),Rattus norvegicus (Rat),52.1,637.0,3e-186,653.3,sp|Q63357|MYO1D_RAT Unconventional myosin-Id OS=Rattus norvegicus OX=10116 GN=Myo1d PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030048; GO:0030424; GO:0030673; GO:0030900; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0044853; GO:0048306; GO:0051015; GO:0061502; GO:0097440,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; forebrain development [GO:0030900]; protein transport [GO:0015031],actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904],GO:0003774; GO:0003824; GO:0005768; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_04595,1.6681516508372336,FUN_022279-T1,Peve_00022093,Pocillopora_meandrina_HIv1___RNAseq.g4703.t2,three_way,75.602,FUN_022279-T1,Q7ZWS1,DUS3L_XENLA,,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),Xenopus laevis (African clawed frog),54.4,634.0,7.399999999999997e-190,665.2,sp|Q7ZWS1|DUS3L_XENLA tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Xenopus laevis OX=8355 GN=dus3l PE=2 SV=1,GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0008270; GO:0017150; GO:0050660; GO:0102265; GO:0106414,mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine47 synthase activity [GO:0102265]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0006399; GO:0016071; GO:0016491; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; mRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_04609,1.6387507859325603,FUN_022305-T1,Peve_00003816,Pocillopora_meandrina_HIv1___RNAseq.g3971.t1,three_way,36.00233333333333,,,,,,,,,,,,,,,,,
OG_04619,1.0835959740413983,FUN_022321-T1,Peve_00021706,Pocillopora_meandrina_HIv1___RNAseq.g4642.t1,three_way,52.955333333333336,,,,,,,,,,,,,,,,,
OG_04620,2.9454821778819973,FUN_022322-T1,Peve_00021644,Pocillopora_meandrina_HIv1___RNAseq.g4643.t1,three_way,86.02233333333332,,,,,,,,,,,,,,,,,
OG_04621,2.1609874301106973,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_04624,1.2353050156036818,FUN_022332-T1,Peve_00028602,Pocillopora_meandrina_HIv1___RNAseq.g4651.t2,three_way,52.3965,FUN_022332-T1,P26008,,,,,27.8,994.0,3.3000000000000003e-81,305.1,sp|P26008|ITAV_CHICK Integrin alpha-V OS=Gallus gallus OX=9031 GN=ITGAV PE=2 SV=1,,,,,,
OG_04635,1.2134252213017271,FUN_022357-T1,Peve_00021682,Pocillopora_meandrina_HIv1___RNAseq.g4585.t1,three_way,74.13533333333334,FUN_022357-T1,P55011,S12A2_HUMAN,,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (hNKCC1),Homo sapiens (Human),45.9,1014.0,4e-238,826.2,sp|P55011|S12A2_HUMAN Solute carrier family 12 member 2 OS=Homo sapiens OX=9606 GN=SLC12A2 PE=1 SV=1,GO:0005886; GO:0006811; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015377; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0031253; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0044298; GO:0045795; GO:0046873; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0061044; GO:0070062; GO:0070634; GO:0071944; GO:0072488; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:0150104; GO:1902476; GO:1903561; GO:1904450; GO:1904464; GO:1990573; GO:1990869,ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; monoatomic ion transport [GO:0006811]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ammonium channel activity [GO:0008519]; chloride:monoatomic cation symporter activity [GO:0015377]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]; protein-folding chaperone binding [GO:0051087]; sodium:potassium:chloride symporter activity [GO:0008511],GO:0002376; GO:0003013; GO:0005215; GO:0005886; GO:0023052; GO:0043226; GO:0048870; GO:0055085,immune system process; circulatory system process; transporter activity; plasma membrane; signaling; organelle; cell motility; transmembrane transport
OG_04651,2.799972743830734,FUN_022386-T3,Peve_00037603,Pocillopora_meandrina_HIv1___RNAseq.g9310.t1,three_way,63.92666666666666,FUN_022386-T3,B8V7S0,,,,,48.6,251.0,2.8e-62,241.5,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_04652,1.1757414514165254,FUN_022389-T1,Peve_00037602,Pocillopora_meandrina_HIv1___TS.g19607.t1,three_way,66.46,FUN_022389-T1,D3Z2X2,DNHD1_MOUSE,,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),Mus musculus (Mouse),22.8,4456.0,4.4999999999999995e-257,891.3,sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3,GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316,flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],dynein complex [GO:0030286]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; isomerase activity; reproductive process; organelle; cilium organization; cell motility; ATP-dependent activity
OG_04662,1.2281388151080266,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4000000000000004e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04666,1.2145803980987626,FUN_022414-T1,Peve_00037631,Pocillopora_meandrina_HIv1___RNAseq.g4357.t1,three_way,37.86366666666667,,,,,,,,,,,,,,,,,
OG_04670,1.3399874111773942,FUN_022428-T1,Peve_00037611,Pocillopora_meandrina_HIv1___RNAseq.g4345.t1,three_way,59.46366666666667,FUN_022428-T1,Q9VCX3,,,,,31.2,253.0,4.2e-31,136.7,sp|Q9VCX3|RM45_DROME Large ribosomal subunit protein mL45 OS=Drosophila melanogaster OX=7227 GN=mRpL45 PE=2 SV=1,,,,,,
OG_04679,1.1567983318699957,FUN_022452-T1,Peve_00009229,Pocillopora_meandrina_HIv1___RNAseq.g4320.t1,three_way,51.78233333333333,FUN_022452-T1,B2LT64,TLR2_GIRCA,,Toll-like receptor 2 (CD antigen CD282),Giraffa camelopardalis (Giraffe),30.2,199.0,2.2e-17,92.0,sp|B2LT64|TLR2_GIRCA Toll-like receptor 2 OS=Giraffa camelopardalis OX=9894 GN=TLR2 PE=3 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0042497; GO:0043235; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727,cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_04682,1.1044405862786606,FUN_022473-T2,Peve_00020969,Pocillopora_meandrina_HIv1___RNAseq.g4307.t1,three_way,65.6105,,,,,,,,,,,,,,,,,
OG_04684,1.336976329748221,FUN_022475-T1,Peve_00020972,Pocillopora_meandrina_HIv1___RNAseq.g4305.t1,three_way,57.77916666666667,,,,,,,,,,,,,,,,,
OG_04685,1.0414243745825924,FUN_022476-T1,Peve_00020971,Pocillopora_meandrina_HIv1___RNAseq.g4304.t1,three_way,48.067,,,,,,,,,,,,,,,,,
OG_04695,1.4616159938770208,FUN_022487-T1,Peve_00002927,Pocillopora_meandrina_HIv1___RNAseq.g4290.t1,three_way,61.783,,,,,,,,,,,,,,,,,
OG_04719,1.755277798220363,FUN_022545-T1,Peve_00003430,Pocillopora_meandrina_HIv1___RNAseq.g4154.t1,three_way,65.10566666666666,FUN_022545-T1,Q7T3E6,,,,,44.2,226.0,4.7e-45,183.3,sp|Q7T3E6|BMI1B_DANRE Polycomb complex protein BMI-1-B OS=Danio rerio OX=7955 GN=bmi1b PE=2 SV=1,,,,,,
OG_04720,1.182877917577541,FUN_022569-T1,Peve_00000937,Pocillopora_meandrina_HIv1___RNAseq.g4156.t1,three_way,73.66833333333334,,,,,,,,,,,,,,,,,
OG_04721,1.00945907514441,FUN_022578-T1,Peve_00020592,Pocillopora_meandrina_HIv1___RNAseq.g4435.t1,three_way,84.55266666666667,FUN_022578-T1,Q9JLI7,SPAG6_MOUSE,,Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog),Mus musculus (Mouse),87.9,506.0,1.2e-81,305.4,sp|Q9JLI7|SPAG6_MOUSE Sperm-associated antigen 6 OS=Mus musculus OX=10090 GN=Spag6 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0003356; GO:0005576; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0021591; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0051649; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716,"cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]",acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lateral wall of outer hair cell [GO:0120249]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm principal piece [GO:0097228],microtubule binding [GO:0008017],GO:0003016; GO:0005576; GO:0005829; GO:0007010; GO:0007018; GO:0007155; GO:0007163; GO:0008092; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877,respiratory system process; extracellular region; cytosol; cytoskeleton organization; microtubule-based movement; cell adhesion; establishment or maintenance of cell polarity; cytoskeletal protein binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process
OG_04759,1.036566576921278,FUN_022649-T1,Peve_00019793,Pocillopora_meandrina_HIv1___RNAseq.g4450.t2,three_way,87.07466666666667,FUN_022649-T1,Q6ZWH5,NEK10_HUMAN,,Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10),Homo sapiens (Human),45.7,1046.0,4.3e-211,736.5,sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911,mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372],extracellular region [GO:0005576]; protein kinase complex [GO:1902911],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003016; GO:0003824; GO:0005576; GO:0007018; GO:0016740; GO:0140096,"respiratory system process; catalytic activity; extracellular region; microtubule-based movement; transferase activity; catalytic activity, acting on a protein"
OG_04771,1.0426340343299108,FUN_022673-T1,Peve_00010102,Pocillopora_meandrina_HIv1___RNAseq.g4124.t2,three_way,59.6315,FUN_022673-T1,Q3U821,,,,,33.9,785.0,7.1e-103,376.7,sp|Q3U821|WDR75_MOUSE WD repeat-containing protein 75 OS=Mus musculus OX=10090 GN=Wdr75 PE=1 SV=1,,,,,,
OG_04775,1.432954833516852,FUN_022679-T1,Peve_00018004,Pocillopora_meandrina_HIv1___RNAseq.g4840.t1,three_way,62.58166666666666,FUN_022679-T1,Q9UKJ3,,,,,46.6,223.0,1.2e-49,199.5,sp|Q9UKJ3|GPTC8_HUMAN G patch domain-containing protein 8 OS=Homo sapiens OX=9606 GN=GPATCH8 PE=1 SV=2,,,,,,
OG_04778,1.1090071084523858,FUN_022684-T1,Peve_00019690,Pocillopora_meandrina_HIv1___TS.g22251.t2,three_way,75.05633333333333,FUN_022684-T1,O94880,PHF14_HUMAN,,PHD finger protein 14,Homo sapiens (Human),48.8,291.0,4.8e-73,276.6,sp|O94880|PHF14_HUMAN PHD finger protein 14 OS=Homo sapiens OX=9606 GN=PHF14 PE=1 SV=3,GO:0000122; GO:0000785; GO:0002314; GO:0005634; GO:0005694; GO:0005737; GO:0008270; GO:0008285; GO:0010463; GO:0042393; GO:0048286; GO:0060916; GO:0072201; GO:0140566; GO:2000584; GO:2000791,germinal center B cell differentiation [GO:0002314]; lung alveolus development [GO:0048286]; mesenchymal cell proliferation [GO:0010463]; mesenchymal cell proliferation involved in lung development [GO:0060916]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122],chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634],histone binding [GO:0042393]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270],GO:0002376; GO:0005634; GO:0005694; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0060090,immune system process; nucleus; chromosome; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; molecular adaptor activity
OG_04783,1.772850103077629,FUN_022694-T1,Peve_00045101,Pocillopora_meandrina_HIv1___RNAseq.g4831.t1,three_way,58.6035,,,,,,,,,,,,,,,,,
OG_04784,1.6786075830010097,FUN_022696-T1,Peve_00045102,Pocillopora_meandrina_HIv1___TS.g22242.t1,three_way,67.26566666666666,,,,,,,,,,,,,,,,,
OG_04786,1.359024841115696,FUN_022700-T1,Peve_00018683,Pocillopora_meandrina_HIv1___RNAseq.g4826.t1,three_way,70.454,FUN_022700-T1,Q9NS86,LANC2_HUMAN,,LanC-like protein 2 (Testis-specific adriamycin sensitivity protein),Homo sapiens (Human),49.2,386.0,2.1e-89,330.9,sp|Q9NS86|LANC2_HUMAN LanC-like protein 2 OS=Homo sapiens OX=9606 GN=LANCL2 PE=1 SV=1,GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0009789; GO:0010314; GO:0030864; GO:0031179; GO:0032266; GO:0045892; GO:0070273,carbohydrate metabolic process [GO:0005975]; negative regulation of DNA-templated transcription [GO:0045892]; peptide modification [GO:0031179]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789],cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314],GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005975; GO:0006355; GO:0008289; GO:0043226,nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; carbohydrate metabolic process; regulation of DNA-templated transcription; lipid binding; organelle
OG_04794,1.328421115840074,FUN_022710-T1,Peve_00006885,Pocillopora_meandrina_HIv1___RNAseq.g4817.t1,three_way,81.13166666666666,FUN_022710-T1,Q3T904,ATG9A_BOVIN,,Autophagy-related protein 9A (APG9-like 1) (Autophagy protein 9),Bos taurus (Bovine),54.5,462.0,1.2e-152,541.6,sp|Q3T904|ATG9A_BOVIN Autophagy-related protein 9A OS=Bos taurus OX=9913 GN=ATG9A PE=2 SV=1,GO:0000045; GO:0000139; GO:0000407; GO:0000421; GO:0000423; GO:0005739; GO:0005776; GO:0005789; GO:0005794; GO:0005802; GO:0017128; GO:0031902; GO:0031966; GO:0034045; GO:0034497; GO:0034727; GO:0055038; GO:0060349; GO:0061709; GO:0097300,autophagosome assembly [GO:0000045]; bone morphogenesis [GO:0060349]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed necrotic cell death [GO:0097300]; protein localization to phagophore assembly site [GO:0034497]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802],phospholipid scramblase activity [GO:0017128],GO:0005215; GO:0005739; GO:0005773; GO:0005794; GO:0006914; GO:0012501; GO:0043226,transporter activity; mitochondrion; vacuole; Golgi apparatus; autophagy; programmed cell death; organelle
OG_04808,1.3824762010126246,FUN_022767-T1,Peve_00014658,Pocillopora_meandrina_HIv1___RNAseq.g4729.t1,three_way,73.63166666666666,FUN_022767-T1,Q7ZX22,WDR24_XENLA,,GATOR2 complex protein WDR24 (EC 2.3.2.27),Xenopus laevis (African clawed frog),38.4,799.0,4.6e-160,566.6,sp|Q7ZX22|WDR24_XENLA GATOR2 complex protein WDR24 OS=Xenopus laevis OX=8355 GN=wdr24 PE=2 SV=1,GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0008270; GO:0016239; GO:0031669; GO:0034198; GO:0061630; GO:0061700; GO:0085020; GO:1904263,autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016740; GO:0140096,"catalytic activity; cytosol; autophagy; transferase activity; catalytic activity, acting on a protein"
OG_04814,1.0930935434561544,FUN_022778-T1,Peve_00021168,Pocillopora_meandrina_HIv1___RNAseq.g4772.t1,three_way,76.42866666666667,,,,,,,,,,,,,,,,,
OG_04815,1.0058300288608293,FUN_022787-T1,Peve_00030606,Pocillopora_meandrina_HIv1___TS.g22189.t1,three_way,80.07866666666666,FUN_022787-T1,Q95R48,,,,,30.0,397.0,2.1000000000000002e-48,194.5,sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2,,,,,,
OG_04833,1.4952207477438308,FUN_022827-T1,Peve_00028898,Pocillopora_meandrina_HIv1___RNAseq.g3431.t1,three_way,84.11833333333334,FUN_022827-T1,Q0IJ33,,,,,54.4,362.0,6.2e-117,422.2,sp|Q0IJ33|TM129_XENTR E3 ubiquitin-protein ligase TM129 OS=Xenopus tropicalis OX=8364 GN=tmem129 PE=2 SV=1,,,,,,
OG_04869,1.3881300384323243,FUN_022896-T1,Peve_00001719,Pocillopora_meandrina_HIv1___RNAseq.g3697.t1,three_way,53.845,,,,,,,,,,,,,,,,,
OG_04881,1.1264894872880569,FUN_022915-T1,Peve_00001787,Pocillopora_meandrina_HIv1___RNAseq.g3711.t1,three_way,84.37066666666666,FUN_022915-T1,P55036,PSMD4_HUMAN,,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),Homo sapiens (Human),60.6,383.0,1.1e-98,361.7,sp|P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMD4 PE=1 SV=1,GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226; GO:0060090,RNA binding; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_04890,2.821566519176164,FUN_022933-T1,Peve_00016029,Pocillopora_meandrina_HIv1___RNAseq.g3734.t1,three_way,55.45366666666667,,,,,,,,,,,,,,,,,
OG_04911,1.2248339444909349,FUN_022963-T1,Peve_00011891,Pocillopora_meandrina_HIv1___RNAseq.g3767.t1,three_way,65.58466666666666,FUN_022963-T1,P29275,AA2BR_HUMAN,,Adenosine receptor A2b,Homo sapiens (Human),30.9,304.0,7e-20,99.8,sp|P29275|AA2BR_HUMAN Adenosine receptor A2b OS=Homo sapiens OX=9606 GN=ADORA2B PE=1 SV=1,GO:0001609; GO:0002882; GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0007190; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0042311; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171,activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087]; vasodilation [GO:0042311],glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930],GO:0002376; GO:0003012; GO:0003013; GO:0005886; GO:0016192; GO:0060089,immune system process; muscle system process; circulatory system process; plasma membrane; vesicle-mediated transport; molecular transducer activity
OG_04917,1.229497666190661,FUN_022971-T1,Peve_00011907,Pocillopora_meandrina_HIv1___RNAseq.g3757.t1,three_way,63.9935,FUN_022971-T1,A9ULG4,AUP1_XENTR,,Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),35.3,306.0,6.1e-41,169.5,sp|A9ULG4|AUP1_XENTR Lipid droplet-regulating VLDL assembly factor AUP1 OS=Xenopus tropicalis OX=8364 GN=aup1 PE=2 SV=1,GO:0005789; GO:0005811; GO:0034389; GO:0036503; GO:0043130; GO:0140042; GO:1990044,ERAD pathway [GO:0036503]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; protein localization to lipid droplet [GO:1990044],endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811],ubiquitin binding [GO:0043130],GO:0005811; GO:0030163; GO:0043226,lipid droplet; protein catabolic process; organelle
OG_04930,1.046282203928699,FUN_022997-T1,Peve_00006903,Pocillopora_meandrina_HIv1___RNAseq.g3793.t1,three_way,49.0015,,,,,,,,,,,,,,,,,
OG_04932,1.6766572010625411,FUN_023000-T1,Peve_00024659,Pocillopora_meandrina_HIv1___RNAseq.g3813.t1,three_way,53.00183333333333,FUN_023000-T1,Q90Z00,FGR1A_DANRE,,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,804.0,7.2e-136,486.5,sp|Q90Z00|FGR1A_DANRE Fibroblast growth factor receptor 1-A OS=Danio rerio OX=7955 GN=fgfr1a PE=1 SV=2,GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043410; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699,anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04950,1.1097652935250175,FUN_023040-T1,Peve_00008504,Pocillopora_meandrina_HIv1___RNAseq.g3859.t1,three_way,86.40083333333334,FUN_023040-T1,Q28479,IDH3B_MACFA,,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),57.6,337.0,1.3e-112,407.9,"sp|Q28479|IDH3B_MACFA Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial OS=Macaca fascicularis OX=9541 GN=IDH3B PE=2 SV=2",GO:0000287; GO:0005739; GO:0006099; GO:0006102; GO:0016616; GO:0051287,isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],mitochondrion [GO:0005739],"magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_04961,3.2422935052064217,FUN_023053-T1,Peve_00027088,Pocillopora_meandrina_HIv1___RNAseq.g13314.t1,three_way,61.67966666666666,,,,,,,,,,,,,,,,,
OG_04964,1.1482474346955696,FUN_023063-T1,Peve_00024670,Pocillopora_meandrina_HIv1___RNAseq.g3882.t1,three_way,80.55416666666666,FUN_023063-T1,Q66L33,,,,,68.8,192.0,2e-75,283.9,sp|Q66L33|MK16A_XENLA Protein MAK16 homolog A OS=Xenopus laevis OX=8355 GN=mak16-a PE=2 SV=1,,,,,,
OG_04969,1.4304067865672383,FUN_023074-T1,Peve_00014065,Pocillopora_meandrina_HIv1___RNAseq.g1647.t1,three_way,71.61066666666666,FUN_023074-T1,Q8NBF2,,,,,51.1,704.0,3.9e-195,682.9,sp|Q8NBF2|NHLC2_HUMAN NHL repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=NHLRC2 PE=1 SV=1,,,,,,
OG_04979,1.9204890901635283,FUN_023099-T1,Peve_00006979,Pocillopora_meandrina_HIv1___TS.g4182.t1,three_way,64.4485,FUN_023099-T1,P55115,,,,,34.9,278.0,7e-41,171.0,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_05006,1.2212677654075803,FUN_023156-T1,Peve_00017446,Pocillopora_meandrina_HIv1___RNAseq.g12683.t1,three_way,83.89033333333333,FUN_023156-T1,Q8VC12,,,,,73.1,439.0,8.5e-185,647.9,sp|Q8VC12|HUTU_MOUSE Urocanate hydratase OS=Mus musculus OX=10090 GN=Uroc1 PE=1 SV=2,,,,,,
OG_05010,2.1349596280578083,FUN_023162-T1,Peve_00018796,Pocillopora_meandrina_HIv1___TS.g25340.t2b,three_way,66.74266666666666,FUN_023162-T1,Q6BEA2,PRS27_RAT,,Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin),Rattus norvegicus (Rat),41.8,256.0,1.7e-54,214.5,sp|Q6BEA2|PRS27_RAT Serine protease 27 OS=Rattus norvegicus OX=10116 GN=Prss27 PE=2 SV=1,GO:0004252; GO:0005576; GO:0005886; GO:0006508,proteolysis [GO:0006508],extracellular region [GO:0005576]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_05023,1.680398753862521,FUN_023186-T1,Peve_00009988,Pocillopora_meandrina_HIv1___RNAseq.g668.t1,three_way,64.46583333333334,FUN_023186-T1,Q6NXT6,TAPT1_HUMAN,,Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor),Homo sapiens (Human),52.5,503.0,7.099999999999999e-135,482.6,sp|Q6NXT6|TAPT1_HUMAN Transmembrane anterior posterior transformation protein 1 homolog OS=Homo sapiens OX=9606 GN=TAPT1 PE=1 SV=1,GO:0001503; GO:0005654; GO:0005789; GO:0005813; GO:0005829; GO:0014032; GO:0016020; GO:0016520; GO:0030030; GO:0036064; GO:0045724; GO:0048706; GO:0051216; GO:0061036; GO:1903012,cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654],growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005654; GO:0005815; GO:0005829; GO:0048856; GO:0060089,nucleoplasm; microtubule organizing center; cytosol; anatomical structure development; molecular transducer activity
OG_05031,2.2139699874694267,FUN_023205-T1,Peve_00010002,Pocillopora_meandrina_HIv1___RNAseq.g681.t2,three_way,61.8175,FUN_023205-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),41.3,150.0,3.5e-26,119.8,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_05045,1.0962979817188032,FUN_023231-T1,Peve_00029854,Pocillopora_meandrina_HIv1___RNAseq.g17040.t1,three_way,64.61666666666667,FUN_023231-T1,Q9WU56,PUS1_MOUSE,,Pseudouridylate synthase 1 homolog (EC 5.4.99.-) (tRNA pseudouridine synthase 1) (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I),Mus musculus (Mouse),44.1,338.0,8.4e-74,279.3,sp|Q9WU56|PUS1_MOUSE Pseudouridylate synthase 1 homolog OS=Mus musculus OX=10090 GN=Pus1 PE=1 SV=2,GO:0000049; GO:0002153; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0009982; GO:0031119; GO:0045944; GO:0106029; GO:0160147; GO:1990481,mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119],mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(38-40) synthase activity [GO:0160147],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006355; GO:0006399; GO:0016071; GO:0016853; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; regulation of DNA-templated transcription; tRNA metabolic process; mRNA metabolic process; isomerase activity; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_05048,1.0740604145100152,FUN_023237-T1,Peve_00029851,Pocillopora_meandrina_HIv1___RNAseq.g17389.t1,three_way,74.06716666666667,FUN_023237-T1,B9FHF3,DJB6_ORYSJ,,DnaJ protein ERDJ3B (Chaperone protein dnaJ B6) (OsDjB6) (Endoplasmic reticulum dnaJ domain-containing protein 3B) (OsERdj3B),Oryza sativa subsp. japonica (Rice),47.3,55.0,6.4e-09,64.3,sp|B9FHF3|DJB6_ORYSJ DnaJ protein ERDJ3B OS=Oryza sativa subsp. japonica OX=39947 GN=ERDJ3B PE=1 SV=1,GO:0005737; GO:0005788; GO:0042026; GO:0051082; GO:0051087,protein refolding [GO:0042026],cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788],protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0006457,protein folding
OG_05062,1.8352911184640524,FUN_023259-T1,Peve_00019266,Pocillopora_meandrina_HIv1___RNAseq.g574.t1,three_way,69.79666666666667,,,,,,,,,,,,,,,,,
OG_05071,5.544653588281533,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_05072,1.5830284527448035,FUN_023298-T1,Peve_00041305,Pocillopora_meandrina_HIv1___RNAseq.g17780.t1,three_way,76.65966666666667,FUN_023298-T1,Q5XIH9,HPDL_RAT,,4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) (EC 1.13.11.46) (Glyoxalase domain-containing protein 1),Rattus norvegicus (Rat),32.8,390.0,1.4e-48,195.3,sp|Q5XIH9|HPDL_RAT 4-hydroxyphenylpyruvate dioxygenase-like protein OS=Rattus norvegicus OX=10116 GN=Hpdl PE=2 SV=1,GO:0003868; GO:0005739; GO:0009072; GO:0046872; GO:0050585,aromatic amino acid metabolic process [GO:0009072],mitochondrion [GO:0005739],4-hydroxymandelate synthase activity [GO:0050585]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_05082,1.5802309020818124,FUN_023314-T1,Peve_00017882,Pocillopora_meandrina_HIv1___RNAseq.g17767.t1,three_way,79.65150000000001,FUN_023314-T1,P47870,GBRB2_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Homo sapiens (Human),40.5,321.0,5.9e-61,236.5,sp|P47870|GBRB2_HUMAN Gamma-aminobutyric acid receptor subunit beta-2 OS=Homo sapiens OX=9606 GN=GABRB2 PE=1 SV=2,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0022851; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0051932; GO:0060119; GO:0060384; GO:0070062; GO:0071420; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05107,1.074683428920227,FUN_023365-T1,Peve_00005350,Pocillopora_meandrina_HIv1___TS.g17124.t1,three_way,78.19416666666667,FUN_023365-T1,Q15542,TAF5_HUMAN,,Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100),Homo sapiens (Human),27.4,361.0,1.6e-32,142.5,sp|Q15542|TAF5_HUMAN Transcription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3,GO:0000124; GO:0000785; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006357; GO:0006367; GO:0015629; GO:0016251; GO:0033276; GO:0042789; GO:0042802; GO:0045893; GO:0051123; GO:0060261,DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276],identical protein binding [GO:0042802]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0005654; GO:0005856; GO:0006351; GO:0006355; GO:0016071; GO:0043226; GO:0065003; GO:0140223,nucleus; nucleoplasm; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; organelle; protein-containing complex assembly; general transcription initiation factor activity
OG_05120,1.1139027382397626,FUN_023382-T1,Peve_00014629,Pocillopora_meandrina_HIv1___RNAseq.g17514.t1,three_way,70.77666666666667,FUN_023382-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),27.7,411.0,1.6e-37,158.7,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05124,1.2360655074954787,FUN_023388-T1,Peve_00038655,Pocillopora_meandrina_HIv1___TS.g17146.t1,three_way,77.67366666666666,FUN_023388-T1,H9D1R1,,,,,53.0,151.0,1.9000000000000002e-38,162.9,sp|H9D1R1|TXD12_EPICO Thioredoxin domain-containing protein 12 OS=Epinephelus coioides OX=94232 GN=Txndc12 PE=1 SV=1,,,,,,
OG_05129,1.1285198643446237,FUN_023394-T2,Peve_00038661,Pocillopora_meandrina_HIv1___RNAseq.g17627.t1,three_way,62.523,FUN_023394-T2,P10746,HEM4_HUMAN,,Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase),Homo sapiens (Human),36.3,262.0,2.3e-39,164.1,sp|P10746|HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens OX=9606 GN=Mgu PE=1 SV=1,GO:0004852; GO:0005542; GO:0005739; GO:0005829; GO:0006780; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0048034; GO:0070541; GO:0071243; GO:0071418,cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780],cytosol [GO:0005829]; mitochondrion [GO:0005739],folic acid binding [GO:0005542]; uroporphyrinogen-III synthase activity [GO:0004852],GO:0003824; GO:0005739; GO:0005829; GO:0016829; GO:0043226,catalytic activity; mitochondrion; cytosol; lyase activity; organelle
OG_05134,1.189064226662769,FUN_023405-T1,Peve_00016099,Pocillopora_meandrina_HIv1___RNAseq.g17555.t1,three_way,68.52166666666666,,,,,,,,,,,,,,,,,
OG_05150,1.9605726820972136,FUN_023433-T1,Peve_00019225,Pocillopora_meandrina_HIv1___TS.g25287.t1,three_way,71.47266666666667,FUN_023433-T1,Q9UBG0,MRC2_HUMAN,,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),Homo sapiens (Human),32.6,132.0,8.5e-14,80.5,sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2,GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023,collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649],focal adhesion [GO:0005925]; membrane [GO:0016020],carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023],GO:0016192; GO:0030154; GO:0060089,vesicle-mediated transport; cell differentiation; molecular transducer activity
OG_05169,2.0079251369775046,FUN_023497-T1,Peve_00017459,Pocillopora_meandrina_HIv1___RNAseq.g539.t1,three_way,83.72433333333333,FUN_023497-T1,Q7T292,,,,,56.8,301.0,4.9e-98,359.4,sp|Q7T292|MFRN2_DANRE Mitoferrin-2 OS=Danio rerio OX=7955 GN=slc25a28 PE=2 SV=1,,,,,,
OG_05177,1.1987827862538456,FUN_023507-T1,Peve_00005822,Pocillopora_meandrina_HIv1___RNAseq.g568.t1,three_way,58.58383333333333,,,,,,,,,,,,,,,,,
OG_05231,1.178966023587558,FUN_023644-T1,Peve_00027824,Pocillopora_meandrina_HIv1___RNAseq.g17819.t1,three_way,74.502,,,,,,,,,,,,,,,,,
OG_05252,1.0014194277952484,FUN_023700-T1,Peve_00017416,Pocillopora_meandrina_HIv1___RNAseq.g17595.t2b,three_way,81.831,FUN_023700-T1,O14776,TCRG1_HUMAN,,Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150),Homo sapiens (Human),60.9,274.0,1.7000000000000001e-65,251.1,sp|O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=2,GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063,mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation factor activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_05262,1.5029118892863778,FUN_023774-T1,Peve_00036451,Pocillopora_meandrina_HIv1___RNAseq.g24245.t1,three_way,66.79066666666667,FUN_023774-T1,Q8BXN7,PPM1K_MOUSE,,Protein phosphatase Mn(2+)-dependent 1K (Branched-chain alpha-ketoacid dehydrogenase phosphatase) (BCKDH) (BDP) (EC 3.1.3.16) (Protein phosphatase 2C family member) (Protein phosphatase 2C isoform kappa) (PP2C-kappa) ([3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)]-phosphatase) (EC 3.1.3.52),Mus musculus (Mouse),42.5,358.0,5.8e-70,266.2,sp|Q8BXN7|PPM1K_MOUSE Protein phosphatase Mn(2+)-dependent 1K OS=Mus musculus OX=10090 GN=Ppm1k PE=1 SV=1,GO:0004722; GO:0005739; GO:0005759; GO:0009083; GO:0030145; GO:0047385; GO:1902108,branched-chain amino acid catabolic process [GO:0009083]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],[3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity [GO:0047385]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005739; GO:0006520; GO:0007005; GO:0016787; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; mitochondrion; amino acid metabolic process; mitochondrion organization; hydrolase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_05268,1.0090468143039488,FUN_023921-T1,Peve_00026572,Pocillopora_meandrina_HIv1___TS.g27910.t1,three_way,65.93933333333332,,,,,,,,,,,,,,,,,
OG_05269,1.200617050059069,FUN_023922-T1,Peve_00017665,Pocillopora_meandrina_HIv1___TS.g28130.t1a,three_way,66.8095,FUN_023922-T1,Q3UMC0,AFG2A_MOUSE,,ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5),Mus musculus (Mouse),47.8,856.0,3.2e-207,723.4,sp|Q3UMC0|AFG2A_MOUSE ATPase family gene 2 protein homolog A OS=Mus musculus OX=10090 GN=Afg2a PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275,brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856,catalytic activity; mitochondrion; cytosol; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development
OG_05274,1.5756350912026198,FUN_023928-T1,Peve_00026565,Pocillopora_meandrina_HIv1___TS.g27906.t1a,three_way,36.54933333333333,FUN_023928-T1,Q3V2Q8,N42L1_MOUSE,,NEDD4-binding protein 2-like 1,Mus musculus (Mouse),51.4,175.0,3.6999999999999997e-41,172.2,sp|Q3V2Q8|N42L1_MOUSE NEDD4-binding protein 2-like 1 OS=Mus musculus OX=10090 GN=N4bp2l1 PE=1 SV=1,,,,,,
OG_05276,1.0747288723097217,FUN_023934-T1,Peve_00017662,Pocillopora_meandrina_HIv1___RNAseq.g18854.t1,three_way,58.2855,,,,,,,,,,,,,,,,,
OG_05277,1.024247077087734,FUN_023935-T1,Peve_00017663,Pocillopora_meandrina_HIv1___RNAseq.g18855.t1,three_way,79.559,FUN_023935-T1,Q91X58,ZFN2B_MOUSE,,AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein),Mus musculus (Mouse),63.0,135.0,4.5e-51,203.0,sp|Q91X58|ZFN2B_MOUSE AN1-type zinc finger protein 2B OS=Mus musculus OX=10090 GN=Zfand2b PE=1 SV=1,GO:0000502; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0016020; GO:0031593; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047,"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; proteasome complex [GO:0000502],K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270],GO:0005783; GO:0006886; GO:0030163; GO:0043226; GO:0055085,endoplasmic reticulum; intracellular protein transport; protein catabolic process; organelle; transmembrane transport
OG_05281,1.0507954373041712,FUN_023943-T2,Peve_00023222,Pocillopora_meandrina_HIv1___RNAseq.g18860.t1,three_way,70.39283333333333,FUN_023943-T2,Q9JHI7,EXOS9_MOUSE,,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),Mus musculus (Mouse),48.0,452.0,3.4e-104,380.2,sp|Q9JHI7|EXOS9_MOUSE Exosome complex component RRP45 OS=Mus musculus OX=10090 GN=Exosc9 PE=1 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0000228; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0030307; GO:0035925; GO:0045944; GO:0061629; GO:0071028; GO:0071035; GO:0101019,nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0000228; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006355; GO:0016071; GO:0043226,nuclear chromosome; RNA binding; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_05294,1.2156643368597249,FUN_023962-T1,Peve_00043985,Pocillopora_meandrina_HIv1___RNAseq.g18585.t1,three_way,84.302,,,,,,,,,,,,,,,,,
OG_05300,1.3645884504712351,FUN_023970-T1,Peve_00025471,Pocillopora_meandrina_HIv1___TS.g27927.t1a,three_way,49.32233333333333,FUN_023970-T1,Q9R0W9,ACHA6_MOUSE,,Neuronal acetylcholine receptor subunit alpha-6,Mus musculus (Mouse),31.3,332.0,1.1e-41,172.9,sp|Q9R0W9|ACHA6_MOUSE Neuronal acetylcholine receptor subunit alpha-6 OS=Mus musculus OX=10090 GN=Chrna6 PE=1 SV=2,GO:0004888; GO:0005892; GO:0014059; GO:0022848; GO:0034703; GO:0035095; GO:0042734; GO:0045211; GO:0051899; GO:0098691; GO:0098878; GO:0099171,behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059],acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neurotransmitter receptor complex [GO:0098878]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0060089,transporter activity; molecular transducer activity
OG_05304,1.7955316128206478,FUN_023976-T1,Peve_00020879,Pocillopora_meandrina_HIv1___RNAseq.g19436.t1,three_way,62.5495,FUN_023976-T1,Q9HBW9,AGRL4_HUMAN,,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",Homo sapiens (Human),37.6,93.0,1.4e-08,65.1,sp|Q9HBW9|AGRL4_HUMAN Adhesion G protein-coupled receptor L4 OS=Homo sapiens OX=9606 GN=ADGRL4 PE=1 SV=3,GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0031410,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0031410; GO:0043226; GO:0060089,plasma membrane; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05316,1.045911164726385,FUN_024001-T1,Peve_00034187,Pocillopora_meandrina_HIv1___RNAseq.g19350.t1,three_way,77.74116666666666,FUN_024001-T1,P15056,BRAF_HUMAN,,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),Homo sapiens (Human),47.0,743.0,1.8999999999999998e-173,610.9,sp|P15056|BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens OX=9606 GN=BRAF PE=1 SV=4,GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007173; GO:0008270; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0033077; GO:0033138; GO:0034446; GO:0034451; GO:0035019; GO:0036064; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043231; GO:0043367; GO:0043369; GO:0043524; GO:0044297; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0098793; GO:0098794; GO:0098978; GO:0099170; GO:0106310; GO:1900026; GO:2000301; GO:2000352,"animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542]",cell body [GO:0044297]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007155; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; cell adhesion; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05363,2.0686857266961955,FUN_024144-T1,Peve_00036832,Pocillopora_meandrina_HIv1___RNAseq.g19865.t1,three_way,39.884166666666665,,,,,,,,,,,,,,,,,
OG_05371,1.1208464429707896,FUN_024173-T1,Peve_00010869,Pocillopora_meandrina_HIv1___RNAseq.g13457.t1,three_way,74.04,FUN_024173-T1,Q2UPB1,,,,,24.9,454.0,1.8e-29,132.1,sp|Q2UPB1|ACLC_ASPOR Cytochrome P450 monooxygenase aclC OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) OX=510516 GN=aclC PE=3 SV=1,,,,,,
OG_05377,2.7835533941076864,FUN_024194-T1,Peve_00018695,Pocillopora_meandrina_HIv1___RNAseq.g18881.t1,three_way,60.04266666666667,FUN_024194-T1,O75330,HMMR_HUMAN,,Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168),Homo sapiens (Human),45.3,148.0,1.2e-20,103.6,sp|O75330|HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens OX=9606 GN=HMMR PE=1 SV=2,GO:0005540; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0006898; GO:0009986; GO:0015630; GO:0016020; GO:0030214; GO:0038024,hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cell surface [GO:0009986]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819],cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540],GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0016192; GO:0038024; GO:0043226; GO:1901135,microtubule organizing center; cytosol; cytoskeleton; plasma membrane; vesicle-mediated transport; cargo receptor activity; organelle; carbohydrate derivative metabolic process
OG_05395,1.5748027403594282,FUN_024222-T1,Peve_00031895,Pocillopora_meandrina_HIv1___RNAseq.g18914.t1,three_way,77.07900000000001,FUN_024222-T1,Q13887,KLF5_HUMAN,,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),Homo sapiens (Human),38.6,166.0,5.3e-19,96.7,sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1901653; GO:1990830; GO:1990837,angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816],chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005654; GO:0005794; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleoplasm; Golgi apparatus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05398,1.1244101345767192,FUN_024327-T2,Peve_00016300,Pocillopora_meandrina_HIv1___RNAseq.g18921.t1,three_way,43.888,FUN_024327-T2,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),38.0,108.0,1.7e-11,71.6,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_05410,1.31907422675151,FUN_024344-T1,Peve_00016805,Pocillopora_meandrina_HIv1___RNAseq.g18930.t1,three_way,83.4915,FUN_024344-T1,F1QN74,,,,,50.1,435.0,4.5e-125,449.5,sp|F1QN74|ZMY10_DANRE Zinc finger MYND domain-containing protein 10 OS=Danio rerio OX=7955 GN=zmynd10 PE=2 SV=1,,,,,,
OG_05416,1.2099112881207812,FUN_024354-T1,Peve_00024185,Pocillopora_meandrina_HIv1___RNAseq.g18690.t1,three_way,66.696,FUN_024354-T1,Q5I0M0,SETMR_RAT,,Histone-lysine N-methyltransferase SETMAR (EC 2.1.1.357) (SET domain and mariner transposase fusion protein homolog),Rattus norvegicus (Rat),46.7,289.0,3.1000000000000003e-66,253.4,sp|Q5I0M0|SETMR_RAT Histone-lysine N-methyltransferase SETMAR OS=Rattus norvegicus OX=10116 GN=Setmar PE=2 SV=1,GO:0000014; GO:0000729; GO:0000793; GO:0003677; GO:0003690; GO:0003697; GO:0004519; GO:0005634; GO:0006303; GO:0006308; GO:0008270; GO:0008283; GO:0015074; GO:0031297; GO:0032259; GO:0035861; GO:0042054; GO:0042800; GO:0042803; GO:0044547; GO:0044774; GO:0045814; GO:0045892; GO:0046975; GO:0140954; GO:2001034; GO:2001251,"cell population proliferation [GO:0008283]; DNA catabolic process [GO:0006308]; DNA double-strand break processing [GO:0000729]; DNA integration [GO:0015074]; double-strand break repair via nonhomologous end joining [GO:0006303]; methylation [GO:0032259]; mitotic DNA integrity checkpoint signaling [GO:0044774]; negative regulation of chromosome organization [GO:2001251]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; replication fork processing [GO:0031297]",condensed chromosome [GO:0000793]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone methyltransferase activity [GO:0042054]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromosome; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_05446,1.0743881895627834,FUN_024402-T1,Peve_00007147,Pocillopora_meandrina_HIv1___RNAseq.g18634.t1,three_way,78.25166666666667,FUN_024402-T1,O54865,,,,,51.5,532.0,1.4e-146,521.2,sp|O54865|GCYB1_MOUSE Guanylate cyclase soluble subunit beta-1 OS=Mus musculus OX=10090 GN=Gucy1b1 PE=1 SV=1,,,,,,
OG_05450,1.0794956397390292,FUN_024408-T1,Peve_00015478,Pocillopora_meandrina_HIv1___TS.g28030.t1,three_way,67.57766666666666,FUN_024408-T1,Q8I719,KGP_PLAF7,,cGMP-dependent protein kinase (EC 2.7.11.12) (PfPKG),Plasmodium falciparum (isolate 3D7),26.9,245.0,7.8e-13,77.4,sp|Q8I719|KGP_PLAF7 cGMP-dependent protein kinase OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PKG PE=1 SV=1,GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005952; GO:0006468; GO:0007165; GO:0007276; GO:0019898; GO:0030553; GO:0046872; GO:0106310,gamete generation [GO:0007276]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005783; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_05453,2.1689305522719398,FUN_024411-T1,Peve_00011775,Pocillopora_meandrina_HIv1___RNAseq.g18636.t1,three_way,77.30883333333334,FUN_024411-T1,Q7T163,KDISB_DANRE,,Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B),Danio rerio (Zebrafish) (Brachydanio rerio),35.3,893.0,4.3999999999999996e-141,504.6,sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3,GO:0005770; GO:0007399; GO:0019887; GO:0030165; GO:0031902; GO:0038180,nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399],late endosome [GO:0005770]; late endosome membrane [GO:0031902],PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887],GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0098772,endosome; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_05457,2.232027035645656,FUN_024418-T1,Peve_00029260,Pocillopora_meandrina_HIv1___RNAseq.g18720.t1,three_way,74.32566666666666,FUN_024418-T1,Q98SN7,,,,,55.1,345.0,5e-110,399.4,sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1,,,,,,
OG_05477,2.033559674292749,FUN_024467-T1,Peve_00026395,Pocillopora_meandrina_HIv1___RNAseq.g18560.t1,three_way,49.363166666666665,,,,,,,,,,,,,,,,,
OG_05489,1.3957028312556683,FUN_024487-T1,Peve_00042022,Pocillopora_meandrina_HIv1___RNAseq.g18539.t1,three_way,70.27733333333333,FUN_024487-T1,A2BGL3,,,,,31.5,111.0,1.6e-08,60.8,sp|A2BGL3|WSCD2_DANRE Sialate:O-sulfotransferase 2 OS=Danio rerio OX=7955 GN=wscd2 PE=3 SV=1,,,,,,
OG_05497,1.882039939321047,FUN_024556-T1,Peve_00039499,Pocillopora_meandrina_HIv1___RNAseq.g18655.t1,three_way,76.91333333333333,FUN_024556-T1,Q9GKT2,,,,,52.6,310.0,6.9e-100,365.5,sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1,,,,,,
OG_05502,1.028150066056359,FUN_024566-T1,Peve_00009964,Pocillopora_meandrina_HIv1___RNAseq.g19087.t1,three_way,94.32233333333332,FUN_024566-T1,P81436,OGT1_RABIT,,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),Oryctolagus cuniculus (Rabbit),77.1,1013.0,5.3000000000000025e-211,736.1,sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2,GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263,apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0006355; GO:0008289; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; nucleus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid binding; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05503,1.7016967876690734,FUN_024567-T1,Peve_00036070,Pocillopora_meandrina_HIv1___RNAseq.g19088.t1,three_way,78.1325,FUN_024567-T1,Q8WXW3,PIBF1_HUMAN,,Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90),Homo sapiens (Human),39.1,713.0,3.8000000000000003e-119,430.6,sp|Q8WXW3|PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens OX=9606 GN=PIBF1 PE=1 SV=2,GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0036064; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515,activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],interleukin-4 receptor binding [GO:0005136],GO:0002376; GO:0005615; GO:0005634; GO:0005815; GO:0007010; GO:0043226; GO:0044782,immune system process; extracellular space; nucleus; microtubule organizing center; cytoskeleton organization; organelle; cilium organization
OG_05506,1.4564960164648182,FUN_024587-T1,Peve_00037917,Pocillopora_meandrina_HIv1___RNAseq.2717_t,three_way,63.268,,,,,,,,,,,,,,,,,
OG_05558,1.1695461248646155,FUN_024776-T1,Peve_00036224,Pocillopora_meandrina_HIv1___RNAseq.g18814.t1,three_way,89.42866666666667,FUN_024776-T1,Q8BTV1,TUSC3_MOUSE,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33) (Tumor suppressor candidate 3),Mus musculus (Mouse),65.9,299.0,8.100000000000001e-124,444.9,sp|Q8BTV1|TUSC3_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 OS=Mus musculus OX=10090 GN=Tusc3 PE=1 SV=1,GO:0005739; GO:0008250; GO:0015693; GO:0018279; GO:0050890; GO:0062062,cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279],mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250],oligosaccharyltransferase complex binding [GO:0062062],GO:0005739; GO:0009101; GO:0043226; GO:0050877; GO:1901135,mitochondrion; glycoprotein biosynthetic process; organelle; nervous system process; carbohydrate derivative metabolic process
OG_05566,1.4413125200807473,FUN_024796-T1,Peve_00007042,Pocillopora_meandrina_HIv1___RNAseq.g18794.t1,three_way,55.33416666666667,,,,,,,,,,,,,,,,,
OG_05573,1.3488607056239896,FUN_024861-T1,Peve_00026074,Pocillopora_meandrina_HIv1___RNAseq.g18770.t1,three_way,57.13,FUN_024861-T1,Q8NEG2,,,,,29.7,182.0,2.8e-08,60.8,sp|Q8NEG2|CG057_HUMAN Uncharacterized protein C7orf57 OS=Homo sapiens OX=9606 GN=C7orf57 PE=1 SV=3,,,,,,
OG_05582,2.2524124468897035,FUN_024906-T1,Peve_00038387,Pocillopora_meandrina_HIv1___RNAseq.g19419.t1,three_way,66.53216666666667,FUN_024906-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),24.3,382.0,1.2000000000000001e-30,135.6,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05585,1.275796340623321,FUN_024916-T1,Peve_00007311,Pocillopora_meandrina_HIv1___RNAseq.g22868.t1,three_way,51.687666666666665,,,,,,,,,,,,,,,,,
OG_05589,1.488297660733768,FUN_025035-T1,Peve_00038379,Pocillopora_meandrina_HIv1___RNAseq.g19423.t1,three_way,84.7295,FUN_025035-T1,Q6DCE3,ZNT9_XENLA,,"Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9)",Xenopus laevis (African clawed frog),48.4,517.0,2.8e-121,437.2,"sp|Q6DCE3|ZNT9_XENLA Proton-coupled zinc antiporter SLC30A9, mitochondrial OS=Xenopus laevis OX=8355 GN=slc30a9 PE=2 SV=1",GO:0005385; GO:0005634; GO:0005783; GO:0006829; GO:0006882; GO:0010821; GO:0015297; GO:0031410; GO:0031966,intracellular zinc ion homeostasis [GO:0006882]; regulation of mitochondrion organization [GO:0010821]; zinc ion transport [GO:0006829],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],antiporter activity [GO:0015297]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005634; GO:0005783; GO:0031410; GO:0043226,transporter activity; nucleus; endoplasmic reticulum; cytoplasmic vesicle; organelle
OG_05601,1.078470354019757,FUN_025233-T1,Peve_00034838,Pocillopora_meandrina_HIv1___RNAseq.g13605.t1,three_way,74.29116666666667,FUN_025233-T1,P49916,DNLI3_HUMAN,,DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3),Homo sapiens (Human),56.4,922.0,2.1e-265,916.8,sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2,GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]",DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0007005; GO:0016874; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; mitochondrion organization; ligase activity; organelle; catalytic activity, acting on DNA"
OG_05609,1.013207038637697,FUN_025294-T1,Peve_00040955,Pocillopora_meandrina_HIv1___RNAseq.g13469.t1,three_way,53.38583333333333,,,,,,,,,,,,,,,,,
OG_05611,1.5005595883883074,FUN_025296-T1,Peve_00001926,Pocillopora_meandrina_HIv1___RNAseq.g11490.t1,three_way,45.81016666666667,,,,,,,,,,,,,,,,,
OG_05622,1.016418027807665,FUN_025315-T1,Peve_00027083,Pocillopora_meandrina_HIv1___RNAseq.g13448.t1,three_way,79.72466666666666,FUN_025315-T1,P30038,AL4A1_HUMAN,,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)",Homo sapiens (Human),55.4,552.0,1.2e-183,644.4,"sp|P30038|AL4A1_HUMAN Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH4A1 PE=1 SV=3",GO:0003842; GO:0004029; GO:0005739; GO:0005759; GO:0005829; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802,4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_05626,1.5099041447777322,FUN_025321-T1,Peve_00027089,Pocillopora_meandrina_HIv1___RNAseq.g13423.t1,three_way,58.5,,,,,,,,,,,,,,,,,
OG_05637,1.9006042511438368,FUN_025338-T2,Peve_00000776,Pocillopora_meandrina_HIv1___RNAseq.g24106.t1,three_way,62.506,,,,,,,,,,,,,,,,,
OG_05640,2.50519436286984,FUN_025348-T1,Peve_00004327,Pocillopora_meandrina_HIv1___TS.g2360.t1a,three_way,40.693666666666665,,,,,,,,,,,,,,,,,
OG_05674,1.1071970014134085,FUN_025504-T1,Peve_00040926,Pocillopora_meandrina_HIv1___RNAseq.g13217.t1,three_way,54.756166666666665,FUN_025504-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),42.3,196.0,3.5e-33,144.8,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05691,1.8047656912536505,FUN_025542-T1,Peve_00032958,Pocillopora_meandrina_HIv1___RNAseq.g13798.t1,three_way,69.249,,,,,,,,,,,,,,,,,
OG_05707,1.0079405089562972,FUN_025580-T1,Peve_00010640,Pocillopora_meandrina_HIv1___RNAseq.g13742.t1,three_way,70.19,FUN_025580-T1,B1AUE5,PEX10_MOUSE,,Peroxisome biogenesis factor 10 (EC 2.3.2.27) (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10),Mus musculus (Mouse),43.1,313.0,1.7e-62,241.5,sp|B1AUE5|PEX10_MOUSE Peroxisome biogenesis factor 10 OS=Mus musculus OX=10090 GN=Pex10 PE=2 SV=1,GO:0000209; GO:0005777; GO:0005778; GO:0008270; GO:0016562; GO:0034614; GO:0061630,"cellular response to reactive oxygen species [GO:0034614]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein polyubiquitination [GO:0000209]",peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005777; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; peroxisome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05721,2.123543341416384,FUN_025629-T1,Peve_00032155,Pocillopora_meandrina_HIv1___TS.g16003.t1,three_way,70.9745,FUN_025629-T1,A2AP18,,,,,46.6,736.0,4.500000000000001e-186,652.9,"sp|A2AP18|PLCH2_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 OS=Mus musculus OX=10090 GN=Plch2 PE=1 SV=2",,,,,,
OG_05750,1.7605500215297092,FUN_025682-T1,Peve_00000456,Pocillopora_meandrina_HIv1___TS.g2103.t1,three_way,67.785,FUN_025682-T1,Q3UQ28,PXDN_MOUSE,,Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Mus musculus (Mouse),38.9,742.0,5.6000000000000005e-126,454.1,sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005198; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003,catalytic activity; structural molecule activity; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly
OG_05759,1.4455874378751403,FUN_025700-T1,Peve_00004692,Pocillopora_meandrina_HIv1___RNAseq.g13829.t1,three_way,50.16833333333334,FUN_025700-T1,P13116,,,,,38.1,97.0,4.7e-06,55.5,sp|P13116|SRC2_XENLA Tyrosine-protein kinase Src-2 OS=Xenopus laevis OX=8355 GN=src-b PE=2 SV=3,,,,,,
OG_05769,1.0893023712238683,FUN_025728-T1,Peve_00024169,Pocillopora_meandrina_HIv1___RNAseq.g10438.t1,three_way,70.458,FUN_025728-T1,Q8WZA2,RPGF4_HUMAN,,Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII),Homo sapiens (Human),49.9,351.0,4.2e-105,382.9,sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1,GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0050796; GO:0098686; GO:0098693,adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of insulin secretion [GO:0050796]; regulation of synaptic vesicle cycle [GO:0098693],cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0002376; GO:0005829; GO:0005886; GO:0016192; GO:0060090; GO:0098772,immune system process; cytosol; plasma membrane; vesicle-mediated transport; molecular adaptor activity; molecular function regulator activity
OG_05809,2.19010417196306,FUN_025809-T2,Peve_00017944,Pocillopora_meandrina_HIv1___TS.g19642.t2,three_way,56.2395,FUN_025809-T2,Q08EN7,,,,,29.7,286.0,1.6e-26,122.5,sp|Q08EN7|ZCPW2_MOUSE Zinc finger CW-type PWWP domain protein 2 homolog OS=Mus musculus OX=10090 GN=Zcwpw2 PE=2 SV=2,,,,,,
OG_05813,1.4942806786406693,FUN_025815-T1,Peve_00002524,Pocillopora_meandrina_HIv1___RNAseq.g9337.t1,three_way,46.56366666666667,FUN_025815-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),32.5,126.0,2e-11,71.2,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05819,1.8882078667843656,FUN_025826-T1,Peve_00036290,Pocillopora_meandrina_HIv1___RNAseq.g9346.t1,three_way,60.5495,FUN_025826-T1,B8V7Q1,,,,,39.9,3257.0,0.0,2112.0,sp|B8V7Q1|PCDL_ACRMI Protocadherin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05831,1.6516645793289546,FUN_025871-T1,Peve_00012180,Pocillopora_meandrina_HIv1___RNAseq.g10343.t1,three_way,78.87733333333334,FUN_025871-T1,Q9Y5Z0,BACE2_HUMAN,,Beta-secretase 2 (EC 3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase),Homo sapiens (Human),33.6,307.0,3e-36,154.5,sp|Q9Y5Z0|BACE2_HUMAN Beta-secretase 2 OS=Homo sapiens OX=9606 GN=BACE2 PE=1 SV=1,GO:0004190; GO:0005768; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0016020; GO:0016485; GO:0016486; GO:0032438; GO:0033162; GO:0042593; GO:0042985; GO:0050435,amyloid-beta metabolic process [GO:0050435]; glucose homeostasis [GO:0042593]; melanosome organization [GO:0032438]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],aspartic-type endopeptidase activity [GO:0004190],GO:0003824; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_05849,1.3206838578235385,FUN_025921-T2,Peve_00028582,Pocillopora_meandrina_HIv1___RNAseq.g3140.t1,three_way,66.67733333333334,FUN_025921-T2,Q924Y0,,,,,28.8,392.0,3.3e-45,184.1,sp|Q924Y0|BODG_MOUSE Gamma-butyrobetaine dioxygenase OS=Mus musculus OX=10090 GN=Bbox1 PE=1 SV=1,,,,,,
OG_05854,2.132978733781832,FUN_025929-T1,Peve_00027749,Pocillopora_meandrina_HIv1___RNAseq.g10531.t1,three_way,67.36683333333333,FUN_025929-T1,Q6NUT3,MFS12_HUMAN,,Major facilitator superfamily domain-containing protein 12,Homo sapiens (Human),33.6,529.0,5.6e-76,287.0,sp|Q6NUT3|MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens OX=9606 GN=MFSD12 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05865,1.24415917071463,FUN_025974-T1,Peve_00002327,Pocillopora_meandrina_HIv1___RNAseq.g10508.t1,three_way,78.03366666666666,,,,,,,,,,,,,,,,,
OG_05866,1.1885162773669438,FUN_025975-T1,Peve_00002326,Pocillopora_meandrina_HIv1___RNAseq.g10507.t1,three_way,57.90466666666666,,,,,,,,,,,,,,,,,
OG_05882,1.342941461159502,FUN_026035-T1,Peve_00022186,Pocillopora_meandrina_HIv1___TS.g13968.t3,three_way,87.66533333333334,FUN_026035-T1,Q5ZKI4,,,,,58.3,604.0,6.5000000000000004e-186,652.1,sp|Q5ZKI4|CCD93_CHICK Coiled-coil domain-containing protein 93 OS=Gallus gallus OX=9031 GN=CCDC93 PE=2 SV=1,,,,,,
OG_05885,1.1441722254620363,FUN_026038-T1,Peve_00022188,Pocillopora_meandrina_HIv1___RNAseq.g10551.t1,three_way,73.833,FUN_026038-T1,A0JMH2,,,,,40.4,292.0,2.700000000000001e-59,230.3,sp|A0JMH2|CB069_DANRE Mitochondrial protein C2orf69 homolog OS=Danio rerio OX=7955 GN=zgc:153521 PE=2 SV=1,,,,,,
OG_05888,1.1577896701150427,FUN_026052-T1,Peve_00022191,Pocillopora_meandrina_HIv1___RNAseq.g10554.t1,three_way,94.17266666666669,,,,,,,,,,,,,,,,,
OG_05897,1.0264417399256731,FUN_026073-T1,Peve_00002028,Pocillopora_meandrina_HIv1___RNAseq.g10563.t1a,three_way,88.83766666666666,FUN_026073-T1,Q5F495,,,,,81.9,204.0,3.4000000000000003e-100,365.9,sp|Q5F495|PHOCN_CHICK MOB-like protein phocein OS=Gallus gallus OX=9031 GN=MOB4 PE=2 SV=1,,,,,,
OG_05909,1.0048489042554185,FUN_026100-T1,Peve_00013337,Pocillopora_meandrina_HIv1___RNAseq.g10578.t1,three_way,53.79516666666667,FUN_026100-T1,Q6ZSS7,MFSD6_HUMAN,,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog),Homo sapiens (Human),46.2,106.0,1.0000000000000001e-23,114.0,sp|Q6ZSS7|MFSD6_HUMAN Major facilitator superfamily domain-containing protein 6 OS=Homo sapiens OX=9606 GN=MFSD6 PE=1 SV=2,GO:0005886; GO:0016020; GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590],membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0002376; GO:0005886,immune system process; plasma membrane
OG_05916,1.2155455360427876,FUN_026108-T1,Peve_00014996,Pocillopora_meandrina_HIv1___RNAseq.g10317.t1,three_way,87.78083333333333,FUN_026108-T1,Q9HD67,MYO10_HUMAN,,Unconventional myosin-X (Unconventional myosin-10),Homo sapiens (Human),45.4,2065.0,0.0,1582.8,sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3,GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002,cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]",GO:0003774; GO:0003824; GO:0005730; GO:0005829; GO:0005886; GO:0008092; GO:0008289; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleolus; cytosol; plasma membrane; cytoskeletal protein binding; lipid binding; isomerase activity; organelle; ATP-dependent activity
OG_05920,1.1009984443460432,FUN_026136-T1,Peve_00029016,Pocillopora_meandrina_HIv1___RNAseq.g6100.t1,three_way,47.75216666666667,,,,,,,,,,,,,,,,,
OG_05926,1.4783099329003375,FUN_026150-T1,Peve_00020731,Pocillopora_meandrina_HIv1___RNAseq.g3216.t1,three_way,83.78333333333333,FUN_026150-T1,Q9UJ83,HACL1_HUMAN,,2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2),Homo sapiens (Human),60.0,578.0,2.3e-206,719.9,sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2,GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:0106359; GO:0106376; GO:1903512,fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0005654; GO:0005777; GO:0005829; GO:0006629; GO:0016829; GO:0043226,catalytic activity; nucleoplasm; peroxisome; cytosol; lipid metabolic process; lyase activity; organelle
OG_05962,1.2516066149744,FUN_026309-T1,Peve_00036856,Pocillopora_meandrina_HIv1___RNAseq.g3064.t1,three_way,88.59666666666666,FUN_026309-T1,Q6X1Y6,ASIC3_MOUSE,,Acid-sensing ion channel 3 (ASIC3) (Amiloride-sensitive cation channel 3) (Dorsal root ASIC) (DRASIC),Mus musculus (Mouse),31.1,453.0,2.4e-56,222.2,sp|Q6X1Y6|ASIC3_MOUSE Acid-sensing ion channel 3 OS=Mus musculus OX=10090 GN=Asic3 PE=1 SV=2,GO:0005261; GO:0005737; GO:0005886; GO:0006812; GO:0006814; GO:0009408; GO:0009612; GO:0010447; GO:0015280; GO:0034220; GO:0042931; GO:0050907; GO:0050915; GO:0050961; GO:0050965; GO:0050966; GO:0050968; GO:0050974; GO:0051649; GO:0051899; GO:0160125,detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception [GO:0050961]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; establishment of localization in cell [GO:0051649]; membrane depolarization [GO:0051899]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of sour taste [GO:0050915]; sodium ion transport [GO:0006814],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],enterobactin transmembrane transporter activity [GO:0042931]; ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated sodium channel activity [GO:0160125],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_05967,1.2324246560717076,FUN_026374-T1,Peve_00021083,Pocillopora_meandrina_HIv1___RNAseq.g290.t1,three_way,60.242,FUN_026374-T1,Q9NZB8,,,,,44.6,231.0,2.5999999999999996e-43,177.2,sp|Q9NZB8|MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens OX=9606 GN=MOCS1 PE=1 SV=3,,,,,,
OG_05990,1.370684598096656,FUN_026477-T1,Peve_00002334,Pocillopora_meandrina_HIv1___RNAseq.g4181.t1,three_way,66.879,,,,,,,,,,,,,,,,,
OG_06000,1.2214409353612548,FUN_026489-T1,Peve_00002086,Pocillopora_meandrina_HIv1___TS.g21598.t2,three_way,57.582,FUN_026489-T1,Q9BUL9,,,,,37.9,87.0,2.8e-09,63.9,sp|Q9BUL9|RPP25_HUMAN Ribonuclease P protein subunit p25 OS=Homo sapiens OX=9606 GN=RPP25 PE=1 SV=1,,,,,,
OG_06007,1.337861379021622,FUN_026527-T1,Peve_00021565,Pocillopora_meandrina_HIv1___RNAseq.g4205.t1,three_way,58.59633333333333,,,,,,,,,,,,,,,,,
OG_06011,1.1369104367006666,FUN_026537-T1,Peve_00034458,Pocillopora_meandrina_HIv1___RNAseq.18533_t,three_way,67.80466666666666,,,,,,,,,,,,,,,,,
OG_06022,1.939517025728684,FUN_026564-T1,Peve_00043274,Pocillopora_meandrina_HIv1___RNAseq.g4519.t1,three_way,45.92583333333333,FUN_026564-T1,Q9DD78,,,,,32.7,107.0,3.3e-12,75.1,sp|Q9DD78|TLR21_CHICK Toll-like receptor 2 type-1 OS=Gallus gallus OX=9031 GN=TLR2-1 PE=2 SV=1,,,,,,
OG_06029,1.00735055611368,FUN_026590-T1,Peve_00043908,Pocillopora_meandrina_HIv1___RNAseq.g4497.t1,three_way,58.6655,FUN_026590-T1,A4D1E9,GTPBA_HUMAN,,GTP-binding protein 10 (Protein obg homolog 2) (ObgH2),Homo sapiens (Human),46.9,286.0,1.5e-65,252.3,sp|A4D1E9|GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens OX=9606 GN=GTPBP10 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254,ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0003924; GO:0005694; GO:0005730; GO:0005739; GO:0016787; GO:0042254; GO:0043226,RNA binding; catalytic activity; GTPase activity; chromosome; nucleolus; mitochondrion; hydrolase activity; ribosome biogenesis; organelle
OG_06030,1.4017326741774143,FUN_026591-T1,Peve_00035407,Pocillopora_meandrina_HIv1___RNAseq.g4496.t1,three_way,59.29,,,,,,,,,,,,,,,,,
OG_06035,1.0892018883851045,FUN_026628-T1,Peve_00030693,Pocillopora_meandrina_HIv1___RNAseq.g4477.t1,three_way,52.323,FUN_026628-T1,Q86VD9,PIGZ_HUMAN,,"GPI alpha-1,2-mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3)",Homo sapiens (Human),34.0,556.0,2.2e-66,255.0,"sp|Q86VD9|PIGZ_HUMAN GPI alpha-1,2-mannosyltransferase 4 OS=Homo sapiens OX=9606 GN=PIGZ PE=1 SV=4",GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]",GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06042,1.2380983974292294,FUN_026705-T1,Peve_00018528,Pocillopora_meandrina_HIv1___RNAseq.g9382.t1,three_way,63.395,FUN_026705-T1,Q1LUQ4,,,,,23.4,559.0,4.5e-32,141.0,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_06049,1.1916780027914258,FUN_026721-T1,Peve_00018533,Pocillopora_meandrina_HIv1___RNAseq.g9388.t1,three_way,45.75816666666667,,,,,,,,,,,,,,,,,
OG_06057,2.3461285230813638,FUN_026741-T2,Peve_00006716,Pocillopora_meandrina_HIv1___RNAseq.g9416.t1,three_way,57.72766666666666,FUN_026741-T2,Q8BKN6,,,,,53.6,261.0,1.3000000000000001e-71,271.6,sp|Q8BKN6|HS3SA_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 OS=Mus musculus OX=10090 GN=Hs3st3a1 PE=2 SV=1,,,,,,
OG_06060,2.1210530885293224,FUN_026826-T1,Peve_00021661,Pocillopora_meandrina_HIv1___RNAseq.g2905.t1,three_way,81.5875,FUN_026826-T1,Q6PHS6,,,,,41.4,950.0,6.9e-205,715.7,sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1,,,,,,
OG_06070,1.346552611762169,FUN_026918-T1,Peve_00013241,Pocillopora_meandrina_HIv1___TS.g19711.t1,three_way,50.77583333333333,FUN_026918-T1,Q96NB3,,,,,29.6,328.0,8.3e-19,95.9,sp|Q96NB3|ZN830_HUMAN Zinc finger protein 830 OS=Homo sapiens OX=9606 GN=ZNF830 PE=1 SV=2,,,,,,
OG_06071,1.0570093356941503,FUN_026976-T1,Peve_00013247,Pocillopora_meandrina_HIv1___TS.g17924.t2,three_way,66.8675,FUN_026976-T1,Q9NZ56,FMN2_HUMAN,,Formin-2,Homo sapiens (Human),40.8,449.0,2e-89,331.6,sp|Q9NZ56|FMN2_HUMAN Formin-2 OS=Homo sapiens OX=9606 GN=FMN2 PE=1 SV=4,GO:0003779; GO:0005634; GO:0005730; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0015031; GO:0015629; GO:0016192; GO:0016477; GO:0030036; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781,actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0005730; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0022414; GO:0043226; GO:0048856; GO:0048870,cytokinesis; nucleus; nucleolus; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; reproductive process; organelle; anatomical structure development; cell motility
OG_06078,1.254558329285148,FUN_026989-T1,Peve_00012936,Pocillopora_meandrina_HIv1___RNAseq.g10353.t1,three_way,77.742,FUN_026989-T1,Q6UW02,,,,,30.3,472.0,2.6e-70,267.7,sp|Q6UW02|CP20A_HUMAN Cytochrome P450 20A1 OS=Homo sapiens OX=9606 GN=CYP20A1 PE=1 SV=1,,,,,,
OG_06088,1.3366080820429884,FUN_027087-T1,Peve_00012239,Pocillopora_meandrina_HIv1___RNAseq.g24966.t1,three_way,81.16233333333334,FUN_027087-T1,E9Q3T6,PRD14_MOUSE,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Mus musculus (Mouse),53.8,234.0,2.2e-67,257.7,sp|E9Q3T6|PRD14_MOUSE PR domain zinc finger protein 14 OS=Mus musculus OX=10090 GN=Prdm14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0032259; GO:0040029; GO:0040037; GO:0045814; GO:0048873; GO:0060818; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of gene expression [GO:0010468]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_06099,1.2915309880796852,FUN_027735-T1,Peve_00036492,Pocillopora_meandrina_HIv1___RNAseq.g13904.t1,three_way,70.82816666666666,FUN_027735-T1,O94888,UBXN7_HUMAN,,UBX domain-containing protein 7,Homo sapiens (Human),41.6,500.0,1e-93,345.5,sp|O94888|UBXN7_HUMAN UBX domain-containing protein 7 OS=Homo sapiens OX=9606 GN=UBXN7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_06114,1.0072639154010163,FUN_027831-T1,Peve_00020551,Pocillopora_meandrina_HIv1___RNAseq.g13868.t1,three_way,74.62966666666667,FUN_027831-T1,Q9H892,,,,,27.8,753.0,8.2e-63,243.4,sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2,,,,,,
OG_06119,1.1821384534949984,FUN_027850-T1,Peve_00024333,Pocillopora_meandrina_HIv1___TS.g11653.t1,three_way,77.86916666666667,,,,,,,,,,,,,,,,,
OG_06134,1.205480100351454,FUN_027944-T2,Peve_00023150,Pocillopora_meandrina_HIv1___TS.g11810.t1,three_way,50.5155,,,,,,,,,,,,,,,,,
OG_06135,1.2756952683934664,FUN_027946-T1,Peve_00034208,Pocillopora_meandrina_HIv1___RNAseq.g14033.t1,three_way,60.9715,FUN_027946-T1,Q0V9T8,,,,,63.8,229.0,1e-86,322.4,sp|Q0V9T8|BIVM_XENTR Basic immunoglobulin-like variable motif-containing protein OS=Xenopus tropicalis OX=8364 GN=bivm PE=2 SV=1,,,,,,
OG_06152,1.3199521924943267,FUN_027984-T2,Peve_00011299,Pocillopora_meandrina_HIv1___RNAseq.g13864.t1,three_way,75.97583333333333,,,,,,,,,,,,,,,,,
OG_06157,2.03342162821115,FUN_028000-T1,Peve_00023138,Pocillopora_meandrina_HIv1___RNAseq.g14071.t1,three_way,85.642,FUN_028000-T1,Q80W32,DRC9_MOUSE,,Dynein regulatory complex protein 9 (IQ domain-containing protein G),Mus musculus (Mouse),40.1,357.0,2.6999999999999998e-62,240.7,sp|Q80W32|DRC9_MOUSE Dynein regulatory complex protein 9 OS=Mus musculus OX=10090 GN=Iqcg PE=1 SV=1,GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126,sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544],GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0048856,cytosol; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; anatomical structure development
OG_06165,1.0967168127841038,FUN_028016-T1,Peve_00036498,Pocillopora_meandrina_HIv1___TS.g11693.t1,three_way,59.587,FUN_028016-T1,P23416,GLRA2_HUMAN,,Glycine receptor subunit alpha-2,Homo sapiens (Human),36.1,449.0,4.7e-67,256.9,sp|P23416|GLRA2_HUMAN Glycine receptor subunit alpha-2 OS=Homo sapiens OX=9606 GN=GLRA2 PE=1 SV=1,GO:0004888; GO:0005886; GO:0007218; GO:0016594; GO:0016934; GO:0022852; GO:0034220; GO:0034707; GO:0042995; GO:0043231; GO:0046872; GO:0050804; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0098982; GO:0099634; GO:1902476; GO:1904315,cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic ion transmembrane transport [GO:0034220]; neuropeptide signaling pathway [GO:0007218],cell projection [GO:0042995]; chloride channel complex [GO:0034707]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0060089,transporter activity; plasma membrane; organelle; transmembrane transport; molecular transducer activity
OG_06171,1.2273398413611816,FUN_028024-T1,Peve_00010827,Pocillopora_meandrina_HIv1___RNAseq.g13915.t1,three_way,86.50533333333333,,,,,,,,,,,,,,,,,
OG_06177,2.3632380607781083,FUN_028040-T1,Peve_00020094,Pocillopora_meandrina_HIv1___RNAseq.g13938.t1,three_way,66.845,,,,,,,,,,,,,,,,,
OG_06189,1.3330901089249512,FUN_028104-T1,Peve_00004896,Pocillopora_meandrina_HIv1___RNAseq.g15572.t1,three_way,86.157,FUN_028104-T1,Q6XBT4,,,,,36.7,343.0,4.1e-42,173.7,sp|Q6XBT4|USF1_BOVIN Upstream stimulatory factor 1 OS=Bos taurus OX=9913 GN=USF1 PE=2 SV=1,,,,,,
OG_06192,1.081572737005851,FUN_028114-T1,Peve_00019695,Pocillopora_meandrina_HIv1___RNAseq.g15565.t1,three_way,50.1775,FUN_028114-T1,P56182,RRP1_HUMAN,,Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein),Homo sapiens (Human),33.4,347.0,2.3e-47,191.8,sp|P56182|RRP1_HUMAN Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens OX=9606 GN=RRP1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0006364; GO:0030688,rRNA processing [GO:0006364],"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]",RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0043226,RNA binding; nucleus; chromosome; nucleolus; organelle
OG_06194,1.5307530649836796,FUN_028116-T1,Peve_00030851,Pocillopora_meandrina_HIv1___RNAseq.g15563.t1,three_way,44.718833333333336,,,,,,,,,,,,,,,,,
OG_06195,1.4190572481691133,FUN_028120-T1,Peve_00033839,Pocillopora_meandrina_HIv1___TS.g10588.t1b,three_way,59.40266666666667,,,,,,,,,,,,,,,,,
OG_06214,2.357621672931992,FUN_028155-T1,Peve_00031152,Pocillopora_meandrina_HIv1___RNAseq.g16459.t1,three_way,39.693000000000005,,,,,,,,,,,,,,,,,
OG_06215,2.890222406624402,FUN_028156-T1,Peve_00027512,Pocillopora_meandrina_HIv1___RNAseq.g16461.t1,three_way,34.681666666666665,,,,,,,,,,,,,,,,,
OG_06216,1.32694997225817,FUN_028157-T1,Peve_00010295,Pocillopora_meandrina_HIv1___RNAseq.g16467.t1,three_way,45.73066666666666,,,,,,,,,,,,,,,,,
OG_06222,1.0389016223546554,FUN_028166-T1,Peve_00044585,Pocillopora_meandrina_HIv1___RNAseq.g16474.t1,three_way,55.586666666666666,FUN_028166-T1,Q6AI12,,,,,49.2,59.0,3.6e-10,67.0,sp|Q6AI12|ANR40_HUMAN Ankyrin repeat domain-containing protein 40 OS=Homo sapiens OX=9606 GN=ANKRD40 PE=1 SV=2,,,,,,
OG_06226,1.280757246439686,FUN_028172-T1,Peve_00020832,Pocillopora_meandrina_HIv1___RNAseq.g16468.t1,three_way,88.88433333333333,FUN_028172-T1,Q8WW35,DYT2B_HUMAN,,Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2),Homo sapiens (Human),61.2,116.0,7.4e-38,157.9,sp|Q8WW35|DYT2B_HUMAN Dynein light chain Tctex-type protein 2B OS=Homo sapiens OX=9606 GN=DYNLT2B PE=1 SV=2,GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0060271; GO:0120293; GO:1902017; GO:1905799,cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein axonemal particle [GO:0120293],dynein intermediate chain binding [GO:0045505],GO:0005929; GO:0007018; GO:0043226; GO:0044782,cilium; microtubule-based movement; organelle; cilium organization
OG_06235,1.5242682520755262,FUN_028191-T1,Peve_00001300,Pocillopora_meandrina_HIv1___RNAseq.g16519.t1,three_way,59.74283333333334,FUN_028191-T1,Q5UNS8,,,,,28.1,352.0,4.5000000000000003e-23,110.9,sp|Q5UNS8|YR665_MIMIV Uncharacterized protein R665 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R665 PE=4 SV=1,,,,,,
OG_06261,1.1753421354148723,FUN_028279-T1,Peve_00003674,Pocillopora_meandrina_HIv1___RNAseq.g15496.t1,three_way,60.25483333333333,FUN_028279-T1,Q1L8I0,,,,,35.2,687.0,2.8e-90,334.7,sp|Q1L8I0|PUS7L_DANRE Pseudouridylate synthase PUS7L OS=Danio rerio OX=7955 GN=pus7l PE=2 SV=1,,,,,,
OG_06271,1.1879089612280556,FUN_028303-T1,Peve_00027867,Pocillopora_meandrina_HIv1___RNAseq.g15547.t1,three_way,85.15633333333334,FUN_028303-T1,Q32LN4,CFA45_BOVIN,,Cilia- and flagella-associated protein 45,Bos taurus (Bovine),35.3,547.0,1e-17,93.2,sp|Q32LN4|CFA45_BOVIN Cilia- and flagella-associated protein 45 OS=Bos taurus OX=9913 GN=CFAP45 PE=1 SV=2,GO:0005576; GO:0005879; GO:0016208; GO:0030317; GO:0036126; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0160112,cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],9+0 motile cilium [GO:0097728]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],AMP binding [GO:0016208],GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_06272,1.2406446771243378,FUN_028304-T1,Peve_00027868,Pocillopora_meandrina_HIv1___RNAseq.g15548.t1,three_way,58.65733333333333,FUN_028304-T1,Q9BZE1,RM37_HUMAN,,"Large ribosomal subunit protein mL37 (39S ribosomal protein L2, mitochondrial) (L2mt) (MRP-L2) (39S ribosomal protein L37, mitochondrial) (L37mt) (MRP-L37)",Homo sapiens (Human),29.1,327.0,5.3000000000000004e-30,133.3,sp|Q9BZE1|RM37_HUMAN Large ribosomal subunit protein mL37 OS=Homo sapiens OX=9606 GN=MRPL37 PE=1 SV=2,GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543,mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005739; GO:0005840; GO:0043226,RNA binding; structural molecule activity; mitochondrion; ribosome; organelle
OG_06282,2.324738216003957,FUN_028452-T1,Peve_00003099,Pocillopora_meandrina_HIv1___RNAseq.g16134.t1,three_way,56.43066666666667,FUN_028452-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),45.5,308.0,6.7000000000000004e-74,279.6,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06298,1.254992622447238,FUN_028498-T2,Peve_00019598,Pocillopora_meandrina_HIv1___RNAseq.g15238.t2,three_way,79.519,FUN_028498-T2,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),35.8,617.0,1e-97,360.1,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_06300,1.596103576762393,FUN_028505-T1,Peve_00022933,Pocillopora_meandrina_HIv1___RNAseq.g15900.t1b,three_way,61.44466666666667,FUN_028505-T1,P49288,,,,,25.1,271.0,1.2e-09,65.5,sp|P49288|MTR1C_CHICK Melatonin receptor type 1C OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_06319,1.0583673260654494,FUN_028795-T1,Peve_00000745,Pocillopora_meandrina_HIv1___RNAseq.g20731.t1,three_way,70.815,FUN_028795-T1,P52756,RBM5_HUMAN,,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),Homo sapiens (Human),39.6,768.0,1.8e-75,285.8,sp|P52756|RBM5_HUMAN RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2,GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0006915; GO:0008270; GO:0008285; GO:0043065; GO:0043231,"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0012501; GO:0016071; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; cytosol; programmed cell death; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06332,1.228988291348949,FUN_028889-T2,Peve_00044599,Pocillopora_meandrina_HIv1___RNAseq.g12803.t1,three_way,74.40866666666666,,,,,,,,,,,,,,,,,
OG_06344,1.5796199908522124,FUN_028909-T1,Peve_00041428,Pocillopora_meandrina_HIv1___RNAseq.g20758.t1,three_way,59.083,,,,,,,,,,,,,,,,,
OG_06346,1.5931565610647471,FUN_028912-T1,Peve_00041442,Pocillopora_meandrina_HIv1___RNAseq.g22342.t1,three_way,75.41166666666666,FUN_028912-T1,Q96DF8,ESS2_HUMAN,,Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2),Homo sapiens (Human),39.3,458.0,2.7e-72,274.2,sp|Q96DF8|ESS2_HUMAN Splicing factor ESS-2 homolog OS=Homo sapiens OX=9606 GN=ESS2 PE=1 SV=1,GO:0000398; GO:0005634; GO:0007399; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634],,GO:0005634; GO:0016071; GO:0043226; GO:0048856,nucleus; mRNA metabolic process; organelle; anatomical structure development
OG_06360,1.7487211741585138,FUN_028963-T1,Peve_00025110,Pocillopora_meandrina_HIv1___RNAseq.g25566.t1,three_way,55.882666666666665,,,,,,,,,,,,,,,,,
OG_06373,1.181354838274375,FUN_028978-T1,Peve_00029291,Pocillopora_meandrina_HIv1___RNAseq.g25600.t1,three_way,57.49583333333333,FUN_028978-T1,P35331,,,,,29.0,978.0,1.4e-95,352.8,sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06398,1.189002832320959,FUN_029059-T2,Peve_00002500,Pocillopora_meandrina_HIv1___RNAseq.g25824.t1,three_way,47.455333333333336,FUN_029059-T2,Q6PJN8,,,,,34.8,267.0,4.9e-39,164.1,sp|Q6PJN8|DALD3_MOUSE DALR anticodon-binding domain-containing protein 3 OS=Mus musculus OX=10090 GN=Dalrd3 PE=2 SV=1,,,,,,
OG_06410,1.312693215520394,FUN_029093-T1,Peve_00007821,Pocillopora_meandrina_HIv1___TS.g9197.t1,three_way,87.07566666666666,FUN_029093-T1,Q6GNL7,AL1L1_XENLA,,Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1),Xenopus laevis (African clawed frog),64.4,634.0,9.2e-244,844.3,sp|Q6GNL7|AL1L1_XENLA Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Xenopus laevis OX=8355 GN=aldh1l1 PE=2 SV=1,GO:0004029; GO:0005829; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730],cytosol [GO:0005829],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155],GO:0003824; GO:0005829; GO:0006091; GO:0006575; GO:0016491; GO:0055086,catalytic activity; cytosol; generation of precursor metabolites and energy; modified amino acid metabolic process; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_06411,1.48280030751168,FUN_029094-T1,Peve_00033474,Pocillopora_meandrina_HIv1___RNAseq.g25750.t1,three_way,77.252,FUN_029094-T1,Q8N468,,,,,33.0,479.0,7.7e-58,226.5,sp|Q8N468|MFD4A_HUMAN Major facilitator superfamily domain-containing protein 4A OS=Homo sapiens OX=9606 GN=MFSD4A PE=1 SV=3,,,,,,
OG_06424,1.0558608299951286,FUN_029113-T1,Peve_00013129,Pocillopora_meandrina_HIv1___RNAseq.g25757.t1,three_way,79.15533333333333,FUN_029113-T1,A7RK30,,,,,66.5,364.0,2.7e-136,486.5,sp|A7RK30|QORL2_NEMVE Quinone oxidoreductase-like protein 2 homolog OS=Nematostella vectensis OX=45351 GN=v1g238856 PE=3 SV=1,,,,,,
OG_06435,1.0706892574426492,FUN_029129-T1,Peve_00004668,Pocillopora_meandrina_HIv1___TS.g9227.t1,three_way,79.41,,,,,,,,,,,,,,,,,
OG_06439,1.165371167826253,FUN_029142-T1,Peve_00029530,Pocillopora_meandrina_HIv1___RNAseq.g27965.t1,three_way,74.99333333333334,FUN_029142-T1,Q8K4Z4,,,,,25.3,324.0,7e-19,97.1,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_06462,1.189192582256107,FUN_029193-T1,Peve_00032838,Pocillopora_meandrina_HIv1___RNAseq.g25517.t1,three_way,55.414,FUN_029193-T1,Q1RMZ1,SAMTR_HUMAN,,S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-),Homo sapiens (Human),38.7,411.0,3.7e-70,266.9,sp|Q1RMZ1|SAMTR_HUMAN S-adenosylmethionine sensor upstream of mTORC1 OS=Homo sapiens OX=9606 GN=SAMTOR PE=1 SV=1,GO:0005829; GO:0008168; GO:0032259; GO:0034198; GO:0044877; GO:0061431; GO:1903432; GO:1904047; GO:1904262; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to methionine [GO:0061431]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263]; regulation of TORC1 signaling [GO:1903432],cytosol [GO:0005829],methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0005829; GO:0016740,catalytic activity; cytosol; transferase activity
OG_06472,1.000517577224031,FUN_029234-T1,Peve_00045061,Pocillopora_meandrina_HIv1___RNAseq.g25553.t1,three_way,64.42733333333334,FUN_029234-T1,O15427,MOT4_HUMAN,,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),Homo sapiens (Human),27.4,398.0,5.9999999999999996e-40,166.8,sp|O15427|MOT4_HUMAN Monocarboxylate transporter 4 OS=Homo sapiens OX=9606 GN=SLC16A3 PE=1 SV=1,GO:0003723; GO:0005886; GO:0008028; GO:0015650; GO:0015718; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0031965; GO:0035873; GO:0035879; GO:0042867; GO:0050833; GO:1901475,lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],lactate:proton symporter activity [GO:0015650]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; RNA binding [GO:0003723],GO:0003723; GO:0005215; GO:0005886; GO:0055085,RNA binding; transporter activity; plasma membrane; transmembrane transport
OG_06477,1.099902663646491,FUN_029244-T1,Peve_00013750,Pocillopora_meandrina_HIv1___TS.g8847.t1b,three_way,82.03566666666667,FUN_029244-T1,A2RUV5,,,,,60.9,727.0,4.3999999999999996e-259,896.0,sp|A2RUV5|HFM1_XENTR Probable ATP-dependent DNA helicase HFM1 OS=Xenopus tropicalis OX=8364 GN=hfm1 PE=2 SV=1,,,,,,
OG_06499,1.579790188984988,FUN_029290-T1,Peve_00036558,Pocillopora_meandrina_HIv1___RNAseq.g11162.t1,three_way,72.6425,FUN_029290-T1,O95602,RPA1_HUMAN,,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),Homo sapiens (Human),50.1,1092.0,2e-264,913.7,sp|O95602|RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2,GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005739; GO:0006360; GO:0008270; GO:0071667; GO:1904750,negative regulation of protein localization to nucleolus [GO:1904750]; transcription by RNA polymerase I [GO:0006360],chromatin [GO:0000785]; chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005694; GO:0005739; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"DNA binding; catalytic activity; nucleoplasm; chromosome; mitochondrion; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06500,1.8676096110451497,FUN_029291-T1,Peve_00036559,Pocillopora_meandrina_HIv1___RNAseq.g11686.t1,three_way,61.11266666666666,FUN_029291-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),44.3,300.0,2.0999999999999997e-68,263.1,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06519,1.5926608914859384,FUN_029326-T2,Peve_00031600,Pocillopora_meandrina_HIv1___RNAseq.g11792.t1a,three_way,80.827,FUN_029326-T2,A4Q9F0,TTLL7_MOUSE,,Tubulin polyglutamylase TTLL7 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 7) (mTTLL7),Mus musculus (Mouse),48.4,798.0,2.5e-211,736.9,sp|A4Q9F0|TTLL7_MOUSE Tubulin polyglutamylase TTLL7 OS=Mus musculus OX=10090 GN=Ttll7 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005874; GO:0007399; GO:0018095; GO:0030154; GO:0030425; GO:0036064; GO:0043014; GO:0043204; GO:0046872; GO:0048487; GO:0070740; GO:0097731; GO:0106437; GO:0106438,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; protein polyglutamylation [GO:0018095],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; perikaryon [GO:0043204],"alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005929; GO:0008092; GO:0016874; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; cytoskeletal protein binding; ligase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06527,1.0254580037791736,FUN_029356-T1,Peve_00023383,Pocillopora_meandrina_HIv1___RNAseq.g17292.t1,three_way,73.16533333333334,FUN_029356-T1,Q15397,,,,,44.1,424.0,5.2e-92,339.7,sp|Q15397|PUM3_HUMAN Pumilio homolog 3 OS=Homo sapiens OX=9606 GN=PUM3 PE=1 SV=3,,,,,,
OG_06528,1.4983748052199108,FUN_029357-T1,Peve_00023328,Pocillopora_meandrina_HIv1___RNAseq.g17291.t1,three_way,87.65433333333334,FUN_029357-T1,Q9UIJ7,KAD3_HUMAN,,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)",Homo sapiens (Human),57.9,209.0,2.1e-67,256.9,"sp|Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase AK3, mitochondrial OS=Homo sapiens OX=9606 GN=AK3 PE=1 SV=4",GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0016874; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899,ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; ligase activity [GO:0016874]; nucleoside triphosphate adenylate kinase activity [GO:0046899],GO:0003824; GO:0005739; GO:0016740; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; transferase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_06556,1.623755603528058,FUN_029438-T1,Peve_00028188,Pocillopora_meandrina_HIv1___RNAseq.g17152.t1,three_way,76.8055,FUN_029438-T1,Q8IZF0,NALCN_HUMAN,,Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1),Homo sapiens (Human),41.8,1604.0,0.0,1137.9,sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1,GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805,"calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]",monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06576,2.645519946916703,FUN_029521-T2,Peve_00028580,Pocillopora_meandrina_HIv1___RNAseq.g17111.t1,three_way,61.62799999999999,FUN_029521-T2,P0DN10,,,,,63.5,52.0,2.7e-14,83.6,sp|P0DN10|VKT6_ANEVI U-actitoxin-Avd3i OS=Anemonia viridis OX=51769 PE=3 SV=1,,,,,,
OG_06615,1.0327678519750925,FUN_029771-T1,Peve_00042908,Pocillopora_meandrina_HIv1___RNAseq.g5152.t1,three_way,51.961666666666666,,,,,,,,,,,,,,,,,
OG_06621,1.1720604466875952,FUN_029882-T1,Peve_00024289,Pocillopora_meandrina_HIv1___RNAseq.g17341.t1,three_way,72.087,FUN_029882-T1,Q9BT73,,,,,34.5,119.0,2.2e-13,76.6,sp|Q9BT73|PSMG3_HUMAN Proteasome assembly chaperone 3 OS=Homo sapiens OX=9606 GN=PSMG3 PE=1 SV=1,,,,,,
OG_06626,1.5380459541265952,FUN_030056-T1,Peve_00040199,Pocillopora_meandrina_HIv1___RNAseq.g17348.t1,three_way,57.199666666666666,,,,,,,,,,,,,,,,,
OG_06630,1.2381835499850729,FUN_030078-T1,Peve_00018131,Pocillopora_meandrina_HIv1___RNAseq.g20156.t1,three_way,75.601,,,,,,,,,,,,,,,,,
OG_06632,1.5954923662236409,FUN_030140-T1,Peve_00027504,Pocillopora_meandrina_HIv1___RNAseq.g11469.t1,three_way,91.03816666666668,,,,,,,,,,,,,,,,,
OG_06642,2.528077800448832,FUN_030643-T1,Peve_00006240,Pocillopora_meandrina_HIv1___RNAseq.g21086.t1,three_way,75.03066666666666,FUN_030643-T1,P52493,,,,,33.6,143.0,3.3e-19,96.3,sp|P52493|UBC2_NEUCR Ubiquitin-conjugating enzyme E2 2 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mus-8 PE=3 SV=4,,,,,,
OG_06661,1.6517655719732411,FUN_030880-T1,Peve_00043612,Pocillopora_meandrina_HIv1___RNAseq.g30296.t1,three_way,70.443,,,,,,,,,,,,,,,,,
OG_06678,2.4074673180874897,FUN_031081-T1,Peve_00031208,Pocillopora_meandrina_HIv1___RNAseq.g25502.t1,three_way,48.558,,,,,,,,,,,,,,,,,
OG_06694,1.4834531886854334,FUN_031242-T1,Peve_00043062,Pocillopora_meandrina_HIv1___RNAseq.g5191.t1,three_way,62.47316666666666,FUN_031242-T1,A0A0G2L7I0,SPRTN_DANRE,,DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan),Danio rerio (Zebrafish) (Brachydanio rerio),60.6,279.0,7.3e-94,345.9,sp|A0A0G2L7I0|SPRTN_DANRE DNA-dependent metalloprotease SPRTN OS=Danio rerio OX=7955 GN=sprtn PE=3 SV=1,GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0006508; GO:0006974; GO:0008270; GO:0016540; GO:0031593; GO:0106300,DNA damage response [GO:0006974]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508],chromatin [GO:0000785]; nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_06697,1.624198243625458,FUN_031252-T1,Peve_00015905,Pocillopora_meandrina_HIv1___RNAseq.g5183.t1,three_way,69.73966666666666,FUN_031252-T1,O15033,AREL1_HUMAN,,Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1),Homo sapiens (Human),45.2,814.0,7.6e-194,679.1,sp|O15033|AREL1_HUMAN Apoptosis-resistant E3 ubiquitin protein ligase 1 OS=Homo sapiens OX=9606 GN=AREL1 PE=1 SV=3,GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0050727; GO:0061630; GO:0070979; GO:1990390,apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005829; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; cytosol; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_06708,2.396641004055746,FUN_031289-T1,Peve_00026529,Pocillopora_meandrina_HIv1___RNAseq.g5169.t1,three_way,74.811,FUN_031289-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),58.3,599.0,8.2e-179,629.8,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_06722,1.2446422950958602,FUN_031477-T1,Peve_00026545,Pocillopora_meandrina_HIv1___RNAseq.g5079.t1,three_way,55.821,FUN_031477-T1,Q5FYA8,ARSH_HUMAN,,Arylsulfatase H (ASH) (EC 3.1.6.-),Homo sapiens (Human),29.7,536.0,5.5e-48,193.7,sp|Q5FYA8|ARSH_HUMAN Arylsulfatase H OS=Homo sapiens OX=9606 GN=ARSH PE=2 SV=1,GO:0004065; GO:0005788; GO:0016020; GO:0046872,,endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_06731,1.198208401194259,FUN_031508-T1,Peve_00004814,Pocillopora_meandrina_HIv1___RNAseq.g5115.t1,three_way,90.06433333333334,FUN_031508-T1,Q86TJ2,TAD2B_HUMAN,,Transcriptional adapter 2-beta (ADA2-like protein beta) (ADA2-beta),Homo sapiens (Human),45.8,432.0,9.7e-101,368.6,sp|Q86TJ2|TAD2B_HUMAN Transcriptional adapter 2-beta OS=Homo sapiens OX=9606 GN=TADA2B PE=1 SV=2,GO:0000124; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006338; GO:0006357; GO:0008270; GO:0043484; GO:0045893; GO:0070461,chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461],chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06732,1.138640487022289,FUN_031509-T1,Peve_00004815,Pocillopora_meandrina_HIv1___TS.g23836.t1,three_way,71.6965,FUN_031509-T1,A7SIM4,HAP2_NEMVE,,Hapless 2 (Generative cell specific 1),Nematostella vectensis (Starlet sea anemone),51.4,905.0,3.5e-260,899.4,sp|A7SIM4|HAP2_NEMVE Hapless 2 OS=Nematostella vectensis OX=45351 GN=HAP2 PE=1 SV=1,GO:0005886; GO:0007338; GO:0008289,single fertilization [GO:0007338],plasma membrane [GO:0005886],lipid binding [GO:0008289],GO:0005886; GO:0008289; GO:0022414,plasma membrane; lipid binding; reproductive process
OG_06733,2.233307002308449,FUN_031517-T2,Peve_00045249,Pocillopora_meandrina_HIv1___TS.g23839.t1,three_way,57.293,FUN_031517-T2,Q8NBJ9,SIDT2_HUMAN,,SID1 transmembrane family member 2,Homo sapiens (Human),23.9,440.0,5.2e-15,84.7,sp|Q8NBJ9|SIDT2_HUMAN SID1 transmembrane family member 2 OS=Homo sapiens OX=9606 GN=SIDT2 PE=1 SV=2,GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0051033; GO:0061178,cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033],GO:0003677; GO:0003723; GO:0005215; GO:0005764; GO:0005773; GO:0005886; GO:0043226; GO:0048856,DNA binding; RNA binding; transporter activity; lysosome; vacuole; plasma membrane; organelle; anatomical structure development
OG_06743,1.4433197658988015,FUN_031549-T1,Peve_00022771,Pocillopora_meandrina_HIv1___RNAseq.g5142.t1,three_way,79.50266666666667,FUN_031549-T1,Q5F480,ITPK1_CHICK,,"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)",Gallus gallus (Chicken),42.8,320.0,4.6e-77,289.7,sp|Q5F480|ITPK1_CHICK Inositol-tetrakisphosphate 1-kinase OS=Gallus gallus OX=9031 GN=ITPK1 PE=2 SV=1,GO:0000287; GO:0000825; GO:0005524; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052835; GO:0070266,inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266],,"ATP binding [GO:0005524]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,5,6-tetrakisphosphate 1-kinase activity [GO:0047325]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]",GO:0003824; GO:0012501; GO:0016740; GO:0016853,catalytic activity; programmed cell death; transferase activity; isomerase activity
OG_06761,1.7290233116255975,FUN_031592-T1,Peve_00012523,Pocillopora_meandrina_HIv1___RNAseq.g5060.t1,three_way,68.10383333333334,FUN_031592-T1,P41823,,,,,25.5,165.0,2.3e-09,64.3,sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2,,,,,,
OG_06767,1.118585095773892,FUN_031606-T1,Peve_00012513,Pocillopora_meandrina_HIv1___RNAseq.g5968.t1,three_way,73.351,FUN_031606-T1,Q9HBF4,ZFYV1_HUMAN,,Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1),Homo sapiens (Human),53.5,708.0,2.7999999999999996e-217,756.5,sp|Q9HBF4|ZFYV1_HUMAN Zinc finger FYVE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZFYVE1 PE=1 SV=1,GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0044829; GO:0048471; GO:0097629; GO:0140042; GO:1990462,cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; positive regulation by host of viral genome replication [GO:0044829],autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407],"1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]",GO:0005739; GO:0005773; GO:0005783; GO:0005794; GO:0005811; GO:0006914; GO:0008289; GO:0043226,mitochondrion; vacuole; endoplasmic reticulum; Golgi apparatus; lipid droplet; autophagy; lipid binding; organelle
OG_06818,1.4085615735625423,FUN_031724-T1,Peve_00000894,Pocillopora_meandrina_HIv1___TS.g24210.t1,three_way,56.0895,FUN_031724-T1,Q9P219,DAPLE_HUMAN,,Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2),Homo sapiens (Human),35.4,432.0,7.8e-60,235.3,sp|Q9P219|DAPLE_HUMAN Protein Daple OS=Homo sapiens OX=9606 GN=CCDC88C PE=1 SV=3,GO:0001578; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005576; GO:0005737; GO:0005813; GO:0007026; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043296; GO:0044782; GO:0046330; GO:0046983; GO:0051959; GO:0060071; GO:0090090; GO:0120197; GO:1902691,"apical constriction [GO:0003383]; cilium organization [GO:0044782]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule bundle formation [GO:0001578]; mucociliary clearance [GO:0120197]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of JNK cascade [GO:0046330]; protein destabilization [GO:0031648]; respiratory basal cell differentiation [GO:1902691]; small GTPase-mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",apical junction complex [GO:0043296]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular region [GO:0005576],dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983],GO:0003016; GO:0005576; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0030154; GO:0044782; GO:0098772,respiratory system process; extracellular region; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; cell differentiation; cilium organization; molecular function regulator activity
OG_06856,1.3031766688664053,FUN_031834-T1,Peve_00030278,Pocillopora_meandrina_HIv1___TS.g24318.t1,three_way,70.685,FUN_031834-T1,Q29RY4,RNZ1_BOVIN,,Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1),Bos taurus (Bovine),47.7,329.0,4e-78,293.1,sp|Q29RY4|RNZ1_BOVIN Zinc phosphodiesterase ELAC protein 1 OS=Bos taurus OX=9913 GN=ELAC1 PE=2 SV=1,GO:0004549; GO:0005634; GO:0005654; GO:0005829; GO:0042780; GO:0042781; GO:0046872; GO:0072344,rescue of stalled ribosome [GO:0072344]; tRNA 3'-end processing [GO:0042780],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]; tRNA-specific ribonuclease activity [GO:0004549],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; nucleoplasm; cytosol; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_06861,1.1719746764418002,FUN_031852-T2,Peve_00030298,Pocillopora_meandrina_HIv1___RNAseq.g5614.t1,three_way,88.76,FUN_031852-T2,P62861,RS30_HUMAN,,Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein (FAU ubiquitin like and ribosomal protein S30 fusion) [Cleaved into: Ubiquitin-like protein FUBI; Small ribosomal subunit protein eS30 (40S ribosomal protein S30)],Homo sapiens (Human),66.9,133.0,1.8999999999999998e-39,163.3,sp|P62861|RS30_HUMAN Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein OS=Homo sapiens OX=9606 GN=FAU PE=1 SV=2,GO:0002181; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0016567; GO:0019731; GO:0019941; GO:0022626; GO:0022627; GO:0031386; GO:0031625; GO:0050830; GO:0061844,antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small ribosomal subunit [GO:0015935],protein tag activity [GO:0031386]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625],GO:0002181; GO:0002376; GO:0003723; GO:0005198; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005840; GO:0031386; GO:0043226; GO:0098542,cytoplasmic translation; immune system process; RNA binding; structural molecule activity; extracellular space; nucleus; nucleoplasm; cytosol; ribosome; protein tag activity; organelle; defense response to other organism
OG_06867,1.0064174395218666,FUN_031863-T1,Peve_00011065,Pocillopora_meandrina_HIv1___RNAseq.g5636.t1,three_way,61.019666666666666,,,,,,,,,,,,,,,,,
OG_06911,1.510687379557928,FUN_031971-T1,Peve_00043665,Pocillopora_meandrina_HIv1___RNAseq.g30205.t1,three_way,62.97566666666667,,,,,,,,,,,,,,,,,
OG_06913,1.924759521206741,FUN_031974-T2,Peve_00043636,Pocillopora_meandrina_HIv1___TS.g22504.t1,three_way,69.29716666666667,FUN_031974-T2,Q866F4,,,,,31.2,818.0,1.2e-97,360.5,sp|Q866F4|ADCYA_RABIT Adenylate cyclase type 10 OS=Oryctolagus cuniculus OX=9986 GN=ADCY10 PE=2 SV=1,,,,,,
OG_06922,2.5391972856068743,FUN_032012-T1,Peve_00028791,Pocillopora_meandrina_HIv1___RNAseq.g30267.t1,three_way,74.29599999999999,FUN_032012-T1,Q20191,,,,,44.3,228.0,1.5e-45,185.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_06945,1.3520498783185373,FUN_032055-T1,Peve_00012449,Pocillopora_meandrina_HIv1___RNAseq.g6020.t1,three_way,62.906666666666666,,,,,,,,,,,,,,,,,
OG_06951,1.070723999397324,FUN_032064-T1,Peve_00024743,Pocillopora_meandrina_HIv1___RNAseq.g6044.t3,three_way,55.462,FUN_032064-T1,Q28DL4,TRAF6_XENTR,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),25.1,346.0,2.8e-20,101.3,sp|Q28DL4|TRAF6_XENTR TNF receptor-associated factor 6 OS=Xenopus tropicalis OX=8364 GN=traf6 PE=2 SV=1,GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0008270; GO:0019222; GO:0042981; GO:0043122; GO:0070534; GO:0141124,intracellular signaling cassette [GO:0141124]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of metabolic process [GO:0019222],cell cortex [GO:0005938]; lipid droplet [GO:0005811]; nucleus [GO:0005634],tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005811; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; lipid droplet; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06970,1.48010226361574,FUN_032103-T1,Peve_00011281,Pocillopora_meandrina_HIv1___RNAseq.g5999.t1,three_way,81.78566666666667,,,,,,,,,,,,,,,,,
OG_06975,1.0446567953821302,FUN_032110-T1,Peve_00030226,Pocillopora_meandrina_HIv1___RNAseq.g5391.t1,three_way,85.20466666666667,FUN_032110-T1,Q8K4M5,COMD1_MOUSE,,COMM domain-containing protein 1 (Protein Murr1),Mus musculus (Mouse),46.2,182.0,1.9e-40,167.2,sp|Q8K4M5|COMD1_MOUSE COMM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Commd1 PE=1 SV=2,GO:0005507; GO:0005546; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006289; GO:0006878; GO:0006893; GO:0010008; GO:0015031; GO:0019871; GO:0031398; GO:0031462; GO:0031648; GO:0032088; GO:0032434; GO:0034383; GO:0034394; GO:0042632; GO:0042803; GO:0043325; GO:0048227; GO:0050750; GO:0055037; GO:0055070; GO:0070300; GO:0080025; GO:0097006; GO:1902072; GO:1902306; GO:1904109; GO:1905751; GO:2000009; GO:2000010,cholesterol homeostasis [GO:0042632]; copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; intracellular copper ion homeostasis [GO:0006878]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902072]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of cholesterol import [GO:1904109]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein transport [GO:0015031]; regulation of plasma lipoprotein particle levels [GO:0097006]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037],"copper ion binding [GO:0005507]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]",GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0006281; GO:0006355; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772,nucleus; nucleoplasm; endosome; cytosol; DNA repair; regulation of DNA-templated transcription; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_06978,1.0102784718512223,FUN_032113-T1,Peve_00030230,Pocillopora_meandrina_HIv1___RNAseq.g5388.t1,three_way,75.95,,,,,,,,,,,,,,,,,
OG_06986,1.0757938946648875,FUN_032125-T1,Peve_00040713,Pocillopora_meandrina_HIv1___RNAseq.g5366.t1,three_way,78.05966666666667,FUN_032125-T1,Q6DF57,,,,,46.3,95.0,4e-16,85.9,sp|Q6DF57|GPT11_XENTR G patch domain-containing protein 11 OS=Xenopus tropicalis OX=8364 GN=gpatch11 PE=2 SV=1,,,,,,
OG_06988,1.0714899789981829,FUN_032129-T1,Peve_00040715,Pocillopora_meandrina_HIv1___RNAseq.g5362.t1,three_way,64.65516666666666,FUN_032129-T1,Q9BWU0,NADAP_HUMAN,,Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein),Homo sapiens (Human),37.0,637.0,3.2000000000000002e-87,324.3,sp|Q9BWU0|NADAP_HUMAN Kanadaptin OS=Homo sapiens OX=9606 GN=SLC4A1AP PE=1 SV=2,GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231,,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],mRNA binding [GO:0003729],GO:0003723; GO:0005654; GO:0005886; GO:0043226,RNA binding; nucleoplasm; plasma membrane; organelle
OG_06998,1.3797840257338172,FUN_032147-T1,Peve_00007908,Pocillopora_meandrina_HIv1___RNAseq.g5342.t1,three_way,65.17866666666666,FUN_032147-T1,Q3U435,MMP25_MOUSE,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-),Mus musculus (Mouse),37.3,566.0,7.6e-77,289.7,sp|Q3U435|MMP25_MOUSE Matrix metalloproteinase-25 OS=Mus musculus OX=10090 GN=Mmp25 PE=2 SV=1,GO:0004222; GO:0005886; GO:0006508; GO:0008270; GO:0009986; GO:0016504; GO:0031012; GO:0060022; GO:0098552,hard palate development [GO:0060022]; proteolysis [GO:0006508],cell surface [GO:0009986]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],metalloendopeptidase activity [GO:0004222]; peptidase activator activity [GO:0016504]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030312; GO:0031012; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; external encapsulating structure; extracellular matrix; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07002,1.6063532506535063,FUN_032154-T1,Peve_00003238,Pocillopora_meandrina_HIv1___RNAseq.g5326.t1,three_way,41.39083333333333,,,,,,,,,,,,,,,,,
OG_07016,1.6218587443784145,FUN_032192-T1,Peve_00020047,Pocillopora_meandrina_HIv1___RNAseq.g24665.t1,three_way,77.12066666666666,,,,,,,,,,,,,,,,,
OG_07019,1.0026273402557475,FUN_032195-T1,Peve_00017484,Pocillopora_meandrina_HIv1___RNAseq.g24403.t1,three_way,73.50766666666667,FUN_032195-T1,Q6YJI5,,,,,48.1,445.0,3.1e-113,410.2,sp|Q6YJI5|TRM11_CHICK tRNA (guanine(10)-N(2))-methyltransferase TRMT11 OS=Gallus gallus OX=9031 GN=TRMT11 PE=2 SV=1,,,,,,
OG_07021,1.17545354475328,FUN_032200-T2,Peve_00017491,Pocillopora_meandrina_HIv1___RNAseq.g24414.t1,three_way,73.51166666666667,FUN_032200-T2,Q6DDS9,XRCC5_XENLA,,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (Ku80),Xenopus laevis (African clawed frog),38.2,744.0,6.100000000000001e-130,466.5,sp|Q6DDS9|XRCC5_XENLA X-ray repair cross-complementing protein 5 OS=Xenopus laevis OX=8355 GN=xrcc5.L PE=1 SV=1,GO:0000723; GO:0003678; GO:0003684; GO:0003690; GO:0005524; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564,DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; telomere maintenance [GO:0000723],Ku70:Ku80 complex [GO:0043564],ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; hydrolase activity [GO:0016787]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07037,1.336786819334781,FUN_032232-T1,Peve_00043437,Pocillopora_meandrina_HIv1___RNAseq.g24836.t1,three_way,68.60266666666666,FUN_032232-T1,Q6DG22,ADA_DANRE,,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,350.0,3.3e-91,336.7,sp|Q6DG22|ADA_DANRE Adenosine deaminase OS=Danio rerio OX=7955 GN=ada PE=2 SV=2,GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161,adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110],anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764],2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07038,1.1061715119406408,FUN_032233-T1,Peve_00012061,Pocillopora_meandrina_HIv1___RNAseq.g24837.t1,three_way,53.79233333333333,,,,,,,,,,,,,,,,,
OG_07047,1.7548795320921589,FUN_032252-T1,Peve_00042110,Pocillopora_meandrina_HIv1___RNAseq.g24907.t1a,three_way,67.65599999999999,FUN_032252-T1,Q92539,LPIN2_HUMAN,,Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2),Homo sapiens (Human),37.9,927.0,2.0999999999999998e-129,464.9,sp|Q92539|LPIN2_HUMAN Phosphatidate phosphatase LPIN2 OS=Homo sapiens OX=9606 GN=LPIN2 PE=1 SV=1,GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944,cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0006629; GO:0016787; GO:0043226; GO:0060090; GO:0140110,catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; lipid metabolic process; hydrolase activity; organelle; molecular adaptor activity; transcription regulator activity
OG_07062,1.4353398013151388,FUN_032288-T1,Peve_00015511,Pocillopora_meandrina_HIv1___RNAseq.g24311.t1,three_way,76.559,FUN_032288-T1,Q6P5E8,DGKQ_MOUSE,,Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta),Mus musculus (Mouse),40.0,879.0,2.1e-185,651.0,sp|Q6P5E8|DGKQ_MOUSE Diacylglycerol kinase theta OS=Mus musculus OX=10090 GN=Dgkq PE=1 SV=1,GO:0004143; GO:0004697; GO:0005524; GO:0005730; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007173; GO:0007189; GO:0007200; GO:0008270; GO:0010628; GO:0010629; GO:0012506; GO:0016363; GO:0016607; GO:0030297; GO:0030971; GO:0043274; GO:0046339; GO:0046834; GO:0047649; GO:0051591; GO:0070493; GO:0090037; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903413; GO:1903432; GO:2000064; GO:2000182,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to bile acid [GO:1903413]; diacylglycerol metabolic process [GO:0046339]; epidermal growth factor receptor signaling pathway [GO:0007173]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506],alkylglycerol kinase activity [GO:0047649]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; DNA-binding transcription factor binding [GO:0140297]; phospholipase binding [GO:0043274]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; zinc ion binding [GO:0008270],GO:0003824; GO:0005730; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleolus; endosome; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07092,1.2344045024117885,FUN_032349-T1,Peve_00012757,Pocillopora_meandrina_HIv1___RNAseq.g29801.t1,three_way,87.25633333333333,FUN_032349-T1,Q5XHC1,,,,,53.7,296.0,1.2e-84,314.7,sp|Q5XHC1|CFA96_XENLA Cilia-and flagella-associated protein 96 OS=Xenopus laevis OX=8355 GN=cfap96.L PE=2 SV=1,,,,,,
OG_07094,1.1916576028903991,FUN_032352-T1,Peve_00024032,Pocillopora_meandrina_HIv1___RNAseq.g29803.t2,three_way,59.69416666666667,FUN_032352-T1,P15535,,,,,44.9,265.0,1.6e-63,245.0,"sp|P15535|B4GT1_MOUSE Beta-1,4-galactosyltransferase 1 OS=Mus musculus OX=10090 GN=B4galt1 PE=1 SV=1",,,,,,
OG_07117,1.758636944329005,FUN_032394-T1,Peve_00018856,Pocillopora_meandrina_HIv1___RNAseq.g29832.t1,three_way,75.89816666666667,FUN_032394-T1,P40123,CAP2_HUMAN,,Adenylyl cyclase-associated protein 2 (CAP 2),Homo sapiens (Human),40.3,467.0,2.3e-79,297.7,sp|P40123|CAP2_HUMAN Adenylyl cyclase-associated protein 2 OS=Homo sapiens OX=9606 GN=CAP2 PE=1 SV=1,GO:0000902; GO:0003779; GO:0005737; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0014069; GO:0019933; GO:0042802; GO:0099140,actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; presynaptic actin cytoskeleton organization [GO:0099140]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802],GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0043226,plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle
OG_07144,2.801039766024467,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_07151,1.6739783825331431,FUN_032520-T1,Peve_00000679,Pocillopora_meandrina_HIv1___RNAseq.g24739.t1,three_way,55.748,,,,,,,,,,,,,,,,,
OG_07165,1.1002322823926862,FUN_032583-T1,Peve_00026847,Pocillopora_meandrina_HIv1___RNAseq.g24648.t1,three_way,42.123333333333335,,,,,,,,,,,,,,,,,
OG_07186,1.0412790362931976,FUN_032677-T1,Peve_00015961,Pocillopora_meandrina_HIv1___RNAseq.g24111.t1,three_way,50.2185,FUN_032677-T1,Q9D361,,,,,41.7,151.0,6.1e-15,83.6,sp|Q9D361|SNR48_MOUSE U11/U12 small nuclear ribonucleoprotein 48 kDa protein OS=Mus musculus OX=10090 GN=Snrnp48 PE=2 SV=2,,,,,,
OG_07187,1.1740970769581534,FUN_032678-T1,Peve_00015962,Pocillopora_meandrina_HIv1___RNAseq.g24110.t1,three_way,84.3185,FUN_032678-T1,Q9BRI3,ZNT2_HUMAN,,Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2),Homo sapiens (Human),48.8,299.0,5.2e-77,290.0,sp|Q9BRI3|ZNT2_HUMAN Proton-coupled zinc antiporter SLC30A2 OS=Homo sapiens OX=9606 GN=SLC30A2 PE=1 SV=2,GO:0005385; GO:0005737; GO:0005743; GO:0005765; GO:0005770; GO:0005886; GO:0006882; GO:0010008; GO:0010043; GO:0030658; GO:0042589; GO:0042802; GO:0043231; GO:0046872; GO:0062111; GO:0071577; GO:0099503; GO:0140826; GO:0140882; GO:0140914; GO:0140915; GO:0140916; GO:0140917,intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc export across plasma membrane [GO:0140882]; zinc ion import into lysosome [GO:0140916]; zinc ion import into mitochondrion [GO:0140917]; zinc ion import into organelle [GO:0062111]; zinc ion import into secretory vesicle [GO:0140914]; zinc ion import into zymogen granule [GO:0140915]; zinc ion transmembrane transport [GO:0071577],cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; secretory vesicle [GO:0099503]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_07198,1.185916693201544,FUN_032706-T1,Peve_00029923,Pocillopora_meandrina_HIv1___RNAseq.g29870.t1,three_way,82.68833333333333,FUN_032706-T1,Q63ZI0,,,,,51.8,257.0,2.8e-65,250.4,sp|Q63ZI0|KCNK9_XENLA Potassium channel subfamily K member 9 OS=Xenopus laevis OX=8355 GN=kcnk9 PE=2 SV=1,,,,,,
OG_07220,1.9421776944889293,FUN_032813-T1,Peve_00010364,Pocillopora_meandrina_HIv1___TS.g24962.t1,three_way,46.85066666666666,FUN_032813-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),40.7,327.0,6.7e-59,230.7,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_07237,1.2184313745782225,FUN_032910-T1,Peve_00014535,Pocillopora_meandrina_HIv1___TS.g12925.t1,three_way,45.20733333333333,,,,,,,,,,,,,,,,,
OG_07249,1.5011530604408077,FUN_032988-T2,Peve_00014547,Pocillopora_meandrina_HIv1___RNAseq.8254_t,three_way,56.93683333333333,FUN_032988-T2,Q8IWU6,SULF1_HUMAN,,Extracellular sulfatase Sulf-1 (hSulf-1) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form],Homo sapiens (Human),39.1,844.0,2.4e-151,538.1,sp|Q8IWU6|SULF1_HUMAN Extracellular sulfatase Sulf-1 OS=Homo sapiens OX=9606 GN=SULF1 PE=1 SV=1,GO:0001822; GO:0001937; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0006915; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0032836; GO:0035860; GO:0040036; GO:0040037; GO:0045121; GO:0048010; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686,apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449],GO:0003012; GO:0003014; GO:0003824; GO:0005615; GO:0005783; GO:0005886; GO:0012501; GO:0016787; GO:0030198; GO:0043226; GO:0048856; GO:1901135,muscle system process; renal system process; catalytic activity; extracellular space; endoplasmic reticulum; plasma membrane; programmed cell death; hydrolase activity; extracellular matrix organization; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_07251,1.1393773770057884,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_07253,1.3864280030356242,FUN_033016-T1,Peve_00015569,Pocillopora_meandrina_HIv1___RNAseq.g24465.t1,three_way,50.23716666666667,FUN_033016-T1,Q20911,,,,,32.7,107.0,1.5e-06,56.6,sp|Q20911|CUBN_CAEEL Cubilin homolog OS=Caenorhabditis elegans OX=6239 GN=cubn-1 PE=1 SV=4,,,,,,
OG_07264,1.7232447436459235,FUN_033047-T1,Peve_00020149,Pocillopora_meandrina_HIv1___RNAseq.g24182.t1,three_way,58.319,FUN_033047-T1,Q09596,,,,,32.5,212.0,1.9e-20,100.9,sp|Q09596|GST5_CAEEL Probable glutathione S-transferase 5 OS=Caenorhabditis elegans OX=6239 GN=gst-5 PE=1 SV=1,,,,,,
OG_07265,2.494827910138269,FUN_033056-T1,Peve_00024296,Pocillopora_meandrina_HIv1___RNAseq.g25129.t1,three_way,51.20366666666667,FUN_033056-T1,Q9UGM3,,,,,54.1,218.0,8e-62,239.6,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_07267,1.1555632223981225,FUN_033115-T1,Peve_00034200,Pocillopora_meandrina_HIv1___RNAseq.g29761.t1,three_way,71.55166666666666,,,,,,,,,,,,,,,,,
OG_07270,1.4774828199002552,FUN_033126-T1,Peve_00043509,Pocillopora_meandrina_HIv1___RNAseq.g29765.t1,three_way,88.98233333333334,FUN_033126-T1,O14802,RPC1_HUMAN,,DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160),Homo sapiens (Human),69.2,1391.0,0.0,1951.8,sp|O14802|RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens OX=9606 GN=POLR3A PE=1 SV=2,GO:0000287; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005737; GO:0005739; GO:0005829; GO:0006351; GO:0008270; GO:0016020; GO:0032728; GO:0042797; GO:0045087; GO:0051607; GO:0071667,defense response to virus [GO:0051607]; DNA-templated transcription [GO:0006351]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006351; GO:0006399; GO:0016740; GO:0043226; GO:0098542; GO:0140098,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; defense response to other organism; catalytic activity, acting on RNA"
OG_07281,1.1144388721792258,FUN_033488-T1,Peve_00033737,Pocillopora_meandrina_HIv1___RNAseq.g12099.t1,three_way,71.806,FUN_033488-T1,Q60848,HELLS_MOUSE,,Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein),Mus musculus (Mouse),50.1,807.0,3.8e-200,699.9,sp|Q60848|HELLS_MOUSE Lymphocyte-specific helicase OS=Mus musculus OX=10090 GN=Hells PE=1 SV=2,GO:0000775; GO:0001655; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006338; GO:0006346; GO:0006915; GO:0016787; GO:0030098; GO:0031507; GO:0031508; GO:0043066; GO:0044027; GO:0046651; GO:0051301; GO:0141119; GO:1990830; GO:2001243,apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin formation [GO:0031507]; kidney development [GO:0001822]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin formation [GO:0031508]; urogenital system development [GO:0001655],"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]",ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787],GO:0002376; GO:0003824; GO:0005634; GO:0006325; GO:0012501; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,immune system process; catalytic activity; nucleus; chromatin organization; programmed cell death; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_07284,1.3517487490480484,FUN_033608-T1,Peve_00041752,Pocillopora_meandrina_HIv1___RNAseq.g24385.t1,three_way,81.65133333333334,FUN_033608-T1,Q9QUR6,,,,,66.5,708.0,4.9e-299,1028.1,sp|Q9QUR6|PPCE_MOUSE Prolyl endopeptidase OS=Mus musculus OX=10090 GN=Prep PE=1 SV=1,,,,,,
OG_07303,1.1885759412311063,FUN_033689-T1,Peve_00010871,Pocillopora_meandrina_HIv1___TS.g21813.t1,three_way,59.508,FUN_033689-T1,Q62867,GGH_RAT,,Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase),Rattus norvegicus (Rat),39.4,322.0,1.9000000000000001e-59,231.1,sp|Q62867|GGH_RAT Gamma-glutamyl hydrolase OS=Rattus norvegicus OX=10116 GN=Ggh PE=1 SV=1,GO:0005615; GO:0005764; GO:0005773; GO:0009410; GO:0010043; GO:0032868; GO:0034722; GO:0042470; GO:0045471; GO:0046900,response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900],extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773],gamma-glutamyl-peptidase activity [GO:0034722],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006575; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; modified amino acid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07310,1.323509932719945,FUN_033698-T1,Peve_00027578,Pocillopora_meandrina_HIv1___TS.g8559.t1,three_way,66.93816666666667,,,,,,,,,,,,,,,,,
OG_07318,1.9983182585172647,FUN_033711-T1,Peve_00014636,Pocillopora_meandrina_HIv1___RNAseq.g28838.t1,three_way,71.58500000000001,FUN_033711-T1,O00418,EF2K_HUMAN,,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),Homo sapiens (Human),45.3,695.0,2.2e-155,550.8,sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2,GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637,cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]",GO:0003824; GO:0005829; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07319,1.438270218887002,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),34.7,404.0,4.399999999999997e-47,191.8,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07319,1.438270218887002,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),36.6,243.0,1.1e-37,160.6,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07322,1.360953381470895,FUN_033715-T1,Peve_00017870,Pocillopora_meandrina_HIv1___RNAseq.g22319.t1,three_way,70.41133333333333,FUN_033715-T1,Q9ZNT0,VPS4_ARATH,,Protein SUPPRESSOR OF K(+) TRANSPORT GROWTH DEFECT 1 (AtSKD1) (EC 3.6.4.6) (Protein VACUOLAR PROTEIN SORTING 4),Arabidopsis thaliana (Mouse-ear cress),47.0,330.0,2.0000000000000003e-74,281.2,sp|Q9ZNT0|VPS4_ARATH Protein SUPPRESSOR OF K(+) TRANSPORT GROWTH DEFECT 1 OS=Arabidopsis thaliana OX=3702 GN=SKD1 PE=1 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005771; GO:0005777; GO:0007032; GO:0007033; GO:0009506; GO:0010091; GO:0015031; GO:0016192; GO:0016887; GO:0032585; GO:0055075; GO:0055078,endosome organization [GO:0007032]; potassium ion homeostasis [GO:0055075]; protein transport [GO:0015031]; sodium ion homeostasis [GO:0055078]; trichome branching [GO:0010091]; vacuole organization [GO:0007033]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005634; GO:0005768; GO:0005777; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nucleus; endosome; peroxisome; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_07352,1.3130150806210446,FUN_033760-T2,Peve_00009251,Pocillopora_meandrina_HIv1___TS.g8526.t2,three_way,62.784333333333336,FUN_033760-T2,Q1E3S4,,,,,31.7,183.0,2e-13,78.2,sp|Q1E3S4|FES1_COCIM Hsp70 nucleotide exchange factor FES1 OS=Coccidioides immitis (strain RS) OX=246410 GN=FES1 PE=3 SV=2,,,,,,
OG_07368,1.1783095198017646,FUN_033785-T1,Peve_00014251,Pocillopora_meandrina_HIv1___RNAseq.18346_t,three_way,74.81,FUN_033785-T1,Q4R4W5,IDI1_MACFA,,Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),57.0,221.0,2.9e-72,273.1,sp|Q4R4W5|IDI1_MACFA Isopentenyl-diphosphate Delta-isomerase 1 OS=Macaca fascicularis OX=9541 GN=IDI1 PE=2 SV=2,GO:0004452; GO:0005777; GO:0006695; GO:0009240; GO:0046872; GO:0050992,cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240],peroxisome [GO:0005777],isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872],GO:0003824; GO:0005777; GO:0006629; GO:0016853; GO:0043226,catalytic activity; peroxisome; lipid metabolic process; isomerase activity; organelle
OG_07374,1.395457175892303,FUN_033796-T1,Peve_00029689,Pocillopora_meandrina_HIv1___RNAseq.g26321.t1,three_way,45.691,,,,,,,,,,,,,,,,,
OG_07377,1.4747727014455767,FUN_033799-T2,Peve_00007573,Pocillopora_meandrina_HIv1___RNAseq.g26317.t1,three_way,61.620666666666665,,,,,,,,,,,,,,,,,
OG_07427,1.5695572540727207,FUN_033911-T1,Peve_00035948,Pocillopora_meandrina_HIv1___RNAseq.g28376.t1,three_way,39.52483333333333,,,,,,,,,,,,,,,,,
OG_07438,1.025750821895967,FUN_033928-T1,Peve_00022640,Pocillopora_meandrina_HIv1___RNAseq.g26589.t1,three_way,76.85166666666666,FUN_033928-T1,A6H8T2,,,,,34.0,712.0,1.4e-110,402.1,sp|A6H8T2|DNAI7_DANRE Dynein axonemal intermediate chain 7 OS=Danio rerio OX=7955 GN=dnai7 PE=2 SV=2,,,,,,
OG_07447,1.194825427235245,FUN_033939-T1,Peve_00020991,Pocillopora_meandrina_HIv1___RNAseq.g26576.t1,three_way,38.9615,,,,,,,,,,,,,,,,,
OG_07468,1.3411666212369449,FUN_033978-T1,Peve_00004849,Pocillopora_meandrina_HIv1___RNAseq.g26112.t1,three_way,70.29166666666667,FUN_033978-T1,Q1LVW0,,,,,36.9,895.0,1.8e-163,578.2,sp|Q1LVW0|ABT3A_DANRE Ankyrin repeat- and BTB/POZ domain-containing protein 3-A OS=Danio rerio OX=7955 GN=abtb3a PE=3 SV=2,,,,,,
OG_07489,1.0213919267132463,FUN_034016-T1,Peve_00034969,Pocillopora_meandrina_HIv1___RNAseq.g26078.t1,three_way,63.12616666666667,,,,,,,,,,,,,,,,,
OG_07508,1.065931706701863,FUN_034050-T2,Peve_00022956,Pocillopora_meandrina_HIv1___TS.g18783.t1,three_way,73.61983333333333,FUN_034050-T2,Q22516,CHD3_CAEEL,,Chromodomain-helicase-DNA-binding protein 3 homolog (CHD-3) (EC 3.6.4.-),Caenorhabditis elegans,46.0,63.0,6.7e-12,73.6,sp|Q22516|CHD3_CAEEL Chromodomain-helicase-DNA-binding protein 3 homolog OS=Caenorhabditis elegans OX=6239 GN=chd-3 PE=2 SV=2,GO:0000118; GO:0000785; GO:0001709; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0006338; GO:0008270; GO:0016581; GO:0016887; GO:0040027; GO:0042393; GO:0046580; GO:0140658,cell fate determination [GO:0001709]; chromatin remodeling [GO:0006338]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of vulval development [GO:0040027],chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; NuRD complex [GO:0016581],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0016787; GO:0016853; GO:0042393; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; chromatin organization; hydrolase activity; isomerase activity; histone binding; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07509,1.1396062775616138,FUN_034051-T1,Peve_00009941,Pocillopora_meandrina_HIv1___RNAseq.g26031.t1,three_way,79.378,FUN_034051-T1,O93257,XRCC6_CHICK,,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP/AP lyase Ku70) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (DNA repair protein XRCC6) (Ku autoantigen protein p70 homolog) (Ku70),Gallus gallus (Chicken),46.8,583.0,2.6e-147,523.9,sp|O93257|XRCC6_CHICK X-ray repair cross-complementing protein 5 OS=Gallus gallus OX=9031 GN=XRCC6 PE=2 SV=1,GO:0000723; GO:0003678; GO:0003684; GO:0003723; GO:0005524; GO:0005654; GO:0005694; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564; GO:0045892; GO:0051575; GO:0070419; GO:0071480; GO:1990904,cellular response to gamma radiation [GO:0071480]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA-templated transcription [GO:0045892]; telomere maintenance [GO:0000723],chromosome [GO:0005694]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006355; GO:0016787; GO:0016829; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; chromosome; DNA repair; DNA recombination; regulation of DNA-templated transcription; hydrolase activity; lyase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07514,1.2124104322902105,FUN_034059-T1,Peve_00031737,Pocillopora_meandrina_HIv1___RNAseq.g26048.t1,three_way,65.53866666666667,FUN_034059-T1,Q3ZCC3,TRAF6_BOVIN,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Bos taurus (Bovine),40.0,490.0,3.3e-95,350.5,sp|Q3ZCC3|TRAF6_BOVIN TNF receptor-associated factor 6 OS=Bos taurus OX=9913 GN=TRAF6 PE=2 SV=1,GO:0000045; GO:0000122; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009898; GO:0019886; GO:0023035; GO:0030316; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0033209; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045944; GO:0046330; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0097400; GO:0098696; GO:0098978; GO:0140374; GO:0141198; GO:1904996,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0005829; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; cytosol; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07531,1.095887479340773,FUN_034107-T1,Peve_00035269,Pocillopora_meandrina_HIv1___RNAseq.g25964.t2,three_way,76.35033333333332,FUN_034107-T1,B5X4E0,,,,,33.2,289.0,2.6e-39,164.1,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_07550,2.4553805803336948,FUN_034132-T1,Peve_00006384,Pocillopora_meandrina_HIv1___RNAseq.g7012.t1,three_way,59.236666666666665,FUN_034132-T1,A0A2B4RP11,,,,,53.8,372.0,1.1e-103,378.3,sp|A0A2B4RP11|CGLR1_STYPI Cyclic GMP-AMP synthase-like receptor 1 OS=Stylophora pistillata OX=50429 GN=cGLR1 PE=1 SV=1,,,,,,
OG_07556,1.424614833393972,FUN_034160-T1,Peve_00018779,Pocillopora_meandrina_HIv1___RNAseq.g26286.t1,three_way,47.58283333333333,FUN_034160-T1,O17645,HST2_CAEEL,,Heparan sulfate 2-O-sulfotransferase hst-2 (Heparan sulfotransferase 2) (EC 2.8.2.-) (HS2ST1 homolog),Caenorhabditis elegans,26.5,230.0,5.2e-07,58.2,sp|O17645|HST2_CAEEL Heparan sulfate 2-O-sulfotransferase hst-2 OS=Caenorhabditis elegans OX=6239 GN=hst-2 PE=1 SV=2,GO:0000139; GO:0004394; GO:0005794; GO:0015012; GO:0030334; GO:0040018; GO:1902667,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of multicellular organism growth [GO:0040018]; regulation of axon guidance [GO:1902667]; regulation of cell migration [GO:0030334],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],heparan sulfate 2-sulfotransferase activity [GO:0004394],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_07559,1.160418684354372,FUN_034173-T1,Peve_00006812,Pocillopora_meandrina_HIv1___RNAseq.g26278.t1,three_way,85.85433333333333,FUN_034173-T1,Q6UPE0,CHDH_RAT,,"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)",Rattus norvegicus (Rat),63.8,450.0,6.7e-177,621.7,"sp|Q6UPE0|CHDH_RAT Choline dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Chdh PE=1 SV=1",GO:0005743; GO:0008812; GO:0019285; GO:0050660,glycine betaine biosynthetic process from choline [GO:0019285],mitochondrial inner membrane [GO:0005743],choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0006575; GO:0016491,catalytic activity; modified amino acid metabolic process; oxidoreductase activity
OG_07588,1.474440062127929,FUN_034291-T1,Peve_00013954,Pocillopora_meandrina_HIv1___RNAseq.g28511.t1,three_way,73.35566666666666,,,,,,,,,,,,,,,,,
OG_07590,1.376956563872643,FUN_034294-T1,Peve_00013952,Pocillopora_meandrina_HIv1___RNAseq.g28509.t1,three_way,53.21816666666667,,,,,,,,,,,,,,,,,
OG_07592,1.1399346726054835,FUN_034297-T1,Peve_00013947,Pocillopora_meandrina_HIv1___RNAseq.g28506.t1,three_way,74.32883333333334,,,,,,,,,,,,,,,,,
OG_07628,1.3376537366302046,FUN_034376-T1,Peve_00027168,Pocillopora_meandrina_HIv1___RNAseq.g26154.t1,three_way,68.84483333333333,FUN_034376-T1,E7FAG6,AMR1A_DANRE,,Activating molecule in BECN1-regulated autophagy protein 1A,Danio rerio (Zebrafish) (Brachydanio rerio),26.3,954.0,1.9e-61,238.8,sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2,GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0006914; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0043231; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; chordate embryonic development [GO:0043009]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741],autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634],protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005856; GO:0006914; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; mitochondrion; vacuole; endoplasmic reticulum; cytosol; cytoskeleton; autophagy; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_07645,1.0274817346414906,FUN_034460-T1,Peve_00025955,Pocillopora_meandrina_HIv1___RNAseq.g25842.t2,three_way,66.28216666666667,FUN_034460-T1,Q8QGX4,PRKDC_CHICK,,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1),Gallus gallus (Chicken),40.0,1500.0,3.2e-308,1059.7,sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1,GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0008630; GO:0031571; GO:0033152; GO:0035979; GO:0042254; GO:0070419; GO:0106310,double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723],nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016740; GO:0032200; GO:0042254; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; transferase activity; telomere organization; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_07652,1.3530663672259824,FUN_034486-T1,Peve_00043236,Pocillopora_meandrina_HIv1___RNAseq.g28569.t1,three_way,78.29433333333334,FUN_034486-T1,Q13613,,,,,45.0,387.0,6.2e-98,360.5,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_07657,1.1202411415274796,FUN_034599-T1,Peve_00039728,Pocillopora_meandrina_HIv1___RNAseq.g25886.t1,three_way,67.98116666666667,FUN_034599-T1,E1BZR9,,,,,41.2,466.0,4.099999999999999e-96,354.0,sp|E1BZR9|TCPR1_CHICK Tectonin beta-propeller repeat-containing protein 1 OS=Gallus gallus OX=9031 GN=TECPR1 PE=3 SV=1,,,,,,
OG_07661,1.0688044497400842,FUN_034712-T2,Peve_00037083,Pocillopora_meandrina_HIv1___TS.g18658.t2,three_way,85.44166666666666,FUN_034712-T2,Q3SX41,,,,,67.1,234.0,2.8e-84,313.9,sp|Q3SX41|LC7L3_BOVIN Luc7-like protein 3 OS=Bos taurus OX=9913 GN=LUC7L3 PE=2 SV=1,,,,,,
OG_07662,1.0065561772729492,FUN_034715-T1,Peve_00014894,Pocillopora_meandrina_HIv1___RNAseq.g28726.t1,three_way,68.227,FUN_034715-T1,P31399,,,,,34.0,144.0,3.6e-21,102.8,"sp|P31399|ATP5H_RAT ATP synthase peripheral stalk subunit d, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5pd PE=1 SV=3",,,,,,
OG_07683,1.777689041144754,FUN_034801-T1,Peve_00007555,Pocillopora_meandrina_HIv1___RNAseq.g12302.t1,three_way,39.9515,,,,,,,,,,,,,,,,,
OG_07687,1.013287541535394,FUN_034808-T1,Peve_00034936,Pocillopora_meandrina_HIv1___RNAseq.g12307.t1,three_way,87.922,FUN_034808-T1,Q5R4A0,UBA3_PONAB,,NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),68.8,432.0,2.3e-185,649.8,sp|Q5R4A0|UBA3_PONAB NEDD8-activating enzyme E1 catalytic subunit OS=Pongo abelii OX=9601 GN=UBA3 PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0007113; GO:0019781; GO:0032991; GO:0042802; GO:0045116; GO:0046982; GO:0051726,endomitotic cell cycle [GO:0007113]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982],GO:0000278; GO:0003824; GO:0005634; GO:0016874; GO:0043226; GO:0140096; GO:0140657,"mitotic cell cycle; catalytic activity; nucleus; ligase activity; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07699,1.0067705779381866,FUN_034833-T1,Peve_00010451,Pocillopora_meandrina_HIv1___RNAseq.g27185.t1,three_way,51.098,,,,,,,,,,,,,,,,,
OG_07716,1.355629037950174,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_07720,1.0789449695838986,FUN_034875-T1,Peve_00005784,Pocillopora_meandrina_HIv1___RNAseq.g27164.t1b,three_way,85.19866666666667,FUN_034875-T1,Q8QZR1,ATTY_MOUSE,,Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase),Mus musculus (Mouse),53.7,408.0,7.9e-140,498.4,sp|Q8QZR1|ATTY_MOUSE Tyrosine aminotransferase OS=Mus musculus OX=10090 GN=Tat PE=1 SV=1,GO:0004838; GO:0005739; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0071548,2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],mitochondrion [GO:0005739],amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine-2-oxoglutarate transaminase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_07732,1.365048707209758,FUN_034893-T1,Peve_00037337,Pocillopora_meandrina_HIv1___RNAseq.g27805.t1,three_way,60.900333333333336,FUN_034893-T1,Q8R4E9,CDT1_MOUSE,,DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein),Mus musculus (Mouse),32.5,449.0,1.2e-50,203.0,sp|Q8R4E9|CDT1_MOUSE DNA replication factor Cdt1 OS=Mus musculus OX=10090 GN=Cdt1 PE=1 SV=1,GO:0000076; GO:0000776; GO:0003677; GO:0003682; GO:0005634; GO:0016604; GO:0030174; GO:0033262; GO:0051315; GO:0071163; GO:0072708; GO:2000104; GO:2000105,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of DNA-templated DNA replication [GO:2000104]; positive regulation of DNA-templated DNA replication [GO:2000105]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708],kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0043226; GO:0065003,DNA binding; nucleus; organelle; protein-containing complex assembly
OG_07759,1.3897389030270704,FUN_034953-T1,Peve_00036672,Pocillopora_meandrina_HIv1___TS.g15182.t2,three_way,75.75533333333334,FUN_034953-T1,Q944H0,,,,,50.2,488.0,3.1e-143,510.0,sp|Q944H0|PEAM2_ARATH Phosphoethanolamine N-methyltransferase 2 OS=Arabidopsis thaliana OX=3702 GN=NMT2 PE=1 SV=2,,,,,,
OG_07772,1.626764785280477,FUN_034983-T1,Peve_00009294,Pocillopora_meandrina_HIv1___RNAseq.g12158.t1,three_way,52.6345,FUN_034983-T1,A2A259,PK2L1_MOUSE,,Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog),Mus musculus (Mouse),25.5,509.0,4.6e-40,168.7,sp|A2A259|PK2L1_MOUSE Polycystin-2-like protein 1 OS=Mus musculus OX=10090 GN=Pkd2l1 PE=1 SV=1,GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0009415; GO:0015269; GO:0015629; GO:0031410; GO:0034703; GO:0034704; GO:0042802; GO:0043235; GO:0044325; GO:0050912; GO:0051262; GO:0051289; GO:0051371; GO:0060170; GO:0071467; GO:0071468; GO:0097730; GO:0098662; GO:0160128; GO:1990760,cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; smoothened signaling pathway [GO:0007224],actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; pH-gated monoatomic ion channel activity [GO:0160128]; sodium channel activity [GO:0005272]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0031410; GO:0043226; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,transporter activity; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; cytoplasmic vesicle; organelle; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_07773,1.0076854249229494,FUN_034984-T1,Peve_00009292,Pocillopora_meandrina_HIv1___TS.g14469.t2,three_way,75.10966666666667,FUN_034984-T1,Q502K2,SAMH1_DANRE,,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,480.0,3.3e-162,573.2,sp|Q502K2|SAMH1_DANRE Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Danio rerio OX=7955 GN=samhd1 PE=2 SV=2,GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0036269; GO:0045087; GO:0045088; GO:0045540; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0106375; GO:0110025,dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA damage response [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; swimming behavior [GO:0036269],nucleus [GO:0005634]; site of double-strand break [GO:0035861],deoxynucleoside triphosphate hydrolase activity [GO:0106375]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0055086; GO:0065003; GO:0098542; GO:1901135,immune system process; DNA binding; RNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; defense response to other organism; carbohydrate derivative metabolic process
OG_07778,1.1250543017787114,FUN_034994-T1,Peve_00024604,Pocillopora_meandrina_HIv1___TS.g3464.t1,three_way,66.411,FUN_034994-T1,O02667,,,,,24.4,308.0,6.8e-18,93.2,sp|O02667|AA3R_RABIT Adenosine receptor A3 OS=Oryctolagus cuniculus OX=9986 GN=ADORA3 PE=2 SV=1,,,,,,
OG_07782,1.1380716719376058,FUN_035002-T1,Peve_00024598,Pocillopora_meandrina_HIv1___RNAseq.g12128.t1,three_way,74.33966666666667,FUN_035002-T1,Q9NRW4,,,,,54.7,172.0,8e-51,201.8,sp|Q9NRW4|DUS22_HUMAN Dual specificity protein phosphatase 22 OS=Homo sapiens OX=9606 GN=DUSP22 PE=1 SV=1,,,,,,
OG_07807,1.4909957341447737,FUN_035052-T1,Peve_00011121,Pocillopora_meandrina_HIv1___RNAseq.g27741.t1,three_way,68.56233333333333,FUN_035052-T1,Q9C2L8,,,,,29.8,168.0,2.7e-14,80.5,sp|Q9C2L8|RAB7_NEUCR Ypt/Rab-type GTPase Rab7 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=gtp-14 PE=3 SV=1,,,,,,
OG_07813,1.2127372979926034,FUN_035061-T1,Peve_00025324,Pocillopora_meandrina_HIv1___RNAseq.g22114.t1,three_way,61.75866666666667,,,,,,,,,,,,,,,,,
OG_07832,1.0947192474100784,FUN_035154-T1,Peve_00006880,Pocillopora_meandrina_HIv1___RNAseq.g27634.t1,three_way,56.06466666666667,FUN_035154-T1,Q9UKV3,,,,,30.4,280.0,5e-24,114.8,sp|Q9UKV3|ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens OX=9606 GN=ACIN1 PE=1 SV=2,,,,,,
OG_07838,1.0492564236271096,FUN_035169-T1,Peve_00036181,Pocillopora_meandrina_HIv1___RNAseq.g27918.t1,three_way,87.309,FUN_035169-T1,Q9JK84,,,,,54.5,299.0,5.5000000000000004e-80,299.3,sp|Q9JK84|PAR6G_MOUSE Partitioning defective 6 homolog gamma OS=Mus musculus OX=10090 GN=Pard6g PE=2 SV=1,,,,,,
OG_07848,1.0428419346097637,FUN_035190-T1,Peve_00044650,Pocillopora_meandrina_HIv1___RNAseq.g27958.t1,three_way,60.0245,,,,,,,,,,,,,,,,,
OG_07859,1.267813318404886,FUN_035214-T1,Peve_00027702,Pocillopora_meandrina_HIv1___RNAseq.g27840.t2,three_way,74.03666666666668,FUN_035214-T1,Q8RDT4,,,,,46.5,372.0,1.0000000000000001e-88,328.6,sp|Q8RDT4|MEGL_FUSNN L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=FN1419 PE=1 SV=1,,,,,,
OG_07884,1.1368326886222904,FUN_035261-T1,Peve_00032642,Pocillopora_meandrina_HIv1___TS.g15222.t2,three_way,64.01466666666667,,,,,,,,,,,,,,,,,
OG_07890,1.9037205139914395,FUN_035269-T1,Peve_00029229,Pocillopora_meandrina_HIv1___RNAseq.g27867.t1,three_way,75.15266666666666,FUN_035269-T1,Q9NUD7,,,,,23.3,356.0,2.7e-12,74.7,sp|Q9NUD7|CT096_HUMAN Uncharacterized protein C20orf96 OS=Homo sapiens OX=9606 GN=C20orf96 PE=1 SV=2,,,,,,
OG_07893,1.3283749982978748,FUN_035272-T1,Peve_00044991,Pocillopora_meandrina_HIv1___RNAseq.g27864.t1,three_way,73.48066666666666,FUN_035272-T1,Q6NRC9,,,,,41.0,1022.0,1.9e-99,365.5,sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1,,,,,,
OG_07908,1.3171414186183383,FUN_035360-T1,Peve_00016223,Pocillopora_meandrina_HIv1___RNAseq.g12230.t1,three_way,43.8945,FUN_035360-T1,Q8CAS9,,,,,41.1,163.0,2.6999999999999997e-25,118.6,sp|Q8CAS9|PARP9_MOUSE Protein mono-ADP-ribosyltransferase PARP9 OS=Mus musculus OX=10090 GN=Parp9 PE=1 SV=2,,,,,,
OG_07914,1.770275511229559,FUN_035393-T1,Peve_00005174,Pocillopora_meandrina_HIv1___RNAseq.g12212.t1,three_way,60.65866666666667,,,,,,,,,,,,,,,,,
OG_07918,1.0721311657961272,FUN_035403-T1,Peve_00002640,Pocillopora_meandrina_HIv1___TS.g3526.t1,three_way,88.887,,,,,,,,,,,,,,,,,
OG_07935,1.240964863538336,FUN_035439-T1,Peve_00037156,Pocillopora_meandrina_HIv1___RNAseq.g27578.t1,three_way,43.833333333333336,,,,,,,,,,,,,,,,,
OG_07972,1.2659785726276296,FUN_035547-T1,Peve_00036924,Pocillopora_meandrina_HIv1___RNAseq.11135_t,three_way,45.327,,,,,,,,,,,,,,,,,
OG_08004,1.2847126180726298,FUN_035653-T1,Peve_00028212,Pocillopora_meandrina_HIv1___RNAseq.g28108.t1,three_way,78.766,FUN_035653-T1,Q568Z7,CIB2_RAT,,Calcium and integrin-binding family member 2,Rattus norvegicus (Rat),52.7,188.0,6.2e-54,213.0,sp|Q568Z7|CIB2_RAT Calcium and integrin-binding family member 2 OS=Rattus norvegicus OX=10116 GN=Cib2 PE=1 SV=1,GO:0000287; GO:0001750; GO:0001917; GO:0005178; GO:0005509; GO:0005737; GO:0005829; GO:0005927; GO:0007204; GO:0031594; GO:0032420; GO:0032437; GO:0042383; GO:0042803; GO:0044877; GO:0045494; GO:0055074; GO:0071318; GO:0071944,calcium ion homeostasis [GO:0055074]; cellular response to ATP [GO:0071318]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cytosolic calcium ion concentration [GO:0007204],cell periphery [GO:0071944]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420],calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0005829; GO:0005886,cytosol; plasma membrane
OG_08006,1.1742979904308577,FUN_035655-T1,Peve_00030364,Pocillopora_meandrina_HIv1___RNAseq.g28111.t1,three_way,77.333,FUN_035655-T1,Q5F389,WWOX_CHICK,,WW domain-containing oxidoreductase (EC 1.1.1.-),Gallus gallus (Chicken),57.5,414.0,3.9e-110,399.8,sp|Q5F389|WWOX_CHICK WW domain-containing oxidoreductase OS=Gallus gallus OX=9031 GN=WWOX PE=2 SV=2,GO:0001649; GO:0003713; GO:0005739; GO:0005764; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001241,cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575],enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005739; GO:0005764; GO:0005773; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016491; GO:0030154; GO:0043226; GO:0060090; GO:0140110,catalytic activity; mitochondrion; lysosome; vacuole; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; oxidoreductase activity; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_08027,1.2216455743308483,FUN_035682-T1,Peve_00041297,Pocillopora_meandrina_HIv1___RNAseq.g28149.t1,three_way,75.479,FUN_035682-T1,Q8BJT9,,,,,56.2,560.0,2.7e-180,633.3,sp|Q8BJT9|EDEM2_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 2 OS=Mus musculus OX=10090 GN=Edem2 PE=1 SV=1,,,,,,
OG_08029,1.5154717794807808,FUN_035684-T1,Peve_00041295,Pocillopora_meandrina_HIv1___RNAseq.g11804.t1a,three_way,62.284333333333336,FUN_035684-T1,Q6GM78,ASGL1_XENLA,,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],Xenopus laevis (African clawed frog),43.1,269.0,2.8e-45,183.7,sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1,GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917],asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798],GO:0003824; GO:0006520; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_08030,1.5555000145804705,FUN_035688-T1,Peve_00041294,Pocillopora_meandrina_HIv1___RNAseq.g11804.t1b,three_way,57.10333333333333,,,,,,,,,,,,,,,,,
OG_08053,1.9798122299597605,FUN_035748-T1,Peve_00014368,Pocillopora_meandrina_HIv1___TS.g3212.t1,three_way,61.029833333333336,FUN_035748-T1,Q9P2E3,ZNFX1_HUMAN,,NFX1-type zinc finger-containing protein 1,Homo sapiens (Human),38.2,1862.0,1.3e-311,1071.2,sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2,GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0006325; GO:0016853; GO:0031047; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; chromatin organization; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; defense response to other organism; ATP-dependent activity
OG_08089,1.4298420310220368,FUN_035821-T1,Peve_00037800,Pocillopora_meandrina_HIv1___RNAseq.g11931.t1,three_way,74.61166666666666,FUN_035821-T1,A8DZE6,WTIP_DANRE,,Wilms tumor protein 1-interacting protein homolog (WT1-interacting protein homolog),Danio rerio (Zebrafish) (Brachydanio rerio),52.4,191.0,1.8e-56,220.7,sp|A8DZE6|WTIP_DANRE Wilms tumor protein 1-interacting protein homolog OS=Danio rerio OX=7955 GN=wtip PE=3 SV=1,GO:0000132; GO:0000932; GO:0001666; GO:0001947; GO:0003140; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0010882; GO:0014032; GO:0022604; GO:0035331; GO:0035844; GO:0036064; GO:0046872; GO:0060271; GO:0061032; GO:0061371,cilium assembly [GO:0060271]; cloaca development [GO:0035844]; cytoskeleton organization [GO:0007010]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; establishment of mitotic spindle orientation [GO:0000132]; heart looping [GO:0001947]; negative regulation of hippo signaling [GO:0035331]; neural crest cell development [GO:0014032]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cell morphogenesis [GO:0022604]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666]; visceral serous pericardium development [GO:0061032],adherens junction [GO:0005912]; ciliary basal body [GO:0036064]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667],metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005815; GO:0006355; GO:0007010; GO:0043226; GO:0044782; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; regulation of DNA-templated transcription; cytoskeleton organization; organelle; cilium organization; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_08092,1.0556607801189912,FUN_035825-T1,Peve_00037803,Pocillopora_meandrina_HIv1___RNAseq.g11934.t1,three_way,85.167,FUN_035825-T1,Q80VY9,DHX33_MOUSE,,ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33),Mus musculus (Mouse),58.4,630.0,1.3e-219,764.2,sp|Q80VY9|DHX33_MOUSE ATP-dependent RNA helicase DHX33 OS=Mus musculus OX=10090 GN=Dhx33 PE=1 SV=1,GO:0000182; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227,positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08094,1.5633983493789243,FUN_035829-T1,Peve_00002595,Pocillopora_meandrina_HIv1___RNAseq.g11938.t1,three_way,39.348333333333336,,,,,,,,,,,,,,,,,
OG_08096,1.0692349929630425,FUN_035837-T1,Peve_00032517,Pocillopora_meandrina_HIv1___RNAseq.g11959.t1,three_way,60.47533333333333,FUN_035837-T1,Q16820,,,,,34.7,380.0,1.9e-53,213.0,sp|Q16820|MEP1B_HUMAN Meprin A subunit beta OS=Homo sapiens OX=9606 GN=MEP1B PE=1 SV=3,,,,,,
OG_08107,1.067998112196999,FUN_035857-T1,Peve_00032515,Pocillopora_meandrina_HIv1___TS.g3285.t1,three_way,57.440000000000005,FUN_035857-T1,O97860,,,,,39.8,319.0,5.3e-62,239.6,sp|O97860|PPA5_RABIT Tartrate-resistant acid phosphatase type 5 OS=Oryctolagus cuniculus OX=9986 GN=ACP5 PE=2 SV=1,,,,,,
OG_08143,1.802768405034928,FUN_035908-T1,Peve_00006733,Pocillopora_meandrina_HIv1___TS.g3371.t1,three_way,92.83516666666668,,,,,,,,,,,,,,,,,
OG_08144,1.960268731523876,FUN_035913-T1,Peve_00006734,Pocillopora_meandrina_HIv1___RNAseq.g12035.t1,three_way,56.841,,,,,,,,,,,,,,,,,
OG_08196,1.025515779303082,FUN_036040-T1,Peve_00011088,Pocillopora_meandrina_HIv1___RNAseq.g27265.t1,three_way,59.95966666666666,FUN_036040-T1,Q9VD28,JMJD6_DROME,,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Jumonji domain-containing protein 6) (Phosphatidylserine receptor) (dPSR),Drosophila melanogaster (Fruit fly),27.5,291.0,4.3e-23,110.9,sp|Q9VD28|JMJD6_DROME Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 OS=Drosophila melanogaster OX=7227 GN=JMJD6 PE=2 SV=1,GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006909; GO:0018395; GO:0033746; GO:0033749; GO:0035212; GO:0043066; GO:0046329; GO:0046872; GO:0048512; GO:0070815; GO:0106140,cell competition in a multicellular organism [GO:0035212]; circadian behavior [GO:0048512]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H3R2 demethylase activity [GO:0033746]; histone H4R3 demethylase activity [GO:0033749]; metal ion binding [GO:0046872]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016192; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; vesicle-mediated transport; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_08202,1.83264276618488,FUN_036047-T1,Peve_00029867,Pocillopora_meandrina_HIv1___RNAseq.g27387.t1,three_way,71.29666666666667,FUN_036047-T1,Q2HJ57,,,,,48.2,137.0,3.2999999999999997e-29,129.4,sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3,,,,,,
OG_08228,1.0197943544580454,FUN_036100-T1,Peve_00032196,Pocillopora_meandrina_HIv1___RNAseq.g27435.t1,three_way,77.412,FUN_036100-T1,Q0P8I7,GMHD_CAMJE,,GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-),Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168),41.3,310.0,2.6e-64,247.3,sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1,GO:0003978; GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404,capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289],,GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; UDP-glucose 4-epimerase activity [GO:0003978],GO:0003824; GO:0005975; GO:0016491; GO:0016853; GO:0065003,catalytic activity; carbohydrate metabolic process; oxidoreductase activity; isomerase activity; protein-containing complex assembly
OG_08229,2.745707374393418,FUN_036101-T1,Peve_00032197,Pocillopora_meandrina_HIv1___RNAseq.g10817.t1,three_way,53.59666666666666,,,,,,,,,,,,,,,,,
OG_08233,1.0234907286652883,FUN_036109-T1,Peve_00003699,Pocillopora_meandrina_HIv1___RNAseq.g27427.t1,three_way,71.93266666666666,FUN_036109-T1,Q330K2,NDUF6_HUMAN,,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)",Homo sapiens (Human),51.8,301.0,2.4e-85,317.0,"sp|Q330K2|NDUF6_HUMAN NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 OS=Homo sapiens OX=9606 GN=NDUFAF6 PE=1 SV=2",GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0009058; GO:0032981,biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,GO:0005634; GO:0005739; GO:0043226; GO:0065003,nucleus; mitochondrion; organelle; protein-containing complex assembly
OG_08237,1.7552774746450257,FUN_036116-T1,Peve_00000283,Pocillopora_meandrina_HIv1___RNAseq.g27423.t1,three_way,63.0515,FUN_036116-T1,O34313,NTPES_BACSU,,"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]",Bacillus subtilis (strain 168),27.1,510.0,4.6e-36,154.8,sp|O34313|NTPES_BACSU Trifunctional nucleotide phosphoesterase protein YfkN OS=Bacillus subtilis (strain 168) OX=224308 GN=yfkN PE=1 SV=1,GO:0000166; GO:0005576; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872,nucleotide catabolic process [GO:0009166],extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288],"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]",GO:0003824; GO:0005576; GO:0016787; GO:0055086,catalytic activity; extracellular region; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_08241,1.3874349449676897,FUN_036143-T1,Peve_00000292,Pocillopora_meandrina_HIv1___TS.g14803.t1,three_way,87.003,FUN_036143-T1,Q13885,TBB2A_HUMAN,,Tubulin beta-2A chain (Tubulin beta class IIa),Homo sapiens (Human),69.0,432.0,1.8e-185,650.2,sp|Q13885|TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens OX=9606 GN=TUBB2A PE=1 SV=1,GO:0000226; GO:0000278; GO:0001764; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0021987; GO:0045171; GO:0046872; GO:0070062; GO:0072686; GO:1903561,cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0003824; GO:0003924; GO:0005198; GO:0005634; GO:0005856; GO:0007010; GO:0016787; GO:0043226; GO:0048856; GO:0048870,mitotic cell cycle; catalytic activity; GTPase activity; structural molecule activity; nucleus; cytoskeleton; cytoskeleton organization; hydrolase activity; organelle; anatomical structure development; cell motility
OG_08242,1.259764588928624,FUN_036149-T1,Peve_00000295,Pocillopora_meandrina_HIv1___RNAseq.g27458.t1,three_way,66.75033333333333,FUN_036149-T1,Q6PIP5,,,,,34.3,601.0,4e-89,330.5,sp|Q6PIP5|NUDC1_MOUSE NudC domain-containing protein 1 OS=Mus musculus OX=10090 GN=Nudcd1 PE=1 SV=2,,,,,,
OG_08245,1.0976048843228858,FUN_036153-T1,Peve_00006918,Pocillopora_meandrina_HIv1___RNAseq.g27466.t1,three_way,71.90833333333333,FUN_036153-T1,P49895,IOD1_HUMAN,,Type I iodothyronine deiodinase (EC 1.21.99.3) (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase),Homo sapiens (Human),47.8,180.0,1.1e-40,168.3,sp|P49895|IOD1_HUMAN Type I iodothyronine deiodinase OS=Homo sapiens OX=9606 GN=DIO1 PE=1 SV=3,GO:0004800; GO:0005789; GO:0005886; GO:0006520; GO:0006590; GO:0008430; GO:0016323; GO:0033798; GO:0042403; GO:0042404; GO:0042446,amino acid metabolic process [GO:0006520]; hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403],basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006520; GO:0006575; GO:0016491,catalytic activity; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity
OG_08252,2.382942974972437,FUN_036161-T1,Peve_00039217,Pocillopora_meandrina_HIv1___RNAseq.g27496.t1,three_way,49.679833333333335,FUN_036161-T1,Q9D6X6,,,,,31.2,346.0,1.5e-33,145.2,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
OG_08254,1.073282175012903,FUN_036164-T1,Peve_00027211,Pocillopora_meandrina_HIv1___RNAseq.g27499.t1,three_way,89.75383333333333,FUN_036164-T1,Q5RC80,RBM39_PONAB,,RNA-binding protein 39 (RNA-binding motif protein 39),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),58.2,385.0,3.1e-117,423.7,sp|Q5RC80|RBM39_PONAB RNA-binding protein 39 OS=Pongo abelii OX=9601 GN=RBM39 PE=2 SV=1,GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]",centriolar satellite [GO:0034451]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; RS domain binding [GO:0050733],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_08256,1.2444356913061534,FUN_036166-T2,Peve_00027202,Pocillopora_meandrina_HIv1___RNAseq.g27501.t1,three_way,89.64366666666666,FUN_036166-T2,O93477,,,,,79.8,430.0,3.8e-206,718.8,sp|O93477|SAHHB_XENLA Adenosylhomocysteinase B OS=Xenopus laevis OX=8355 GN=ahcy-b PE=2 SV=1,,,,,,
OG_08265,1.013330745890092,FUN_036177-T1,Peve_00027216,Pocillopora_meandrina_HIv1___RNAseq.g27511.t1,three_way,55.68066666666667,,,,,,,,,,,,,,,,,
OG_08289,1.0893163529637706,FUN_036224-T1,Peve_00025944,Pocillopora_meandrina_HIv1___RNAseq.g27547.t1,three_way,76.61933333333333,FUN_036224-T1,P41123,,,,,62.6,211.0,9e-68,258.1,sp|P41123|RL13_RAT Large ribosomal subunit protein eL13 OS=Rattus norvegicus OX=10116 GN=Rpl13 PE=1 SV=2,,,,,,
OG_08299,1.2637144576871011,FUN_036248-T1,Peve_00045282,Pocillopora_meandrina_HIv1___TS.g14942.t1,three_way,59.625,,,,,,,,,,,,,,,,,
OG_08318,1.1453209491615644,FUN_036742-T1,Peve_00018098,Pocillopora_meandrina_HIv1___RNAseq.g12110.t1,three_way,78.11333333333333,FUN_036742-T1,Q86U44,MTA70_HUMAN,,N(6)-adenosine-methyltransferase catalytic subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N(6)-adenosine-methyltransferase 70 kDa subunit) (MT-A70),Homo sapiens (Human),40.3,442.0,2.4000000000000003e-80,300.8,sp|Q86U44|MTA70_HUMAN N(6)-adenosine-methyltransferase catalytic subunit METTL3 OS=Homo sapiens OX=9606 GN=METTL3 PE=1 SV=2,GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204,"cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006325; GO:0016071; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098542; GO:0140098,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; chromatin organization; mRNA metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; defense response to other organism; catalytic activity, acting on RNA"
OG_08338,1.1081807743722036,FUN_036852-T1,Peve_00036539,Pocillopora_meandrina_HIv1___RNAseq.g10654.t1,three_way,83.33333333333333,FUN_036852-T1,A0A7U2MMF3,ADHB_ASPFN,,Zinc-type alcohol dehydrogenase B (EC 1.1.1.1),Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167),27.4,296.0,3.4e-19,97.4,sp|A0A7U2MMF3|ADHB_ASPFN Zinc-type alcohol dehydrogenase B OS=Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) OX=332952 GN=adhB PE=1 SV=1,GO:0008270; GO:0016491,,,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08340,1.6841921159737885,FUN_036857-T1,Peve_00001064,Pocillopora_meandrina_HIv1___RNAseq.g27062.t1,three_way,73.51566666666666,FUN_036857-T1,Q8BTI7,,,,,29.1,158.0,2.6e-07,58.9,sp|Q8BTI7|ANR52_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Mus musculus OX=10090 GN=Ankrd52 PE=1 SV=1,,,,,,
OG_08361,1.7918158459844633,FUN_036910-T1,Peve_00018417,Pocillopora_meandrina_HIv1___RNAseq.g10815.t1,three_way,60.812666666666665,,,,,,,,,,,,,,,,,
OG_08365,1.0696794713838644,FUN_036917-T1,Peve_00018360,Pocillopora_meandrina_HIv1___TS.g13339.t1,three_way,60.458,FUN_036917-T1,Q6DJL7,,,,,32.4,238.0,1e-06,55.8,sp|Q6DJL7|BORA_XENLA Protein aurora borealis OS=Xenopus laevis OX=8355 GN=bora PE=2 SV=1,,,,,,
OG_08374,1.5895161241359266,FUN_036939-T1,Peve_00040037,Pocillopora_meandrina_HIv1___TS.g13373.t2,three_way,65.984,FUN_036939-T1,A0A2R8QF68,GRIK2_DANRE,,"Glutamate receptor ionotropic, kainate 2 (GluK2)",Danio rerio (Zebrafish) (Brachydanio rerio),26.9,878.0,3.2999999999999996e-90,334.7,"sp|A0A2R8QF68|GRIK2_DANRE Glutamate receptor ionotropic, kainate 2 OS=Danio rerio OX=7955 GN=grik2 PE=3 SV=1",GO:0005886; GO:0015277; GO:0022849; GO:0032983; GO:0035249; GO:0042734; GO:0050804; GO:0098839; GO:1904315,"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]",kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734],glutamate-gated calcium ion channel activity [GO:0022849]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0060089,transporter activity; plasma membrane; signaling; molecular transducer activity
OG_08448,1.597946324697476,FUN_037212-T1,Peve_00039296,Pocillopora_meandrina_HIv1___RNAseq.g11061.t1,three_way,42.151333333333326,,,,,,,,,,,,,,,,,
OG_08450,1.0421678132956702,FUN_037214-T1,Peve_00012947,Pocillopora_meandrina_HIv1___RNAseq.g11059.t1,three_way,90.98433333333334,,,,,,,,,,,,,,,,,
OG_08460,1.4778803605702582,FUN_037229-T1,Peve_00006216,Pocillopora_meandrina_HIv1___RNAseq.g11032.t1,three_way,76.78283333333334,FUN_037229-T1,B6D5P3,DAAF1_PERLE,,Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50),Peromyscus leucopus (White-footed mouse),53.7,326.0,1.7e-26,122.5,sp|B6D5P3|DAAF1_PERLE Dynein axonemal assembly factor 1 OS=Peromyscus leucopus OX=10041 GN=Dnaaf1 PE=2 SV=1,GO:0005930; GO:0035082; GO:0060271; GO:0070840,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271],axoneme [GO:0005930],dynein complex binding [GO:0070840],GO:0007010; GO:0044782,cytoskeleton organization; cilium organization
OG_08483,1.2964875757914749,FUN_037317-T1,Peve_00009173,Pocillopora_meandrina_HIv1___RNAseq.g24177.t1,three_way,64.93,FUN_037317-T1,O73888,,,,,38.0,216.0,6.1e-27,122.5,sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3,,,,,,
OG_08490,1.5381380678712318,FUN_037327-T1,Peve_00006233,Pocillopora_meandrina_HIv1___RNAseq.g10694.t1,three_way,65.693,FUN_037327-T1,Q90YK3,,,,,49.0,437.0,2.1e-133,477.2,sp|Q90YK3|GGLO_SCYTO L-gulonolactone oxidase OS=Scyliorhinus torazame OX=75743 GN=GULO PE=2 SV=1,,,,,,
OG_08492,1.0222941128017229,FUN_037334-T1,Peve_00006154,Pocillopora_meandrina_HIv1___RNAseq.g10739.t1,three_way,47.57333333333333,FUN_037334-T1,O22558,STY8_ARATH,,Serine/threonine-protein kinase STY8 (EC 2.7.11.1) (Serine/threonine/tyrosine-protein kinase 8),Arabidopsis thaliana (Mouse-ear cress),25.3,277.0,4.9e-16,88.2,sp|O22558|STY8_ARATH Serine/threonine-protein kinase STY8 OS=Arabidopsis thaliana OX=3702 GN=STY8 PE=1 SV=2,GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0009658; GO:0106310,chloroplast organization [GO:0009658],cytosol [GO:0005829],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_08493,1.3016238314292834,FUN_037341-T1,Peve_00006166,Pocillopora_meandrina_HIv1___RNAseq.g10757.t1,three_way,60.51666666666667,FUN_037341-T1,Q1MT80,GBP4_DANRE,,Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,370.0,4.899999999999997e-35,151.0,sp|Q1MT80|GBP4_DANRE Guanylate-binding protein 4 OS=Danio rerio OX=7955 GN=gbp4 PE=1 SV=1,GO:0001780; GO:0003924; GO:0005525; GO:0006954; GO:0042742; GO:0042981; GO:0045087; GO:0061702; GO:0070944,defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; neutrophil homeostasis [GO:0001780]; neutrophil-mediated killing of bacterium [GO:0070944]; regulation of apoptotic process [GO:0042981],canonical inflammasome complex [GO:0061702],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0002376; GO:0003824; GO:0003924; GO:0006954; GO:0016787; GO:0098542,immune system process; catalytic activity; GTPase activity; inflammatory response; hydrolase activity; defense response to other organism
OG_08511,1.1578823774591716,FUN_037425-T2,Peve_00014237,Pocillopora_meandrina_HIv1___RNAseq.g10955.t1,three_way,83.41216666666666,FUN_037425-T2,P31266,,,,,75.5,440.0,3.4e-193,676.0,sp|P31266|SUH_MOUSE Recombining binding protein suppressor of hairless OS=Mus musculus OX=10090 GN=Rbpj PE=1 SV=1,,,,,,
OG_08516,1.0637404952173366,FUN_037445-T1,Peve_00027035,Pocillopora_meandrina_HIv1___RNAseq.g10976.t1,three_way,56.40266666666667,FUN_037445-T1,Q56UN5,M3K19_HUMAN,,"Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)",Homo sapiens (Human),61.7,274.0,1.7999999999999997e-95,353.2,sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens OX=9606 GN=MAP3K19 PE=2 SV=1,GO:0000165; GO:0004709; GO:0005524; GO:0106310,MAPK cascade [GO:0000165],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_08522,1.1357435376247385,FUN_037455-T2,Peve_00044122,Pocillopora_meandrina_HIv1___RNAseq.g1369.t1,three_way,78.81866666666667,FUN_037455-T2,B2GUP8,MITOS_XENTR,,"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),59.1,613.0,1.9999999999999999e-193,677.2,sp|B2GUP8|MITOS_XENTR Mitochondrial potassium channel ATP-binding subunit OS=Xenopus tropicalis OX=8364 GN=abcb8 PE=2 SV=1,GO:0005524; GO:0005739; GO:0005743; GO:0016887; GO:0062157; GO:0071805; GO:0140359,potassium ion transmembrane transport [GO:0071805],mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_08525,1.0654994562503193,FUN_037458-T2,Peve_00036027,Pocillopora_meandrina_HIv1___RNAseq.g1372.t1,three_way,51.31883333333333,,,,,,,,,,,,,,,,,
OG_08528,1.5952202411680194,FUN_037469-T1,Peve_00036019,Pocillopora_meandrina_HIv1___RNAseq.g1383.t1,three_way,59.05133333333333,FUN_037469-T1,Q7Z407,CSMD3_HUMAN,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Homo sapiens (Human),27.5,262.0,1.4e-15,85.5,sp|Q7Z407|CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens OX=9606 GN=CSMD3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_08532,1.3587188474911216,FUN_037482-T1,Peve_00020426,Pocillopora_meandrina_HIv1___RNAseq.g1396.t1,three_way,70.77866666666667,,,,,,,,,,,,,,,,,
OG_08533,1.454514737486636,FUN_037483-T1,Peve_00020422,Pocillopora_meandrina_HIv1___RNAseq.g1397.t1,three_way,72.69066666666667,,,,,,,,,,,,,,,,,
OG_08539,1.180465880467128,FUN_037489-T1,Peve_00020410,Pocillopora_meandrina_HIv1___RNAseq.g1305.t1,three_way,76.29033333333334,FUN_037489-T1,A2VEI2,MICU1_DROME,,"Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1)",Drosophila melanogaster (Fruit fly),53.7,376.0,1.5e-108,394.8,"sp|A2VEI2|MICU1_DROME Calcium uptake protein 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MICU1 PE=2 SV=1",GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051560; GO:0051561; GO:0072375; GO:1990246,anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246],calcium ion binding [GO:0005509],GO:0050877; GO:0055085,nervous system process; transmembrane transport
OG_08546,1.7613001306171563,FUN_037508-T1,Peve_00028562,Pocillopora_meandrina_HIv1___RNAseq.g1315.t1,three_way,65.59033333333333,,,,,,,,,,,,,,,,,
OG_08551,1.4434704124444908,FUN_037526-T1,Peve_00044841,Pocillopora_meandrina_HIv1___RNAseq.g10605.t1,three_way,68.244,,,,,,,,,,,,,,,,,
OG_08566,1.20681340474189,FUN_037567-T1,Peve_00035306,Pocillopora_meandrina_HIv1___RNAseq.g1583.t1,three_way,65.91883333333334,FUN_037567-T1,Q6DDX3,,,,,42.9,77.0,8.7e-12,72.8,sp|Q6DDX3|F19XB_XENLA Protein FAM199X-B OS=Xenopus laevis OX=8355 GN=fam199x-b PE=2 SV=1,,,,,,
OG_08574,1.2069133415558115,FUN_037585-T1,Peve_00035295,Pocillopora_meandrina_HIv1___RNAseq.g1593.t1,three_way,55.684666666666665,FUN_037585-T1,Q6AY61,,,,,27.9,272.0,1.1e-15,85.5,sp|Q6AY61|PRS23_RAT Serine protease 23 OS=Rattus norvegicus OX=10116 GN=Prss23 PE=2 SV=1,,,,,,
OG_08600,1.1067165714059155,FUN_037743-T1,Peve_00037357,Pocillopora_meandrina_HIv1___RNAseq.g1333.t1,three_way,65.298,FUN_037743-T1,Q9EP82,,,,,31.0,355.0,1.4e-37,158.7,sp|Q9EP82|WDR4_MOUSE tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 OS=Mus musculus OX=10090 GN=Wdr4 PE=1 SV=2,,,,,,
OG_08635,1.8523831239626976,FUN_037806-T1,Peve_00003980,Pocillopora_meandrina_HIv1___RNAseq.g1566.t1,three_way,45.65533333333333,,,,,,,,,,,,,,,,,
OG_08640,1.2125299657597668,FUN_037825-T1,Peve_00002906,Pocillopora_meandrina_HIv1___RNAseq.g1448.t1,three_way,60.30683333333334,FUN_037825-T1,Q9QZ49,,,,,29.2,226.0,2e-11,71.2,sp|Q9QZ49|UBXN8_MOUSE UBX domain-containing protein 8 OS=Mus musculus OX=10090 GN=Ubxn8 PE=1 SV=1,,,,,,
OG_08641,1.9222655559201631,FUN_037826-T1,Peve_00002905,Pocillopora_meandrina_HIv1___RNAseq.g1449.t1,three_way,85.02733333333333,FUN_037826-T1,Q9JHI5,IVD_MOUSE,,"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1)",Mus musculus (Mouse),73.5,388.0,3.4e-169,597.0,"sp|Q9JHI5|IVD_MOUSE Isovaleryl-CoA dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Ivd PE=1 SV=1",GO:0005654; GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0031966; GO:0042802; GO:0050660,branched-chain amino acid catabolic process [GO:0009083]; L-leucine catabolic process [GO:0006552],mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],3-methylbutanoyl-CoA dehydrogenase activity [GO:0008470]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_08652,1.241483896027233,FUN_037848-T1,Peve_00002751,Pocillopora_meandrina_HIv1___RNAseq.g1439.t1,three_way,86.26866666666666,FUN_037848-T1,Q0VC03,,,,,47.5,394.0,1.8e-102,374.4,sp|Q0VC03|MFSD5_BOVIN Molybdate-anion transporter OS=Bos taurus OX=9913 GN=MFSD5 PE=2 SV=1,,,,,,
OG_08653,1.551561362100813,FUN_037849-T1,Peve_00002752,Pocillopora_meandrina_HIv1___RNAseq.g1438.t1,three_way,68.4055,,,,,,,,,,,,,,,,,
OG_08663,2.252450068300538,FUN_037896-T1,Peve_00028733,Pocillopora_meandrina_HIv1___TS.g8473.t1,three_way,53.025666666666666,FUN_037896-T1,Q7TN88,,,,,25.8,1720.0,6.2e-137,491.9,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08666,1.061645623078368,FUN_037900-T1,Peve_00028723,Pocillopora_meandrina_HIv1___RNAseq.g28679.t1,three_way,73.453,FUN_037900-T1,Q8NEP7,,,,,30.5,295.0,1.8e-27,125.2,sp|Q8NEP7|KLDC9_HUMAN Kelch domain-containing protein 9 OS=Homo sapiens OX=9606 GN=KLHDC9 PE=1 SV=2,,,,,,
OG_08667,1.149449106054364,FUN_037903-T1,Peve_00028717,Pocillopora_meandrina_HIv1___RNAseq.g28653.t1,three_way,61.3495,FUN_037903-T1,Q5XK85,,,,,25.0,1134.0,1.4e-34,150.2,sp|Q5XK85|KATIP_XENLA Protein KATNIP homolog OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_08678,1.0874135299392118,FUN_037917-T1,Peve_00013499,Pocillopora_meandrina_HIv1___RNAseq.g26497.t1,three_way,94.88433333333332,FUN_037917-T1,Q8IVV7,GID4_HUMAN,,Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog),Homo sapiens (Human),79.3,188.0,5.6e-91,335.1,sp|Q8IVV7|GID4_HUMAN Glucose-induced degradation protein 4 homolog OS=Homo sapiens OX=9606 GN=GID4 PE=1 SV=1,GO:0000151; GO:0005829; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005829; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; cytosol; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_08683,1.577491067412805,FUN_037923-T2,Peve_00004174,Pocillopora_meandrina_HIv1___RNAseq.g26228.t1,three_way,76.59416666666667,FUN_037923-T2,P51178,PLCD1_HUMAN,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III) (PLC-III) (Phospholipase C-delta-1) (PLC-delta-1)",Homo sapiens (Human),30.7,792.0,1.8000000000000002e-86,322.4,"sp|P51178|PLCD1_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 OS=Homo sapiens OX=9606 GN=PLCD1 PE=1 SV=2",GO:0001786; GO:0004435; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0006644; GO:0016042; GO:0032794; GO:0046488; GO:0070062; GO:0070300; GO:0141212,lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C/protein kinase C signal transduction [GO:0141212]; phospholipid metabolic process [GO:0006644],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],"calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phosphatidylserine binding [GO:0001786]",GO:0003824; GO:0005886; GO:0006629; GO:0008289; GO:0016787; GO:0043226,catalytic activity; plasma membrane; lipid metabolic process; lipid binding; hydrolase activity; organelle
OG_08685,1.3970712680036714,FUN_037926-T1,Peve_00005837,Pocillopora_meandrina_HIv1___RNAseq.g26224.t1,three_way,74.24433333333334,FUN_037926-T1,A0A0G2K1Q8,ABCA3_RAT,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Rattus norvegicus (Rat),46.9,1760.0,0.0,1404.0,sp|A0A0G2K1Q8|ABCA3_RAT Phospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1,GO:0005319; GO:0005524; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032368; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid transport [GO:0032368]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_08690,1.0190076104020904,FUN_037933-T1,Peve_00025647,Pocillopora_meandrina_HIv1___RNAseq.g26215.t1,three_way,47.622,FUN_037933-T1,Q4V832,,,,,29.1,413.0,9.999999999999999e-27,123.2,sp|Q4V832|AP4AT_XENLA AP-4 complex accessory subunit tepsin OS=Xenopus laevis OX=8355 GN=tepsin PE=2 SV=2,,,,,,
OG_08693,2.718955940768794,FUN_037937-T1,Peve_00015638,Pocillopora_meandrina_HIv1___RNAseq.g26202.t1,three_way,78.55583333333333,FUN_037937-T1,Q5M9B1,,,,,51.3,226.0,6.9e-63,242.3,sp|Q5M9B1|SPSB3_XENLA SPRY domain-containing SOCS box protein 3 OS=Xenopus laevis OX=8355 GN=spsb3 PE=2 SV=1,,,,,,
OG_08701,1.0128746168382865,FUN_037950-T1,Peve_00040736,Pocillopora_meandrina_HIv1___RNAseq.g26516.t1,three_way,47.437000000000005,,,,,,,,,,,,,,,,,
OG_08781,1.4723132941429675,FUN_038067-T1,Peve_00010945,Pocillopora_meandrina_HIv1___RNAseq.g787.t1,three_way,64.63766666666666,,,,,,,,,,,,,,,,,
OG_08788,1.1329305852346545,FUN_038080-T1,Peve_00030065,Pocillopora_meandrina_HIv1___RNAseq.g805.t1,three_way,70.712,FUN_038080-T1,A7SLC8,,,,,63.6,176.0,5.8e-59,228.8,sp|A7SLC8|NAT9_NEMVE N-acetyltransferase 9-like protein OS=Nematostella vectensis OX=45351 GN=nat9 PE=3 SV=1,,,,,,
OG_08811,1.4498000093364956,FUN_038134-T1,Peve_00043379,Pocillopora_meandrina_HIv1___RNAseq.g764.t1,three_way,80.85533333333333,FUN_038134-T1,Q8L7C8,RWA1_ARATH,,Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-),Arabidopsis thaliana (Mouse-ear cress),42.3,433.0,1.8000000000000002e-81,305.1,sp|Q8L7C8|RWA1_ARATH Protein REDUCED WALL ACETYLATION 1 OS=Arabidopsis thaliana OX=3702 GN=RWA1 PE=2 SV=1,GO:0000139; GO:0005794; GO:0009834; GO:0016491; GO:0016740; GO:0045491; GO:0045492; GO:1990937,plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740],GO:0003824; GO:0005794; GO:0005975; GO:0016491; GO:0016740; GO:0043226; GO:0071554,catalytic activity; Golgi apparatus; carbohydrate metabolic process; oxidoreductase activity; transferase activity; organelle; cell wall organization or biogenesis
OG_08837,1.5359192165090645,FUN_038181-T1,Peve_00009435,Pocillopora_meandrina_HIv1___TS.g5496.t3,three_way,80.30433333333333,FUN_038181-T1,Q8TAT6,NPL4_HUMAN,,Nuclear protein localization protein 4 homolog (Protein NPL4),Homo sapiens (Human),53.6,616.0,7.4e-203,708.4,sp|Q8TAT6|NPL4_HUMAN Nuclear protein localization protein 4 homolog OS=Homo sapiens OX=9606 GN=NPLOC4 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0008270; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0051117; GO:0070530,"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006886; GO:0030163; GO:0043226,nucleus; nucleoplasm; endoplasmic reticulum; cytosol; intracellular protein transport; protein catabolic process; organelle
OG_08858,2.087927224484709,FUN_038244-T2,Peve_00029668,Pocillopora_meandrina_HIv1___TS.g5461.t1,three_way,77.83200000000001,FUN_038244-T2,Q15822,ACHA2_HUMAN,,Neuronal acetylcholine receptor subunit alpha-2 (Nicotinic acetylcholine receptor subunit alpha-2),Homo sapiens (Human),34.7,505.0,3.8e-83,310.5,sp|Q15822|ACHA2_HUMAN Neuronal acetylcholine receptor subunit alpha-2 OS=Homo sapiens OX=9606 GN=CHRNA2 PE=1 SV=2,GO:0005654; GO:0005886; GO:0005892; GO:0006811; GO:0007165; GO:0007271; GO:0007274; GO:0015464; GO:0016020; GO:0022848; GO:0034220; GO:0034703; GO:0035094; GO:0043005; GO:0045171; GO:0045202; GO:0045211; GO:0050997; GO:0051899; GO:0071316; GO:0095500; GO:0098828; GO:0098878; GO:0120111; GO:1901363,"acetylcholine receptor signaling pathway [GO:0095500]; cellular response to nicotine [GO:0071316]; membrane depolarization [GO:0051899]; modulation of inhibitory postsynaptic potential [GO:0098828]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; neuromuscular synaptic transmission [GO:0007274]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; nucleoplasm; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_08878,1.2201782769913727,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_08902,1.6462152347654166,FUN_038330-T1,Peve_00023108,Pocillopora_meandrina_HIv1___RNAseq.g1119.t2,three_way,80.42033333333333,FUN_038330-T1,Q9EQY0,ERN1_MOUSE,,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],Mus musculus (Mouse),44.5,954.0,2.3e-213,743.8,sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus OX=10090 GN=Ern1 PE=1 SV=1,GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005739; GO:0005789; GO:0006468; GO:0017148; GO:0019899; GO:0030544; GO:0030968; GO:0033120; GO:0035924; GO:0036498; GO:0042803; GO:0043507; GO:0043531; GO:0046777; GO:0051879; GO:0070054; GO:0070059; GO:0070301; GO:0071333; GO:0106310; GO:1900103; GO:1901142; GO:1904294; GO:1904707; GO:1990597; GO:1990604; GO:1990630,"cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; negative regulation of translation [GO:0017148]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]",AIP1-IRE1 complex [GO:1990597]; endoplasmic reticulum membrane [GO:0005789]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637],ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521],GO:0003824; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140096; GO:0140098,"catalytic activity; mitochondrion; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_08904,1.0479566334322117,FUN_038333-T1,Peve_00023105,Pocillopora_meandrina_HIv1___RNAseq.g1117.t1,three_way,47.60166666666667,FUN_038333-T1,Q1JPJ9,,,,,41.1,202.0,1.7999999999999998e-35,151.8,sp|Q1JPJ9|EF2KT_BOVIN Protein-lysine N-methyltransferase EEF2KMT OS=Bos taurus OX=9913 GN=EEF2KMT PE=2 SV=2,,,,,,
OG_08909,1.0833821526582188,FUN_038340-T1,Peve_00000096,Pocillopora_meandrina_HIv1___RNAseq.g1108.t1,three_way,79.30233333333334,FUN_038340-T1,Q17770,,,,,56.6,431.0,9.2e-145,515.0,sp|Q17770|PDI2_CAEEL Protein disulfide-isomerase 2 OS=Caenorhabditis elegans OX=6239 GN=pdi-2 PE=1 SV=1,,,,,,
OG_08911,1.3355153796569823,FUN_038345-T1,Peve_00000092,Pocillopora_meandrina_HIv1___RNAseq.g1104.t1,three_way,95.93,FUN_038345-T1,A4IHR1,IT70A_XENTR,,Intraflagellar transport protein 70A (Tetratricopeptide repeat protein 30A) (TPR repeat protein 30A),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),78.8,646.0,2e-307,1055.8,sp|A4IHR1|IT70A_XENTR Intraflagellar transport protein 70A OS=Xenopus tropicalis OX=8364 GN=ift70a PE=2 SV=1,GO:0001501; GO:0001822; GO:0005879; GO:0005929; GO:0018095; GO:0042073; GO:0060271,cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; protein polyglutamylation [GO:0018095]; skeletal system development [GO:0001501],axonemal microtubule [GO:0005879]; cilium [GO:0005929],,GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_08928,1.3383561593198876,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08929,1.2029218429426232,FUN_038387-T1,Peve_00000060,Pocillopora_meandrina_HIv1___RNAseq.g28287.t1,three_way,63.87316666666666,FUN_038387-T1,P55202,,,,,36.6,940.0,3e-137,491.1,sp|P55202|ANPRB_ANGJA Atrial natriuretic peptide receptor 2 OS=Anguilla japonica OX=7937 GN=npr2 PE=2 SV=1,,,,,,
OG_08942,1.134560715307028,FUN_038415-T1,Peve_00000011,Pocillopora_meandrina_HIv1___RNAseq.g1190.t1,three_way,60.18366666666667,FUN_038415-T1,Q9NZS9,,,,,33.4,416.0,1.4e-60,235.3,sp|Q9NZS9|BFAR_HUMAN Bifunctional apoptosis regulator OS=Homo sapiens OX=9606 GN=BFAR PE=1 SV=1,,,,,,
OG_08945,1.5901646877081572,FUN_038418-T1,Peve_00000006,Pocillopora_meandrina_HIv1___RNAseq.g1186.t1,three_way,79.584,FUN_038418-T1,P17844,DDX5_HUMAN,,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),Homo sapiens (Human),68.1,470.0,2.1999999999999997e-192,673.7,sp|P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003729; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0031053; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1990841; GO:1990904; GO:2001014,"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08951,1.1992941738675276,FUN_038424-T1,Peve_00000118,Pocillopora_meandrina_HIv1___RNAseq.g1179.t1,three_way,52.31733333333333,FUN_038424-T1,Q9DCV4,,,,,48.9,237.0,4.7000000000000004e-57,223.0,sp|Q9DCV4|RMD1_MOUSE Regulator of microtubule dynamics protein 1 OS=Mus musculus OX=10090 GN=Rmdn1 PE=1 SV=2,,,,,,
OG_08956,1.163358811358847,FUN_038431-T1,Peve_00000107,Pocillopora_meandrina_HIv1___RNAseq.g1060.t1,three_way,80.83533333333334,FUN_038431-T1,Q8IX18,,,,,54.5,730.0,2.7000000000000003e-223,776.5,sp|Q8IX18|DHX40_HUMAN Probable ATP-dependent RNA helicase DHX40 OS=Homo sapiens OX=9606 GN=DHX40 PE=1 SV=2,,,,,,
OG_08980,1.02951438692003,FUN_038498-T1,Peve_00013507,Pocillopora_meandrina_HIv1___RNAseq.g28197.t1,three_way,73.013,FUN_038498-T1,Q96FN9,,,,,54.3,162.0,1.5e-46,187.2,sp|Q96FN9|DTD2_HUMAN D-aminoacyl-tRNA deacylase 2 OS=Homo sapiens OX=9606 GN=DTD2 PE=1 SV=1,,,,,,
OG_08981,1.0444065114643946,FUN_038499-T1,Peve_00013488,Pocillopora_meandrina_HIv1___RNAseq.g28195.t1,three_way,71.18633333333334,FUN_038499-T1,Q6DGP7,,,,,47.9,117.0,2e-24,113.2,sp|Q6DGP7|LYRM1_DANRE LYR motif containing protein 1 OS=Danio rerio OX=7955 GN=lyrm1 PE=3 SV=1,,,,,,
OG_08987,1.371185903969742,FUN_038507-T2,Peve_00041684,Pocillopora_meandrina_HIv1___RNAseq.g28173.t1,three_way,75.75433333333334,FUN_038507-T2,Q4R7R1,,,,,61.6,357.0,4.3e-122,439.5,sp|Q4R7R1|D42E1_MACFA Short-chain dehydrogenase/reductase family 42E member 1 OS=Macaca fascicularis OX=9541 GN=SDR42E1 PE=2 SV=1,,,,,,
OG_09021,3.698278885996164,FUN_038610-T1,Peve_00002803,Pocillopora_meandrina_HIv1___RNAseq.g988.t1,three_way,58.11266666666667,FUN_038610-T1,Q60437,BAIP2_CRIGR,,BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),31.7,221.0,2.2e-23,111.7,sp|Q60437|BAIP2_CRIGR BAR/IMD domain-containing adapter protein 2 OS=Cricetulus griseus OX=10029 GN=BAIAP2 PE=1 SV=1,GO:0001726; GO:0005654; GO:0005829; GO:0005856; GO:0007009; GO:0008093; GO:0008360; GO:0016020; GO:0030175; GO:0030838; GO:0032956; GO:0051017; GO:0051764; GO:0070064,actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],cytoskeletal anchor activity [GO:0008093]; proline-rich region binding [GO:0070064],GO:0005654; GO:0005829; GO:0005856; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; cytosol; cytoskeleton; organelle; molecular adaptor activity; membrane organization
OG_09028,1.940315591878796,FUN_038621-T1,Peve_00042047,Pocillopora_meandrina_HIv1___RNAseq.g1161.t1,three_way,51.117666666666665,FUN_038621-T1,Q5NVA9,,,,,38.2,327.0,3.0999999999999995e-43,178.3,sp|Q5NVA9|EME1_PONAB Structure-specific endonuclease subunit EME1 OS=Pongo abelii OX=9601 GN=EME1 PE=3 SV=1,,,,,,
OG_09036,1.1043986197066484,FUN_038637-T1,Peve_00013493,Pocillopora_meandrina_HIv1___RNAseq.g26491.t1,three_way,71.66766666666666,FUN_038637-T1,P70426,,,,,43.2,183.0,1.3999999999999998e-29,131.7,sp|P70426|RIT1_MOUSE GTP-binding protein Rit1 OS=Mus musculus OX=10090 GN=Rit1 PE=1 SV=1,,,,,,
OG_09043,1.3526763864467553,FUN_038697-T1,Peve_00013468,Pocillopora_meandrina_HIv1___RNAseq.g26461.t2,three_way,78.3395,FUN_038697-T1,Q9Y383,LC7L2_HUMAN,,Putative RNA-binding protein Luc7-like 2,Homo sapiens (Human),60.3,239.0,6.6e-79,295.8,sp|Q9Y383|LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004,mRNA splice site recognition [GO:0006376],nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226; GO:0065003,RNA binding; organelle; protein-containing complex assembly
OG_09075,1.2955813130576128,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_09086,1.0892403787079972,FUN_038833-T1,Peve_00028686,Pocillopora_meandrina_HIv1___RNAseq.21094_t,three_way,62.954166666666666,FUN_038833-T1,O15169,AXIN1_HUMAN,,Axin-1 (Axis inhibition protein 1) (hAxin),Homo sapiens (Human),27.2,904.0,3.3e-52,208.4,sp|O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens OX=9606 GN=AXIN1 PE=1 SV=2,GO:0000209; GO:0001701; GO:0002039; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0010629; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060,apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605],beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006325; GO:0006355; GO:0006913; GO:0007010; GO:0012501; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0065003; GO:0098772,nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; chromatin organization; regulation of DNA-templated transcription; nucleocytoplasmic transport; cytoskeleton organization; programmed cell death; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity
OG_09134,1.1206871105426142,FUN_039701-T1,Peve_00008100,Pocillopora_meandrina_HIv1___RNAseq.g14123.t1,three_way,57.217333333333336,,,,,,,,,,,,,,,,,
OG_09138,1.4187921453174912,FUN_039777-T1,Peve_00017586,Pocillopora_meandrina_HIv1___TS.g1210.t1,three_way,63.503,,,,,,,,,,,,,,,,,
OG_09143,1.0535429827941445,FUN_039791-T2,Peve_00017605,Pocillopora_meandrina_HIv1___TS.g1219.t1,three_way,73.25066666666666,FUN_039791-T2,Q8RYE9,,,,,39.4,216.0,1.7999999999999998e-35,151.0,sp|Q8RYE9|GPPL3_ARATH Haloacid dehalogenase-like hydrolase domain-containing protein At2g33255 OS=Arabidopsis thaliana OX=3702 GN=At2g33255 PE=1 SV=1,,,,,,
OG_09146,2.311122133645564,FUN_039798-T1,Peve_00017577,Pocillopora_meandrina_HIv1___RNAseq.g7474.t1,three_way,69.27600000000001,,,,,,,,,,,,,,,,,
OG_09149,1.3189085549466746,FUN_039803-T1,Peve_00017581,Pocillopora_meandrina_HIv1___RNAseq.g7477.t2,three_way,74.33033333333334,FUN_039803-T1,Q6BZW3,,,,,30.8,399.0,7.6e-32,139.8,sp|Q6BZW3|BTN1_YARLI Protein BTN1 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=BTN1 PE=3 SV=1,,,,,,
OG_09173,1.757884406221224,FUN_039849-T1,Peve_00006320,Pocillopora_meandrina_HIv1___RNAseq.g7298.t1,three_way,70.33566666666667,FUN_039849-T1,A8WQK3,,,,,33.2,506.0,8.5e-67,256.5,sp|A8WQK3|ACH1_CAEBR Acetylcholine receptor subunit alpha-type acr-16 OS=Caenorhabditis briggsae OX=6238 GN=acr-16 PE=3 SV=2,,,,,,
OG_09204,1.061696379310337,FUN_039892-T1,Peve_00021860,Pocillopora_meandrina_HIv1___RNAseq.g7364.t1,three_way,45.9685,FUN_039892-T1,Q9JK41,COPT1_RAT,,High affinity copper uptake protein 1 (Copper transporter 1) (rCTR1) (Liver regeneration-related protein LRRGT00200) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form],Rattus norvegicus (Rat),31.9,144.0,2e-09,64.3,sp|Q9JK41|COPT1_RAT High affinity copper uptake protein 1 OS=Rattus norvegicus OX=10116 GN=Slc31a1 PE=2 SV=1,GO:0001525; GO:0005375; GO:0005507; GO:0005770; GO:0005886; GO:0006825; GO:0006878; GO:0014704; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042802; GO:0042908; GO:0042910; GO:0043025; GO:0051259; GO:0051649; GO:0055037; GO:0055038; GO:0055085; GO:0072719; GO:0098705; GO:1902601,angiogenesis [GO:0001525]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; transmembrane transport [GO:0055085]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085; GO:0065003,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport; protein-containing complex assembly
OG_09210,1.03313113352835,FUN_039923-T1,Peve_00010141,Pocillopora_meandrina_HIv1___RNAseq.g7340.t1,three_way,61.899,,,,,,,,,,,,,,,,,
OG_09213,1.1700668557358502,FUN_039930-T2,Peve_00010154,Pocillopora_meandrina_HIv1___TS.g1088.t1,three_way,69.904,FUN_039930-T2,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),33.0,5128.0,0.0,2459.9,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09216,1.1182878879174118,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_09236,1.372727056269017,FUN_039982-T1,Peve_00014323,Pocillopora_meandrina_HIv1___RNAseq.g7548.t1,three_way,78.11166666666666,FUN_039982-T1,Q9R0C8,VAV3_MOUSE,,Guanine nucleotide exchange factor VAV3 (VAV-3),Mus musculus (Mouse),36.8,766.0,1.9e-123,444.9,sp|Q9R0C8|VAV3_MOUSE Guanine nucleotide exchange factor VAV3 OS=Mus musculus OX=10090 GN=Vav3 PE=1 SV=2,GO:0001525; GO:0001772; GO:0005085; GO:0005154; GO:0005737; GO:0005886; GO:0006906; GO:0006974; GO:0007229; GO:0007264; GO:0008270; GO:0008361; GO:0009410; GO:0016477; GO:0030031; GO:0030032; GO:0030593; GO:0030890; GO:0045785; GO:0050853; GO:0051897,angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; DNA damage response [GO:0006974]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; small GTPase-mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906],cytoplasm [GO:0005737]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886],epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270],GO:0002376; GO:0005886; GO:0048870; GO:0061024; GO:0098772,immune system process; plasma membrane; cell motility; membrane organization; molecular function regulator activity
OG_09241,1.199663257409514,FUN_040029-T1,Peve_00025977,Pocillopora_meandrina_HIv1___RNAseq.g8448.t1,three_way,44.02483333333333,FUN_040029-T1,Q8BZ20,,,,,27.0,711.0,1.1e-55,220.7,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_09255,1.6099160570101685,FUN_040054-T1,Peve_00016114,Pocillopora_meandrina_HIv1___RNAseq.g8468.t1,three_way,76.35666666666667,FUN_040054-T1,O09172,GSH0_MOUSE,,Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit),Mus musculus (Mouse),40.4,275.0,1.6000000000000002e-48,194.5,sp|O09172|GSH0_MOUSE Glutamate--cysteine ligase regulatory subunit OS=Mus musculus OX=10090 GN=Gclm PE=1 SV=1,GO:0004357; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007584; GO:0008637; GO:0009410; GO:0014823; GO:0017109; GO:0035226; GO:0035729; GO:0035733; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237,apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],glutamate-cysteine ligase complex [GO:0017109],glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0007005; GO:0016874,circulatory system process; catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; mitochondrion organization; ligase activity
OG_09267,1.1784255161618875,FUN_040072-T1,Peve_00021005,Pocillopora_meandrina_HIv1___RNAseq.g7692.t2,three_way,86.87233333333333,FUN_040072-T1,Q6PB70,,,,,38.3,838.0,5e-155,549.7,sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3,,,,,,
OG_09306,1.473564339877483,FUN_040203-T1,Peve_00038111,Pocillopora_meandrina_HIv1___TS.g1483.t1,three_way,55.532,,,,,,,,,,,,,,,,,
OG_09309,1.003504893296238,FUN_040206-T1,Peve_00038134,Pocillopora_meandrina_HIv1___RNAseq.g7739.t1,three_way,73.89966666666666,FUN_040206-T1,Q5EA19,,,,,50.3,181.0,5.1e-47,189.1,sp|Q5EA19|ARL15_BOVIN ADP-ribosylation factor-like protein 15 OS=Bos taurus OX=9913 GN=ARL15 PE=2 SV=1,,,,,,
OG_09347,1.0066568523643151,FUN_040402-T1,Peve_00014984,Pocillopora_meandrina_HIv1___RNAseq.g6531.t1,three_way,64.912,FUN_040402-T1,P19137,LAMA1_MOUSE,,Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha),Mus musculus (Mouse),22.5,3355.0,9.5e-78,295.0,sp|P19137|LAMA1_MOUSE Laminin subunit alpha-1 OS=Mus musculus OX=10090 GN=Lama1 PE=1 SV=2,GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046,branching involved in salivary gland morphogenesis [GO:0060445]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888],basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; signaling receptor binding [GO:0005102],GO:0005198; GO:0005576; GO:0005615; GO:0007155; GO:0007163; GO:0008289; GO:0030154; GO:0030312; GO:0031012; GO:0048856,structural molecule activity; extracellular region; extracellular space; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09377,1.2267752993108774,FUN_040610-T1,Peve_00015406,Pocillopora_meandrina_HIv1___TS.g215.t1,three_way,55.4595,,,,,,,,,,,,,,,,,
OG_09379,1.4141747917542886,FUN_040615-T1,Peve_00015411,Pocillopora_meandrina_HIv1___RNAseq.g6470.t1,three_way,87.62333333333333,FUN_040615-T1,E9PV86,,,,,44.3,711.0,1.7e-153,544.7,sp|E9PV86|MCTP1_MOUSE Multiple C2 and transmembrane domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mctp1 PE=1 SV=1,,,,,,
OG_09384,1.3844729804799736,FUN_040673-T1,Peve_00015420,Pocillopora_meandrina_HIv1___RNAseq.g6458.t1,three_way,49.12566666666667,,,,,,,,,,,,,,,,,
OG_09399,1.0162520275003284,FUN_040713-T1,Peve_00002272,Pocillopora_meandrina_HIv1___TS.g280.t1,three_way,81.17566666666667,FUN_040713-T1,Q9Z2E1,,,,,43.9,255.0,6.899999999999999e-49,195.7,sp|Q9Z2E1|MBD2_MOUSE Methyl-CpG-binding domain protein 2 OS=Mus musculus OX=10090 GN=Mbd2 PE=1 SV=2,,,,,,
OG_09413,1.1228323147087544,FUN_040950-T1,Peve_00008820,Pocillopora_meandrina_HIv1___RNAseq.g27113.t1,three_way,67.32266666666666,FUN_040950-T1,Q969X6,UTP4_HUMAN,,U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component),Homo sapiens (Human),32.1,701.0,1.7e-102,375.2,sp|Q969X6|UTP4_HUMAN U3 small nucleolar RNA-associated protein 4 homolog OS=Homo sapiens OX=9606 GN=UTP4 PE=1 SV=1,GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455; GO:0042274,"maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of DNA-templated transcription [GO:0006355]; ribosomal small subunit biogenesis [GO:0042274]",90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0043226,RNA binding; nucleoplasm; chromosome; nucleolus; regulation of DNA-templated transcription; organelle
OG_09420,1.0422911721837298,FUN_040987-T1,Peve_00031413,Pocillopora_meandrina_HIv1___RNAseq.g12093.t1,three_way,53.817,FUN_040987-T1,Q8TCF1,ZFAN1_HUMAN,,AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1),Homo sapiens (Human),40.6,266.0,4.9e-48,193.0,sp|Q8TCF1|ZFAN1_HUMAN AN1-type zinc finger protein 1 OS=Homo sapiens OX=9606 GN=ZFAND1 PE=1 SV=1,GO:0005737; GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843,cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494],proteasome binding [GO:0070628]; zinc ion binding [GO:0008270],GO:0043226,organelle
OG_09426,1.1004720676734543,FUN_041310-T1,Peve_00023188,Pocillopora_meandrina_HIv1___TS.g11106.t1,three_way,76.71966666666667,FUN_041310-T1,P50532,,,,,62.6,1213.0,5.000000000000001e-227,789.6,sp|P50532|SMC4_XENLA Structural maintenance of chromosomes protein 4 OS=Xenopus laevis OX=8355 GN=smc4 PE=1 SV=1,,,,,,
OG_09453,1.1177130323864586,FUN_041461-T1,Peve_00007408,Pocillopora_meandrina_HIv1___RNAseq.g15690.t1,three_way,83.71133333333334,FUN_041461-T1,P61602,,,,,48.9,184.0,7.9e-45,181.8,sp|P61602|NCALD_BOVIN Neurocalcin-delta OS=Bos taurus OX=9913 GN=NCALD PE=1 SV=2,,,,,,
OG_09481,1.139176391201381,FUN_041509-T1,Peve_00025395,Pocillopora_meandrina_HIv1___RNAseq.g16082.t1,three_way,78.44016666666667,FUN_041509-T1,P13773,,,,,23.2,228.0,1.4e-12,75.5,sp|P13773|CAR1_DICDI Cyclic AMP receptor 1 OS=Dictyostelium discoideum OX=44689 GN=carA-1 PE=1 SV=1,,,,,,
OG_09528,1.0913830614438758,FUN_041599-T1,Peve_00025739,Pocillopora_meandrina_HIv1___RNAseq.g15300.t1,three_way,61.832,,,,,,,,,,,,,,,,,
OG_09531,2.7151649884224884,FUN_041609-T1,Peve_00036118,Pocillopora_meandrina_HIv1___RNAseq.g15296.t1,three_way,62.51383333333334,,,,,,,,,,,,,,,,,
OG_09585,1.1277369867548608,FUN_041725-T1,Peve_00014618,Pocillopora_meandrina_HIv1___RNAseq.g15480.t2b,three_way,60.04133333333333,,,,,,,,,,,,,,,,,
OG_09598,1.1481720151085395,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_09611,1.6590138646726096,FUN_041769-T1,Peve_00041575,Pocillopora_meandrina_HIv1___RNAseq.g15246.t1,three_way,89.10266666666666,,,,,,,,,,,,,,,,,
OG_09615,1.277155611458802,FUN_041775-T1,Peve_00014827,Pocillopora_meandrina_HIv1___RNAseq.g15891.t1,three_way,93.94866666666668,FUN_041775-T1,Q8I1F4,,,,,87.3,236.0,1.4000000000000001e-117,424.1,sp|Q8I1F4|FBRL_DROER rRNA 2'-O-methyltransferase fibrillarin OS=Drosophila erecta OX=7220 GN=Fib PE=3 SV=1,,,,,,
OG_09622,1.1228794017846584,FUN_041786-T1,Peve_00038537,Pocillopora_meandrina_HIv1___RNAseq.g15774.t1,three_way,61.81633333333333,FUN_041786-T1,Q01887,,,,,38.8,624.0,3.9e-114,413.7,sp|Q01887|RYK_MOUSE Tyrosine-protein kinase RYK OS=Mus musculus OX=10090 GN=Ryk PE=1 SV=2,,,,,,
OG_09625,1.473184687800038,FUN_041789-T1,Peve_00038532,Pocillopora_meandrina_HIv1___RNAseq.g15770.t1,three_way,64.701,FUN_041789-T1,O15072,ATS3_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme),Homo sapiens (Human),30.6,992.0,5.3e-119,430.6,sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4,GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748,collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_09626,1.3195262123276394,FUN_041790-T1,Peve_00038533,Pocillopora_meandrina_HIv1___RNAseq.g15769.t1,three_way,61.01483333333333,FUN_041790-T1,Q8TE57,ATS16_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Homo sapiens (Human),30.0,1013.0,6.7e-112,407.1,sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_09627,1.7490611083252297,FUN_041794-T1,Peve_00009375,Pocillopora_meandrina_HIv1___RNAseq.g15767.t1,three_way,43.15016666666666,FUN_041794-T1,Q4VC17,ATS18_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-),Mus musculus (Mouse),27.2,1006.0,3.1e-77,292.0,sp|Q4VC17|ATS18_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Mus musculus OX=10090 GN=Adamts18 PE=2 SV=2,GO:0001654; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0090331,extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0030198; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; extracellular matrix organization; anatomical structure development; catalytic activity, acting on a protein"
OG_09628,1.6644851383583947,FUN_041799-T1,Peve_00025729,Pocillopora_meandrina_HIv1___RNAseq.g15850.t2,three_way,48.657,FUN_041799-T1,Q4VSN1,DUSTY_DANRE,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Danio rerio (Zebrafish) (Brachydanio rerio),33.2,265.0,3.3e-27,125.6,sp|Q4VSN1|DUSTY_DANRE Dual serine/threonine and tyrosine protein kinase OS=Danio rerio OX=7955 GN=dstyk PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0048568; GO:0048570; GO:0060036; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; embryonic organ development [GO:0048568]; negative regulation of apoptotic process [GO:0043066]; notochord cell vacuolation [GO:0060036]; notochord morphogenesis [GO:0048570]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_09638,1.292617533085864,FUN_041833-T1,Peve_00039120,Pocillopora_meandrina_HIv1___RNAseq.g15818.t1,three_way,53.50833333333333,,,,,,,,,,,,,,,,,
OG_09644,1.293583454577166,FUN_041839-T1,Peve_00009639,Pocillopora_meandrina_HIv1___RNAseq.g15081.t1,three_way,63.03933333333333,FUN_041839-T1,Q9UKB3,,,,,38.9,144.0,6e-25,115.5,sp|Q9UKB3|DJC12_HUMAN DnaJ homolog subfamily C member 12 OS=Homo sapiens OX=9606 GN=DNAJC12 PE=1 SV=1,,,,,,
OG_09645,1.0402063741201697,FUN_041840-T1,Peve_00009640,Pocillopora_meandrina_HIv1___RNAseq.g15080.t1,three_way,69.50733333333334,,,,,,,,,,,,,,,,,
OG_09663,1.8282997334899136,FUN_041874-T1,Peve_00040563,Pocillopora_meandrina_HIv1___RNAseq.g15106.t3,three_way,72.21516666666666,FUN_041874-T1,P49959,MRE11_HUMAN,,Double-strand break repair protein MRE11 (EC 3.1.-.-) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),Homo sapiens (Human),55.2,538.0,4.6e-166,586.3,sp|P49959|MRE11_HUMAN Double-strand break repair protein MRE11 OS=Homo sapiens OX=9606 GN=MRE11 PE=1 SV=3,GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008283; GO:0008296; GO:0008408; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0032206; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0062176; GO:0070533; GO:0097552; GO:0098687; GO:0110025; GO:2000781; GO:2001033,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; R-loop processing [GO:0062176]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; cadherin binding [GO:0045296]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; catalytic activity, acting on DNA"
OG_09674,3.1564730043848623,FUN_041896-T1,Peve_00026173,Pocillopora_meandrina_HIv1___RNAseq.6056_t,three_way,57.614666666666665,FUN_041896-T1,Q90WM5,,,,,36.3,292.0,2.0000000000000002e-29,131.7,sp|Q90WM5|DMRT3_TAKRU Doublesex- and mab-3-related transcription factor 3 OS=Takifugu rubripes OX=31033 GN=dmrt3 PE=2 SV=2,,,,,,
OG_09693,2.4237076443188834,FUN_041922-T1,Peve_00007867,Pocillopora_meandrina_HIv1___RNAseq.g15626.t1,three_way,82.96933333333334,FUN_041922-T1,Q5I0R4,,,,,53.6,222.0,4.2e-63,242.7,sp|Q5I0R4|CF300_XENTR Cilia- and flagella-associated protein 300 OS=Xenopus tropicalis OX=8364 GN=cfap300 PE=2 SV=1,,,,,,
OG_09696,2.080407488301155,FUN_041927-T1,Peve_00025329,Pocillopora_meandrina_HIv1___RNAseq.g15250.t1,three_way,59.38166666666667,FUN_041927-T1,Q3UPY5,,,,,44.6,630.0,8.2e-144,512.3,sp|Q3UPY5|GLBL2_MOUSE Beta-galactosidase-1-like protein 2 OS=Mus musculus OX=10090 GN=Glb1l2 PE=1 SV=1,,,,,,
OG_09698,1.0998277883436989,FUN_041929-T1,Peve_00022681,Pocillopora_meandrina_HIv1___RNAseq.g15697.t1,three_way,59.108,FUN_041929-T1,Q6AYB8,GO45_RAT,,Golgin-45 (Basic leucine zipper nuclear factor 1),Rattus norvegicus (Rat),29.6,422.0,1.5e-25,119.0,sp|Q6AYB8|GO45_RAT Golgin-45 OS=Rattus norvegicus OX=10116 GN=Blzf1 PE=1 SV=1,GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001,Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005794; GO:0016192; GO:0043226; GO:0072659,nucleus; Golgi apparatus; vesicle-mediated transport; organelle; protein localization to plasma membrane
OG_09705,1.0437984193613563,FUN_041939-T1,Peve_00023589,Pocillopora_meandrina_HIv1___RNAseq.g15705.t1,three_way,68.18516666666667,FUN_041939-T1,Q15696,U2AFM_HUMAN,,"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)",Homo sapiens (Human),56.4,172.0,6.7e-51,202.6,sp|Q15696|U2AFM_HUMAN U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 OS=Homo sapiens OX=9606 GN=ZRSR2 PE=1 SV=2,GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008270; GO:0008380; GO:0030628; GO:0042802; GO:0089701,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701],identical protein binding [GO:0042802]; pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0016071; GO:0065003,RNA binding; nucleoplasm; mRNA metabolic process; protein-containing complex assembly
OG_09706,1.1404655853616676,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),68.5,89.0,1.8e-32,143.7,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_09706,1.1404655853616676,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),29.7,138.0,2.2e-06,57.0,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_09718,1.0569108770188362,FUN_041964-T1,Peve_00043505,Pocillopora_meandrina_HIv1___RNAseq.g15913.t3,three_way,63.089666666666666,FUN_041964-T1,O31463,,,,,40.8,304.0,3.8000000000000003e-59,229.9,sp|O31463|HMT_BACSU Homocysteine S-methyltransferase YbgG OS=Bacillus subtilis (strain 168) OX=224308 GN=ybgG PE=4 SV=1,,,,,,
OG_09720,1.376524548773641,FUN_041966-T1,Peve_00043494,Pocillopora_meandrina_HIv1___RNAseq.g15916.t1,three_way,81.62733333333334,FUN_041966-T1,P19984,,,,,44.6,130.0,2.5e-20,99.8,sp|P19984|PROF2_ACACA Profilin-2 OS=Acanthamoeba castellanii OX=5755 PE=1 SV=3,,,,,,
OG_09750,1.2077569177730838,FUN_042019-T1,Peve_00044153,Pocillopora_meandrina_HIv1___RNAseq.g15192.t1,three_way,80.45633333333333,FUN_042019-T1,Q9DAN9,,,,,37.8,148.0,6.900000000000001e-23,109.0,sp|Q9DAN9|CF97D_MOUSE Sperm axonemal maintenance protein CFAP97D1 OS=Mus musculus OX=10090 GN=Cfap97d1 PE=2 SV=1,,,,,,
OG_09770,1.1058166229569182,FUN_042051-T1,Peve_00025418,Pocillopora_meandrina_HIv1___RNAseq.g15145.t1,three_way,44.09616666666667,FUN_042051-T1,Q8BHR2,,,,,29.9,294.0,1.7e-33,146.4,sp|Q8BHR2|ENOX1_MOUSE Ecto-NOX disulfide-thiol exchanger 1 OS=Mus musculus OX=10090 GN=Enox1 PE=2 SV=1,,,,,,
OG_09775,4.800598764405073,FUN_042071-T1,Peve_00038496,Pocillopora_meandrina_HIv1___RNAseq.g6232.t1,three_way,63.51566666666667,FUN_042071-T1,Q96MM6,,,,,35.6,643.0,1.3e-106,388.7,sp|Q96MM6|HS12B_HUMAN Heat shock 70 kDa protein 12B OS=Homo sapiens OX=9606 GN=HSPA12B PE=1 SV=2,,,,,,
OG_09783,3.4529857711297742,FUN_042583-T1,Peve_00034294,Pocillopora_meandrina_HIv1___RNAseq.g16882.t1,three_way,83.662,FUN_042583-T1,P09132,SRP19_HUMAN,,Signal recognition particle 19 kDa protein (SRP19),Homo sapiens (Human),47.1,140.0,3.1000000000000002e-27,122.9,sp|P09132|SRP19_HUMAN Signal recognition particle 19 kDa protein OS=Homo sapiens OX=9606 GN=SRP19 PE=1 SV=3,GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006617; GO:0008312; GO:0016604; GO:0048500,"cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]","cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]",7S RNA binding [GO:0008312]; RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0005829; GO:0043226; GO:0065003,RNA binding; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_09787,1.0572329807139005,FUN_042589-T1,Peve_00012671,Pocillopora_meandrina_HIv1___RNAseq.g16875.t1,three_way,61.26133333333333,FUN_042589-T1,P25122,KCNC1_RAT,,Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (RAW2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),Rattus norvegicus (Rat),43.0,461.0,4.9e-93,344.0,sp|P25122|KCNC1_RAT Voltage-gated potassium channel KCNC1 OS=Rattus norvegicus OX=10116 GN=Kcnc1 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030425; GO:0030673; GO:0032589; GO:0032590; GO:0032809; GO:0034765; GO:0034767; GO:0035864; GO:0042734; GO:0043025; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0046872; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901379; GO:1901381; GO:1990089,action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of monoatomic ion transmembrane transport [GO:0034767]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transmembrane transport [GO:1901379]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636],axolemma [GO:0030673]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; neuron projection membrane [GO:0032589]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0008092; GO:0048856; GO:0055085; GO:0065003,transporter activity; cytoskeletal protein binding; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_09797,1.1775461729386028,FUN_042605-T1,Peve_00034914,Pocillopora_meandrina_HIv1___RNAseq.g16849.t1a,three_way,81.68166666666667,FUN_042605-T1,Q9QUM7,,,,,46.1,798.0,1.1e-204,714.9,sp|Q9QUM7|MSH5_MOUSE MutS protein homolog 5 OS=Mus musculus OX=10090 GN=Msh5 PE=1 SV=1,,,,,,
OG_09820,1.5389245577134671,FUN_042653-T1,Peve_00038268,Pocillopora_meandrina_HIv1___RNAseq.g16812.t1,three_way,75.381,FUN_042653-T1,Q8R4F0,MCLN3_MOUSE,,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),Mus musculus (Mouse),39.9,491.0,5.2000000000000004e-89,330.1,sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1,GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171,inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171],lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289; GO:0030154,transporter activity; plasma membrane; lipid binding; cell differentiation
OG_09823,1.0100403876640875,FUN_042656-T1,Peve_00031588,Pocillopora_meandrina_HIv1___RNAseq.g4910.t1a,three_way,75.37983333333334,FUN_042656-T1,Q5VYK3,ECM29_HUMAN,,Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog),Homo sapiens (Human),44.3,1886.0,0.0,1510.7,sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2,GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628,ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248],centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502],molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628],GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005815; GO:0030163; GO:0031410; GO:0043226; GO:0060090; GO:0065003,nucleus; nucleoplasm; endosome; endoplasmic reticulum; microtubule organizing center; protein catabolic process; cytoplasmic vesicle; organelle; molecular adaptor activity; protein-containing complex assembly
OG_09828,1.6822514261874215,FUN_042664-T1,Peve_00031593,Pocillopora_meandrina_HIv1___RNAseq.g16712.t1,three_way,76.901,FUN_042664-T1,Q96K37,,,,,52.1,217.0,4.2e-50,199.5,sp|Q96K37|S35E1_HUMAN Solute carrier family 35 member E1 OS=Homo sapiens OX=9606 GN=SLC35E1 PE=1 SV=2,,,,,,
OG_09852,1.048535382988144,FUN_042843-T1,Peve_00023281,Pocillopora_meandrina_HIv1___RNAseq.g7256.t1,three_way,66.93900000000001,FUN_042843-T1,Q6ZZY0,,,,,56.5,483.0,1.4e-176,620.9,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_09864,1.3305525800454112,FUN_042873-T1,Peve_00028527,Pocillopora_meandrina_HIv1___TS.g983.t1,three_way,62.68216666666667,FUN_042873-T1,Q8BZM1,GLMN_MOUSE,,Glomulin (FK506-binding protein-associated protein) (FAP) (FKBP-associated protein),Mus musculus (Mouse),27.1,619.0,2.1e-59,231.9,sp|Q8BZM1|GLMN_MOUSE Glomulin OS=Mus musculus OX=10090 GN=Glmn PE=1 SV=1,GO:0001570; GO:0001819; GO:0001843; GO:0005102; GO:0005171; GO:0007166; GO:0008285; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031625; GO:0032434; GO:0032743; GO:0040029; GO:0042130; GO:0042327; GO:0042692; GO:0055105; GO:0072359,cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; epigenetic regulation of gene expression [GO:0040029]; muscle cell differentiation [GO:0042692]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of phosphorylation [GO:0042327]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461],hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105],GO:0006325; GO:0030154; GO:0048856; GO:0098772,chromatin organization; cell differentiation; anatomical structure development; molecular function regulator activity
OG_09866,1.1081146651902485,FUN_042875-T1,Peve_00040165,Pocillopora_meandrina_HIv1___RNAseq.g7231.t1,three_way,78.882,FUN_042875-T1,Q9Y6K8,,,,,36.4,563.0,2e-101,372.1,sp|Q9Y6K8|KAD5_HUMAN Adenylate kinase isoenzyme 5 OS=Homo sapiens OX=9606 GN=AK5 PE=1 SV=2,,,,,,
OG_09869,1.0189656563847596,FUN_042878-T1,Peve_00015664,Pocillopora_meandrina_HIv1___RNAseq.g7228.t1,three_way,78.19666666666667,FUN_042878-T1,Q9UHB4,,,,,54.6,599.0,1.2e-192,674.5,sp|Q9UHB4|NDOR1_HUMAN NADPH-dependent diflavin oxidoreductase 1 OS=Homo sapiens OX=9606 GN=NDOR1 PE=1 SV=1,,,,,,
OG_09884,1.293183713089279,FUN_042957-T1,Peve_00039056,Pocillopora_meandrina_HIv1___RNAseq.g7123.t1,three_way,46.98266666666667,FUN_042957-T1,Q5TM64,,,,,30.0,120.0,2.3e-13,78.2,sp|Q5TM64|CF136_MACMU Uncharacterized protein C6orf136 homolog OS=Macaca mulatta OX=9544 PE=4 SV=1,,,,,,
OG_09894,1.375809628362921,FUN_042988-T1,Peve_00036062,Pocillopora_meandrina_HIv1___RNAseq.g7093.t1,three_way,53.70933333333333,,,,,,,,,,,,,,,,,
OG_09895,2.660156088032299,FUN_042989-T1,Peve_00031072,Pocillopora_meandrina_HIv1___RNAseq.g7089.t1,three_way,80.24966666666667,FUN_042989-T1,Q8BS35,,,,,54.4,397.0,1.2e-125,451.4,sp|Q8BS35|ALKMO_MOUSE Alkylglycerol monooxygenase OS=Mus musculus OX=10090 GN=Agmo PE=1 SV=1,,,,,,
OG_09897,1.21475749541463,FUN_042992-T1,Peve_00031062,Pocillopora_meandrina_HIv1___TS.g753.t1,three_way,81.38566666666667,FUN_042992-T1,Q7SXV9,,,,,42.9,289.0,1.3e-49,198.4,sp|Q7SXV9|CALUB_DANRE Calumenin-B OS=Danio rerio OX=7955 GN=calub PE=2 SV=1,,,,,,
OG_09920,1.163143630598715,FUN_043031-T1,Peve_00026965,Pocillopora_meandrina_HIv1___TS.g793.t1,three_way,52.451,FUN_043031-T1,Q9FN03,,,,,28.7,334.0,5.500000000000001e-28,129.0,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_09936,1.9812468179568503,FUN_043096-T1,Peve_00033763,Pocillopora_meandrina_HIv1___RNAseq.g7008.t1,three_way,52.39533333333333,,,,,,,,,,,,,,,,,
OG_09944,1.7984352082958197,FUN_043111-T1,Peve_00014954,Pocillopora_meandrina_HIv1___RNAseq.g7894.t1,three_way,96.616,FUN_043111-T1,Q8JGS9,,,,,89.1,101.0,5.5e-47,188.0,sp|Q8JGS9|RS18_DANRE Small ribosomal subunit protein uS13 OS=Danio rerio OX=7955 GN=rps18 PE=1 SV=1,,,,,,
OG_09947,1.6944458306198755,FUN_043114-T1,Peve_00026299,Pocillopora_meandrina_HIv1___RNAseq.g7891.t2,three_way,80.283,,,,,,,,,,,,,,,,,
OG_09963,1.265553079745233,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_09968,1.0324597217233766,FUN_043149-T1,Peve_00011390,Pocillopora_meandrina_HIv1___RNAseq.g6853.t1,three_way,78.382,FUN_043149-T1,Q8TE57,ATS16_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Homo sapiens (Human),35.3,1002.0,3.1000000000000004e-157,558.1,sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_09981,1.312592575040014,FUN_043171-T1,Peve_00025849,Pocillopora_meandrina_HIv1___RNAseq.g6793.t1,three_way,67.71433333333333,,,,,,,,,,,,,,,,,
OG_09987,1.6120914682936576,FUN_043181-T1,Peve_00043024,Pocillopora_meandrina_HIv1___RNAseq.g18637.t1,three_way,60.36716666666666,FUN_043181-T1,Q8MIQ9,,,,,52.9,493.0,4.6e-133,476.9,sp|Q8MIQ9|P_PIG P protein OS=Sus scrofa OX=9823 GN=Oca2 PE=2 SV=3,,,,,,
OG_09988,1.0748806892290803,FUN_043182-T1,Peve_00043027,Pocillopora_meandrina_HIv1___RNAseq.g6806.t1,three_way,59.36083333333333,FUN_043182-T1,Q9Z136,,,,,38.8,361.0,3.4e-62,241.9,sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1,,,,,,
OG_09996,1.7405294947289902,FUN_043221-T1,Peve_00037105,Pocillopora_meandrina_HIv1___RNAseq.g6778.t1,three_way,51.28266666666666,FUN_043221-T1,Q91770,,,,,71.2,59.0,1.8e-16,87.8,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_10022,1.2773817350595194,FUN_043264-T1,Peve_00032613,Pocillopora_meandrina_HIv1___RNAseq.g8889.t1,three_way,60.43216666666667,FUN_043264-T1,P79795,NRP1_CHICK,,Neuropilin-1 (A5 protein),Gallus gallus (Chicken),28.2,255.0,3.2e-12,75.9,sp|P79795|NRP1_CHICK Neuropilin-1 OS=Gallus gallus OX=9031 GN=NRP1 PE=2 SV=1,GO:0001570; GO:0001755; GO:0002040; GO:0005021; GO:0005886; GO:0005925; GO:0007155; GO:0007411; GO:0008201; GO:0009611; GO:0010595; GO:0017154; GO:0022035; GO:0030424; GO:0030947; GO:0031966; GO:0032584; GO:0038085; GO:0043679; GO:0044295; GO:0046872; GO:0048010; GO:0048729; GO:0051491; GO:0070852; GO:0098743,axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell aggregation [GO:0098743]; neural crest cell migration [GO:0001755]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to wounding [GO:0009611]; rhombomere cell migration [GO:0022035]; sprouting angiogenesis [GO:0002040]; tissue morphogenesis [GO:0048729]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570],axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell body fiber [GO:0070852]; focal adhesion [GO:0005925]; growth cone membrane [GO:0032584]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886],heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0030154; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; cell differentiation; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10049,1.0324154303361248,FUN_043323-T1,Peve_00007512,Pocillopora_meandrina_HIv1___RNAseq.g8950.t1,three_way,56.72266666666666,,,,,,,,,,,,,,,,,
OG_10051,1.1269654600907208,FUN_043325-T1,Peve_00043035,Pocillopora_meandrina_HIv1___RNAseq.g8952.t1,three_way,72.11733333333333,FUN_043325-T1,Q2HWF0,FBP1L_RAT,,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),Rattus norvegicus (Rat),31.6,604.0,1.9000000000000002e-74,281.6,sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320,autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GTPase binding [GO:0051020]; lipid binding [GO:0008289],GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0008289; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0061024,cytosol; cytoskeleton; plasma membrane; autophagy; lipid binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; membrane organization
OG_10055,1.1078777178972865,FUN_043349-T1,Peve_00043040,Pocillopora_meandrina_HIv1___TS.g20680.t2,three_way,60.5675,FUN_043349-T1,P20909,,,,,33.1,236.0,3.2e-34,149.4,sp|P20909|COBA1_RAT Collagen alpha-1(XI) chain OS=Rattus norvegicus OX=10116 GN=Col11a1 PE=1 SV=2,,,,,,
OG_10068,1.1422581770701852,FUN_043373-T1,Peve_00004901,Pocillopora_meandrina_HIv1___RNAseq.g8977.t1,three_way,57.378,FUN_043373-T1,Q76EC5,,,,,29.8,275.0,1.6000000000000002e-33,144.8,sp|Q76EC5|CHST9_MOUSE Carbohydrate sulfotransferase 9 OS=Mus musculus OX=10090 GN=Chst9 PE=2 SV=1,,,,,,
OG_10080,1.0788546518447069,FUN_043390-T1,Peve_00024249,Pocillopora_meandrina_HIv1___RNAseq.g9001.t1,three_way,67.44416666666666,FUN_043390-T1,A7SBN6,,,,,51.0,480.0,1.3e-114,414.8,sp|A7SBN6|ZGPAT_NEMVE Zinc finger CCCH-type with G patch domain-containing protein OS=Nematostella vectensis OX=45351 GN=v1g244155 PE=3 SV=1,,,,,,
OG_10084,1.046091002387236,FUN_043401-T1,Peve_00024054,Pocillopora_meandrina_HIv1___RNAseq.g9066.t1,three_way,43.906,,,,,,,,,,,,,,,,,
OG_10093,1.0739797558883502,FUN_043424-T1,Peve_00022202,Pocillopora_meandrina_HIv1___RNAseq.g7845.t1,three_way,57.81816666666666,,,,,,,,,,,,,,,,,
OG_10100,1.2558526687724856,FUN_043438-T1,Peve_00028841,Pocillopora_meandrina_HIv1___RNAseq.g7850.t1,three_way,48.59733333333333,FUN_043438-T1,F6RRD7,,,,,49.2,181.0,8.9e-38,159.8,sp|F6RRD7|RPAP2_BOVIN Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 OS=Bos taurus OX=9913 GN=RPAP2 PE=2 SV=1,,,,,,
OG_10104,2.1872541574217967,FUN_043446-T1,Peve_00028845,Pocillopora_meandrina_HIv1___TS.g1655.t1,three_way,49.04,FUN_043446-T1,O60241,AGRB2_HUMAN,,Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2),Homo sapiens (Human),30.9,175.0,8.7e-11,70.5,sp|O60241|AGRB2_HUMAN Adhesion G protein-coupled receptor B2 OS=Homo sapiens OX=9606 GN=ADGRB2 PE=1 SV=2,GO:0004930; GO:0005576; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016020; GO:0016525; GO:0033173; GO:0051965; GO:0098978,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]; positive regulation of synapse assembly [GO:0051965],extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005576; GO:0005886; GO:0048856; GO:0060089,extracellular region; plasma membrane; anatomical structure development; molecular transducer activity
OG_10108,1.037190426015495,FUN_043456-T1,Peve_00031070,Pocillopora_meandrina_HIv1___RNAseq.g7904.t1,three_way,80.63666666666667,FUN_043456-T1,Q9JM13,RABX5_MOUSE,,Rab5 GDP/GTP exchange factor (Rabex-5),Mus musculus (Mouse),40.0,468.0,2.6e-94,347.4,sp|Q9JM13|RABX5_MOUSE Rab5 GDP/GTP exchange factor OS=Mus musculus OX=10090 GN=Rabgef1 PE=1 SV=1,GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0015031; GO:0030425; GO:0031267; GO:0031982; GO:0032715; GO:0032764; GO:0033004; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0051649; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:0098830; GO:0098935; GO:1900235,dendritic transport [GO:0098935]; establishment of localization in cell [GO:0051649]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; nucleolus [GO:0005730]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037]; vesicle [GO:0031982],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005730; GO:0005768; GO:0005829; GO:0007018; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0048870; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleolus; endosome; cytosol; microtubule-based movement; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10139,1.806913106738387,FUN_043526-T1,Peve_00011962,Pocillopora_meandrina_HIv1___RNAseq.g8034.t1,three_way,58.651,FUN_043526-T1,Q9NY43,,,,,44.1,118.0,1.7e-15,84.3,sp|Q9NY43|BARH2_HUMAN BarH-like 2 homeobox protein OS=Homo sapiens OX=9606 GN=BARHL2 PE=1 SV=2,,,,,,
OG_10157,1.2775126202638036,FUN_043552-T1,Peve_00009534,Pocillopora_meandrina_HIv1___RNAseq.g8003.t1,three_way,72.05633333333333,,,,,,,,,,,,,,,,,
OG_10164,1.4824895466099044,FUN_043563-T1,Peve_00008973,Pocillopora_meandrina_HIv1___RNAseq.g8051.t1,three_way,64.55266666666667,FUN_043563-T1,P53812,PIPNB_RAT,,Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta),Rattus norvegicus (Rat),55.7,264.0,4.7e-75,283.1,sp|P53812|PIPNB_RAT Phosphatidylinositol transfer protein beta isoform OS=Rattus norvegicus OX=10116 GN=Pitpnb PE=1 SV=2,GO:0000139; GO:0001701; GO:0005737; GO:0005789; GO:0005794; GO:0006890; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0120019; GO:0140338,"in utero embryonic development [GO:0001701]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; sphingomyelin transfer activity [GO:0140338],GO:0005215; GO:0005794; GO:0008289; GO:0016192; GO:0043226; GO:0048856,transporter activity; Golgi apparatus; lipid binding; vesicle-mediated transport; organelle; anatomical structure development
OG_10175,1.4470705840310196,FUN_043584-T1,Peve_00045195,Pocillopora_meandrina_HIv1___RNAseq.g6988.t1,three_way,66.09083333333334,FUN_043584-T1,P21180,CO2_MOUSE,,Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)],Mus musculus (Mouse),25.1,491.0,5.4e-29,131.0,sp|P21180|CO2_MOUSE Complement C2 OS=Mus musculus OX=10090 GN=C2 PE=1 SV=2,GO:0004252; GO:0005615; GO:0006508; GO:0006958; GO:0007584; GO:0032496; GO:0045087; GO:0046872; GO:0097066; GO:2000427,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; proteolysis [GO:0006508]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to thyroid hormone [GO:0097066]",extracellular space [GO:0005615],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003824; GO:0005615; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_10176,1.4631496662324424,FUN_043585-T1,Peve_00045227,Pocillopora_meandrina_HIv1___RNAseq.g6986.t1,three_way,56.91216666666666,FUN_043585-T1,Q9BYX4,IFIH1_HUMAN,,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),Homo sapiens (Human),27.6,1184.0,1.0000000000000001e-88,330.1,sp|Q9BYX4|IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,GO:0002753; GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0065003; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; hydrolase activity; isomerase activity; organelle; molecular transducer activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10184,2.0316092793118528,FUN_043599-T1,Peve_00007612,Pocillopora_meandrina_HIv1___RNAseq.g6951.t1,three_way,61.132,FUN_043599-T1,Q68CP4,HGNAT_HUMAN,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Homo sapiens (Human),42.6,591.0,3.1e-113,410.6,sp|Q68CP4|HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens OX=9606 GN=HGSNAT PE=1 SV=2,GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0005886; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; plasma membrane; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10186,1.0375202003863635,FUN_043601-T1,Peve_00040384,Pocillopora_meandrina_HIv1___RNAseq.g6949.t1,three_way,45.54,FUN_043601-T1,Q4LDE5,SVEP1_HUMAN,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",Homo sapiens (Human),28.0,1276.0,2.1e-133,478.8,"sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3",GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193,epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0034330; GO:0043226; GO:0048856; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell junction organization; organelle; anatomical structure development; cell adhesion mediator activity
OG_10201,1.4257893421740233,FUN_043629-T1,Peve_00008240,Pocillopora_meandrina_HIv1___RNAseq.g6901.t1,three_way,72.333,FUN_043629-T1,B2GUY0,MA1B1_RAT,,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1)",Rattus norvegicus (Rat),48.4,674.0,2.1e-163,577.4,"sp|B2GUY0|MA1B1_RAT Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Rattus norvegicus OX=10116 GN=Man1b1 PE=2 SV=2",GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0031410; GO:0036503; GO:0044322,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0031410; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle
OG_10207,1.0156156906977218,FUN_043642-T1,Peve_00041942,Pocillopora_meandrina_HIv1___RNAseq.g7410.t1,three_way,83.61566666666667,,,,,,,,,,,,,,,,,
OG_10208,1.304339274824306,FUN_043643-T1,Peve_00004207,Pocillopora_meandrina_HIv1___RNAseq.g7409.t1,three_way,56.01,,,,,,,,,,,,,,,,,
OG_10220,1.0049023089994915,FUN_043795-T1,Peve_00030767,Pocillopora_meandrina_HIv1___RNAseq.g14508.t1,three_way,61.468,,,,,,,,,,,,,,,,,
